2021	9	23	Nervous system disorders	Tremor	1	1	0
2021	9	23	Nervous system disorders	Syncope	1	1	0
2021	9	23	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	9	23	Nervous system disorders	Dizziness	1	1	0
2021	9	24	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	9	24	Nervous system disorders	Syncope	1	1	0
2021	9	24	Investigations	Body temperature increased	1	1	0
2021	9	24	Nervous system disorders	Dizziness	1	1	0
2021	9	24	Investigations	Blood pressure decreased	1	1	0
2021	9	24	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	9	24	General disorders and administration site conditions	Chills	1	1	0
2021	9	25	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	9	25	General disorders and administration site conditions	Fatigue	1	1	0
2021	9	25	General disorders and administration site conditions	Pyrexia	1	1	0
2021	9	27	Nervous system disorders	Syncope	2	2	0
2021	9	27	Nervous system disorders	Headache	2	2	0
2021	9	27	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	9	27	General disorders and administration site conditions	Swelling face	1	1	0
2021	9	27	Nervous system disorders	Dizziness	1	1	0
2021	9	27	Nervous system disorders	Presyncope	1	1	0
2021	9	27	Vascular disorders	Pallor	1	1	0
2021	9	27	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	9	27	General disorders and administration site conditions	Chest pain	1	1	0
2021	9	27	Musculoskeletal and connective tissue disorders	Muscle rigidity	1	1	0
2021	9	27	Ear and labyrinth disorders	Ear discomfort	1	1	0
2021	9	27	Gastrointestinal disorders	Nausea	1	1	0
2021	9	27	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	9	27	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	9	27	Skin and subcutaneous tissue disorders	Hypohidrosis	1	1	0
2021	9	28	General disorders and administration site conditions	Chills	2	2	0
2021	9	28	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	9	28	Gastrointestinal disorders	Nausea	1	1	0
2021	9	28	Gastrointestinal disorders	Vomiting	1	1	0
2021	9	28	General disorders and administration site conditions	Injection site pain	1	1	0
2021	9	28	General disorders and administration site conditions	Chest pain	1	1	0
2021	9	28	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	9	28	Infections and infestations	Urinary tract infection	1	1	0
2021	9	28	Ear and labyrinth disorders	Vertigo	1	1	0
2021	9	28	General disorders and administration site conditions	Feeling hot	1	1	0
2021	9	28	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2021	9	28	Nervous system disorders	Dizziness	1	1	0
2021	9	28	Eye disorders	Visual impairment	1	1	0
2021	9	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	9	28	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	9	28	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	9	29	Nervous system disorders	Dizziness	3	3	0
2021	9	29	General disorders and administration site conditions	Chest pain	3	3	0
2021	9	29	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2021	9	29	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	9	29	Nervous system disorders	Headache	2	2	0
2021	9	29	Nervous system disorders	Tremor	2	2	0
2021	9	29	Vascular disorders	Pallor	2	2	0
2021	9	29	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	9	29	Nervous system disorders	Presyncope	2	2	0
2021	9	29	Gastrointestinal disorders	Nausea	2	2	0
2021	9	29	Gastrointestinal disorders	Vomiting	1	1	0
2021	9	29	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	9	29	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	9	29	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	9	29	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	9	29	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	9	29	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	9	29	Vascular disorders	Hot flush	1	1	0
2021	9	29	General disorders and administration site conditions	Asthenia	1	1	0
2021	9	29	Investigations	Blood pressure increased	1	1	0
2021	9	29	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	9	29	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	9	29	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	9	29	Psychiatric disorders	Panic attack	1	1	0
2021	9	29	Cardiac disorders	Pericarditis	1	1	0
2021	9	29	Eye disorders	Photopsia	1	1	0
2021	9	29	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	9	29	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	9	29	General disorders and administration site conditions	Fatigue	1	1	0
2021	9	29	Nervous system disorders	Paraesthesia	1	1	0
2021	9	29	Nervous system disorders	Syncope	1	1	0
2021	9	29	Investigations	Heart rate increased	1	1	0
2021	9	29	General disorders and administration site conditions	Axillary pain	1	1	0
2021	9	29	General disorders and administration site conditions	Malaise	1	1	0
2021	9	29	General disorders and administration site conditions	Thirst	1	1	0
2021	9	29	General disorders and administration site conditions	Pyrexia	1	1	0
2021	9	29	Nervous system disorders	Balance disorder	1	1	0
2021	9	30	Nervous system disorders	Headache	3	3	0
2021	9	30	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	9	30	General disorders and administration site conditions	Pyrexia	2	2	0
2021	9	30	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	9	30	Nervous system disorders	Dizziness	2	2	0
2021	9	30	Nervous system disorders	Presyncope	2	2	0
2021	9	30	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	9	30	Gastrointestinal disorders	Nausea	1	1	0
2021	9	30	Gastrointestinal disorders	Vomiting	1	1	0
2021	9	30	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	9	30	Nervous system disorders	Paraesthesia	1	1	0
2021	9	30	Nervous system disorders	Syncope	1	1	0
2021	9	30	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	9	30	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	9	30	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	9	30	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	9	30	Vascular disorders	Pallor	1	1	0
2021	9	30	Immune system disorders	Anaphylactic reaction	1	1	0
2021	9	30	Investigations	Blood pressure decreased	1	1	0
2021	9	30	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	9	30	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2021	10	1	General disorders and administration site conditions	Chest pain	3	3	0
2021	10	1	Cardiac disorders	Pericarditis	2	2	0
2021	10	1	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	10	1	Nervous system disorders	Headache	2	2	0
2021	10	1	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2021	10	1	Nervous system disorders	Neuralgia	2	2	0
2021	10	1	Nervous system disorders	Paraesthesia	2	2	0
2021	10	1	Gastrointestinal disorders	Nausea	2	2	0
2021	10	1	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	10	1	Infections and infestations	Oral herpes	1	1	0
2021	10	1	Investigations	Fibrin D dimer increased	1	1	0
2021	10	1	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	1	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	1	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	10	1	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	1	Nervous system disorders	Loss of consciousness	1	1	0
2021	10	1	Gastrointestinal disorders	Mouth ulceration	1	1	0
2021	10	1	Nervous system disorders	Hypoaesthesia	1	1	0
2021	10	1	General disorders and administration site conditions	Discomfort	1	1	0
2021	10	1	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	10	1	Ear and labyrinth disorders	Vertigo	1	1	0
2021	10	1	General disorders and administration site conditions	Swelling	1	1	0
2021	10	1	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	1	General disorders and administration site conditions	Fatigue	1	1	0
2021	10	1	Nervous system disorders	Dysgeusia	1	1	0
2021	10	1	Skin and subcutaneous tissue disorders	Skin burning sensation	1	1	0
2021	10	1	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	10	1	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	1	Nervous system disorders	Tremor	1	1	0
2021	10	1	Eye disorders	Vision blurred	1	1	0
2021	10	1	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	1	Nervous system disorders	Seizure	1	1	0
2021	10	1	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	10	1	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	10	1	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	1	Ear and labyrinth disorders	Ear pain	1	1	0
2021	10	1	Investigations	Heart rate increased	1	1	0
2021	10	1	Nervous system disorders	Dizziness	1	1	0
2021	10	1	Vascular disorders	Pallor	1	1	0
2021	10	1	Ear and labyrinth disorders	Hypoacusis	1	1	0
2021	10	1	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	1	General disorders and administration site conditions	Gait inability	1	1	0
2021	10	1	Injury, poisoning and procedural complications	Underdose	1	1	0
2021	10	2	Gastrointestinal disorders	Nausea	3	3	0
2021	10	2	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	10	2	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	10	2	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	10	2	Infections and infestations	Cellulitis	1	1	0
2021	10	2	Nervous system disorders	Dizziness	1	1	0
2021	10	2	Cardiac disorders	Palpitations	1	1	0
2021	10	2	Nervous system disorders	Headache	1	1	0
2021	10	2	Nervous system disorders	Lethargy	1	1	0
2021	10	2	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	2	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	2	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	10	2	General disorders and administration site conditions	Fatigue	1	1	0
2021	10	3	General disorders and administration site conditions	Injection site reaction	3	3	0
2021	10	3	Gastrointestinal disorders	Nausea	2	2	0
2021	10	3	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	3	Cardiac disorders	Arrhythmia	1	1	0
2021	10	3	General disorders and administration site conditions	Chest pain	1	1	0
2021	10	3	Cardiac disorders	Pericarditis	1	1	0
2021	10	3	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	10	3	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	4	General disorders and administration site conditions	Chest pain	7	7	0
2021	10	4	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2021	10	4	Nervous system disorders	Headache	4	4	0
2021	10	4	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	10	4	Nervous system disorders	Dizziness	3	3	0
2021	10	4	Cardiac disorders	Tachycardia	3	3	0
2021	10	4	Cardiac disorders	Pericarditis	3	3	0
2021	10	4	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	10	4	Cardiac disorders	Palpitations	2	2	0
2021	10	4	Nervous system disorders	Syncope	2	2	0
2021	10	4	Investigations	Heart rate abnormal	1	1	0
2021	10	4	Investigations	Heart rate irregular	1	1	0
2021	10	4	Skin and subcutaneous tissue disorders	Petechiae	1	1	0
2021	10	4	Vascular disorders	Hot flush	1	1	0
2021	10	4	General disorders and administration site conditions	Injection site pain	1	1	0
2021	10	4	Investigations	Fibrin D dimer increased	1	1	0
2021	10	4	Gastrointestinal disorders	Nausea	1	1	0
2021	10	4	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	4	Investigations	Troponin increased	1	1	0
2021	10	4	Cardiac disorders	Myocarditis	1	1	0
2021	10	4	General disorders and administration site conditions	Fatigue	1	1	0
2021	10	4	Psychiatric disorders	Insomnia	1	1	0
2021	10	4	Gastrointestinal disorders	Faeces discoloured	1	1	0
2021	10	4	General disorders and administration site conditions	Feeling hot	1	1	0
2021	10	4	Eye disorders	Eye swelling	1	1	0
2021	10	4	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	10	4	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	4	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	10	4	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	10	4	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	10	4	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	10	4	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	10	4	Renal and urinary disorders	Urinary incontinence	1	1	0
2021	10	4	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	4	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	4	General disorders and administration site conditions	Chills	1	1	0
2021	10	4	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	10	4	Cardiac disorders	Angina pectoris	1	1	0
2021	10	4	Vascular disorders	Hypertension	1	1	0
2021	10	4	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	5	Nervous system disorders	Dizziness	7	7	0
2021	10	5	General disorders and administration site conditions	Injection site reaction	5	5	0
2021	10	5	General disorders and administration site conditions	Fatigue	4	4	0
2021	10	5	Gastrointestinal disorders	Nausea	3	3	0
2021	10	5	Nervous system disorders	Headache	3	3	0
2021	10	5	General disorders and administration site conditions	Chest pain	3	3	0
2021	10	5	Cardiac disorders	Palpitations	2	2	0
2021	10	5	Nervous system disorders	Disturbance in attention	2	2	0
2021	10	5	Nervous system disorders	Paraesthesia	2	2	0
2021	10	5	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	10	5	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	5	Investigations	Blood pressure increased	1	1	0
2021	10	5	Psychiatric disorders	Sleep inertia	1	1	0
2021	10	5	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	10	5	Cardiac disorders	Ventricular tachycardia	1	1	0
2021	10	5	Eye disorders	Eye pain	1	1	0
2021	10	5	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	10	5	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	5	General disorders and administration site conditions	Feeling hot	1	1	0
2021	10	5	Skin and subcutaneous tissue disorders	Blister	1	1	0
2021	10	5	Vascular disorders	Peripheral coldness	1	1	0
2021	10	5	Gastrointestinal disorders	Melaena	1	1	0
2021	10	5	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2021	10	5	Nervous system disorders	Syncope	1	1	0
2021	10	5	Nervous system disorders	Hypoaesthesia	1	1	0
2021	10	5	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	5	Vascular disorders	Cyanosis	1	1	0
2021	10	5	Investigations	Electrocardiogram	1	1	0
2021	10	5	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	5	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	5	Cardiac disorders	Cyanosis	1	1	0
2021	10	5	Eye disorders	Eye pruritus	1	1	0
2021	10	5	Gastrointestinal disorders	Hypoaesthesia oral	1	1	0
2021	10	5	General disorders and administration site conditions	Chills	1	1	0
2021	10	5	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2021	10	5	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	10	5	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	10	5	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	10	5	Ear and labyrinth disorders	Ear pain	1	1	0
2021	10	5	Nervous system disorders	Presyncope	1	1	0
2021	10	5	Skin and subcutaneous tissue disorders	Skin discolouration	1	1	0
2021	10	5	Vascular disorders	Pallor	1	1	0
2021	10	5	General disorders and administration site conditions	Injection site joint pain	1	1	0
2021	10	5	General disorders and administration site conditions	Thirst	1	1	0
2021	10	5	Psychiatric disorders	Abnormal dreams	1	1	0
2021	10	6	General disorders and administration site conditions	Injection site reaction	4	4	0
2021	10	6	Nervous system disorders	Dizziness	3	3	0
2021	10	6	Nervous system disorders	Headache	3	3	0
2021	10	6	Cardiac disorders	Pericarditis	2	2	0
2021	10	6	General disorders and administration site conditions	Chest pain	2	2	0
2021	10	6	General disorders and administration site conditions	Injection site pain	2	2	0
2021	10	6	Nervous system disorders	Lethargy	2	2	0
2021	10	6	Nervous system disorders	Paraesthesia	2	2	0
2021	10	6	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	10	6	Nervous system disorders	Presyncope	2	2	0
2021	10	6	Nervous system disorders	Syncope	2	2	0
2021	10	6	Respiratory, thoracic and mediastinal disorders	Epistaxis	2	2	0
2021	10	6	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	6	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	6	Respiratory, thoracic and mediastinal disorders	Dry throat	1	1	0
2021	10	6	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	6	General disorders and administration site conditions	Inflammation	1	1	0
2021	10	6	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	6	Nervous system disorders	Hypoaesthesia	1	1	0
2021	10	6	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	6	General disorders and administration site conditions	Fatigue	1	1	0
2021	10	6	Psychiatric disorders	Insomnia	1	1	0
2021	10	6	Ear and labyrinth disorders	Vertigo	1	1	0
2021	10	6	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	6	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	10	6	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2021	10	6	Gastrointestinal disorders	Toothache	1	1	0
2021	10	6	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	10	6	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	6	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	10	6	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	6	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	10	6	General disorders and administration site conditions	Asthenia	1	1	0
2021	10	6	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	10	6	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	10	6	General disorders and administration site conditions	Swelling face	1	1	0
2021	10	6	Eye disorders	Vision blurred	1	1	0
2021	10	6	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	6	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2021	10	6	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	10	6	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2021	10	7	Nervous system disorders	Headache	7	7	0
2021	10	7	General disorders and administration site conditions	Pyrexia	5	4	0
2021	10	7	Cardiac disorders	Palpitations	5	5	0
2021	10	7	General disorders and administration site conditions	Injection site reaction	5	4	0
2021	10	7	General disorders and administration site conditions	Fatigue	4	4	0
2021	10	7	Musculoskeletal and connective tissue disorders	Myalgia	4	3	0
2021	10	7	General disorders and administration site conditions	Chest pain	4	4	0
2021	10	7	Nervous system disorders	Dizziness	4	4	0
2021	10	7	Gastrointestinal disorders	Vomiting	4	4	0
2021	10	7	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	10	7	General disorders and administration site conditions	Chills	3	3	0
2021	10	7	Nervous system disorders	Syncope	3	3	0
2021	10	7	Eye disorders	Vision blurred	3	3	0
2021	10	7	Gastrointestinal disorders	Nausea	3	3	0
2021	10	7	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	10	7	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	10	7	Gastrointestinal disorders	Abdominal pain upper	2	2	0
2021	10	7	General disorders and administration site conditions	Temperature regulation disorder	1	1	0
2021	10	7	Nervous system disorders	Cognitive disorder	1	1	0
2021	10	7	Vascular disorders	Hypertension	1	1	0
2021	10	7	Vascular disorders	Pallor	1	1	0
2021	10	7	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	7	General disorders and administration site conditions	Malaise	1	1	0
2021	10	7	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2021	10	7	Cardiac disorders	Postural orthostatic tachycardia syndrome	1	1	0
2021	10	7	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2021	10	7	Nervous system disorders	Head discomfort	1	0	0
2021	10	7	Nervous system disorders	Seizure	1	1	0
2021	10	7	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	7	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	10	7	Gastrointestinal disorders	Swollen tongue	1	1	0
2021	10	7	General disorders and administration site conditions	Injection site urticaria	1	1	0
2021	10	7	Nervous system disorders	Paraesthesia	1	1	0
2021	10	7	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	10	7	General disorders and administration site conditions	Feeling hot	1	1	0
2021	10	7	Infections and infestations	Otitis media	1	1	0
2021	10	7	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	7	Eye disorders	Eye swelling	1	1	0
2021	10	7	Nervous system disorders	Tremor	1	1	0
2021	10	7	Skin and subcutaneous tissue disorders	Stevens-Johnson syndrome	1	0	0
2021	10	7	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	10	7	General disorders and administration site conditions	Crying	1	1	0
2021	10	7	General disorders and administration site conditions	Pain	1	1	0
2021	10	7	Nervous system disorders	Burning sensation	1	1	0
2021	10	7	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	10	7	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	7	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	10	7	General disorders and administration site conditions	Facial pain	1	1	0
2021	10	7	Ear and labyrinth disorders	Tinnitus	1	0	0
2021	10	7	Gastrointestinal disorders	Abdominal distension	1	1	0
2021	10	7	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	10	7	Skin and subcutaneous tissue disorders	Pruritus	1	0	0
2021	10	8	General disorders and administration site conditions	Injection site reaction	16	16	0
2021	10	8	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2021	10	8	Nervous system disorders	Headache	5	5	0
2021	10	8	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	10	8	Gastrointestinal disorders	Nausea	4	4	0
2021	10	8	General disorders and administration site conditions	Fatigue	4	4	0
2021	10	8	Reproductive system and breast disorders	Dysmenorrhoea	4	4	0
2021	10	8	Reproductive system and breast disorders	Menstrual disorder	4	4	0
2021	10	8	General disorders and administration site conditions	Chest pain	4	4	0
2021	10	8	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	10	8	General disorders and administration site conditions	Pyrexia	3	3	0
2021	10	8	Nervous system disorders	Dizziness	3	3	0
2021	10	8	Cardiac disorders	Pericarditis	3	3	0
2021	10	8	Vascular disorders	Hypertension	2	2	0
2021	10	8	General disorders and administration site conditions	Injection site rash	2	2	0
2021	10	8	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2021	10	8	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	10	8	Reproductive system and breast disorders	Menstruation irregular	2	2	0
2021	10	8	Nervous system disorders	Paraesthesia	2	2	0
2021	10	8	Cardiac disorders	Palpitations	2	2	0
2021	10	8	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	10	8	Cardiac disorders	Atrioventricular block first degree	1	1	0
2021	10	8	General disorders and administration site conditions	Injection site pain	1	1	0
2021	10	8	Investigations	Fibrin D dimer increased	1	1	0
2021	10	8	Nervous system disorders	Lethargy	1	1	0
2021	10	8	Psychiatric disorders	Confusional state	1	1	0
2021	10	8	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	8	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	8	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	8	Product issues	Device connection issue	1	1	0
2021	10	8	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	8	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2021	10	8	Investigations	Electrocardiogram abnormal	1	1	0
2021	10	8	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	10	8	Gastrointestinal disorders	Odynophagia	1	1	0
2021	10	8	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	8	General disorders and administration site conditions	Feeling hot	1	1	0
2021	10	8	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2021	10	8	Reproductive system and breast disorders	Pelvic pain	1	1	0
2021	10	8	Nervous system disorders	Syncope	1	1	0
2021	10	8	Psychiatric disorders	Irritability	1	1	0
2021	10	8	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	8	Respiratory, thoracic and mediastinal disorders	Pulmonary pain	1	1	0
2021	10	8	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	10	8	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	8	Nervous system disorders	Tremor	1	1	0
2021	10	8	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	10	8	Vascular disorders	Thrombosis	1	1	0
2021	10	8	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	10	8	General disorders and administration site conditions	Pain	1	1	0
2021	10	8	Investigations	Blood pressure increased	1	1	0
2021	10	8	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	10	8	General disorders and administration site conditions	Axillary pain	1	1	0
2021	10	8	Injury, poisoning and procedural complications	Underdose	1	1	0
2021	10	8	Cardiac disorders	Angina pectoris	1	1	0
2021	10	8	Investigations	Heart rate increased	1	1	0
2021	10	8	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	10	8	Vascular disorders	Pallor	1	1	0
2021	10	8	Eye disorders	Vision blurred	1	1	0
2021	10	8	Gastrointestinal disorders	Haematochezia	1	1	0
2021	10	8	Nervous system disorders	Aphasia	1	1	0
2021	10	8	Nervous system disorders	Seizure	1	1	0
2021	10	8	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	8	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	10	8	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	10	8	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	8	Eye disorders	Lid sulcus deepened	1	1	0
2021	10	8	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	10	8	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2021	10	8	Nervous system disorders	Neuralgia	1	1	0
2021	10	9	General disorders and administration site conditions	Injection site reaction	7	6	0
2021	10	9	Nervous system disorders	Headache	5	4	0
2021	10	9	General disorders and administration site conditions	Fatigue	4	4	0
2021	10	9	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	10	9	Gastrointestinal disorders	Nausea	2	2	0
2021	10	9	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	10	9	Nervous system disorders	Tremor	2	2	0
2021	10	9	General disorders and administration site conditions	Influenza like illness	1	0	0
2021	10	9	Nervous system disorders	Dizziness	1	1	0
2021	10	9	Vascular disorders	Hypertension	1	1	0
2021	10	9	General disorders and administration site conditions	Malaise	1	1	0
2021	10	9	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	9	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	10	9	Cardiac disorders	Palpitations	1	1	0
2021	10	9	General disorders and administration site conditions	Injection site pain	1	1	0
2021	10	9	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	9	Reproductive system and breast disorders	Testicular pain	1	1	0
2021	10	9	Eye disorders	Eyelid irritation	1	1	0
2021	10	9	Nervous system disorders	Somnolence	1	1	0
2021	10	9	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	9	General disorders and administration site conditions	Pain	1	1	0
2021	10	9	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	10	9	Vascular disorders	Flushing	1	1	0
2021	10	9	Gastrointestinal disorders	Aphthous ulcer	1	0	0
2021	10	9	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	10	9	Respiratory, thoracic and mediastinal disorders	Hyperventilation	1	1	0
2021	10	9	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	10	9	Nervous system disorders	Paraesthesia	1	1	0
2021	10	10	Nervous system disorders	Headache	6	5	0
2021	10	10	General disorders and administration site conditions	Injection site reaction	6	5	0
2021	10	10	General disorders and administration site conditions	Chest pain	3	3	0
2021	10	10	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	10	Gastrointestinal disorders	Nausea	3	3	0
2021	10	10	Cardiac disorders	Palpitations	2	2	0
2021	10	10	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	10	10	General disorders and administration site conditions	Swelling	2	2	0
2021	10	10	Nervous system disorders	Dizziness	2	2	0
2021	10	10	Injury, poisoning and procedural complications	Vaccination error	2	0	0
2021	10	10	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2021	10	10	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	10	10	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	10	10	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	10	Respiratory, thoracic and mediastinal disorders	Painful respiration	1	1	0
2021	10	10	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	10	Respiratory, thoracic and mediastinal disorders	Hypopnoea	1	1	0
2021	10	10	Eye disorders	Photophobia	1	1	0
2021	10	10	Ear and labyrinth disorders	Vertigo	1	1	0
2021	10	10	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	10	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	10	10	Nervous system disorders	Migraine	1	1	0
2021	10	10	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	10	Psychiatric disorders	Nervousness	1	1	0
2021	10	10	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	10	10	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	10	10	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	10	10	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	10	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2021	10	10	Vascular disorders	Hot flush	1	1	0
2021	10	10	Investigations	Fibrin D dimer increased	1	1	0
2021	10	10	Nervous system disorders	Lethargy	1	1	0
2021	10	10	Ear and labyrinth disorders	Hyperacusis	1	1	0
2021	10	10	Gastrointestinal disorders	Abdominal distension	1	1	0
2021	10	10	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	10	Infections and infestations	Cystitis	1	1	0
2021	10	11	General disorders and administration site conditions	Injection site reaction	8	8	0
2021	10	11	Cardiac disorders	Pericarditis	4	4	0
2021	10	11	General disorders and administration site conditions	Pyrexia	3	3	0
2021	10	11	Nervous system disorders	Dizziness	3	3	0
2021	10	11	General disorders and administration site conditions	Chest pain	3	3	0
2021	10	11	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2021	10	11	Nervous system disorders	Headache	2	2	0
2021	10	11	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	10	11	General disorders and administration site conditions	Injection site pain	2	2	0
2021	10	11	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2021	10	11	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	10	11	Cardiac disorders	Tachycardia	1	1	0
2021	10	11	General disorders and administration site conditions	Pain	1	1	0
2021	10	11	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	10	11	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	11	Nervous system disorders	Tremor	1	1	0
2021	10	11	General disorders and administration site conditions	Swelling	1	1	0
2021	10	11	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	10	11	General disorders and administration site conditions	Fatigue	1	1	0
2021	10	11	Nervous system disorders	Paraesthesia	1	1	0
2021	10	11	Nervous system disorders	Syncope	1	1	0
2021	10	11	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	11	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	11	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	10	11	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	10	11	Cardiac disorders	Bradycardia	1	1	0
2021	10	11	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	11	Investigations	Heart rate irregular	1	1	0
2021	10	11	Nervous system disorders	Hypoaesthesia	1	1	0
2021	10	11	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	10	11	Cardiac disorders	Palpitations	1	1	0
2021	10	11	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	11	Nervous system disorders	Lethargy	1	1	0
2021	10	11	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	11	Musculoskeletal and connective tissue disorders	Axillary mass	1	1	0
2021	10	11	Eye disorders	Vision blurred	1	1	0
2021	10	11	Gastrointestinal disorders	Lip swelling	1	1	0
2021	10	11	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	10	11	Skin and subcutaneous tissue disorders	Skin exfoliation	1	1	0
2021	10	11	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	10	11	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	10	12	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2021	10	12	General disorders and administration site conditions	Injection site reaction	7	7	0
2021	10	12	General disorders and administration site conditions	Chest pain	5	5	0
2021	10	12	Nervous system disorders	Dizziness	5	5	0
2021	10	12	General disorders and administration site conditions	Chest discomfort	4	4	0
2021	10	12	Nervous system disorders	Hypoaesthesia	4	4	0
2021	10	12	Gastrointestinal disorders	Nausea	4	4	0
2021	10	12	General disorders and administration site conditions	Fatigue	4	4	0
2021	10	12	Nervous system disorders	Paraesthesia	4	4	0
2021	10	12	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2021	10	12	General disorders and administration site conditions	Injection site pain	4	4	0
2021	10	12	Cardiac disorders	Palpitations	3	3	0
2021	10	12	Skin and subcutaneous tissue disorders	Urticaria	3	3	0
2021	10	12	Nervous system disorders	Lethargy	2	2	0
2021	10	12	Nervous system disorders	Neuralgia	2	2	0
2021	10	12	Psychiatric disorders	Insomnia	2	2	0
2021	10	12	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	10	12	Cardiac disorders	Pericarditis	2	2	0
2021	10	12	Nervous system disorders	Headache	2	2	0
2021	10	12	Nervous system disorders	Disturbance in attention	1	1	0
2021	10	12	Nervous system disorders	Seizure	1	1	0
2021	10	12	Respiratory, thoracic and mediastinal disorders	Productive cough	1	1	0
2021	10	12	General disorders and administration site conditions	Chills	1	1	0
2021	10	12	Infections and infestations	Upper respiratory tract infection	1	1	0
2021	10	12	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	10	12	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	10	12	Nervous system disorders	Mental impairment	1	1	0
2021	10	12	Nervous system disorders	Presyncope	1	1	0
2021	10	12	Vascular disorders	Pallor	1	1	0
2021	10	12	Ear and labyrinth disorders	Hypoacusis	1	1	0
2021	10	12	General disorders and administration site conditions	Axillary pain	1	1	0
2021	10	12	General disorders and administration site conditions	Injection site pruritus	1	1	0
2021	10	12	General disorders and administration site conditions	Malaise	1	1	0
2021	10	12	Respiratory, thoracic and mediastinal disorders	Sputum discoloured	1	1	0
2021	10	12	Eye disorders	Eye pain	1	1	0
2021	10	12	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	10	12	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	12	General disorders and administration site conditions	Injection site warmth	1	1	0
2021	10	12	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	10	12	Nervous system disorders	Haemorrhagic stroke	1	1	0
2021	10	12	Nervous system disorders	Tremor	1	1	0
2021	10	12	Cardiac disorders	Tachycardia	1	1	0
2021	10	12	Eye disorders	Diplopia	1	1	0
2021	10	12	General disorders and administration site conditions	Asthenia	1	1	0
2021	10	12	General disorders and administration site conditions	Vaccination site movement impairment	1	1	0
2021	10	12	Nervous system disorders	Burning sensation	1	1	0
2021	10	12	Nervous system disorders	Taste disorder	1	1	0
2021	10	12	Cardiac disorders	Pericardial effusion	1	1	0
2021	10	12	General disorders and administration site conditions	Feeling hot	1	1	0
2021	10	12	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2021	10	12	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	12	Nervous system disorders	Migraine	1	1	0
2021	10	12	General disorders and administration site conditions	Injection site urticaria	1	1	0
2021	10	12	General disorders and administration site conditions	Discomfort	1	1	0
2021	10	12	Injury, poisoning and procedural complications	Product administered at inappropriate site	1	1	0
2021	10	12	Psychiatric disorders	Emotional disorder	1	1	0
2021	10	12	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	10	12	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	12	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2021	10	12	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	12	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2021	10	12	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	13	General disorders and administration site conditions	Injection site reaction	18	18	0
2021	10	13	General disorders and administration site conditions	Fatigue	11	11	0
2021	10	13	Nervous system disorders	Dizziness	11	11	0
2021	10	13	Nervous system disorders	Paraesthesia	11	11	0
2021	10	13	Nervous system disorders	Headache	10	10	0
2021	10	13	General disorders and administration site conditions	Chest pain	10	10	0
2021	10	13	Musculoskeletal and connective tissue disorders	Pain in extremity	9	9	0
2021	10	13	Gastrointestinal disorders	Abdominal pain	8	8	0
2021	10	13	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2021	10	13	Gastrointestinal disorders	Nausea	6	6	0
2021	10	13	Nervous system disorders	Seizure	5	5	0
2021	10	13	Skin and subcutaneous tissue disorders	Urticaria	5	5	0
2021	10	13	General disorders and administration site conditions	Pyrexia	5	5	0
2021	10	13	General disorders and administration site conditions	Injection site pain	4	4	0
2021	10	13	Gastrointestinal disorders	Vomiting	4	4	0
2021	10	13	Reproductive system and breast disorders	Menstrual disorder	4	4	0
2021	10	13	Skin and subcutaneous tissue disorders	Hyperhidrosis	4	4	0
2021	10	13	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	10	13	Skin and subcutaneous tissue disorders	Rash pruritic	3	3	0
2021	10	13	Cardiac disorders	Cardiac flutter	3	3	0
2021	10	13	Psychiatric disorders	Confusional state	3	3	0
2021	10	13	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	10	13	Nervous system disorders	Syncope	3	3	0
2021	10	13	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	3	3	0
2021	10	13	Skin and subcutaneous tissue disorders	Rash	3	3	0
2021	10	13	Nervous system disorders	Facial paralysis	2	2	0
2021	10	13	Reproductive system and breast disorders	Dysmenorrhoea	2	2	0
2021	10	13	Vascular disorders	Pallor	2	2	0
2021	10	13	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	10	13	Vascular disorders	Hypertension	2	2	0
2021	10	13	Cardiac disorders	Pericarditis	2	2	0
2021	10	13	Musculoskeletal and connective tissue disorders	Limb discomfort	2	2	0
2021	10	13	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	10	13	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	10	13	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	2	2	0
2021	10	13	Nervous system disorders	Presyncope	2	2	0
2021	10	13	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	10	13	Nervous system disorders	Hypoaesthesia	2	2	0
2021	10	13	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2021	10	13	Nervous system disorders	Dysgeusia	2	2	0
2021	10	13	Reproductive system and breast disorders	Intermenstrual bleeding	2	2	0
2021	10	13	Cardiac disorders	Ventricular tachycardia	1	1	0
2021	10	13	Gastrointestinal disorders	Toothache	1	1	0
2021	10	13	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	10	13	Psychiatric disorders	Tension	1	1	0
2021	10	13	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	10	13	Respiratory, thoracic and mediastinal disorders	Hyperventilation	1	1	0
2021	10	13	Cardiac disorders	Tachycardia	1	1	0
2021	10	13	Eye disorders	Eye movement disorder	1	1	0
2021	10	13	Gastrointestinal disorders	Constipation	1	1	0
2021	10	13	General disorders and administration site conditions	Asthenia	1	1	0
2021	10	13	General disorders and administration site conditions	Crying	1	1	0
2021	10	13	General disorders and administration site conditions	Vaccination site reaction	1	1	0
2021	10	13	Investigations	Blood pressure increased	1	1	0
2021	10	13	Cardiac disorders	Myocarditis	1	1	0
2021	10	13	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2021	10	13	General disorders and administration site conditions	Mass	1	1	0
2021	10	13	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2021	10	13	Immune system disorders	Hypersensitivity	1	1	0
2021	10	13	Psychiatric disorders	Irritability	1	1	0
2021	10	13	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	13	Reproductive system and breast disorders	Pelvic pain	1	1	0
2021	10	13	Gastrointestinal disorders	Gingival swelling	1	1	0
2021	10	13	Gastrointestinal disorders	Glossitis	1	1	0
2021	10	13	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	13	Psychiatric disorders	Mood swings	1	1	0
2021	10	13	Skin and subcutaneous tissue disorders	Dry skin	1	1	0
2021	10	13	Vascular disorders	Hot flush	1	1	0
2021	10	13	Vascular disorders	Vein dissection	1	1	0
2021	10	13	Gastrointestinal disorders	Mouth ulceration	1	1	0
2021	10	13	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	13	Psychiatric disorders	Hallucination, visual	1	1	0
2021	10	13	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	13	Nervous system disorders	Unresponsive to stimuli	1	1	0
2021	10	13	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	10	13	Cardiac disorders	Palpitations	1	1	0
2021	10	13	General disorders and administration site conditions	Injection site nodule	1	1	0
2021	10	13	Musculoskeletal and connective tissue disorders	Musculoskeletal discomfort	1	1	0
2021	10	13	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2021	10	13	Nervous system disorders	Lethargy	1	1	0
2021	10	13	Psychiatric disorders	Social avoidant behaviour	1	1	0
2021	10	13	Reproductive system and breast disorders	Breast pain	1	1	0
2021	10	13	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	10	13	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2021	10	13	Eye disorders	Vision blurred	1	1	0
2021	10	13	Gastrointestinal disorders	Flatulence	1	1	0
2021	10	13	General disorders and administration site conditions	Facial discomfort	1	1	0
2021	10	13	Immune system disorders	Anaphylactic reaction	1	1	0
2021	10	13	Nervous system disorders	Aphasia	1	1	0
2021	10	13	Nervous system disorders	Balance disorder	1	1	0
2021	10	13	Psychiatric disorders	Hallucination, auditory	1	1	0
2021	10	13	Reproductive system and breast disorders	Haemorrhagic ovarian cyst	1	1	0
2021	10	13	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	13	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	10	13	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	13	Eye disorders	Ocular hyperaemia	1	1	0
2021	10	13	General disorders and administration site conditions	Chills	1	1	0
2021	10	13	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	10	13	Investigations	Haemoglobin decreased	1	1	0
2021	10	13	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	10	13	Nervous system disorders	Neuralgia	1	1	0
2021	10	13	Nervous system disorders	Restless legs syndrome	1	1	0
2021	10	13	Psychiatric disorders	Anxiety	1	1	0
2021	10	13	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	10	13	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2021	10	13	Gastrointestinal disorders	Glossodynia	1	1	0
2021	10	13	General disorders and administration site conditions	Condition aggravated	1	1	0
2021	10	13	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	10	13	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	13	General disorders and administration site conditions	Axillary pain	1	1	0
2021	10	13	Renal and urinary disorders	Urine abnormality	1	1	0
2021	10	14	General disorders and administration site conditions	Injection site reaction	8	8	0
2021	10	14	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2021	10	14	Cardiac disorders	Palpitations	4	4	0
2021	10	14	Nervous system disorders	Paraesthesia	3	3	0
2021	10	14	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	10	14	Nervous system disorders	Dizziness	3	3	0
2021	10	14	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2021	10	14	Skin and subcutaneous tissue disorders	Urticaria	3	3	0
2021	10	14	Gastrointestinal disorders	Nausea	3	3	0
2021	10	14	Nervous system disorders	Headache	3	3	0
2021	10	14	General disorders and administration site conditions	Chest pain	3	3	0
2021	10	14	Cardiac disorders	Pericarditis	2	2	0
2021	10	14	Ear and labyrinth disorders	Tinnitus	2	2	0
2021	10	14	Investigations	Troponin I increased	2	2	0
2021	10	14	General disorders and administration site conditions	Fatigue	2	2	0
2021	10	14	Infections and infestations	Cellulitis	2	2	0
2021	10	14	Nervous system disorders	Bell's palsy	2	2	0
2021	10	14	Cardiac disorders	Tachycardia	2	2	0
2021	10	14	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	10	14	General disorders and administration site conditions	Vaccination site reaction	1	1	0
2021	10	14	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	10	14	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	10	14	Gastrointestinal disorders	Retching	1	1	0
2021	10	14	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	10	14	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	14	Nervous system disorders	Tremor	1	1	0
2021	10	14	Renal and urinary disorders	Renal pain	1	1	0
2021	10	14	Reproductive system and breast disorders	Breast engorgement	1	1	0
2021	10	14	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	14	General disorders and administration site conditions	Swelling	1	1	0
2021	10	14	Nervous system disorders	Migraine	1	1	0
2021	10	14	Vascular disorders	Peripheral coldness	1	1	0
2021	10	14	Cardiac disorders	Myocarditis	1	1	0
2021	10	14	Eye disorders	Photophobia	1	1	0
2021	10	14	Psychiatric disorders	Insomnia	1	1	0
2021	10	14	Psychiatric disorders	Irritability	1	1	0
2021	10	14	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	14	Vascular disorders	Raynaud's phenomenon	1	1	0
2021	10	14	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	10	14	Vascular disorders	Hypotension	1	1	0
2021	10	14	Musculoskeletal and connective tissue disorders	Groin pain	1	1	0
2021	10	14	Nervous system disorders	Hypoaesthesia	1	1	0
2021	10	14	General disorders and administration site conditions	Injection site pain	1	1	0
2021	10	14	Ear and labyrinth disorders	Ear congestion	1	1	0
2021	10	14	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	14	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	14	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	14	Cardiac disorders	Coronary artery stenosis	1	1	0
2021	10	14	General disorders and administration site conditions	Condition aggravated	1	1	0
2021	10	14	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	10	14	Eye disorders	Blepharospasm	1	1	0
2021	10	14	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	14	Skin and subcutaneous tissue disorders	Erythema multiforme	1	1	0
2021	10	14	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	10	15	General disorders and administration site conditions	Injection site reaction	17	17	0
2021	10	15	Nervous system disorders	Headache	10	9	0
2021	10	15	Skin and subcutaneous tissue disorders	Rash	8	8	0
2021	10	15	Gastrointestinal disorders	Vomiting	7	7	0
2021	10	15	Nervous system disorders	Lethargy	6	5	0
2021	10	15	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2021	10	15	Nervous system disorders	Syncope	5	5	0
2021	10	15	General disorders and administration site conditions	Chest pain	5	5	0
2021	10	15	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	10	15	General disorders and administration site conditions	Fatigue	4	4	0
2021	10	15	Nervous system disorders	Dizziness	4	4	0
2021	10	15	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2021	10	15	Nervous system disorders	Paraesthesia	3	3	0
2021	10	15	Cardiac disorders	Tachycardia	3	3	0
2021	10	15	Injury, poisoning and procedural complications	Vaccination error	3	3	0
2021	10	15	Cardiac disorders	Palpitations	3	3	0
2021	10	15	Gastrointestinal disorders	Swollen tongue	3	3	0
2021	10	15	Cardiac disorders	Pericarditis	3	3	0
2021	10	15	General disorders and administration site conditions	Chest discomfort	2	1	0
2021	10	15	General disorders and administration site conditions	Injection site pain	2	2	0
2021	10	15	Musculoskeletal and connective tissue disorders	Pain in extremity	2	1	0
2021	10	15	Nervous system disorders	Migraine	2	2	0
2021	10	15	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	2	2	0
2021	10	15	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	10	15	Gastrointestinal disorders	Dysphagia	2	2	0
2021	10	15	Skin and subcutaneous tissue disorders	Angioedema	2	2	0
2021	10	15	General disorders and administration site conditions	Concomitant disease aggravated	2	1	0
2021	10	15	Nervous system disorders	Presyncope	2	2	0
2021	10	15	Immune system disorders	Anaphylactic reaction	2	2	0
2021	10	15	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	10	15	Nervous system disorders	Taste disorder	2	2	0
2021	10	15	General disorders and administration site conditions	Injection site nodule	1	1	0
2021	10	15	Nervous system disorders	Memory impairment	1	1	0
2021	10	15	Skin and subcutaneous tissue disorders	Livedo reticularis	1	1	0
2021	10	15	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	15	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	10	15	Gastrointestinal disorders	Nausea	1	1	0
2021	10	15	Investigations	Oxygen saturation decreased	1	1	0
2021	10	15	Cardiac disorders	Myopericarditis	1	1	0
2021	10	15	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	15	Skin and subcutaneous tissue disorders	Papule	1	1	0
2021	10	15	Infections and infestations	Ear infection	1	1	0
2021	10	15	Nervous system disorders	Dysgeusia	1	1	0
2021	10	15	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	15	General disorders and administration site conditions	Fat necrosis	1	1	0
2021	10	15	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	10	15	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	15	Vascular disorders	Peripheral coldness	1	1	0
2021	10	15	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	10	15	General disorders and administration site conditions	Asthenia	1	1	0
2021	10	15	Investigations	Blood pressure increased	1	1	0
2021	10	15	Nervous system disorders	Burning sensation	1	1	0
2021	10	15	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	10	15	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	10	15	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	10	15	Eye disorders	Eye pain	1	1	0
2021	10	15	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	10	15	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	15	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	10	15	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	10	15	Investigations	Heart rate increased	1	1	0
2021	10	15	Vascular disorders	Hypertension	1	1	0
2021	10	15	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	15	General disorders and administration site conditions	Thirst	1	1	0
2021	10	15	Eye disorders	Vision blurred	1	1	0
2021	10	15	Gastrointestinal disorders	Lip swelling	1	1	0
2021	10	15	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	15	Musculoskeletal and connective tissue disorders	Limb discomfort	1	0	0
2021	10	15	Nervous system disorders	Seizure	1	1	0
2021	10	15	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	15	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	10	15	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	10	15	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2021	10	15	Infections and infestations	Injection site cellulitis	1	1	0
2021	10	15	Investigations	Troponin I increased	1	1	0
2021	10	15	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2021	10	16	General disorders and administration site conditions	Injection site reaction	5	5	0
2021	10	16	Nervous system disorders	Dizziness	4	4	0
2021	10	16	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	10	16	Gastrointestinal disorders	Diarrhoea	3	3	0
2021	10	16	Nervous system disorders	Hypoaesthesia	3	2	0
2021	10	16	Gastrointestinal disorders	Vomiting	2	2	0
2021	10	16	General disorders and administration site conditions	Pain	2	2	0
2021	10	16	Nervous system disorders	Headache	2	2	0
2021	10	16	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	16	Cardiac disorders	Atrial fibrillation	1	1	0
2021	10	16	Investigations	Heart rate increased	1	1	0
2021	10	16	Musculoskeletal and connective tissue disorders	Pain in extremity	1	0	0
2021	10	16	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	16	General disorders and administration site conditions	Chest pain	1	1	0
2021	10	16	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	16	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	10	16	Gastrointestinal disorders	Nausea	1	1	0
2021	10	16	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	16	Nervous system disorders	Dysgeusia	1	1	0
2021	10	16	Nervous system disorders	Paraesthesia	1	1	0
2021	10	16	Renal and urinary disorders	Pollakiuria	1	1	0
2021	10	16	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	16	Cardiac disorders	Tachycardia	1	1	0
2021	10	16	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	10	16	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	10	16	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	16	Nervous system disorders	Tremor	1	1	0
2021	10	17	Cardiac disorders	Tachycardia	1	1	0
2021	10	17	General disorders and administration site conditions	Swelling	1	1	0
2021	10	17	General disorders and administration site conditions	Fatigue	1	1	0
2021	10	17	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	10	17	Nervous system disorders	Paraesthesia	1	1	0
2021	10	17	Cardiac disorders	Arrhythmia	1	1	0
2021	10	17	General disorders and administration site conditions	Chest pain	1	1	0
2021	10	17	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	17	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	10	17	Vascular disorders	Hypertension	1	1	0
2021	10	17	Investigations	Blood pressure decreased	1	1	0
2021	10	18	General disorders and administration site conditions	Injection site reaction	16	16	0
2021	10	18	Gastrointestinal disorders	Nausea	8	8	0
2021	10	18	Nervous system disorders	Headache	7	7	0
2021	10	18	General disorders and administration site conditions	Chest pain	7	7	0
2021	10	18	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2021	10	18	General disorders and administration site conditions	Fatigue	6	6	0
2021	10	18	General disorders and administration site conditions	Pyrexia	6	6	0
2021	10	18	Nervous system disorders	Syncope	5	5	0
2021	10	18	Gastrointestinal disorders	Vomiting	5	5	0
2021	10	18	Skin and subcutaneous tissue disorders	Pruritus	5	5	0
2021	10	18	Gastrointestinal disorders	Abdominal pain	5	5	0
2021	10	18	Musculoskeletal and connective tissue disorders	Pain in extremity	5	4	0
2021	10	18	Nervous system disorders	Dizziness	5	5	0
2021	10	18	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2021	10	18	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	10	18	Nervous system disorders	Paraesthesia	4	4	0
2021	10	18	Skin and subcutaneous tissue disorders	Rash	3	3	0
2021	10	18	Skin and subcutaneous tissue disorders	Urticaria	3	3	0
2021	10	18	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	10	18	Cardiac disorders	Palpitations	3	3	0
2021	10	18	Gastrointestinal disorders	Diarrhoea	3	3	0
2021	10	18	Gastrointestinal disorders	Dysphagia	2	2	0
2021	10	18	Infections and infestations	Cellulitis	2	2	0
2021	10	18	Nervous system disorders	Lethargy	2	2	0
2021	10	18	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	10	18	Immune system disorders	Anaphylactic reaction	2	2	0
2021	10	18	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	10	18	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	10	18	Vascular disorders	Hypertension	2	2	0
2021	10	18	Cardiac disorders	Pericarditis	2	2	0
2021	10	18	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	0	0
2021	10	18	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	18	Respiratory, thoracic and mediastinal disorders	Productive cough	1	1	0
2021	10	18	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	10	18	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	18	General disorders and administration site conditions	Chills	1	1	0
2021	10	18	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2021	10	18	Cardiac disorders	Cardiac flutter	1	1	0
2021	10	18	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	10	18	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	10	18	Nervous system disorders	Presyncope	1	1	0
2021	10	18	Vascular disorders	Pallor	1	1	0
2021	10	18	General disorders and administration site conditions	Injection site pain	1	1	0
2021	10	18	Psychiatric disorders	Confusional state	1	1	0
2021	10	18	Vascular disorders	Deep vein thrombosis	1	1	0
2021	10	18	Cardiac disorders	Myopericarditis	1	1	0
2021	10	18	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	18	Investigations	Electrocardiogram	1	1	0
2021	10	18	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	10	18	Gastrointestinal disorders	Toothache	1	1	0
2021	10	18	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	10	18	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	18	Nervous system disorders	Tremor	1	1	0
2021	10	18	Respiratory, thoracic and mediastinal disorders	Hyperventilation	1	1	0
2021	10	18	General disorders and administration site conditions	Pain	1	1	0
2021	10	18	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	10	18	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	10	18	Cardiac disorders	Myocarditis	1	1	0
2021	10	18	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2021	10	18	General disorders and administration site conditions	Feeling cold	1	1	0
2021	10	18	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	18	Ear and labyrinth disorders	Vertigo	1	1	0
2021	10	18	General disorders and administration site conditions	Swelling	1	1	0
2021	10	19	General disorders and administration site conditions	Injection site reaction	5	5	0
2021	10	19	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	10	19	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	19	Nervous system disorders	Paraesthesia	3	3	0
2021	10	19	Gastrointestinal disorders	Vomiting	2	2	0
2021	10	19	Nervous system disorders	Dizziness	2	2	0
2021	10	19	Nervous system disorders	Hypoaesthesia	2	2	0
2021	10	19	Musculoskeletal and connective tissue disorders	Pain in jaw	2	2	0
2021	10	19	Gastrointestinal disorders	Nausea	2	2	0
2021	10	19	Immune system disorders	Anaphylactic reaction	2	2	0
2021	10	19	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	10	19	Nervous system disorders	Headache	2	2	0
2021	10	19	General disorders and administration site conditions	Chest pain	2	2	0
2021	10	19	Nervous system disorders	Tremor	2	2	0
2021	10	19	Gastrointestinal disorders	Gingival discomfort	1	1	0
2021	10	19	General disorders and administration site conditions	Swelling face	1	1	0
2021	10	19	Investigations	Heart rate increased	1	1	0
2021	10	19	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	10	19	Nervous system disorders	Cognitive disorder	1	1	0
2021	10	19	Nervous system disorders	Presyncope	1	1	0
2021	10	19	Ear and labyrinth disorders	Hypoacusis	1	1	0
2021	10	19	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	19	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	10	19	Eye disorders	Visual impairment	1	1	0
2021	10	19	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	19	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	10	19	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	10	19	Respiratory, thoracic and mediastinal disorders	Productive cough	1	1	0
2021	10	19	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	10	19	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	19	General disorders and administration site conditions	Chills	1	1	0
2021	10	19	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	10	19	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2021	10	19	Cardiac disorders	Myopericarditis	1	1	0
2021	10	19	Investigations	Electrocardiogram abnormal	1	1	0
2021	10	19	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	19	General disorders and administration site conditions	Therapeutic response unexpected	1	1	0
2021	10	19	Respiratory, thoracic and mediastinal disorders	Sinus congestion	1	1	0
2021	10	19	Vascular disorders	Cyanosis	1	1	0
2021	10	19	Cardiac disorders	Cyanosis	1	1	0
2021	10	19	Respiratory, thoracic and mediastinal disorders	Dry throat	1	1	0
2021	10	19	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	10	19	Cardiac disorders	Palpitations	1	1	0
2021	10	19	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	19	Eye disorders	Eye pain	1	1	0
2021	10	19	Eye disorders	Eye swelling	1	1	0
2021	10	19	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	10	19	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	19	Infections and infestations	Soft tissue infection	1	1	0
2021	10	19	Infections and infestations	Urinary tract infection	1	1	0
2021	10	19	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	10	19	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	10	19	Nervous system disorders	Bell's palsy	1	0	0
2021	10	19	Nervous system disorders	Syncope	1	1	0
2021	10	19	Cardiac disorders	Pericarditis	1	1	0
2021	10	19	Musculoskeletal and connective tissue disorders	Flank pain	1	1	0
2021	10	19	Nervous system disorders	Migraine	1	1	0
2021	10	20	General disorders and administration site conditions	Injection site reaction	8	7	0
2021	10	20	Nervous system disorders	Headache	7	7	1
2021	10	20	General disorders and administration site conditions	Chest pain	6	5	0
2021	10	20	Nervous system disorders	Dizziness	5	5	1
2021	10	20	Gastrointestinal disorders	Nausea	5	5	1
2021	10	20	Blood and lymphatic system disorders	Lymphadenopathy	5	4	0
2021	10	20	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2021	10	20	Cardiac disorders	Palpitations	3	3	0
2021	10	20	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	10	20	General disorders and administration site conditions	Pyrexia	3	3	1
2021	10	20	Cardiac disorders	Pericarditis	3	3	0
2021	10	20	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2021	10	20	General disorders and administration site conditions	Influenza like illness	2	1	0
2021	10	20	General disorders and administration site conditions	Fatigue	2	2	0
2021	10	20	Eye disorders	Vision blurred	2	2	0
2021	10	20	Gastrointestinal disorders	Dysphagia	2	2	0
2021	10	20	Cardiac disorders	Myocarditis	2	2	0
2021	10	20	Injury, poisoning and procedural complications	Underdose	2	2	0
2021	10	20	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	20	Infections and infestations	Meningitis aseptic	1	1	0
2021	10	20	Investigations	Respiratory rate increased	1	1	0
2021	10	20	Nervous system disorders	Hyposmia	1	1	0
2021	10	20	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	0	0
2021	10	20	Injury, poisoning and procedural complications	Brain herniation	1	1	1
2021	10	20	Psychiatric disorders	Confusional state	1	1	0
2021	10	20	Reproductive system and breast disorders	Breast pain	1	1	0
2021	10	20	Respiratory, thoracic and mediastinal disorders	Oropharyngeal discomfort	1	1	0
2021	10	20	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	10	20	Investigations	Heart rate irregular	1	1	0
2021	10	20	Vascular disorders	Hot flush	1	1	0
2021	10	20	Vascular disorders	Hypotension	1	1	0
2021	10	20	General disorders and administration site conditions	Sensation of foreign body	1	1	0
2021	10	20	Nervous system disorders	Paraesthesia	1	1	0
2021	10	20	Respiratory, thoracic and mediastinal disorders	Nasal discomfort	1	1	0
2021	10	20	Investigations	Echocardiogram abnormal	1	1	0
2021	10	20	Cardiac disorders	Cardiac arrest	1	1	1
2021	10	20	General disorders and administration site conditions	Multiple organ dysfunction syndrome	1	1	1
2021	10	20	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	20	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	10	20	Cardiac disorders	Tachycardia	1	1	0
2021	10	20	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	10	20	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	1	1	0
2021	10	20	Nervous system disorders	Brain injury	1	1	1
2021	10	20	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	10	20	Cardiac disorders	Cardiac flutter	1	1	0
2021	10	20	Infections and infestations	Injection site infection	1	1	0
2021	10	20	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2021	10	20	Nervous system disorders	Balance disorder	1	1	0
2021	10	20	Nervous system disorders	Seizure	1	1	0
2021	10	20	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	10	20	General disorders and administration site conditions	Chills	1	1	0
2021	10	20	Psychiatric disorders	Anxiety	1	1	0
2021	10	21	General disorders and administration site conditions	Injection site reaction	14	14	0
2021	10	21	General disorders and administration site conditions	Chest pain	9	9	0
2021	10	21	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2021	10	21	General disorders and administration site conditions	Fatigue	6	6	0
2021	10	21	Nervous system disorders	Paraesthesia	5	5	0
2021	10	21	Nervous system disorders	Dizziness	5	5	0
2021	10	21	General disorders and administration site conditions	Chest discomfort	4	4	0
2021	10	21	Gastrointestinal disorders	Nausea	3	3	0
2021	10	21	General disorders and administration site conditions	Pyrexia	3	3	0
2021	10	21	Cardiac disorders	Palpitations	3	3	0
2021	10	21	Eye disorders	Vision blurred	3	3	0
2021	10	21	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	10	21	Investigations	Heart rate increased	2	2	0
2021	10	21	Nervous system disorders	Headache	2	2	0
2021	10	21	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	10	21	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	10	21	Reproductive system and breast disorders	Intermenstrual bleeding	2	2	0
2021	10	21	Psychiatric disorders	Disorientation	2	2	0
2021	10	21	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	10	21	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	10	21	Nervous system disorders	Syncope	2	2	0
2021	10	21	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	10	21	Infections and infestations	Appendicitis	1	1	0
2021	10	21	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	21	Nervous system disorders	Psychomotor hyperactivity	1	1	0
2021	10	21	Reproductive system and breast disorders	Testicular pain	1	1	0
2021	10	21	Gastrointestinal disorders	Bowel movement irregularity	1	1	0
2021	10	21	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	21	Reproductive system and breast disorders	Prostatitis	1	1	0
2021	10	21	Reproductive system and breast disorders	Scrotal swelling	1	1	0
2021	10	21	Skin and subcutaneous tissue disorders	Rash	1	0	0
2021	10	21	Vascular disorders	Hot flush	1	1	0
2021	10	21	Nervous system disorders	Lethargy	1	1	0
2021	10	21	Psychiatric disorders	Confusional state	1	1	0
2021	10	21	Investigations	Troponin increased	1	1	0
2021	10	21	Skin and subcutaneous tissue disorders	Pruritus	1	0	0
2021	10	21	Cardiac disorders	Pericarditis	1	1	0
2021	10	21	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	21	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	21	Vascular disorders	Peripheral coldness	1	1	0
2021	10	21	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2021	10	21	General disorders and administration site conditions	Injection site paraesthesia	1	1	0
2021	10	21	Psychiatric disorders	Insomnia	1	1	0
2021	10	21	Skin and subcutaneous tissue disorders	Rash vesicular	1	1	0
2021	10	21	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	21	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	10	21	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	10	21	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	21	Reproductive system and breast disorders	Penile pain	1	1	0
2021	10	21	General disorders and administration site conditions	Chills	1	1	0
2021	10	21	Investigations	White blood cell count increased	1	1	0
2021	10	21	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2021	10	21	Psychiatric disorders	Anxiety	1	1	0
2021	10	21	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2021	10	21	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2021	10	21	Eye disorders	Visual impairment	1	1	0
2021	10	21	Renal and urinary disorders	Urinary incontinence	1	1	0
2021	10	21	Ear and labyrinth disorders	Ear pain	1	1	0
2021	10	21	Nervous system disorders	Mental impairment	1	1	0
2021	10	21	Cardiac disorders	Cardiac flutter	1	1	0
2021	10	21	General disorders and administration site conditions	Malaise	1	1	0
2021	10	21	Reproductive system and breast disorders	Ovulation pain	1	1	0
2021	10	21	Skin and subcutaneous tissue disorders	Urticaria	1	0	0
2021	10	22	General disorders and administration site conditions	Injection site reaction	6	6	0
2021	10	22	Nervous system disorders	Headache	5	5	0
2021	10	22	General disorders and administration site conditions	Chest pain	4	4	0
2021	10	22	Gastrointestinal disorders	Vomiting	3	3	0
2021	10	22	Gastrointestinal disorders	Diarrhoea	3	3	0
2021	10	22	Nervous system disorders	Syncope	3	3	0
2021	10	22	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	22	Cardiac disorders	Pericarditis	2	2	0
2021	10	22	General disorders and administration site conditions	Injection site pain	2	2	0
2021	10	22	Nervous system disorders	Dizziness	2	2	0
2021	10	22	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	10	22	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	10	22	Nervous system disorders	Dyskinesia	1	1	0
2021	10	22	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	10	22	Reproductive system and breast disorders	Penile pain	1	1	0
2021	10	22	Eye disorders	Photophobia	1	1	0
2021	10	22	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	22	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	22	General disorders and administration site conditions	Feeling hot	1	1	0
2021	10	22	General disorders and administration site conditions	Swelling	1	1	0
2021	10	22	Reproductive system and breast disorders	Prostatitis	1	1	0
2021	10	22	Reproductive system and breast disorders	Scrotal swelling	1	1	0
2021	10	22	Cardiac disorders	Arrhythmia	1	1	0
2021	10	22	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	22	Reproductive system and breast disorders	Testicular pain	1	1	0
2021	10	22	Gastrointestinal disorders	Nausea	1	1	0
2021	10	22	Investigations	Troponin	1	1	0
2021	10	22	Psychiatric disorders	Confusional state	1	1	0
2021	10	22	Eye disorders	Visual impairment	1	1	0
2021	10	22	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	22	Immune system disorders	Anaphylactic reaction	1	1	0
2021	10	22	Investigations	Blood urine present	1	1	0
2021	10	22	Nervous system disorders	Disturbance in attention	1	1	0
2021	10	22	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	22	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	10	22	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	10	22	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	10	23	Nervous system disorders	Headache	4	4	0
2021	10	23	Nervous system disorders	Hypoaesthesia	3	3	0
2021	10	23	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	23	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	10	23	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2021	10	23	Nervous system disorders	Paraesthesia	2	2	0
2021	10	23	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	10	23	Eye disorders	Photophobia	1	1	0
2021	10	23	General disorders and administration site conditions	Feeling cold	1	1	0
2021	10	23	Nervous system disorders	Syncope	1	1	0
2021	10	23	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	23	Respiratory, thoracic and mediastinal disorders	Pulmonary pain	1	1	0
2021	10	23	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	23	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	10	23	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	23	Nervous system disorders	Migraine	1	1	0
2021	10	23	Eye disorders	Ocular discomfort	1	1	0
2021	10	23	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	10	23	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2021	10	23	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	10	23	Skin and subcutaneous tissue disorders	Miliaria	1	1	0
2021	10	23	Cardiac disorders	Palpitations	1	1	0
2021	10	23	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	10	23	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	23	Nervous system disorders	Lethargy	1	1	0
2021	10	23	Gastrointestinal disorders	Nausea	1	1	0
2021	10	23	Nervous system disorders	Ageusia	1	1	0
2021	10	23	Nervous system disorders	Dizziness postural	1	1	0
2021	10	23	General disorders and administration site conditions	Chest pain	1	1	0
2021	10	23	General disorders and administration site conditions	Inflammation	1	1	0
2021	10	23	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	23	Vascular disorders	Orthostatic hypotension	1	1	0
2021	10	23	Eye disorders	Visual impairment	1	1	0
2021	10	23	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	23	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	10	23	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	23	General disorders and administration site conditions	Chills	1	1	0
2021	10	23	Infections and infestations	Injection site cellulitis	1	1	0
2021	10	23	Infections and infestations	Vestibular neuronitis	1	1	0
2021	10	23	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	10	23	Vascular disorders	Hypertension	1	1	0
2021	10	23	Cardiac disorders	Extrasystoles	1	1	0
2021	10	23	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	23	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2021	10	24	Nervous system disorders	Paraesthesia	4	4	0
2021	10	24	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	24	General disorders and administration site conditions	Injection site reaction	3	3	0
2021	10	24	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	10	24	Nervous system disorders	Hypoaesthesia	2	2	0
2021	10	24	Gastrointestinal disorders	Nausea	2	2	0
2021	10	24	General disorders and administration site conditions	Pyrexia	2	2	0
2021	10	24	General disorders and administration site conditions	Chest pain	2	2	0
2021	10	24	Investigations	Heart rate increased	1	1	0
2021	10	24	Nervous system disorders	Dizziness	1	1	0
2021	10	24	Cardiac disorders	Cardiac flutter	1	1	0
2021	10	24	Nervous system disorders	Amnesia	1	1	0
2021	10	24	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	10	24	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	10	24	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	24	General disorders and administration site conditions	Chills	1	1	0
2021	10	24	Cardiac disorders	Palpitations	1	1	0
2021	10	24	General disorders and administration site conditions	Injection site pain	1	1	0
2021	10	24	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	10	24	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	24	Nervous system disorders	Syncope	1	1	0
2021	10	24	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	24	Respiratory, thoracic and mediastinal disorders	Respiration abnormal	1	1	0
2021	10	24	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	24	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	24	Cardiac disorders	Tachycardia	1	1	0
2021	10	24	Eye disorders	Eye swelling	1	1	0
2021	10	24	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	10	24	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	24	Psychiatric disorders	Abnormal behaviour	1	1	0
2021	10	24	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	10	25	General disorders and administration site conditions	Injection site reaction	8	8	0
2021	10	25	Nervous system disorders	Headache	7	7	0
2021	10	25	General disorders and administration site conditions	Chest pain	7	7	0
2021	10	25	Nervous system disorders	Dizziness	7	7	0
2021	10	25	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2021	10	25	Cardiac disorders	Palpitations	5	5	0
2021	10	25	Gastrointestinal disorders	Nausea	4	4	0
2021	10	25	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	10	25	Nervous system disorders	Syncope	4	4	0
2021	10	25	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	25	Nervous system disorders	Lethargy	3	3	0
2021	10	25	Nervous system disorders	Paraesthesia	3	3	0
2021	10	25	Investigations	Heart rate increased	3	3	0
2021	10	25	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	10	25	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2021	10	25	Vascular disorders	Pallor	3	3	0
2021	10	25	Nervous system disorders	Tremor	3	3	0
2021	10	25	General disorders and administration site conditions	Pain	2	2	0
2021	10	25	Nervous system disorders	Presyncope	2	2	0
2021	10	25	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	10	25	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	10	25	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	10	25	General disorders and administration site conditions	Malaise	2	2	0
2021	10	25	Investigations	Blood pressure decreased	2	2	0
2021	10	25	General disorders and administration site conditions	Chills	2	2	0
2021	10	25	Reproductive system and breast disorders	Intermenstrual bleeding	2	2	0
2021	10	25	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	10	25	General disorders and administration site conditions	Pyrexia	2	2	0
2021	10	25	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2021	10	25	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	10	25	General disorders and administration site conditions	Injection site pain	2	2	0
2021	10	25	Eye disorders	Vitreous detachment	1	1	0
2021	10	25	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	10	25	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	10	25	Product issues	Product colour issue	1	1	0
2021	10	25	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	25	Psychiatric disorders	Depression suicidal	1	1	0
2021	10	25	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	10	25	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	25	Cardiac disorders	Tachycardia	1	1	0
2021	10	25	General disorders and administration site conditions	Asthenia	1	1	0
2021	10	25	Gastrointestinal disorders	Retching	1	1	0
2021	10	25	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	10	25	Cardiac disorders	Pericarditis	1	1	0
2021	10	25	General disorders and administration site conditions	Feeling hot	1	1	0
2021	10	25	General disorders and administration site conditions	Injection site paraesthesia	1	1	0
2021	10	25	General disorders and administration site conditions	Injection site urticaria	1	1	0
2021	10	25	Psychiatric disorders	Insomnia	1	1	0
2021	10	25	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	10	25	Infections and infestations	Oral herpes	1	1	0
2021	10	25	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2021	10	25	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	25	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	25	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	10	25	Product issues	Product quality issue	1	1	0
2021	10	25	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	10	25	Investigations	Electrocardiogram abnormal	1	1	0
2021	10	25	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	10	25	Ear and labyrinth disorders	Deafness unilateral	1	1	0
2021	10	25	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	10	25	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	25	Nervous system disorders	Hypoaesthesia	1	1	0
2021	10	25	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2021	10	25	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2021	10	25	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	26	General disorders and administration site conditions	Injection site reaction	11	10	0
2021	10	26	Nervous system disorders	Headache	6	6	0
2021	10	26	Nervous system disorders	Dizziness	6	6	0
2021	10	26	General disorders and administration site conditions	Chest pain	6	6	0
2021	10	26	Gastrointestinal disorders	Nausea	5	5	0
2021	10	26	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2021	10	26	Skin and subcutaneous tissue disorders	Rash	4	4	0
2021	10	26	General disorders and administration site conditions	Pyrexia	3	3	0
2021	10	26	Investigations	Troponin increased	3	3	0
2021	10	26	Musculoskeletal and connective tissue disorders	Myalgia	3	2	0
2021	10	26	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	26	General disorders and administration site conditions	Injection site pain	2	2	0
2021	10	26	Psychiatric disorders	Confusional state	2	2	0
2021	10	26	Cardiac disorders	Myocarditis	2	2	0
2021	10	26	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	10	26	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	10	26	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	10	26	Ear and labyrinth disorders	Vertigo	2	2	0
2021	10	26	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2021	10	26	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	10	26	General disorders and administration site conditions	Swelling	2	2	0
2021	10	26	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2021	10	26	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2021	10	26	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	26	General disorders and administration site conditions	Injection site lymphadenopathy	1	1	0
2021	10	26	Immune system disorders	Hypersensitivity	1	1	0
2021	10	26	Nervous system disorders	Dysgeusia	1	1	0
2021	10	26	Nervous system disorders	Paraesthesia	1	1	0
2021	10	26	Nervous system disorders	Syncope	1	1	0
2021	10	26	Psychiatric disorders	Insomnia	1	1	0
2021	10	26	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	26	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	26	Nervous system disorders	Burning sensation	1	1	0
2021	10	26	Nervous system disorders	Taste disorder	1	1	0
2021	10	26	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	10	26	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	26	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	10	26	Cardiac disorders	Palpitations	1	1	0
2021	10	26	Nervous system disorders	Lethargy	1	1	0
2021	10	26	Reproductive system and breast disorders	Breast pain	1	1	0
2021	10	26	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	10	26	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	26	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	26	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	26	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	26	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	26	Cardiac disorders	Myopericarditis	1	1	0
2021	10	26	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	26	Investigations	Electrocardiogram	1	1	0
2021	10	26	Investigations	Electrocardiogram abnormal	1	1	0
2021	10	26	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	10	26	Ear and labyrinth disorders	Hypoacusis	1	1	0
2021	10	26	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	10	26	Investigations	Heart rate increased	1	1	0
2021	10	26	Nervous system disorders	Mental impairment	1	1	0
2021	10	26	Reproductive system and breast disorders	Breast enlargement	1	1	0
2021	10	26	Eye disorders	Vision blurred	1	1	0
2021	10	26	Investigations	Blood pressure decreased	1	1	0
2021	10	26	Nervous system disorders	Balance disorder	1	1	0
2021	10	26	Nervous system disorders	Disturbance in attention	1	1	0
2021	10	26	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	10	26	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	10	26	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	10	26	Ear and labyrinth disorders	Deafness	1	1	0
2021	10	26	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	26	Infections and infestations	Injection site cellulitis	1	1	0
2021	10	26	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	10	26	Nervous system disorders	Dysarthria	1	1	0
2021	10	27	General disorders and administration site conditions	Injection site reaction	11	11	0
2021	10	27	General disorders and administration site conditions	Chest pain	8	8	0
2021	10	27	General disorders and administration site conditions	Fatigue	7	7	0
2021	10	27	Nervous system disorders	Headache	7	7	0
2021	10	27	General disorders and administration site conditions	Pyrexia	6	6	0
2021	10	27	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2021	10	27	Nervous system disorders	Dizziness	5	5	0
2021	10	27	Gastrointestinal disorders	Nausea	5	5	0
2021	10	27	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2021	10	27	Nervous system disorders	Paraesthesia	3	3	0
2021	10	27	Gastrointestinal disorders	Vomiting	2	2	0
2021	10	27	General disorders and administration site conditions	Peripheral swelling	2	2	0
2021	10	27	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2021	10	27	General disorders and administration site conditions	Swelling face	2	2	0
2021	10	27	General disorders and administration site conditions	Chills	2	2	0
2021	10	27	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	10	27	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	10	27	Cardiac disorders	Palpitations	2	2	0
2021	10	27	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2021	10	27	Skin and subcutaneous tissue disorders	Swelling face	2	2	0
2021	10	27	Metabolism and nutrition disorders	Dehydration	2	2	0
2021	10	27	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	10	27	Cardiac disorders	Cardiac flutter	2	2	0
2021	10	27	Investigations	Heart rate increased	1	1	0
2021	10	27	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	10	27	Nervous system disorders	Presyncope	1	1	0
2021	10	27	Psychiatric disorders	Sleep disorder	1	1	0
2021	10	27	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	27	General disorders and administration site conditions	Malaise	1	1	0
2021	10	27	Infections and infestations	Herpes zoster	1	1	0
2021	10	27	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	10	27	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2021	10	27	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	10	27	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2021	10	27	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2021	10	27	Eye disorders	Vision blurred	1	1	0
2021	10	27	Gastrointestinal disorders	Flatulence	1	1	0
2021	10	27	Nervous system disorders	Balance disorder	1	1	0
2021	10	27	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	10	27	Cardiac disorders	Arrhythmia	1	1	0
2021	10	27	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	27	Nervous system disorders	Hypoaesthesia	1	1	0
2021	10	27	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	27	Nervous system disorders	Generalised tonic-clonic seizure	1	1	0
2021	10	27	Skin and subcutaneous tissue disorders	Petechiae	1	1	0
2021	10	27	General disorders and administration site conditions	Facial pain	1	1	0
2021	10	27	General disorders and administration site conditions	Injection site pain	1	1	0
2021	10	27	Psychiatric disorders	Confusional state	1	1	0
2021	10	27	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	27	Psychiatric disorders	Delirium	1	1	0
2021	10	27	Skin and subcutaneous tissue disorders	Pityriasis rosea	1	1	0
2021	10	27	Skin and subcutaneous tissue disorders	Rash maculo-papular	1	1	0
2021	10	27	Gastrointestinal disorders	Retching	1	1	0
2021	10	27	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	27	Nervous system disorders	Tremor	1	1	0
2021	10	27	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	10	27	General disorders and administration site conditions	Asthenia	1	1	0
2021	10	27	Psychiatric disorders	Thinking abnormal	1	1	0
2021	10	27	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	10	27	Skin and subcutaneous tissue disorders	Sensitive skin	1	1	0
2021	10	27	Vascular disorders	Flushing	1	1	0
2021	10	27	Cardiac disorders	Cardiac discomfort	1	1	0
2021	10	27	Gastrointestinal disorders	Swollen tongue	1	1	0
2021	10	27	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2021	10	27	Psychiatric disorders	Insomnia	1	1	0
2021	10	27	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	27	Respiratory, thoracic and mediastinal disorders	Sneezing	1	1	0
2021	10	27	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2021	10	27	Cardiac disorders	Pericarditis	1	1	0
2021	10	27	Gastrointestinal disorders	Haematemesis	1	1	0
2021	10	27	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	10	27	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	27	Nervous system disorders	Migraine	1	1	0
2021	10	27	Vascular disorders	Peripheral coldness	1	1	0
2021	10	28	Gastrointestinal disorders	Nausea	5	5	0
2021	10	28	Cardiac disorders	Palpitations	4	4	0
2021	10	28	Skin and subcutaneous tissue disorders	Rash	4	4	0
2021	10	28	Cardiac disorders	Pericarditis	4	4	0
2021	10	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	10	28	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	28	Nervous system disorders	Headache	3	3	0
2021	10	28	General disorders and administration site conditions	Chest pain	3	3	0
2021	10	28	General disorders and administration site conditions	Injection site reaction	3	3	0
2021	10	28	General disorders and administration site conditions	Swelling	2	2	0
2021	10	28	Nervous system disorders	Dizziness	2	2	0
2021	10	28	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	10	28	General disorders and administration site conditions	Pain	2	2	0
2021	10	28	General disorders and administration site conditions	Pyrexia	2	2	0
2021	10	28	Nervous system disorders	Seizure	1	1	0
2021	10	28	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	10	28	Investigations	Troponin abnormal	1	1	0
2021	10	28	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2021	10	28	General disorders and administration site conditions	Injection site pruritus	1	1	0
2021	10	28	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Lymphoma	1	1	0
2021	10	28	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	10	28	Investigations	Heart rate irregular	1	1	0
2021	10	28	Nervous system disorders	Hypoaesthesia	1	1	0
2021	10	28	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	28	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	28	Psychiatric disorders	Emotional distress	1	1	0
2021	10	28	General disorders and administration site conditions	Injection site pain	1	1	0
2021	10	28	Nervous system disorders	Memory impairment	1	1	0
2021	10	28	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	28	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	28	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	10	28	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	10	28	Nervous system disorders	Tremor	1	1	0
2021	10	28	Cardiac disorders	Myocarditis	1	1	0
2021	10	28	Nervous system disorders	Paraesthesia	1	1	0
2021	10	28	Nervous system disorders	Syncope	1	1	0
2021	10	28	Cardiac disorders	Pericardial effusion	1	1	0
2021	10	28	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	10	28	Nervous system disorders	Migraine	1	1	0
2021	10	29	General disorders and administration site conditions	Injection site reaction	13	12	0
2021	10	29	Nervous system disorders	Headache	12	12	0
2021	10	29	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	10	29	General disorders and administration site conditions	Pyrexia	8	8	0
2021	10	29	Blood and lymphatic system disorders	Lymphadenopathy	7	7	0
2021	10	29	General disorders and administration site conditions	Chest pain	7	7	0
2021	10	29	Nervous system disorders	Presyncope	4	4	0
2021	10	29	Nervous system disorders	Hypoaesthesia	4	4	0
2021	10	29	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2021	10	29	General disorders and administration site conditions	Injection site pain	4	4	0
2021	10	29	Nervous system disorders	Paraesthesia	4	4	0
2021	10	29	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	29	Skin and subcutaneous tissue disorders	Rash	3	3	0
2021	10	29	Nervous system disorders	Lethargy	3	3	0
2021	10	29	Cardiac disorders	Tachycardia	3	3	0
2021	10	29	Gastrointestinal disorders	Abdominal pain	3	3	0
2021	10	29	Eye disorders	Vision blurred	2	2	0
2021	10	29	Nervous system disorders	Dizziness	2	2	0
2021	10	29	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	10	29	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	10	29	General disorders and administration site conditions	Injection site pruritus	2	2	0
2021	10	29	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	10	29	Skin and subcutaneous tissue disorders	Angioedema	2	2	0
2021	10	29	Cardiac disorders	Myocarditis	2	2	0
2021	10	29	Cardiac disorders	Palpitations	2	2	0
2021	10	29	Immune system disorders	Hypersensitivity	2	2	0
2021	10	29	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	10	29	Ear and labyrinth disorders	Ear pain	1	1	0
2021	10	29	Investigations	Cardiac murmur	1	1	0
2021	10	29	Skin and subcutaneous tissue disorders	Skin discolouration	1	1	0
2021	10	29	Investigations	Blood pressure decreased	1	1	0
2021	10	29	Psychiatric disorders	Disorientation	1	1	0
2021	10	29	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	10	29	Cardiac disorders	Pericardial rub	1	1	0
2021	10	29	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	10	29	Gastrointestinal disorders	Hypoaesthesia oral	1	1	0
2021	10	29	General disorders and administration site conditions	Chills	1	1	0
2021	10	29	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	10	29	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2021	10	29	Investigations	Electrocardiogram normal	1	1	0
2021	10	29	Investigations	Troponin I increased	1	1	0
2021	10	29	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	10	29	Nervous system disorders	Central nervous system lesion	1	1	0
2021	10	29	Nervous system disorders	Seizure	1	0	0
2021	10	29	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2021	10	29	Ear and labyrinth disorders	Deafness unilateral	1	1	0
2021	10	29	Infections and infestations	Helicobacter gastritis	1	1	0
2021	10	29	Injury, poisoning and procedural complications	Subdural haematoma	1	1	0
2021	10	29	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2021	10	29	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2021	10	29	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	29	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2021	10	29	General disorders and administration site conditions	Discomfort	1	1	0
2021	10	29	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2021	10	29	Nervous system disorders	Guillain-Barre syndrome	1	1	0
2021	10	29	Nervous system disorders	Hemiparesis	1	1	0
2021	10	29	Psychiatric disorders	Restlessness	1	1	0
2021	10	29	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	10	29	Gastrointestinal disorders	Nausea	1	1	0
2021	10	29	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	29	Injury, poisoning and procedural complications	Maternal exposure during breast feeding	1	1	0
2021	10	29	Investigations	Oxygen saturation decreased	1	1	0
2021	10	29	Investigations	Troponin increased	1	1	0
2021	10	29	Nervous system disorders	Paralysis	1	1	0
2021	10	29	Pregnancy, puerperium and perinatal conditions	Foetal hypokinesia	1	1	0
2021	10	29	Psychiatric disorders	Delirium	1	1	0
2021	10	29	Cardiac disorders	Pericarditis	1	1	0
2021	10	29	Infections and infestations	Epididymitis	1	1	0
2021	10	29	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	10	29	Pregnancy, puerperium and perinatal conditions	Abortion threatened	1	1	0
2021	10	29	Gastrointestinal disorders	Swollen tongue	1	1	0
2021	10	29	Investigations	C-reactive protein increased	1	1	0
2021	10	29	Nervous system disorders	Syncope	1	1	0
2021	10	29	Eye disorders	Diplopia	1	1	0
2021	10	29	General disorders and administration site conditions	Asthenia	1	1	0
2021	10	29	Investigations	Echocardiogram normal	1	1	0
2021	10	29	Nervous system disorders	Burning sensation	1	1	0
2021	10	29	Vascular disorders	Flushing	1	1	0
2021	10	29	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	10	30	General disorders and administration site conditions	Fatigue	4	4	0
2021	10	30	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	10	30	Nervous system disorders	Dizziness	2	2	0
2021	10	30	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	10	30	General disorders and administration site conditions	Chest pain	2	2	0
2021	10	30	General disorders and administration site conditions	Pyrexia	2	2	0
2021	10	30	Nervous system disorders	Headache	2	2	0
2021	10	30	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	10	30	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	10	30	Investigations	Heart rate increased	1	1	0
2021	10	30	Eye disorders	Eye oedema	1	1	0
2021	10	30	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	10	30	General disorders and administration site conditions	Malaise	1	1	0
2021	10	30	Infections and infestations	Herpes zoster	1	1	0
2021	10	30	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	10	30	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	10	30	General disorders and administration site conditions	Pain	1	1	0
2021	10	30	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	10	30	Vascular disorders	Flushing	1	1	0
2021	10	30	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	10	30	Eye disorders	Lacrimal gland enlargement	1	1	0
2021	10	30	General disorders and administration site conditions	Injection site rash	1	1	0
2021	10	30	Vascular disorders	Hot flush	1	1	0
2021	10	30	Gastrointestinal disorders	Nausea	1	1	0
2021	10	30	Gastrointestinal disorders	Vomiting	1	1	0
2021	10	30	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	30	Nervous system disorders	Lethargy	1	1	0
2021	10	30	Psychiatric disorders	Confusional state	1	1	0
2021	10	30	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2021	10	31	General disorders and administration site conditions	Injection site reaction	6	6	0
2021	10	31	Nervous system disorders	Headache	5	3	0
2021	10	31	General disorders and administration site conditions	Fatigue	3	3	0
2021	10	31	Respiratory, thoracic and mediastinal disorders	Cough	3	3	0
2021	10	31	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	10	31	Nervous system disorders	Paraesthesia	2	2	0
2021	10	31	General disorders and administration site conditions	Pain	2	1	0
2021	10	31	General disorders and administration site conditions	Swelling	2	2	0
2021	10	31	Reproductive system and breast disorders	Menstruation delayed	2	2	0
2021	10	31	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	10	31	Blood and lymphatic system disorders	Lymphadenopathy	2	1	0
2021	10	31	Gastrointestinal disorders	Nausea	2	2	0
2021	10	31	General disorders and administration site conditions	Injection site pain	2	2	0
2021	10	31	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	0	0
2021	10	31	General disorders and administration site conditions	Oedema	1	1	0
2021	10	31	Investigations	Hepatic enzyme increased	1	1	0
2021	10	31	Psychiatric disorders	Anxiety	1	0	0
2021	10	31	General disorders and administration site conditions	Injection site joint movement impairment	1	1	0
2021	10	31	General disorders and administration site conditions	Pyrexia	1	1	0
2021	10	31	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	10	31	Cardiac disorders	Palpitations	1	0	0
2021	10	31	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	10	31	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	10	31	Eye disorders	Vision blurred	1	0	0
2021	10	31	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	10	31	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	10	31	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2021	10	31	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	10	31	Cardiac disorders	Tachycardia	1	1	0
2021	10	31	General disorders and administration site conditions	Asthenia	1	1	0
2021	10	31	Psychiatric disorders	Confusional state	1	0	0
2021	10	31	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	10	31	Respiratory, thoracic and mediastinal disorders	Stridor	1	1	0
2021	10	31	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	10	31	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	11	1	General disorders and administration site conditions	Injection site reaction	11	11	0
2021	11	1	General disorders and administration site conditions	Chest pain	9	9	0
2021	11	1	Cardiac disorders	Palpitations	8	8	0
2021	11	1	Musculoskeletal and connective tissue disorders	Pain in extremity	7	7	0
2021	11	1	Gastrointestinal disorders	Nausea	6	6	0
2021	11	1	Nervous system disorders	Headache	6	6	0
2021	11	1	General disorders and administration site conditions	Fatigue	6	6	0
2021	11	1	Skin and subcutaneous tissue disorders	Urticaria	5	5	0
2021	11	1	Skin and subcutaneous tissue disorders	Rash	5	5	0
2021	11	1	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2021	11	1	General disorders and administration site conditions	Injection site pain	3	3	0
2021	11	1	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	11	1	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	11	1	Skin and subcutaneous tissue disorders	Pruritus	3	3	0
2021	11	1	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	11	1	General disorders and administration site conditions	Pyrexia	3	3	0
2021	11	1	Gastrointestinal disorders	Diarrhoea	2	1	0
2021	11	1	Nervous system disorders	Bell's palsy	2	2	0
2021	11	1	Nervous system disorders	Lethargy	2	1	0
2021	11	1	Nervous system disorders	Paraesthesia	2	2	0
2021	11	1	Gastrointestinal disorders	Vomiting	2	1	0
2021	11	1	Nervous system disorders	Presyncope	2	2	0
2021	11	1	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	1	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	1	Cardiac disorders	Pericarditis	2	2	0
2021	11	1	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2021	11	1	Blood and lymphatic system disorders	Immune thrombocytopenia	1	1	0
2021	11	1	Musculoskeletal and connective tissue disorders	Synovitis	1	1	0
2021	11	1	Nervous system disorders	Balance disorder	1	1	0
2021	11	1	Respiratory, thoracic and mediastinal disorders	Painful respiration	1	1	0
2021	11	1	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	11	1	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	1	General disorders and administration site conditions	Chills	1	1	0
2021	11	1	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	11	1	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2021	11	1	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2021	11	1	Investigations	Heart rate increased	1	1	0
2021	11	1	Nervous system disorders	Dizziness	1	1	0
2021	11	1	Vascular disorders	Hypertension	1	1	0
2021	11	1	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	1	Eye disorders	Blepharospasm	1	1	0
2021	11	1	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	1	Gastrointestinal disorders	Abdominal distension	1	1	0
2021	11	1	General disorders and administration site conditions	Injection site hypoaesthesia	1	1	0
2021	11	1	Investigations	Troponin increased	1	1	0
2021	11	1	Nervous system disorders	Ageusia	1	1	0
2021	11	1	General disorders and administration site conditions	Injection site nodule	1	1	0
2021	11	1	Investigations	Body temperature abnormal	1	1	0
2021	11	1	Investigations	Fibrin D dimer increased	1	1	0
2021	11	1	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	11	1	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	1	Nervous system disorders	Hypokinesia	1	1	0
2021	11	1	Nervous system disorders	Sedation	1	1	0
2021	11	1	Skin and subcutaneous tissue disorders	Petechiae	1	1	0
2021	11	1	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	11	1	Vascular disorders	Hypotension	1	1	0
2021	11	1	General disorders and administration site conditions	Swelling	1	1	0
2021	11	1	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	11	1	Nervous system disorders	Migraine	1	1	0
2021	11	1	General disorders and administration site conditions	Injection site mass	1	1	0
2021	11	1	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2021	11	1	Infections and infestations	Ear infection	1	1	0
2021	11	1	Nervous system disorders	Anosmia	1	1	0
2021	11	1	Nervous system disorders	Syncope	1	1	0
2021	11	1	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	1	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	1	Nervous system disorders	Tremor	1	1	0
2021	11	1	Cardiac disorders	Tachycardia	1	1	0
2021	11	1	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	11	1	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	11	1	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	1	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	11	2	Nervous system disorders	Headache	7	6	0
2021	11	2	General disorders and administration site conditions	Chest pain	7	5	0
2021	11	2	Musculoskeletal and connective tissue disorders	Myalgia	5	4	0
2021	11	2	Gastrointestinal disorders	Nausea	5	4	0
2021	11	2	General disorders and administration site conditions	Injection site reaction	5	5	0
2021	11	2	General disorders and administration site conditions	Fatigue	4	3	0
2021	11	2	Ear and labyrinth disorders	Vertigo	4	4	0
2021	11	2	Cardiac disorders	Palpitations	4	4	0
2021	11	2	General disorders and administration site conditions	Pyrexia	4	3	0
2021	11	2	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	11	2	Nervous system disorders	Dizziness	3	2	0
2021	11	2	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	2	0
2021	11	2	Investigations	Heart rate increased	2	2	0
2021	11	2	General disorders and administration site conditions	Injection site pain	2	2	0
2021	11	2	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	11	2	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	2	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	11	2	Respiratory, thoracic and mediastinal disorders	Epistaxis	2	2	0
2021	11	2	Nervous system disorders	Presyncope	2	2	0
2021	11	2	Nervous system disorders	Syncope	2	2	0
2021	11	2	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2021	11	2	Nervous system disorders	Balance disorder	2	1	0
2021	11	2	Nervous system disorders	Paraesthesia	2	2	0
2021	11	2	Nervous system disorders	Seizure	2	2	0
2021	11	2	Cardiac disorders	Pericarditis	1	1	0
2021	11	2	Infections and infestations	Vaccination site cellulitis	1	1	0
2021	11	2	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2021	11	2	Musculoskeletal and connective tissue disorders	Muscle spasms	1	0	0
2021	11	2	Nervous system disorders	Migraine	1	1	0
2021	11	2	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2021	11	2	Eye disorders	Iridocyclitis	1	1	0
2021	11	2	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	11	2	Reproductive system and breast disorders	Vaginal haemorrhage	1	0	0
2021	11	2	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	2	Eye disorders	Vision blurred	1	0	0
2021	11	2	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	2	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	11	2	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	11	2	Cardiac disorders	Tachycardia	1	1	0
2021	11	2	Gastrointestinal disorders	Gastrooesophageal reflux disease	1	0	0
2021	11	2	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	2	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	11	2	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	2	Cardiac disorders	Arrhythmia	1	1	0
2021	11	2	Eye disorders	Eye irritation	1	1	0
2021	11	2	Infections and infestations	Appendicitis	1	1	0
2021	11	2	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	2	Musculoskeletal and connective tissue disorders	Myofascial pain syndrome	1	1	0
2021	11	2	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	0	0
2021	11	2	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	11	2	Vascular disorders	Hypotension	1	1	0
2021	11	2	Nervous system disorders	Lethargy	1	1	0
2021	11	2	Psychiatric disorders	Confusional state	1	1	0
2021	11	2	Gastrointestinal disorders	Vomiting	1	1	0
2021	11	2	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	11	2	Blood and lymphatic system disorders	Lymphadenitis	1	1	0
2021	11	2	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	2	Gastrointestinal disorders	Toothache	1	0	0
2021	11	2	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	2	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	2	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	2	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	11	3	General disorders and administration site conditions	Injection site reaction	17	17	0
2021	11	3	Nervous system disorders	Headache	11	11	0
2021	11	3	Gastrointestinal disorders	Nausea	8	8	0
2021	11	3	Blood and lymphatic system disorders	Lymphadenopathy	8	8	0
2021	11	3	General disorders and administration site conditions	Chest discomfort	7	7	0
2021	11	3	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2021	11	3	General disorders and administration site conditions	Chest pain	6	6	0
2021	11	3	Nervous system disorders	Dizziness	5	5	0
2021	11	3	Skin and subcutaneous tissue disorders	Rash	5	5	0
2021	11	3	Musculoskeletal and connective tissue disorders	Pain in extremity	5	5	0
2021	11	3	General disorders and administration site conditions	Pyrexia	5	5	0
2021	11	3	General disorders and administration site conditions	Fatigue	5	5	0
2021	11	3	Nervous system disorders	Syncope	4	4	0
2021	11	3	General disorders and administration site conditions	Malaise	4	4	0
2021	11	3	Nervous system disorders	Lethargy	3	3	0
2021	11	3	Nervous system disorders	Paraesthesia	3	3	0
2021	11	3	Gastrointestinal disorders	Vomiting	3	3	0
2021	11	3	Cardiac disorders	Palpitations	3	3	0
2021	11	3	Eye disorders	Vision blurred	3	3	0
2021	11	3	Psychiatric disorders	Confusional state	2	2	0
2021	11	3	Investigations	Heart rate increased	2	2	0
2021	11	3	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	11	3	Vascular disorders	Pallor	2	2	0
2021	11	3	General disorders and administration site conditions	Feeling hot	2	2	0
2021	11	3	Investigations	Electrocardiogram abnormal	2	2	0
2021	11	3	Cardiac disorders	Pericarditis	2	2	0
2021	11	3	Respiratory, thoracic and mediastinal disorders	Throat tightness	2	2	0
2021	11	3	Cardiac disorders	Tachycardia	2	2	0
2021	11	3	General disorders and administration site conditions	Chills	2	2	0
2021	11	3	Psychiatric disorders	Insomnia	2	2	0
2021	11	3	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	11	3	Nervous system disorders	Dyskinesia	2	2	0
2021	11	3	Cardiac disorders	Myopericarditis	2	2	0
2021	11	3	Respiratory, thoracic and mediastinal disorders	Epistaxis	2	2	0
2021	11	3	General disorders and administration site conditions	Pain	2	2	0
2021	11	3	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	3	Gastrointestinal disorders	Swollen tongue	2	2	0
2021	11	3	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	11	3	Endocrine disorders	Thyrotoxic crisis	1	1	0
2021	11	3	General disorders and administration site conditions	Injection site rash	1	1	0
2021	11	3	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	11	3	Investigations	Electrocardiogram	1	1	0
2021	11	3	Nervous system disorders	Somnolence	1	1	0
2021	11	3	Eye disorders	Iritis	1	1	0
2021	11	3	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	11	3	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	11	3	Nervous system disorders	Head discomfort	1	1	0
2021	11	3	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	3	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2021	11	3	General disorders and administration site conditions	Injection site pain	1	1	0
2021	11	3	Investigations	Chest X-ray	1	1	0
2021	11	3	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	3	Psychiatric disorders	Hallucination	1	1	0
2021	11	3	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	3	Skin and subcutaneous tissue disorders	Dermatitis	1	1	0
2021	11	3	Investigations	Troponin increased	1	1	0
2021	11	3	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	3	Respiratory, thoracic and mediastinal disorders	Dry throat	1	1	0
2021	11	3	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	11	3	Skin and subcutaneous tissue disorders	Rash morbilliform	1	1	0
2021	11	3	Cardiac disorders	Myocarditis	1	1	0
2021	11	3	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	11	3	Investigations	Echocardiogram	1	1	0
2021	11	3	Cardiac disorders	Pericardial effusion	1	1	0
2021	11	3	Gastrointestinal disorders	Dysphagia	1	1	0
2021	11	3	General disorders and administration site conditions	Swelling	1	1	0
2021	11	3	Nervous system disorders	Migraine	1	1	0
2021	11	3	Skin and subcutaneous tissue disorders	Blister	1	1	0
2021	11	3	Eye disorders	Eye pain	1	1	0
2021	11	3	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	3	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	11	3	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	3	Investigations	White blood cell count decreased	1	1	0
2021	11	3	Nervous system disorders	Tremor	1	1	0
2021	11	3	Renal and urinary disorders	Renal pain	1	1	0
2021	11	3	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	11	3	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	11	3	Nervous system disorders	Taste disorder	1	1	0
2021	11	3	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	11	3	Vascular disorders	Flushing	1	1	0
2021	11	3	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2021	11	3	Investigations	Blood pressure decreased	1	1	0
2021	11	3	Nervous system disorders	Disturbance in attention	1	1	0
2021	11	3	Nervous system disorders	Seizure	1	1	0
2021	11	3	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	3	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	3	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	11	3	Investigations	Troponin I increased	1	1	0
2021	11	3	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	11	3	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2021	11	3	Nervous system disorders	Tension headache	1	1	0
2021	11	3	Cardiac disorders	Bundle branch block right	1	1	0
2021	11	3	Ear and labyrinth disorders	Ear pain	1	1	0
2021	11	3	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	3	Nervous system disorders	Presyncope	1	1	0
2021	11	3	Vascular disorders	Hypertension	1	1	0
2021	11	3	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	3	Infections and infestations	Injection site infection	1	1	0
2021	11	4	Nervous system disorders	Headache	9	9	0
2021	11	4	General disorders and administration site conditions	Fatigue	7	6	0
2021	11	4	Musculoskeletal and connective tissue disorders	Myalgia	7	6	0
2021	11	4	General disorders and administration site conditions	Injection site reaction	6	5	0
2021	11	4	Musculoskeletal and connective tissue disorders	Pain in extremity	6	5	0
2021	11	4	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2021	11	4	General disorders and administration site conditions	Chills	4	3	0
2021	11	4	Nervous system disorders	Dizziness	4	4	0
2021	11	4	General disorders and administration site conditions	Pyrexia	4	4	0
2021	11	4	General disorders and administration site conditions	Chest pain	4	4	0
2021	11	4	Gastrointestinal disorders	Nausea	3	3	0
2021	11	4	Investigations	Heart rate increased	3	3	0
2021	11	4	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	11	4	Gastrointestinal disorders	Vomiting	3	3	0
2021	11	4	General disorders and administration site conditions	Injection site pain	3	3	0
2021	11	4	Nervous system disorders	Syncope	3	3	0
2021	11	4	Nervous system disorders	Tremor	2	2	0
2021	11	4	Cardiac disorders	Arrhythmia	2	2	0
2021	11	4	General disorders and administration site conditions	Injection site rash	2	2	0
2021	11	4	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	11	4	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	11	4	General disorders and administration site conditions	Malaise	2	2	0
2021	11	4	Skin and subcutaneous tissue disorders	Rash pruritic	2	2	0
2021	11	4	Investigations	Heart rate irregular	2	2	0
2021	11	4	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	4	Psychiatric disorders	Dysphemia	1	1	0
2021	11	4	Skin and subcutaneous tissue disorders	Petechiae	1	1	0
2021	11	4	Cardiac disorders	Palpitations	1	1	0
2021	11	4	Psychiatric disorders	Confusional state	1	1	0
2021	11	4	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	4	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	11	4	General disorders and administration site conditions	Ulcer	1	1	0
2021	11	4	Nervous system disorders	Bell's palsy	1	1	0
2021	11	4	Nervous system disorders	Loss of consciousness	1	1	0
2021	11	4	Skin and subcutaneous tissue disorders	Yellow skin	1	1	0
2021	11	4	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	11	4	Cardiac disorders	Tachycardia	1	1	0
2021	11	4	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	4	General disorders and administration site conditions	Pain	1	1	0
2021	11	4	Nervous system disorders	Burning sensation	1	1	0
2021	11	4	Nervous system disorders	Electric shock sensation	1	1	0
2021	11	4	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	4	Respiratory, thoracic and mediastinal disorders	Pharyngeal paraesthesia	1	1	0
2021	11	4	Cardiac disorders	Myocarditis	1	1	0
2021	11	4	Nervous system disorders	Paraesthesia	1	1	0
2021	11	4	Psychiatric disorders	Insomnia	1	1	0
2021	11	4	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	4	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2021	11	4	Cardiac disorders	Pericarditis	1	1	0
2021	11	4	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	4	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	4	General disorders and administration site conditions	Swelling	1	1	0
2021	11	4	Nervous system disorders	Migraine	1	1	0
2021	11	4	Vascular disorders	Peripheral coldness	1	1	0
2021	11	4	Eye disorders	Photophobia	1	0	0
2021	11	4	Eye disorders	Vision blurred	1	1	0
2021	11	4	Gastrointestinal disorders	Toothache	1	0	0
2021	11	4	Investigations	Blood urine present	1	1	0
2021	11	4	Nervous system disorders	Amnesia	1	1	0
2021	11	4	Nervous system disorders	Seizure	1	1	0
2021	11	4	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	4	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	11	4	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	4	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	11	4	Vascular disorders	Hypertension	1	1	0
2021	11	4	Vascular disorders	Pallor	1	1	0
2021	11	4	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	4	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	11	4	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	4	General disorders and administration site conditions	Injection site pruritus	1	1	0
2021	11	4	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	11	5	General disorders and administration site conditions	Chest pain	13	13	0
2021	11	5	Gastrointestinal disorders	Nausea	7	7	0
2021	11	5	General disorders and administration site conditions	Injection site reaction	7	7	0
2021	11	5	Musculoskeletal and connective tissue disorders	Pain in extremity	6	6	0
2021	11	5	Nervous system disorders	Dizziness	6	6	0
2021	11	5	Nervous system disorders	Headache	6	6	0
2021	11	5	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2021	11	5	Nervous system disorders	Paraesthesia	5	5	0
2021	11	5	General disorders and administration site conditions	Pyrexia	5	5	0
2021	11	5	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2021	11	5	General disorders and administration site conditions	Injection site pain	4	4	0
2021	11	5	General disorders and administration site conditions	Fatigue	4	4	0
2021	11	5	Nervous system disorders	Migraine	3	3	0
2021	11	5	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	11	5	General disorders and administration site conditions	Concomitant disease aggravated	3	3	0
2021	11	5	Nervous system disorders	Hypoaesthesia	3	3	0
2021	11	5	General disorders and administration site conditions	Influenza like illness	3	3	0
2021	11	5	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	11	5	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	11	5	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	11	5	Cardiac disorders	Palpitations	2	2	0
2021	11	5	Nervous system disorders	Syncope	2	2	0
2021	11	5	General disorders and administration site conditions	Chills	2	2	0
2021	11	5	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	2	2	0
2021	11	5	Nervous system disorders	Dysgeusia	2	2	0
2021	11	5	Nervous system disorders	Lethargy	2	2	0
2021	11	5	General disorders and administration site conditions	Peripheral swelling	2	2	0
2021	11	5	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2021	11	5	Ear and labyrinth disorders	Tinnitus	2	2	0
2021	11	5	Eye disorders	Vision blurred	1	1	0
2021	11	5	Immune system disorders	Anaphylactic reaction	1	1	0
2021	11	5	Nervous system disorders	Seizure	1	1	0
2021	11	5	Psychiatric disorders	Disorientation	1	1	0
2021	11	5	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	5	Respiratory, thoracic and mediastinal disorders	Haemoptysis	1	1	0
2021	11	5	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	11	5	Nervous system disorders	Dysarthria	1	1	0
2021	11	5	Nervous system disorders	Neuralgia	1	1	0
2021	11	5	Cardiac disorders	Bundle branch block right	1	1	0
2021	11	5	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	11	5	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	5	Vascular disorders	Hypertension	1	1	0
2021	11	5	Vascular disorders	Pallor	1	1	0
2021	11	5	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	11	5	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	5	General disorders and administration site conditions	Malaise	1	1	0
2021	11	5	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	11	5	Cardiac disorders	Pericarditis	1	1	0
2021	11	5	Cardiac disorders	Myocarditis	1	1	0
2021	11	5	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	11	5	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	5	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	5	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	5	Cardiac disorders	Tachycardia	1	1	0
2021	11	5	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	11	5	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	5	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2021	11	5	Infections and infestations	Nasopharyngitis	1	1	0
2021	11	5	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	11	5	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	5	Respiratory, thoracic and mediastinal disorders	Choking	1	1	0
2021	11	5	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	5	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	11	5	Vascular disorders	Flushing	1	1	0
2021	11	5	General disorders and administration site conditions	Therapeutic response unexpected	1	1	0
2021	11	5	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2021	11	5	Respiratory, thoracic and mediastinal disorders	Sinus congestion	1	1	0
2021	11	5	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	11	5	Eye disorders	Retinal vein occlusion	1	1	0
2021	11	5	Investigations	Electrocardiogram abnormal	1	1	0
2021	11	5	Nervous system disorders	Somnolence	1	1	0
2021	11	5	Vascular disorders	Hypotension	1	1	0
2021	11	5	General disorders and administration site conditions	Injection site nodule	1	1	0
2021	11	5	Gastrointestinal disorders	Vomiting	1	1	0
2021	11	5	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	5	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	11	6	Nervous system disorders	Headache	4	3	0
2021	11	6	General disorders and administration site conditions	Pyrexia	3	2	0
2021	11	6	General disorders and administration site conditions	Chest pain	3	3	0
2021	11	6	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	11	6	Musculoskeletal and connective tissue disorders	Arthralgia	2	1	0
2021	11	6	Gastrointestinal disorders	Vomiting	2	2	0
2021	11	6	Nervous system disorders	Paraesthesia	2	2	0
2021	11	6	Cardiac disorders	Palpitations	2	2	0
2021	11	6	General disorders and administration site conditions	Pain	2	2	0
2021	11	6	General disorders and administration site conditions	Fatigue	2	1	0
2021	11	6	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	11	6	Investigations	Fibrin D dimer increased	1	1	0
2021	11	6	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	11	6	Cardiac disorders	Myocardial ischaemia	1	1	0
2021	11	6	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	6	Nervous system disorders	Ageusia	1	1	0
2021	11	6	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	11	6	General disorders and administration site conditions	Inflammation	1	1	0
2021	11	6	Infections and infestations	Candida infection	1	0	0
2021	11	6	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	6	General disorders and administration site conditions	Injection site rash	1	1	0
2021	11	6	Investigations	Electrocardiogram abnormal	1	1	0
2021	11	6	Cardiac disorders	Pericarditis	1	1	0
2021	11	6	General disorders and administration site conditions	Swelling	1	1	0
2021	11	6	Nervous system disorders	Migraine	1	1	0
2021	11	6	Eye disorders	Photophobia	1	1	0
2021	11	6	Investigations	C-reactive protein increased	1	1	0
2021	11	6	Nervous system disorders	Anosmia	1	1	0
2021	11	6	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	11	6	Cardiac disorders	Tachycardia	1	1	0
2021	11	6	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	6	Nervous system disorders	Tremor	1	1	0
2021	11	6	Cardiac disorders	Angina pectoris	1	1	0
2021	11	6	Nervous system disorders	Dizziness	1	1	0
2021	11	6	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	11	6	Gastrointestinal disorders	Gastrooesophageal reflux disease	1	1	0
2021	11	6	General disorders and administration site conditions	Chills	1	1	0
2021	11	6	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2021	11	6	Nervous system disorders	Neuralgia	1	1	0
2021	11	6	Nervous system disorders	Restless legs syndrome	1	1	0
2021	11	6	Psychiatric disorders	Anxiety	1	1	0
2021	11	7	Nervous system disorders	Migraine	3	3	0
2021	11	7	Nervous system disorders	Headache	3	3	0
2021	11	7	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2021	11	7	General disorders and administration site conditions	Chest pain	2	2	0
2021	11	7	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	11	7	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	7	Gastrointestinal disorders	Nausea	2	2	0
2021	11	7	General disorders and administration site conditions	Injection site hypoaesthesia	1	1	0
2021	11	7	General disorders and administration site conditions	Injection site pain	1	1	0
2021	11	7	Investigations	Body temperature abnormal	1	1	0
2021	11	7	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	7	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	11	7	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	11	7	Vascular disorders	Hypotension	1	1	0
2021	11	7	General disorders and administration site conditions	Feeling hot	1	1	0
2021	11	7	Psychiatric disorders	Agitation	1	1	0
2021	11	7	General disorders and administration site conditions	Fatigue	1	1	0
2021	11	7	General disorders and administration site conditions	Feeling cold	1	1	0
2021	11	7	Immune system disorders	Hypersensitivity	1	1	0
2021	11	7	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	7	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	11	7	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	7	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	11	7	Nervous system disorders	Tremor	1	1	0
2021	11	7	General disorders and administration site conditions	Swelling face	1	1	0
2021	11	7	Nervous system disorders	Dizziness	1	1	0
2021	11	7	Gastrointestinal disorders	Cheilitis	1	1	0
2021	11	7	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	11	7	Gastrointestinal disorders	Lip swelling	1	1	0
2021	11	7	General disorders and administration site conditions	Pyrexia	1	1	0
2021	11	7	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	11	7	Eye disorders	Eye pruritus	1	1	0
2021	11	7	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2021	11	8	General disorders and administration site conditions	Chest pain	12	12	0
2021	11	8	Nervous system disorders	Headache	9	9	0
2021	11	8	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2021	11	8	General disorders and administration site conditions	Injection site reaction	7	7	0
2021	11	8	General disorders and administration site conditions	Pyrexia	6	6	0
2021	11	8	Nervous system disorders	Dizziness	6	6	0
2021	11	8	Gastrointestinal disorders	Nausea	6	6	0
2021	11	8	Cardiac disorders	Palpitations	5	5	0
2021	11	8	General disorders and administration site conditions	Fatigue	4	4	0
2021	11	8	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2021	11	8	General disorders and administration site conditions	Injection site rash	3	3	0
2021	11	8	Nervous system disorders	Lethargy	3	3	0
2021	11	8	Skin and subcutaneous tissue disorders	Rash	3	3	0
2021	11	8	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2021	11	8	Cardiac disorders	Pericarditis	3	3	0
2021	11	8	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	8	Eye disorders	Vision blurred	2	2	0
2021	11	8	General disorders and administration site conditions	Chills	2	2	0
2021	11	8	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	11	8	Cardiac disorders	Myocarditis	2	2	0
2021	11	8	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	8	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	11	8	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	8	Gastrointestinal disorders	Vomiting	1	1	0
2021	11	8	Investigations	Troponin increased	1	1	0
2021	11	8	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	8	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	11	8	Reproductive system and breast disorders	Penis disorder	1	1	0
2021	11	8	Respiratory, thoracic and mediastinal disorders	Dry throat	1	1	0
2021	11	8	Cardiac disorders	Atrioventricular block first degree	1	1	0
2021	11	8	Gastrointestinal disorders	Pancreatitis	1	1	0
2021	11	8	General disorders and administration site conditions	Injection site pain	1	1	0
2021	11	8	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	11	8	Psychiatric disorders	Confusional state	1	1	0
2021	11	8	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	8	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	11	8	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	8	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	8	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2021	11	8	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2021	11	8	Nervous system disorders	Generalised tonic-clonic seizure	1	1	0
2021	11	8	Nervous system disorders	Speech disorder	1	1	0
2021	11	8	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	8	General disorders and administration site conditions	Pain	1	1	0
2021	11	8	Musculoskeletal and connective tissue disorders	Muscle fatigue	1	1	0
2021	11	8	Nervous system disorders	Taste disorder	1	1	0
2021	11	8	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	8	Immune system disorders	Hypersensitivity	1	1	0
2021	11	8	Nervous system disorders	Dysgeusia	1	1	0
2021	11	8	Nervous system disorders	Paraesthesia	1	1	0
2021	11	8	Psychiatric disorders	Insomnia	1	1	0
2021	11	8	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	11	8	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	8	General disorders and administration site conditions	Swelling	1	1	0
2021	11	8	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2021	11	8	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	8	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	11	8	Infections and infestations	Injection site cellulitis	1	1	0
2021	11	8	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	11	8	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2021	11	8	Nervous system disorders	Neuralgia	1	1	0
2021	11	8	Blood and lymphatic system disorders	Immune thrombocytopenia	1	1	0
2021	11	8	Nervous system disorders	Seizure	1	1	0
2021	11	8	Respiratory, thoracic and mediastinal disorders	Painful respiration	1	1	0
2021	11	8	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	11	8	Investigations	Cardiac murmur	1	1	0
2021	11	8	Investigations	Heart rate increased	1	1	0
2021	11	8	Nervous system disorders	Presyncope	1	1	0
2021	11	8	Vascular disorders	Pallor	1	1	0
2021	11	8	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	8	General disorders and administration site conditions	Injection site movement impairment	1	1	0
2021	11	8	General disorders and administration site conditions	Malaise	1	1	0
2021	11	9	General disorders and administration site conditions	Chest pain	11	10	0
2021	11	9	Respiratory, thoracic and mediastinal disorders	Dyspnoea	10	9	0
2021	11	9	Nervous system disorders	Headache	9	9	0
2021	11	9	Nervous system disorders	Dizziness	7	6	0
2021	11	9	General disorders and administration site conditions	Pyrexia	7	7	0
2021	11	9	Musculoskeletal and connective tissue disorders	Myalgia	5	4	0
2021	11	9	Cardiac disorders	Palpitations	4	4	0
2021	11	9	General disorders and administration site conditions	Chest discomfort	4	4	0
2021	11	9	General disorders and administration site conditions	Fatigue	4	3	0
2021	11	9	Investigations	Heart rate increased	3	3	0
2021	11	9	General disorders and administration site conditions	Injection site reaction	3	3	0
2021	11	9	Nervous system disorders	Lethargy	3	3	0
2021	11	9	Gastrointestinal disorders	Nausea	3	2	0
2021	11	9	Musculoskeletal and connective tissue disorders	Arthralgia	3	2	0
2021	11	9	Nervous system disorders	Syncope	3	3	0
2021	11	9	General disorders and administration site conditions	Injection site pain	3	2	0
2021	11	9	General disorders and administration site conditions	Asthenia	2	2	0
2021	11	9	General disorders and administration site conditions	Axillary pain	2	1	0
2021	11	9	Psychiatric disorders	Confusional state	2	2	0
2021	11	9	Nervous system disorders	Tremor	2	2	0
2021	11	9	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	11	9	Nervous system disorders	Paraesthesia	2	2	0
2021	11	9	General disorders and administration site conditions	Chills	2	2	0
2021	11	9	Nervous system disorders	Dysgeusia	2	2	0
2021	11	9	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	11	9	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	11	9	Metabolism and nutrition disorders	Decreased appetite	2	1	0
2021	11	9	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	9	Vascular disorders	Hypertension	2	1	0
2021	11	9	Cardiac disorders	Myocarditis	2	2	0
2021	11	9	Gastrointestinal disorders	Vomiting	2	1	0
2021	11	9	General disorders and administration site conditions	Injection site swelling	2	1	0
2021	11	9	Investigations	Electrocardiogram	1	1	0
2021	11	9	Psychiatric disorders	Emotional disorder	1	1	0
2021	11	9	Skin and subcutaneous tissue disorders	Rash	1	0	0
2021	11	9	Vascular disorders	Hypotension	1	1	0
2021	11	9	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	9	Psychiatric disorders	Stress	1	1	0
2021	11	9	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	11	9	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	11	9	General disorders and administration site conditions	Malaise	1	0	0
2021	11	9	Psychiatric disorders	Delirium	1	1	0
2021	11	9	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	11	9	General disorders and administration site conditions	Injection site induration	1	1	0
2021	11	9	General disorders and administration site conditions	Thirst decreased	1	1	0
2021	11	9	Investigations	Troponin I	1	1	0
2021	11	9	General disorders and administration site conditions	Injection site warmth	1	1	0
2021	11	9	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2021	11	9	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	11	9	Renal and urinary disorders	Renal pain	1	1	0
2021	11	9	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	11	9	General disorders and administration site conditions	Pain	1	1	0
2021	11	9	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	0	0
2021	11	9	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	11	9	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	9	Blood and lymphatic system disorders	Anaemia	1	1	0
2021	11	9	Cardiac disorders	Pericarditis	1	1	0
2021	11	9	Gastrointestinal disorders	Odynophagia	1	1	0
2021	11	9	General disorders and administration site conditions	Feeling hot	1	1	0
2021	11	9	Nervous system disorders	Somnolence	1	0	0
2021	11	9	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2021	11	9	Respiratory, thoracic and mediastinal disorders	Oropharyngeal discomfort	1	0	0
2021	11	9	Skin and subcutaneous tissue disorders	Blister	1	1	0
2021	11	9	Investigations	Echocardiogram	1	1	0
2021	11	9	Psychiatric disorders	Insomnia	1	1	0
2021	11	9	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	9	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	11	9	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2021	11	9	Nervous system disorders	Neuralgia	1	1	0
2021	11	9	Eye disorders	Visual impairment	1	1	0
2021	11	9	Nervous system disorders	Disturbance in attention	1	1	0
2021	11	9	Psychiatric disorders	Disorientation	1	1	0
2021	11	9	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	9	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	9	Respiratory, thoracic and mediastinal disorders	Respiratory alkalosis	1	1	0
2021	11	9	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	11	9	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	11	9	Blood and lymphatic system disorders	Lymphocytosis	1	1	0
2021	11	9	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	9	Cardiac disorders	Extrasystoles	1	1	0
2021	11	9	General disorders and administration site conditions	Injection site pruritus	1	1	0
2021	11	10	General disorders and administration site conditions	Chest pain	15	15	0
2021	11	10	General disorders and administration site conditions	Injection site reaction	15	15	0
2021	11	10	Nervous system disorders	Dizziness	11	11	0
2021	11	10	General disorders and administration site conditions	Pyrexia	10	10	0
2021	11	10	Nervous system disorders	Headache	9	9	0
2021	11	10	General disorders and administration site conditions	Fatigue	9	9	0
2021	11	10	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	11	10	Gastrointestinal disorders	Vomiting	6	6	0
2021	11	10	Blood and lymphatic system disorders	Lymphadenopathy	6	6	0
2021	11	10	Musculoskeletal and connective tissue disorders	Pain in extremity	6	6	0
2021	11	10	Skin and subcutaneous tissue disorders	Rash	6	6	0
2021	11	10	Cardiac disorders	Pericarditis	5	5	0
2021	11	10	Gastrointestinal disorders	Nausea	4	4	0
2021	11	10	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2021	11	10	General disorders and administration site conditions	Chest discomfort	4	4	0
2021	11	10	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	11	10	Nervous system disorders	Paraesthesia	4	4	0
2021	11	10	Cardiac disorders	Tachycardia	4	4	0
2021	11	10	General disorders and administration site conditions	Concomitant disease aggravated	4	4	0
2021	11	10	General disorders and administration site conditions	Injection site pain	3	3	0
2021	11	10	Nervous system disorders	Syncope	3	3	0
2021	11	10	General disorders and administration site conditions	Malaise	3	3	0
2021	11	10	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2021	11	10	General disorders and administration site conditions	Influenza like illness	3	3	0
2021	11	10	General disorders and administration site conditions	Peripheral swelling	3	3	0
2021	11	10	Nervous system disorders	Lethargy	3	3	0
2021	11	10	General disorders and administration site conditions	Chills	2	2	0
2021	11	10	Psychiatric disorders	Anxiety	2	2	0
2021	11	10	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	11	10	Cardiac disorders	Palpitations	2	2	0
2021	11	10	General disorders and administration site conditions	Feeling cold	2	2	0
2021	11	10	Injury, poisoning and procedural complications	Contusion	2	2	0
2021	11	10	Psychiatric disorders	Delirium	2	2	0
2021	11	10	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2021	11	10	Vascular disorders	Pallor	2	2	0
2021	11	10	Vascular disorders	Deep vein thrombosis	2	2	0
2021	11	10	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	10	Infections and infestations	Herpes zoster	1	1	0
2021	11	10	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	11	10	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	11	10	General disorders and administration site conditions	Swelling face	1	1	0
2021	11	10	Investigations	Cardiac murmur	1	1	0
2021	11	10	Investigations	Heart rate increased	1	1	0
2021	11	10	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	10	Nervous system disorders	Facial paralysis	1	1	0
2021	11	10	Skin and subcutaneous tissue disorders	Skin discolouration	1	1	0
2021	11	10	Vascular disorders	Hypertension	1	1	0
2021	11	10	Infections and infestations	Skin infection	1	1	0
2021	11	10	Nervous system disorders	Seizure	1	1	0
2021	11	10	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	10	Gastrointestinal disorders	Gastrooesophageal reflux disease	1	1	0
2021	11	10	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2021	11	10	Investigations	Troponin I increased	1	1	0
2021	11	10	General disorders and administration site conditions	Facial pain	1	1	0
2021	11	10	General disorders and administration site conditions	Vaccination site pain	1	1	0
2021	11	10	Psychiatric disorders	Confusional state	1	1	0
2021	11	10	Psychiatric disorders	Hallucination	1	1	0
2021	11	10	Psychiatric disorders	Restlessness	1	1	0
2021	11	10	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	11	10	Nervous system disorders	Loss of consciousness	1	1	0
2021	11	10	Psychiatric disorders	Emotional distress	1	1	0
2021	11	10	Skin and subcutaneous tissue disorders	Skin sensitisation	1	1	0
2021	11	10	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	11	10	Investigations	Heart rate irregular	1	1	0
2021	11	10	Nervous system disorders	Head discomfort	1	1	0
2021	11	10	General disorders and administration site conditions	Injection site rash	1	1	0
2021	11	10	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	10	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	11	10	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	10	Nervous system disorders	Dyskinesia	1	1	0
2021	11	10	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	10	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	10	Vascular disorders	Flushing	1	1	0
2021	11	10	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2021	11	10	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	10	Gastrointestinal disorders	Dysphagia	1	1	0
2021	11	10	Nervous system disorders	Migraine	1	1	0
2021	11	10	Social circumstances	Bedridden	1	1	0
2021	11	10	Cardiac disorders	Myocarditis	1	1	0
2021	11	10	General disorders and administration site conditions	Injection site mass	1	1	0
2021	11	10	Psychiatric disorders	Insomnia	1	1	0
2021	11	10	Renal and urinary disorders	Pollakiuria	1	1	0
2021	11	10	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	11	11	General disorders and administration site conditions	Chest pain	10	9	0
2021	11	11	General disorders and administration site conditions	Pyrexia	8	7	0
2021	11	11	Nervous system disorders	Headache	7	7	0
2021	11	11	General disorders and administration site conditions	Injection site reaction	7	7	0
2021	11	11	General disorders and administration site conditions	Fatigue	6	6	0
2021	11	11	General disorders and administration site conditions	Pain	5	5	0
2021	11	11	Gastrointestinal disorders	Nausea	5	5	0
2021	11	11	Cardiac disorders	Palpitations	5	5	0
2021	11	11	Musculoskeletal and connective tissue disorders	Myalgia	5	4	0
2021	11	11	General disorders and administration site conditions	Chills	4	4	0
2021	11	11	General disorders and administration site conditions	Malaise	4	3	0
2021	11	11	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	11	11	General disorders and administration site conditions	Injection site pain	4	3	0
2021	11	11	Skin and subcutaneous tissue disorders	Rash	3	3	0
2021	11	11	Nervous system disorders	Dizziness	3	3	0
2021	11	11	Nervous system disorders	Paraesthesia	3	3	0
2021	11	11	Cardiac disorders	Tachycardia	3	3	0
2021	11	11	Nervous system disorders	Migraine	3	3	0
2021	11	11	Nervous system disorders	Tremor	3	3	0
2021	11	11	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	11	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	11	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	11	11	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	11	11	Nervous system disorders	Hypoaesthesia	2	2	0
2021	11	11	Gastrointestinal disorders	Vomiting	2	2	0
2021	11	11	Investigations	Heart rate irregular	2	1	0
2021	11	11	Infections and infestations	Injection site cellulitis	2	2	0
2021	11	11	Nervous system disorders	Lethargy	2	2	0
2021	11	11	Musculoskeletal and connective tissue disorders	Arthralgia	2	1	0
2021	11	11	Cardiac disorders	Pericarditis	2	2	0
2021	11	11	Investigations	Electrocardiogram	2	2	0
2021	11	11	Eye disorders	Vision blurred	1	1	0
2021	11	11	Eye disorders	Visual impairment	1	1	0
2021	11	11	General disorders and administration site conditions	Feeling drunk	1	1	0
2021	11	11	General disorders and administration site conditions	Multiple organ dysfunction syndrome	1	1	0
2021	11	11	Investigations	Troponin T increased	1	1	0
2021	11	11	Nervous system disorders	Aphasia	1	1	0
2021	11	11	Nervous system disorders	Balance disorder	1	1	0
2021	11	11	Nervous system disorders	Seizure	1	1	0
2021	11	11	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	11	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	11	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	11	11	Respiratory, thoracic and mediastinal disorders	Productive cough	1	1	0
2021	11	11	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	11	General disorders and administration site conditions	Injected limb mobility decreased	1	0	0
2021	11	11	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2021	11	11	General disorders and administration site conditions	Peripheral swelling	1	0	0
2021	11	11	Nervous system disorders	Dysarthria	1	1	0
2021	11	11	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	11	11	Respiratory, thoracic and mediastinal disorders	Tachypnoea	1	1	0
2021	11	11	Skin and subcutaneous tissue disorders	Skin mass	1	1	0
2021	11	11	General disorders and administration site conditions	Swelling face	1	1	0
2021	11	11	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	11	Nervous system disorders	Facial paralysis	1	1	0
2021	11	11	Nervous system disorders	Presyncope	1	1	0
2021	11	11	Psychiatric disorders	Depressed mood	1	1	0
2021	11	11	Vascular disorders	Hypertension	1	1	0
2021	11	11	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	11	Gastrointestinal disorders	Gastrointestinal disorder	1	1	0
2021	11	11	General disorders and administration site conditions	Injection site movement impairment	1	1	0
2021	11	11	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	11	11	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	11	Investigations	Red blood cell sedimentation rate abnormal	1	1	0
2021	11	11	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	11	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	11	11	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	11	11	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	11	11	Musculoskeletal and connective tissue disorders	Muscle fatigue	1	1	0
2021	11	11	Nervous system disorders	Taste disorder	1	1	0
2021	11	11	Reproductive system and breast disorders	Amenorrhoea	1	1	0
2021	11	11	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	11	11	Vascular disorders	Flushing	1	1	0
2021	11	11	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	11	Skin and subcutaneous tissue disorders	Blister	1	1	0
2021	11	11	Cardiac disorders	Myocarditis	1	1	0
2021	11	11	Investigations	C-reactive protein increased	1	1	0
2021	11	11	Nervous system disorders	Dysgeusia	1	1	0
2021	11	11	Nervous system disorders	Neuromyopathy	1	1	0
2021	11	11	Nervous system disorders	Syncope	1	1	0
2021	11	11	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	11	Investigations	Body temperature abnormal	1	1	0
2021	11	11	Reproductive system and breast disorders	Breast pain	1	1	0
2021	11	11	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	11	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	11	11	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	11	Musculoskeletal and connective tissue disorders	Joint stiffness	1	1	0
2021	11	11	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	11	11	Respiratory, thoracic and mediastinal disorders	Dry throat	1	1	0
2021	11	11	Skin and subcutaneous tissue disorders	Parapsoriasis	1	1	0
2021	11	11	Gastrointestinal disorders	Mouth ulceration	1	1	0
2021	11	11	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	11	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	11	11	Nervous system disorders	Coordination abnormal	1	1	0
2021	11	12	General disorders and administration site conditions	Chest pain	9	8	0
2021	11	12	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	11	12	General disorders and administration site conditions	Injection site reaction	6	6	0
2021	11	12	General disorders and administration site conditions	Fatigue	5	5	0
2021	11	12	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2021	11	12	Nervous system disorders	Headache	5	5	0
2021	11	12	Gastrointestinal disorders	Nausea	5	5	0
2021	11	12	General disorders and administration site conditions	Pyrexia	4	3	0
2021	11	12	Gastrointestinal disorders	Diarrhoea	4	4	0
2021	11	12	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2021	11	12	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2021	11	12	General disorders and administration site conditions	Injection site pain	3	3	0
2021	11	12	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2021	11	12	Nervous system disorders	Lethargy	3	3	0
2021	11	12	Nervous system disorders	Dizziness	3	3	0
2021	11	12	Cardiac disorders	Palpitations	3	3	0
2021	11	12	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	11	12	General disorders and administration site conditions	Chills	2	2	0
2021	11	12	General disorders and administration site conditions	Injected limb mobility decreased	2	2	0
2021	11	12	Musculoskeletal and connective tissue disorders	Joint swelling	2	2	0
2021	11	12	Nervous system disorders	Seizure	2	2	0
2021	11	12	Investigations	C-reactive protein increased	2	2	0
2021	11	12	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	11	12	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	12	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2021	11	12	Investigations	Electrocardiogram T wave peaked	1	1	0
2021	11	12	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	12	Cardiac disorders	Pericardial rub	1	1	0
2021	11	12	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	11	12	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2021	11	12	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	11	12	Investigations	Blood alkaline phosphatase increased	1	1	0
2021	11	12	Investigations	Rheumatoid factor increased	1	1	0
2021	11	12	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	12	Reproductive system and breast disorders	Postmenopausal haemorrhage	1	1	0
2021	11	12	General disorders and administration site conditions	Malaise	1	1	0
2021	11	12	Gastrointestinal disorders	Vomiting	1	1	0
2021	11	12	Nervous system disorders	Loss of consciousness	1	1	0
2021	11	12	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	11	12	Cardiac disorders	Tachycardia	1	0	0
2021	11	12	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	12	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	12	General disorders and administration site conditions	Injection site rash	1	1	0
2021	11	12	Investigations	Electrocardiogram abnormal	1	1	0
2021	11	12	Nervous system disorders	Somnolence	1	1	0
2021	11	12	Cardiac disorders	Arrhythmia	1	1	0
2021	11	12	Gastrointestinal disorders	Dry mouth	1	1	0
2021	11	12	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	11	12	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	11	12	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	11	12	Cardiac disorders	Pericarditis	1	1	0
2021	11	12	Gastrointestinal disorders	Dysphagia	1	1	0
2021	11	12	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	12	Infections and infestations	Vaccination site cellulitis	1	1	0
2021	11	12	Reproductive system and breast disorders	Pelvic pain	1	1	0
2021	11	12	Vascular disorders	Peripheral coldness	1	1	0
2021	11	12	Cardiac disorders	Myocarditis	1	1	0
2021	11	12	Gastrointestinal disorders	Swollen tongue	1	1	0
2021	11	12	Nervous system disorders	Dysgeusia	1	1	0
2021	11	12	Nervous system disorders	Paraesthesia	1	1	0
2021	11	12	Nervous system disorders	Syncope	1	1	0
2021	11	12	Psychiatric disorders	Insomnia	1	1	0
2021	11	12	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	12	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	12	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	11	12	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	12	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	12	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	12	Nervous system disorders	Burning sensation	1	1	0
2021	11	12	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	12	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	11	12	Vascular disorders	Flushing	1	1	0
2021	11	13	General disorders and administration site conditions	Chest pain	4	4	0
2021	11	13	Nervous system disorders	Headache	4	4	0
2021	11	13	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2021	11	13	General disorders and administration site conditions	Injection site reaction	3	3	0
2021	11	13	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	11	13	General disorders and administration site conditions	Chills	3	3	0
2021	11	13	General disorders and administration site conditions	Fatigue	3	3	0
2021	11	13	General disorders and administration site conditions	Pyrexia	2	2	0
2021	11	13	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	13	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	11	13	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	11	13	General disorders and administration site conditions	Injection site pain	1	1	0
2021	11	13	Nervous system disorders	Lethargy	1	1	0
2021	11	13	Gastrointestinal disorders	Abdominal distension	1	1	0
2021	11	13	Gastrointestinal disorders	Vomiting	1	1	0
2021	11	13	General disorders and administration site conditions	Injection site hypoaesthesia	1	1	0
2021	11	13	Injury, poisoning and procedural complications	Maternal exposure during breast feeding	1	1	0
2021	11	13	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	13	Nervous system disorders	Hypokinesia	1	1	0
2021	11	13	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2021	11	13	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	11	13	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	11	13	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	11	13	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	13	General disorders and administration site conditions	Swelling	1	1	0
2021	11	13	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	11	13	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2021	11	13	Psychiatric disorders	Insomnia	1	1	0
2021	11	13	General disorders and administration site conditions	Crying	1	1	0
2021	11	13	General disorders and administration site conditions	Pain	1	1	0
2021	11	13	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	11	13	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	13	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	13	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	11	13	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	11	13	Vascular disorders	Superficial vein thrombosis	1	1	0
2021	11	13	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	11	13	Metabolism and nutrition disorders	Dehydration	1	1	0
2021	11	13	Psychiatric disorders	Anxiety	1	1	0
2021	11	13	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	11	13	Investigations	Heart rate increased	1	1	0
2021	11	13	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	13	Nervous system disorders	Dizziness	1	1	0
2021	11	13	Infections and infestations	Herpes zoster	1	1	0
2021	11	14	General disorders and administration site conditions	Fatigue	5	5	0
2021	11	14	Nervous system disorders	Headache	5	5	0
2021	11	14	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	11	14	Reproductive system and breast disorders	Menstrual disorder	4	4	0
2021	11	14	General disorders and administration site conditions	Chest pain	4	4	0
2021	11	14	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	11	14	Gastrointestinal disorders	Vomiting	3	3	0
2021	11	14	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	11	14	Gastrointestinal disorders	Nausea	2	2	0
2021	11	14	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	11	14	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	11	14	General disorders and administration site conditions	Malaise	2	2	0
2021	11	14	Investigations	Heart rate increased	2	2	0
2021	11	14	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	11	14	General disorders and administration site conditions	Pyrexia	2	2	0
2021	11	14	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	14	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	11	14	Skin and subcutaneous tissue disorders	Rash pruritic	1	0	0
2021	11	14	Gastrointestinal disorders	Lip haemorrhage	1	1	0
2021	11	14	Investigations	Red blood cell sedimentation rate increased	1	1	0
2021	11	14	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	11	14	Vascular disorders	Peripheral vein occlusion	1	1	0
2021	11	14	Nervous system disorders	Dizziness	1	1	0
2021	11	14	Vascular disorders	Hypertension	1	1	0
2021	11	14	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	14	Psychiatric disorders	Confusional state	1	1	0
2021	11	14	Vascular disorders	Varicose vein	1	1	0
2021	11	14	Reproductive system and breast disorders	Menstrual discomfort	1	1	0
2021	11	14	General disorders and administration site conditions	Injection site rash	1	1	0
2021	11	14	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	14	Gastrointestinal disorders	Lip swelling	1	0	0
2021	11	14	Reproductive system and breast disorders	Breast mass	1	1	0
2021	11	14	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	11	14	Cardiac disorders	Pericarditis	1	1	0
2021	11	14	Nervous system disorders	Migraine	1	1	0
2021	11	14	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	11	14	Vascular disorders	Vasculitis	1	1	0
2021	11	14	Cardiac disorders	Tachycardia	1	1	0
2021	11	14	Gastrointestinal disorders	Mouth haemorrhage	1	1	0
2021	11	14	Investigations	Blood creatine phosphokinase increased	1	1	0
2021	11	14	Nervous system disorders	Burning sensation	1	1	0
2021	11	14	Respiratory, thoracic and mediastinal disorders	Sinus pain	1	1	0
2021	11	15	General disorders and administration site conditions	Chest pain	11	10	0
2021	11	15	Nervous system disorders	Headache	10	10	0
2021	11	15	Respiratory, thoracic and mediastinal disorders	Dyspnoea	10	9	0
2021	11	15	General disorders and administration site conditions	Fatigue	9	8	0
2021	11	15	Nervous system disorders	Dizziness	6	6	0
2021	11	15	General disorders and administration site conditions	Pyrexia	6	6	0
2021	11	15	Gastrointestinal disorders	Nausea	5	5	0
2021	11	15	Musculoskeletal and connective tissue disorders	Pain in extremity	5	5	0
2021	11	15	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2021	11	15	General disorders and administration site conditions	Injection site reaction	4	4	0
2021	11	15	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2021	11	15	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	11	15	Cardiac disorders	Palpitations	3	3	0
2021	11	15	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	11	15	Nervous system disorders	Hypoaesthesia	3	3	0
2021	11	15	Nervous system disorders	Sciatica	2	2	0
2021	11	15	Cardiac disorders	Myocarditis	2	2	0
2021	11	15	Cardiac disorders	Pericarditis	2	1	0
2021	11	15	Nervous system disorders	Syncope	2	2	0
2021	11	15	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	15	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	15	General disorders and administration site conditions	Feeling hot	2	2	0
2021	11	15	Investigations	Electrocardiogram abnormal	2	2	0
2021	11	15	Psychiatric disorders	Confusional state	2	2	0
2021	11	15	General disorders and administration site conditions	Malaise	1	1	0
2021	11	15	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	11	15	Investigations	Heart rate increased	1	1	0
2021	11	15	Nervous system disorders	Presyncope	1	1	0
2021	11	15	Cardiac disorders	Cardiac disorder	1	1	0
2021	11	15	General disorders and administration site conditions	Chills	1	1	0
2021	11	15	Nervous system disorders	Balance disorder	1	1	0
2021	11	15	Psychiatric disorders	Enuresis	1	1	0
2021	11	15	Renal and urinary disorders	Urinary incontinence	1	1	0
2021	11	15	Investigations	Troponin increased	1	1	0
2021	11	15	Product issues	Product quality issue	1	1	0
2021	11	15	Skin and subcutaneous tissue disorders	Rash maculo-papular	1	1	0
2021	11	15	General disorders and administration site conditions	Injection site pain	1	1	0
2021	11	15	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	15	Gastrointestinal disorders	Dry mouth	1	1	0
2021	11	15	Product issues	Product contamination physical	1	1	0
2021	11	15	Nervous system disorders	Somnolence	1	1	0
2021	11	15	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2021	11	15	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	11	15	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	15	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	15	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	15	Cardiac disorders	Tachycardia	1	1	0
2021	11	15	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	15	General disorders and administration site conditions	Pain	1	1	0
2021	11	15	Investigations	Blood pressure increased	1	1	0
2021	11	15	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	15	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	15	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	11	15	Gastrointestinal disorders	Odynophagia	1	1	0
2021	11	15	General disorders and administration site conditions	Swelling	1	1	0
2021	11	15	Musculoskeletal and connective tissue disorders	Flank pain	1	1	0
2021	11	15	Eye disorders	Photophobia	1	1	0
2021	11	15	Gastrointestinal disorders	Anal incontinence	1	1	0
2021	11	15	General disorders and administration site conditions	Feeling cold	1	1	0
2021	11	15	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	11	16	General disorders and administration site conditions	Chest pain	15	15	0
2021	11	16	Nervous system disorders	Headache	14	14	0
2021	11	16	General disorders and administration site conditions	Fatigue	11	11	0
2021	11	16	General disorders and administration site conditions	Chest discomfort	10	10	0
2021	11	16	Gastrointestinal disorders	Nausea	9	9	0
2021	11	16	General disorders and administration site conditions	Injection site reaction	9	9	0
2021	11	16	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	11	16	Nervous system disorders	Migraine	7	7	0
2021	11	16	General disorders and administration site conditions	Pyrexia	7	7	0
2021	11	16	Cardiac disorders	Palpitations	6	6	0
2021	11	16	Nervous system disorders	Paraesthesia	6	6	0
2021	11	16	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2021	11	16	Nervous system disorders	Dizziness	5	5	0
2021	11	16	Reproductive system and breast disorders	Menstrual disorder	5	5	0
2021	11	16	Musculoskeletal and connective tissue disorders	Pain in extremity	5	5	0
2021	11	16	Gastrointestinal disorders	Vomiting	5	5	0
2021	11	16	Nervous system disorders	Lethargy	4	4	0
2021	11	16	Nervous system disorders	Syncope	4	4	0
2021	11	16	General disorders and administration site conditions	Feeling of body temperature change	3	3	0
2021	11	16	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	11	16	Skin and subcutaneous tissue disorders	Urticaria	3	3	0
2021	11	16	General disorders and administration site conditions	Influenza like illness	3	3	0
2021	11	16	General disorders and administration site conditions	Injected limb mobility decreased	3	3	0
2021	11	16	Eye disorders	Vision blurred	2	2	0
2021	11	16	Eye disorders	Visual impairment	2	2	0
2021	11	16	General disorders and administration site conditions	Swelling	2	2	0
2021	11	16	Nervous system disorders	Hypoaesthesia	2	2	0
2021	11	16	Cardiac disorders	Tachycardia	2	2	0
2021	11	16	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	11	16	General disorders and administration site conditions	Chills	2	2	0
2021	11	16	Nervous system disorders	Presyncope	2	2	0
2021	11	16	Psychiatric disorders	Sleep disorder	2	2	0
2021	11	16	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	16	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	16	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2021	11	16	Nervous system disorders	Tremor	2	2	0
2021	11	16	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	2	2	0
2021	11	16	General disorders and administration site conditions	Injection site pain	2	2	0
2021	11	16	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	11	16	Reproductive system and breast disorders	Dysmenorrhoea	2	2	0
2021	11	16	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	16	General disorders and administration site conditions	Oedema peripheral	1	1	0
2021	11	16	Psychiatric disorders	Mood altered	1	1	0
2021	11	16	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	11	16	General disorders and administration site conditions	Swelling face	1	1	0
2021	11	16	Nervous system disorders	Facial paralysis	1	1	0
2021	11	16	Reproductive system and breast disorders	Postmenopausal haemorrhage	1	1	0
2021	11	16	Vascular disorders	Hypertension	1	1	0
2021	11	16	Investigations	Blood pressure decreased	1	1	0
2021	11	16	Nervous system disorders	Disturbance in attention	1	1	0
2021	11	16	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	16	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2021	11	16	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	11	16	Cardiac disorders	Carditis	1	1	0
2021	11	16	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	16	Respiratory, thoracic and mediastinal disorders	Dry throat	1	1	0
2021	11	16	Gastrointestinal disorders	Pancreatitis	1	1	0
2021	11	16	Infections and infestations	Oral herpes	1	1	0
2021	11	16	Investigations	Fibrin D dimer increased	1	1	0
2021	11	16	Psychiatric disorders	Confusional state	1	1	0
2021	11	16	Reproductive system and breast disorders	Breast pain	1	1	0
2021	11	16	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	16	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2021	11	16	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	11	16	Vascular disorders	Deep vein thrombosis	1	1	0
2021	11	16	Gastrointestinal disorders	Dry mouth	1	1	0
2021	11	16	Gastrointestinal disorders	Mouth ulceration	1	1	0
2021	11	16	General disorders and administration site conditions	Therapeutic response unexpected	1	1	0
2021	11	16	Investigations	Heart rate irregular	1	1	0
2021	11	16	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	16	Investigations	Electrocardiogram abnormal	1	1	0
2021	11	16	Nervous system disorders	Somnolence	1	1	0
2021	11	16	Nervous system disorders	Tonic clonic movements	1	1	0
2021	11	16	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	11	16	Eye disorders	Eye pain	1	1	0
2021	11	16	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	16	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	11	16	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	16	Skin and subcutaneous tissue disorders	Skin disorder	1	1	0
2021	11	16	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	16	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2021	11	16	General disorders and administration site conditions	Pain	1	1	0
2021	11	16	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	1	1	0
2021	11	16	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	16	Respiratory, thoracic and mediastinal disorders	Sinus pain	1	1	0
2021	11	16	General disorders and administration site conditions	Injection site lymphadenopathy	1	1	0
2021	11	16	Metabolism and nutrition disorders	Diabetic ketoacidosis	1	1	0
2021	11	16	Nervous system disorders	Dysgeusia	1	1	0
2021	11	16	Psychiatric disorders	Insomnia	1	1	0
2021	11	16	Reproductive system and breast disorders	Breast mass	1	1	0
2021	11	16	Reproductive system and breast disorders	Menometrorrhagia	1	1	0
2021	11	16	Cardiac disorders	Pericarditis	1	1	0
2021	11	16	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	16	Gastrointestinal disorders	Dysphagia	1	1	0
2021	11	16	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	17	General disorders and administration site conditions	Chest pain	9	9	0
2021	11	17	Nervous system disorders	Headache	9	9	0
2021	11	17	Gastrointestinal disorders	Nausea	9	9	0
2021	11	17	Cardiac disorders	Palpitations	8	8	0
2021	11	17	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	11	17	General disorders and administration site conditions	Fatigue	7	7	0
2021	11	17	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2021	11	17	General disorders and administration site conditions	Pyrexia	6	6	0
2021	11	17	Gastrointestinal disorders	Vomiting	5	5	0
2021	11	17	Cardiac disorders	Tachycardia	5	5	0
2021	11	17	General disorders and administration site conditions	Chest discomfort	5	5	0
2021	11	17	General disorders and administration site conditions	Injection site reaction	5	5	0
2021	11	17	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2021	11	17	Nervous system disorders	Lethargy	4	4	0
2021	11	17	Nervous system disorders	Paraesthesia	4	4	0
2021	11	17	General disorders and administration site conditions	Chills	3	3	0
2021	11	17	General disorders and administration site conditions	Injection site pain	3	3	0
2021	11	17	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2021	11	17	Vascular disorders	Hypertension	3	3	0
2021	11	17	Nervous system disorders	Dizziness	3	3	0
2021	11	17	General disorders and administration site conditions	Injected limb mobility decreased	2	2	0
2021	11	17	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	11	17	Eye disorders	Vision blurred	2	2	0
2021	11	17	General disorders and administration site conditions	Injection site erythema	2	2	0
2021	11	17	Nervous system disorders	Syncope	2	2	0
2021	11	17	Gastrointestinal disorders	Swollen tongue	2	2	0
2021	11	17	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	11	17	General disorders and administration site conditions	Malaise	2	2	0
2021	11	17	Nervous system disorders	Taste disorder	2	2	0
2021	11	17	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	17	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2021	11	17	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	11	17	General disorders and administration site conditions	Swelling face	1	1	0
2021	11	17	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	17	Nervous system disorders	Mental impairment	1	1	0
2021	11	17	Nervous system disorders	Presyncope	1	1	0
2021	11	17	General disorders and administration site conditions	Thirst	1	1	0
2021	11	17	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	11	17	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	11	17	Gastrointestinal disorders	Gastrooesophageal reflux disease	1	1	0
2021	11	17	Psychiatric disorders	Aggression	1	1	0
2021	11	17	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2021	11	17	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	11	17	Nervous system disorders	Disturbance in attention	1	1	0
2021	11	17	Nervous system disorders	Seizure	1	1	0
2021	11	17	Psychiatric disorders	Disorientation	1	1	0
2021	11	17	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	17	Investigations	Fibrin D dimer increased	1	1	0
2021	11	17	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	17	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	17	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	11	17	Infections and infestations	Pneumonia	1	1	0
2021	11	17	Infections and infestations	Vulvovaginal candidiasis	1	1	0
2021	11	17	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	11	17	Nervous system disorders	Somnolence	1	1	0
2021	11	17	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2021	11	17	Skin and subcutaneous tissue disorders	Dry skin	1	1	0
2021	11	17	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	11	17	Vascular disorders	Hot flush	1	1	0
2021	11	17	Gastrointestinal disorders	Dry mouth	1	1	0
2021	11	17	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	11	17	Investigations	Heart rate irregular	1	1	0
2021	11	17	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	17	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2021	11	17	Investigations	C-reactive protein increased	1	1	0
2021	11	17	Vascular disorders	Raynaud's phenomenon	1	1	0
2021	11	17	Cardiac disorders	Pericarditis	1	1	0
2021	11	17	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	17	General disorders and administration site conditions	Feeling hot	1	1	0
2021	11	17	General disorders and administration site conditions	Swelling	1	1	0
2021	11	17	Gastrointestinal disorders	Anal haemorrhage	1	1	0
2021	11	17	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	17	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2021	11	17	Investigations	Blood creatine phosphokinase increased	1	1	0
2021	11	17	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	17	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	17	Eye disorders	Periorbital swelling	1	1	0
2021	11	17	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	17	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	17	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	17	Renal and urinary disorders	Renal pain	1	1	0
2021	11	18	General disorders and administration site conditions	Injection site reaction	22	21	0
2021	11	18	General disorders and administration site conditions	Chest pain	22	22	0
2021	11	18	Nervous system disorders	Headache	19	18	0
2021	11	18	General disorders and administration site conditions	Fatigue	17	17	0
2021	11	18	Nervous system disorders	Dizziness	15	15	0
2021	11	18	General disorders and administration site conditions	Pyrexia	14	13	0
2021	11	18	Respiratory, thoracic and mediastinal disorders	Dyspnoea	13	13	0
2021	11	18	Gastrointestinal disorders	Nausea	12	11	0
2021	11	18	Cardiac disorders	Palpitations	9	9	0
2021	11	18	Blood and lymphatic system disorders	Lymphadenopathy	8	6	0
2021	11	18	Musculoskeletal and connective tissue disorders	Pain in extremity	8	8	0
2021	11	18	General disorders and administration site conditions	Chest discomfort	8	8	0
2021	11	18	Skin and subcutaneous tissue disorders	Rash	8	8	0
2021	11	18	General disorders and administration site conditions	Chills	7	7	0
2021	11	18	Gastrointestinal disorders	Vomiting	7	7	0
2021	11	18	Musculoskeletal and connective tissue disorders	Arthralgia	7	5	0
2021	11	18	General disorders and administration site conditions	Malaise	6	6	0
2021	11	18	Musculoskeletal and connective tissue disorders	Myalgia	6	4	0
2021	11	18	Gastrointestinal disorders	Abdominal pain	5	5	0
2021	11	18	Nervous system disorders	Lethargy	5	5	0
2021	11	18	Skin and subcutaneous tissue disorders	Pruritus	5	5	0
2021	11	18	General disorders and administration site conditions	Influenza like illness	4	4	0
2021	11	18	Psychiatric disorders	Confusional state	4	4	0
2021	11	18	Nervous system disorders	Neuralgia	3	3	0
2021	11	18	Infections and infestations	Nasopharyngitis	3	3	0
2021	11	18	Infections and infestations	Herpes zoster	3	3	0
2021	11	18	Nervous system disorders	Paraesthesia	3	3	0
2021	11	18	Nervous system disorders	Migraine	3	3	0
2021	11	18	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2021	11	18	Investigations	Electrocardiogram abnormal	3	3	0
2021	11	18	Cardiac disorders	Pericarditis	3	3	0
2021	11	18	Nervous system disorders	Presyncope	3	3	0
2021	11	18	Musculoskeletal and connective tissue disorders	Muscular weakness	3	3	0
2021	11	18	General disorders and administration site conditions	Injection site swelling	2	2	0
2021	11	18	Skin and subcutaneous tissue disorders	Cold sweat	2	2	0
2021	11	18	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	18	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	11	18	Musculoskeletal and connective tissue disorders	Neck pain	2	2	0
2021	11	18	Eye disorders	Eye pain	2	2	0
2021	11	18	Nervous system disorders	Tremor	2	2	0
2021	11	18	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	2	2	0
2021	11	18	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	11	18	Vascular disorders	Pallor	2	2	0
2021	11	18	Gastrointestinal disorders	Abdominal discomfort	2	2	0
2021	11	18	General disorders and administration site conditions	Injection site pain	2	2	0
2021	11	18	Cardiac disorders	Myocarditis	2	2	0
2021	11	18	Nervous system disorders	Syncope	2	2	0
2021	11	18	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	11	18	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	11	18	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2021	11	18	General disorders and administration site conditions	Injected limb mobility decreased	2	2	0
2021	11	18	Nervous system disorders	Dysgeusia	2	2	0
2021	11	18	Cardiac disorders	Tachycardia	2	2	0
2021	11	18	Eye disorders	Ocular hyperaemia	2	2	0
2021	11	18	Gastrointestinal disorders	Paraesthesia oral	2	2	0
2021	11	18	Vascular disorders	Hot flush	2	2	0
2021	11	18	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	18	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2021	11	18	Investigations	Blood pressure increased	1	1	0
2021	11	18	Nervous system disorders	Demyelination	1	1	0
2021	11	18	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	18	Vascular disorders	Flushing	1	1	0
2021	11	18	Eye disorders	Eye swelling	1	1	0
2021	11	18	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	11	18	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	18	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2021	11	18	Skin and subcutaneous tissue disorders	Alopecia	1	1	0
2021	11	18	Skin and subcutaneous tissue disorders	Rash papular	1	1	0
2021	11	18	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	18	Musculoskeletal and connective tissue disorders	Flank pain	1	1	0
2021	11	18	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2021	11	18	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	11	18	Eye disorders	Photophobia	1	1	0
2021	11	18	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2021	11	18	Nervous system disorders	Petit mal epilepsy	1	1	0
2021	11	18	Psychiatric disorders	Insomnia	1	1	0
2021	11	18	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	18	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2021	11	18	Vascular disorders	Deep vein thrombosis	1	1	0
2021	11	18	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	11	18	Investigations	Troponin increased	1	1	0
2021	11	18	Investigations	Heart rate irregular	1	1	0
2021	11	18	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	18	Nervous system disorders	Head discomfort	1	1	0
2021	11	18	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	18	Cardiac disorders	Myopericarditis	1	1	0
2021	11	18	General disorders and administration site conditions	Injection site rash	1	1	0
2021	11	18	Musculoskeletal and connective tissue disorders	Tendon pain	1	1	0
2021	11	18	Nervous system disorders	Generalised tonic-clonic seizure	1	1	0
2021	11	18	Nervous system disorders	Somnolence	1	1	0
2021	11	18	Psychiatric disorders	Emotional disorder	1	1	0
2021	11	18	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2021	11	18	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	18	General disorders and administration site conditions	Injection site pruritus	1	1	0
2021	11	18	General disorders and administration site conditions	Oedema peripheral	1	1	0
2021	11	18	Reproductive system and breast disorders	Ovulation pain	1	1	0
2021	11	18	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	11	18	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	11	18	General disorders and administration site conditions	Swelling face	1	1	0
2021	11	18	Infections and infestations	Epstein-Barr virus infection reactivation	1	1	0
2021	11	18	Investigations	Heart rate increased	1	1	0
2021	11	18	Nervous system disorders	Cerebrovascular accident	1	1	0
2021	11	18	Psychiatric disorders	Sleep disorder	1	1	0
2021	11	18	Respiratory, thoracic and mediastinal disorders	Hypopnoea	1	1	0
2021	11	18	Vascular disorders	Hypertension	1	1	0
2021	11	18	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	18	Eye disorders	Blindness	1	1	0
2021	11	18	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2021	11	18	Nervous system disorders	Restless legs syndrome	1	1	0
2021	11	18	Eye disorders	Vision blurred	1	1	0
2021	11	18	Immune system disorders	Anaphylactic reaction	1	1	0
2021	11	18	Nervous system disorders	Disturbance in attention	1	1	0
2021	11	19	General disorders and administration site conditions	Chest pain	12	12	0
2021	11	19	General disorders and administration site conditions	Pyrexia	11	11	0
2021	11	19	Gastrointestinal disorders	Nausea	10	10	0
2021	11	19	General disorders and administration site conditions	Injection site reaction	10	10	0
2021	11	19	General disorders and administration site conditions	Fatigue	9	9	0
2021	11	19	Nervous system disorders	Dizziness	9	9	0
2021	11	19	Musculoskeletal and connective tissue disorders	Myalgia	8	8	0
2021	11	19	General disorders and administration site conditions	Malaise	7	7	0
2021	11	19	Musculoskeletal and connective tissue disorders	Arthralgia	7	7	0
2021	11	19	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2021	11	19	Cardiac disorders	Palpitations	6	6	0
2021	11	19	Nervous system disorders	Headache	5	5	0
2021	11	19	Nervous system disorders	Lethargy	5	5	0
2021	11	19	Musculoskeletal and connective tissue disorders	Pain in extremity	5	5	0
2021	11	19	General disorders and administration site conditions	Chest discomfort	5	5	0
2021	11	19	General disorders and administration site conditions	Asthenia	4	4	0
2021	11	19	General disorders and administration site conditions	Chills	4	4	0
2021	11	19	General disorders and administration site conditions	Injection site pain	4	4	0
2021	11	19	Gastrointestinal disorders	Vomiting	4	4	0
2021	11	19	Nervous system disorders	Paraesthesia	4	4	0
2021	11	19	Respiratory, thoracic and mediastinal disorders	Cough	3	3	0
2021	11	19	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2021	11	19	Respiratory, thoracic and mediastinal disorders	Epistaxis	3	3	0
2021	11	19	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2021	11	19	Nervous system disorders	Presyncope	2	2	0
2021	11	19	Nervous system disorders	Syncope	2	2	0
2021	11	19	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	11	19	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	11	19	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2021	11	19	General disorders and administration site conditions	Feeling abnormal	2	2	0
2021	11	19	Nervous system disorders	Hypoaesthesia	2	2	0
2021	11	19	Nervous system disorders	Migraine	2	2	0
2021	11	19	Psychiatric disorders	Confusional state	2	2	0
2021	11	19	Gastrointestinal disorders	Abdominal pain upper	2	2	0
2021	11	19	General disorders and administration site conditions	Feeling of body temperature change	2	2	0
2021	11	19	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2021	11	19	Nervous system disorders	Tremor	2	2	0
2021	11	19	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	11	19	Vascular disorders	Hypertension	2	2	0
2021	11	19	General disorders and administration site conditions	Injection site rash	2	2	0
2021	11	19	General disorders and administration site conditions	Injection site swelling	2	2	0
2021	11	19	Investigations	Anti-cyclic citrullinated peptide antibody positive	1	1	0
2021	11	19	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	19	Respiratory, thoracic and mediastinal disorders	Haemoptysis	1	1	0
2021	11	19	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	11	19	Infections and infestations	Cellulitis	1	1	0
2021	11	19	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	11	19	Investigations	Troponin I increased	1	1	0
2021	11	19	Musculoskeletal and connective tissue disorders	Arthritis	1	1	0
2021	11	19	Psychiatric disorders	Anxiety	1	1	0
2021	11	19	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	11	19	General disorders and administration site conditions	Swelling face	1	1	0
2021	11	19	Infections and infestations	Meningitis	1	1	0
2021	11	19	Investigations	Heart rate increased	1	1	0
2021	11	19	Musculoskeletal and connective tissue disorders	Rheumatoid arthritis	1	1	0
2021	11	19	Nervous system disorders	Cerebrovascular accident	1	1	0
2021	11	19	Psychiatric disorders	Depressed mood	1	1	0
2021	11	19	Psychiatric disorders	Sleep disorder	1	1	0
2021	11	19	Infections and infestations	Herpes zoster	1	1	0
2021	11	19	Investigations	Rheumatoid factor	1	1	0
2021	11	19	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	11	19	General disorders and administration site conditions	Injection site mass	1	1	0
2021	11	19	Nervous system disorders	Dysgeusia	1	1	0
2021	11	19	Psychiatric disorders	Depression	1	1	0
2021	11	19	Psychiatric disorders	Insomnia	1	1	0
2021	11	19	Cardiac disorders	Pericarditis	1	1	0
2021	11	19	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	19	Gastrointestinal disorders	Dysphagia	1	1	0
2021	11	19	General disorders and administration site conditions	Feeling hot	1	1	0
2021	11	19	General disorders and administration site conditions	Swelling	1	1	0
2021	11	19	Nervous system disorders	Carotid artery dissection	1	1	0
2021	11	19	Nervous system disorders	Paresis	1	1	0
2021	11	19	Reproductive system and breast disorders	Polymenorrhoea	1	1	0
2021	11	19	Cardiac disorders	Tachycardia	1	1	0
2021	11	19	General disorders and administration site conditions	Pain	1	1	0
2021	11	19	Nervous system disorders	Demyelination	1	1	0
2021	11	19	Respiratory, thoracic and mediastinal disorders	Sinus pain	1	1	0
2021	11	19	Skin and subcutaneous tissue disorders	Dermatitis acneiform	1	1	0
2021	11	19	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	19	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	19	Investigations	Chest X-ray normal	1	1	0
2021	11	19	Investigations	Fibrin D dimer increased	1	1	0
2021	11	19	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	19	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	19	Nervous system disorders	Nervous system disorder	1	1	0
2021	11	19	Gastrointestinal disorders	Abdominal rigidity	1	1	0
2021	11	19	Nervous system disorders	Sleep deficit	1	1	0
2021	11	19	Cardiac disorders	Myopericarditis	1	1	0
2021	11	19	Investigations	Electrocardiogram abnormal	1	1	0
2021	11	19	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	11	20	Gastrointestinal disorders	Nausea	8	8	0
2021	11	20	Nervous system disorders	Headache	5	5	0
2021	11	20	General disorders and administration site conditions	Fatigue	4	4	0
2021	11	20	General disorders and administration site conditions	Pyrexia	3	3	0
2021	11	20	Nervous system disorders	Lethargy	2	2	0
2021	11	20	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	11	20	Nervous system disorders	Disturbance in attention	2	2	0
2021	11	20	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	11	20	Nervous system disorders	Dizziness	2	2	0
2021	11	20	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	11	20	General disorders and administration site conditions	Injection site pain	2	2	0
2021	11	20	General disorders and administration site conditions	Chest pain	2	2	0
2021	11	20	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	11	20	Nervous system disorders	Balance disorder	1	1	0
2021	11	20	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	20	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	11	20	Respiratory, thoracic and mediastinal disorders	Yawning	1	1	0
2021	11	20	Investigations	Heart rate increased	1	1	0
2021	11	20	Nervous system disorders	Transient global amnesia	1	1	0
2021	11	20	Psychiatric disorders	Abnormal dreams	1	1	0
2021	11	20	Cardiac disorders	Palpitations	1	1	0
2021	11	20	Investigations	Troponin I	1	1	0
2021	11	20	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	20	Eye disorders	Eyelid ptosis	1	1	0
2021	11	20	General disorders and administration site conditions	Inflammation	1	1	0
2021	11	20	Investigations	Heart rate abnormal	1	1	0
2021	11	20	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	20	Investigations	Electrocardiogram	1	1	0
2021	11	20	Investigations	C-reactive protein increased	1	1	0
2021	11	20	Musculoskeletal and connective tissue disorders	Spinal pain	1	1	0
2021	11	20	Cardiac disorders	Pericarditis	1	1	0
2021	11	20	General disorders and administration site conditions	Swelling	1	1	0
2021	11	20	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	11	20	Eye disorders	Eye pain	1	1	0
2021	11	20	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	20	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	11	20	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	11	20	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2021	11	20	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	21	General disorders and administration site conditions	Chest pain	4	4	0
2021	11	21	Nervous system disorders	Headache	4	4	0
2021	11	21	General disorders and administration site conditions	Pyrexia	3	3	0
2021	11	21	General disorders and administration site conditions	Fatigue	2	2	0
2021	11	21	General disorders and administration site conditions	Injection site mass	2	2	0
2021	11	21	Vascular disorders	Hot flush	2	2	0
2021	11	21	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	11	21	Cardiac disorders	Palpitations	2	2	0
2021	11	21	Psychiatric disorders	Confusional state	2	2	0
2021	11	21	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2021	11	21	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	11	21	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2021	11	21	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2021	11	21	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	11	21	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	21	Nervous system disorders	Dizziness	1	1	0
2021	11	21	Reproductive system and breast disorders	Breast inflammation	1	1	0
2021	11	21	General disorders and administration site conditions	Inflammation	1	1	0
2021	11	21	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	21	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	11	21	General disorders and administration site conditions	Injection site pain	1	1	0
2021	11	21	Reproductive system and breast disorders	Breast pain	1	1	0
2021	11	21	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	11	21	Gastrointestinal disorders	Nausea	1	1	0
2021	11	21	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	11	21	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	21	Nervous system disorders	Migraine	1	1	0
2021	11	21	General disorders and administration site conditions	Injection site paraesthesia	1	1	0
2021	11	21	Nervous system disorders	Dysgeusia	1	1	0
2021	11	21	Nervous system disorders	Paraesthesia	1	1	0
2021	11	21	Nervous system disorders	Syncope	1	1	0
2021	11	21	Psychiatric disorders	Depression	1	1	0
2021	11	21	Cardiac disorders	Tachycardia	1	1	0
2021	11	21	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	11	21	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	21	General disorders and administration site conditions	Pain	1	1	0
2021	11	21	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	1	1	0
2021	11	21	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	11	21	Eye disorders	Eye pain	1	1	0
2021	11	21	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	21	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	11	22	Nervous system disorders	Headache	12	12	0
2021	11	22	General disorders and administration site conditions	Chest pain	11	10	0
2021	11	22	General disorders and administration site conditions	Pyrexia	11	11	0
2021	11	22	Musculoskeletal and connective tissue disorders	Arthralgia	8	8	0
2021	11	22	Gastrointestinal disorders	Nausea	8	8	0
2021	11	22	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2021	11	22	Cardiac disorders	Pericarditis	5	4	0
2021	11	22	Nervous system disorders	Lethargy	5	5	0
2021	11	22	Nervous system disorders	Dizziness	5	5	0
2021	11	22	General disorders and administration site conditions	Fatigue	5	5	0
2021	11	22	General disorders and administration site conditions	Chills	4	4	0
2021	11	22	General disorders and administration site conditions	Injection site rash	4	4	0
2021	11	22	General disorders and administration site conditions	Pain	4	4	0
2021	11	22	Cardiac disorders	Tachycardia	3	3	0
2021	11	22	Nervous system disorders	Hypoaesthesia	3	2	0
2021	11	22	Cardiac disorders	Palpitations	3	3	0
2021	11	22	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	11	22	General disorders and administration site conditions	Injection site pain	3	3	0
2021	11	22	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2021	11	22	Nervous system disorders	Syncope	3	3	0
2021	11	22	Nervous system disorders	Tremor	2	2	0
2021	11	22	Psychiatric disorders	Confusional state	2	2	0
2021	11	22	General disorders and administration site conditions	Injection site swelling	2	2	0
2021	11	22	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	22	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	2	2	0
2021	11	22	General disorders and administration site conditions	Injection site pruritus	2	2	0
2021	11	22	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	11	22	Skin and subcutaneous tissue disorders	Rash erythematous	2	2	0
2021	11	22	General disorders and administration site conditions	Injected limb mobility decreased	2	2	0
2021	11	22	Gastrointestinal disorders	Vomiting	2	2	0
2021	11	22	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	11	22	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	22	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	22	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2021	11	22	Social circumstances	Bedridden	1	1	0
2021	11	22	Cardiac disorders	Myocarditis	1	1	0
2021	11	22	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2021	11	22	Nervous system disorders	Paraesthesia	1	1	0
2021	11	22	Psychiatric disorders	Depression	1	1	0
2021	11	22	Psychiatric disorders	Insomnia	1	1	0
2021	11	22	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	11	22	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	11	22	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	11	22	Nervous system disorders	Hyperaesthesia	1	1	0
2021	11	22	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	22	Nervous system disorders	Burning sensation	1	1	0
2021	11	22	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	11	22	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	11	22	General disorders and administration site conditions	Injection site inflammation	1	1	0
2021	11	22	Infections and infestations	Oral herpes	1	1	0
2021	11	22	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	22	Reproductive system and breast disorders	Breast pain	1	1	0
2021	11	22	Infections and infestations	Staphylococcal infection	1	1	0
2021	11	22	Investigations	Troponin increased	1	1	0
2021	11	22	Psychiatric disorders	Suicidal ideation	1	1	0
2021	11	22	Cardiac disorders	Arrhythmia	1	1	0
2021	11	22	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	11	22	Injury, poisoning and procedural complications	Expired product administered	1	1	0
2021	11	22	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2021	11	22	Musculoskeletal and connective tissue disorders	Bursitis	1	1	0
2021	11	22	Nervous system disorders	Balance disorder	1	1	0
2021	11	22	Psychiatric disorders	Disorientation	1	1	0
2021	11	22	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	11	22	Ear and labyrinth disorders	Deafness	1	1	0
2021	11	22	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	22	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	11	22	Nervous system disorders	Neuralgia	1	1	0
2021	11	22	Psychiatric disorders	Anxiety	1	1	0
2021	11	22	Respiratory, thoracic and mediastinal disorders	Tachypnoea	1	1	0
2021	11	22	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	22	General disorders and administration site conditions	Malaise	1	1	0
2021	11	22	Nervous system disorders	Facial paralysis	1	1	0
2021	11	23	Nervous system disorders	Headache	17	17	0
2021	11	23	Musculoskeletal and connective tissue disorders	Myalgia	16	16	0
2021	11	23	General disorders and administration site conditions	Chest pain	15	15	0
2021	11	23	General disorders and administration site conditions	Injection site reaction	15	15	0
2021	11	23	General disorders and administration site conditions	Pyrexia	15	15	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Dyspnoea	12	12	0
2021	11	23	Gastrointestinal disorders	Nausea	12	12	0
2021	11	23	Musculoskeletal and connective tissue disorders	Arthralgia	11	11	0
2021	11	23	General disorders and administration site conditions	Fatigue	11	11	0
2021	11	23	Skin and subcutaneous tissue disorders	Rash	10	10	0
2021	11	23	Cardiac disorders	Palpitations	9	9	0
2021	11	23	Nervous system disorders	Paraesthesia	9	9	0
2021	11	23	Nervous system disorders	Hypoaesthesia	7	7	0
2021	11	23	Nervous system disorders	Dizziness	7	7	0
2021	11	23	Skin and subcutaneous tissue disorders	Hyperhidrosis	7	7	0
2021	11	23	General disorders and administration site conditions	Chest discomfort	7	7	0
2021	11	23	General disorders and administration site conditions	Malaise	7	7	0
2021	11	23	Gastrointestinal disorders	Vomiting	6	6	0
2021	11	23	Blood and lymphatic system disorders	Lymphadenopathy	6	6	0
2021	11	23	General disorders and administration site conditions	Chills	6	6	0
2021	11	23	Musculoskeletal and connective tissue disorders	Pain in extremity	6	6	0
2021	11	23	Gastrointestinal disorders	Diarrhoea	5	5	0
2021	11	23	General disorders and administration site conditions	Injection site pain	5	5	0
2021	11	23	Nervous system disorders	Lethargy	5	5	0
2021	11	23	General disorders and administration site conditions	Influenza like illness	4	4	0
2021	11	23	Skin and subcutaneous tissue disorders	Urticaria	4	4	0
2021	11	23	General disorders and administration site conditions	Injected limb mobility decreased	4	4	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Cough	4	4	0
2021	11	23	Cardiac disorders	Tachycardia	4	4	0
2021	11	23	Gastrointestinal disorders	Abdominal pain	4	4	0
2021	11	23	Nervous system disorders	Syncope	3	3	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	3	3	0
2021	11	23	General disorders and administration site conditions	Pain	3	3	0
2021	11	23	General disorders and administration site conditions	Concomitant disease aggravated	3	3	0
2021	11	23	Musculoskeletal and connective tissue disorders	Neck pain	3	3	0
2021	11	23	General disorders and administration site conditions	Asthenia	3	3	0
2021	11	23	General disorders and administration site conditions	Injection site rash	3	3	0
2021	11	23	General disorders and administration site conditions	Peripheral swelling	3	3	0
2021	11	23	Infections and infestations	Herpes zoster	3	3	0
2021	11	23	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2021	11	23	General disorders and administration site conditions	Swelling	2	2	0
2021	11	23	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	11	23	Musculoskeletal and connective tissue disorders	Joint swelling	2	2	0
2021	11	23	Psychiatric disorders	Insomnia	2	2	0
2021	11	23	Gastrointestinal disorders	Dyspepsia	2	2	0
2021	11	23	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	11	23	Cardiac disorders	Myocarditis	2	2	0
2021	11	23	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	23	Eye disorders	Photophobia	2	2	0
2021	11	23	Injury, poisoning and procedural complications	Contusion	2	2	0
2021	11	23	General disorders and administration site conditions	Feeling of body temperature change	2	2	0
2021	11	23	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2021	11	23	Nervous system disorders	Tremor	2	2	0
2021	11	23	Nervous system disorders	Migraine	2	2	0
2021	11	23	Reproductive system and breast disorders	Menstruation irregular	2	2	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	2	2	0
2021	11	23	Ear and labyrinth disorders	Tinnitus	2	2	0
2021	11	23	General disorders and administration site conditions	Injection site swelling	2	2	0
2021	11	23	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2021	11	23	Psychiatric disorders	Hallucination	2	2	0
2021	11	23	General disorders and administration site conditions	Injection site dermatitis	1	1	0
2021	11	23	General disorders and administration site conditions	Injection site haematoma	1	1	0
2021	11	23	Nervous system disorders	Post herpetic neuralgia	1	1	0
2021	11	23	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	11	23	Ear and labyrinth disorders	Deafness	1	1	0
2021	11	23	Investigations	Red blood cell sedimentation rate increased	1	1	0
2021	11	23	Investigations	Troponin I increased	1	1	0
2021	11	23	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	11	23	Nervous system disorders	Neuralgia	1	1	0
2021	11	23	Nervous system disorders	Tension headache	1	1	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	11	23	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	23	Cardiac disorders	Cardiomyopathy	1	1	0
2021	11	23	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	23	General disorders and administration site conditions	Oedema peripheral	1	1	0
2021	11	23	Eye disorders	Swelling of eyelid	1	1	0
2021	11	23	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	11	23	Nervous system disorders	Cerebrovascular accident	1	1	0
2021	11	23	Nervous system disorders	Presyncope	1	1	0
2021	11	23	Psychiatric disorders	Sleep disorder	1	1	0
2021	11	23	Cardiac disorders	Cardiac arrest	1	1	0
2021	11	23	Ear and labyrinth disorders	Hyperacusis	1	1	0
2021	11	23	Investigations	Troponin increased	1	1	0
2021	11	23	Nervous system disorders	Ageusia	1	1	0
2021	11	23	Nervous system disorders	Loss of consciousness	1	1	0
2021	11	23	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	11	23	Investigations	Fibrin D dimer increased	1	1	0
2021	11	23	Psychiatric disorders	Confusional state	1	1	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Oropharyngeal discomfort	1	1	0
2021	11	23	Gastrointestinal disorders	Dry mouth	1	1	0
2021	11	23	Investigations	Heart rate irregular	1	1	0
2021	11	23	Nervous system disorders	Head discomfort	1	1	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2021	11	23	Cardiac disorders	Coronary artery dissection	1	1	0
2021	11	23	Gastrointestinal disorders	Bowel movement irregularity	1	1	0
2021	11	23	Infections and infestations	Injection site abscess	1	1	0
2021	11	23	Investigations	Electrocardiogram	1	1	0
2021	11	23	Renal and urinary disorders	Urinary hesitation	1	1	0
2021	11	23	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2021	11	23	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	11	23	Vascular disorders	Hot flush	1	1	0
2021	11	23	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	11	23	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	11	23	Infections and infestations	Abscess	1	1	0
2021	11	23	Infections and infestations	Parotitis	1	1	0
2021	11	23	Renal and urinary disorders	Renal pain	1	1	0
2021	11	23	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	11	23	Cardiac disorders	Bundle branch block	1	1	0
2021	11	23	Gastrointestinal disorders	Constipation	1	1	0
2021	11	23	Infections and infestations	Nasopharyngitis	1	1	0
2021	11	23	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2021	11	23	Musculoskeletal and connective tissue disorders	Muscle fatigue	1	1	0
2021	11	23	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	1	1	0
2021	11	23	Nervous system disorders	Burning sensation	1	1	0
2021	11	23	Nervous system disorders	Dysstasia	1	1	0
2021	11	23	Gastrointestinal disorders	Swollen tongue	1	1	0
2021	11	23	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2021	11	23	Investigations	C-reactive protein increased	1	1	0
2021	11	23	Nervous system disorders	Anosmia	1	1	0
2021	11	23	Psychiatric disorders	Irritability	1	1	0
2021	11	23	Respiratory, thoracic and mediastinal disorders	Sneezing	1	1	0
2021	11	23	Vascular disorders	Haematoma	1	1	0
2021	11	23	Cardiac disorders	Pericarditis	1	1	0
2021	11	23	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	23	Gastrointestinal disorders	Dysphagia	1	1	0
2021	11	23	General disorders and administration site conditions	Feeling hot	1	1	0
2021	11	23	Injury, poisoning and procedural complications	Exposure via breast milk	1	1	0
2021	11	23	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	11	24	General disorders and administration site conditions	Chest pain	20	20	0
2021	11	24	Nervous system disorders	Headache	16	16	0
2021	11	24	General disorders and administration site conditions	Pyrexia	14	13	0
2021	11	24	Respiratory, thoracic and mediastinal disorders	Dyspnoea	12	11	0
2021	11	24	Musculoskeletal and connective tissue disorders	Myalgia	11	10	0
2021	11	24	General disorders and administration site conditions	Fatigue	10	10	0
2021	11	24	Gastrointestinal disorders	Nausea	8	8	0
2021	11	24	General disorders and administration site conditions	Injection site reaction	7	7	0
2021	11	24	Musculoskeletal and connective tissue disorders	Pain in extremity	6	6	0
2021	11	24	Nervous system disorders	Dizziness	6	6	0
2021	11	24	General disorders and administration site conditions	Malaise	6	5	0
2021	11	24	General disorders and administration site conditions	Chest discomfort	6	6	0
2021	11	24	Gastrointestinal disorders	Vomiting	5	5	0
2021	11	24	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2021	11	24	Nervous system disorders	Lethargy	4	4	0
2021	11	24	Cardiac disorders	Pericarditis	4	4	0
2021	11	24	Cardiac disorders	Myocarditis	4	4	0
2021	11	24	General disorders and administration site conditions	Pain	4	4	0
2021	11	24	Cardiac disorders	Palpitations	3	3	0
2021	11	24	Ear and labyrinth disorders	Vertigo	3	3	0
2021	11	24	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	11	24	General disorders and administration site conditions	Chills	3	3	0
2021	11	24	General disorders and administration site conditions	Injection site pain	3	3	0
2021	11	24	Investigations	Electrocardiogram abnormal	3	3	0
2021	11	24	Musculoskeletal and connective tissue disorders	Muscle twitching	3	3	0
2021	11	24	Investigations	Heart rate increased	2	2	0
2021	11	24	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2021	11	24	Investigations	Fibrin D dimer increased	2	2	0
2021	11	24	Cardiac disorders	Tachycardia	2	2	0
2021	11	24	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	11	24	Nervous system disorders	Tremor	2	1	0
2021	11	24	General disorders and administration site conditions	Feeling abnormal	2	2	0
2021	11	24	Nervous system disorders	Paraesthesia	2	2	0
2021	11	24	Gastrointestinal disorders	Gingival blister	1	1	0
2021	11	24	Gastrointestinal disorders	Haematemesis	1	1	0
2021	11	24	General disorders and administration site conditions	Feeling hot	1	1	0
2021	11	24	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	11	24	Infections and infestations	Rhinovirus infection	1	0	0
2021	11	24	Nervous system disorders	Syncope	1	1	0
2021	11	24	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	24	Cardiac disorders	Coronary artery disease	1	1	0
2021	11	24	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	24	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	11	24	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	24	Infections and infestations	Bronchitis	1	0	0
2021	11	24	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2021	11	24	Cardiac disorders	Myocardial infarction	1	1	0
2021	11	24	Nervous system disorders	Burning sensation	1	1	0
2021	11	24	Nervous system disorders	Taste disorder	1	1	0
2021	11	24	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	11	24	Vascular disorders	Flushing	1	1	0
2021	11	24	General disorders and administration site conditions	Injection site rash	1	1	0
2021	11	24	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2021	11	24	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	11	24	Metabolism and nutrition disorders	Increased appetite	1	1	0
2021	11	24	Nervous system disorders	Somnolence	1	1	0
2021	11	24	Infections and infestations	Appendicitis	1	1	0
2021	11	24	Social circumstances	Loss of personal independence in daily activities	1	1	0
2021	11	24	Psychiatric disorders	Hallucination	1	1	0
2021	11	24	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	11	24	Investigations	Oxygen saturation decreased	1	1	0
2021	11	24	Investigations	Troponin increased	1	1	0
2021	11	24	Nervous system disorders	Loss of consciousness	1	1	0
2021	11	24	Nervous system disorders	Nervous system disorder	1	1	0
2021	11	24	Gastrointestinal disorders	Glossodynia	1	1	0
2021	11	24	General disorders and administration site conditions	Oedema	1	1	0
2021	11	24	Nervous system disorders	Presyncope	1	1	0
2021	11	24	Psychiatric disorders	Sleep disorder	1	1	0
2021	11	24	Vascular disorders	Hypertension	1	1	0
2021	11	24	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	11	24	Respiratory, thoracic and mediastinal disorders	Cough	1	0	0
2021	11	24	Cardiac disorders	Sinus bradycardia	1	1	0
2021	11	24	Eye disorders	Vision blurred	1	1	0
2021	11	24	Eye disorders	Visual impairment	1	1	0
2021	11	24	Immune system disorders	Anaphylactic reaction	1	1	0
2021	11	24	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2021	11	24	Nervous system disorders	Balance disorder	1	1	0
2021	11	24	Nervous system disorders	Disturbance in attention	1	1	0
2021	11	24	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	11	24	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	11	24	Vascular disorders	Blood pressure fluctuation	1	1	0
2021	11	24	Cardiac disorders	Cardiac disorder	1	1	0
2021	11	24	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	24	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	11	24	Psychiatric disorders	Anxiety	1	1	0
2021	11	25	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	11	25	General disorders and administration site conditions	Chest pain	8	8	0
2021	11	25	Blood and lymphatic system disorders	Lymphadenopathy	7	7	0
2021	11	25	Nervous system disorders	Dizziness	6	6	0
2021	11	25	General disorders and administration site conditions	Injection site reaction	6	6	0
2021	11	25	General disorders and administration site conditions	Pyrexia	6	6	0
2021	11	25	General disorders and administration site conditions	Fatigue	5	5	0
2021	11	25	Nervous system disorders	Headache	5	5	0
2021	11	25	Gastrointestinal disorders	Diarrhoea	5	5	0
2021	11	25	Gastrointestinal disorders	Nausea	5	5	0
2021	11	25	Cardiac disorders	Palpitations	4	4	0
2021	11	25	Nervous system disorders	Paraesthesia	4	4	0
2021	11	25	Cardiac disorders	Tachycardia	4	4	0
2021	11	25	General disorders and administration site conditions	Injection site pain	4	4	0
2021	11	25	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	11	25	Immune system disorders	Hypersensitivity	3	3	0
2021	11	25	Gastrointestinal disorders	Vomiting	3	3	0
2021	11	25	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	11	25	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2021	11	25	Vascular disorders	Flushing	2	2	0
2021	11	25	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	11	25	Nervous system disorders	Lethargy	2	2	0
2021	11	25	Gastrointestinal disorders	Paraesthesia oral	2	2	0
2021	11	25	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	11	25	Eye disorders	Vision blurred	2	2	0
2021	11	25	General disorders and administration site conditions	Swelling face	2	2	0
2021	11	25	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	11	25	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	11	25	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	11	25	Psychiatric disorders	Confusional state	2	2	0
2021	11	25	Skin and subcutaneous tissue disorders	Swelling face	2	2	0
2021	11	25	Cardiac disorders	Atrial fibrillation	1	1	0
2021	11	25	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	25	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	11	25	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	11	25	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2021	11	25	Vascular disorders	Poor peripheral circulation	1	1	0
2021	11	25	Eye disorders	Visual impairment	1	1	0
2021	11	25	Gastrointestinal disorders	Abdominal tenderness	1	1	0
2021	11	25	Gastrointestinal disorders	Lip swelling	1	1	0
2021	11	25	Immune system disorders	Anaphylactic reaction	1	1	0
2021	11	25	Immune system disorders	Food allergy	1	1	0
2021	11	25	Gastrointestinal disorders	Gastrointestinal disorder	1	1	0
2021	11	25	General disorders and administration site conditions	Malaise	1	1	0
2021	11	25	Renal and urinary disorders	Acute kidney injury	1	1	0
2021	11	25	Nervous system disorders	Cerebrovascular accident	1	1	0
2021	11	25	Nervous system disorders	Presyncope	1	1	0
2021	11	25	Cardiac disorders	Myocarditis	1	1	0
2021	11	25	General disorders and administration site conditions	Injection site mass	1	1	0
2021	11	25	Nervous system disorders	Anosmia	1	1	0
2021	11	25	Nervous system disorders	Dysgeusia	1	1	0
2021	11	25	Nervous system disorders	Syncope	1	1	0
2021	11	25	Psychiatric disorders	Insomnia	1	1	0
2021	11	25	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	11	25	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2021	11	25	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	25	Gastrointestinal disorders	Dysphagia	1	1	0
2021	11	25	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	25	General disorders and administration site conditions	Feeling hot	1	1	0
2021	11	25	General disorders and administration site conditions	Swelling	1	1	0
2021	11	25	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	11	25	Nervous system disorders	Migraine	1	1	0
2021	11	25	Psychiatric disorders	Agitation	1	1	0
2021	11	25	Renal and urinary disorders	Haematuria	1	1	0
2021	11	25	Vascular disorders	Peripheral coldness	1	1	0
2021	11	25	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	11	25	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	25	Infections and infestations	Urinary tract infection	1	1	0
2021	11	25	Investigations	Pulse abnormal	1	1	0
2021	11	25	Nervous system disorders	Burning sensation	1	1	0
2021	11	25	Renal and urinary disorders	Glomerulonephritis	1	1	0
2021	11	25	Respiratory, thoracic and mediastinal disorders	Obstructive airways disorder	1	1	0
2021	11	25	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	11	25	Blood and lymphatic system disorders	Neutrophil function disorder	1	1	0
2021	11	25	Nervous system disorders	Hyperaesthesia	1	1	0
2021	11	25	Nervous system disorders	Tremor	1	1	0
2021	11	25	Infections and infestations	Oral herpes	1	1	0
2021	11	25	Investigations	Pulse absent	1	1	0
2021	11	25	Psychiatric disorders	Hallucination	1	1	0
2021	11	25	Nervous system disorders	Ageusia	1	1	0
2021	11	25	Reproductive system and breast disorders	Testicular swelling	1	1	0
2021	11	25	Blood and lymphatic system disorders	Neutropenia	1	1	0
2021	11	25	Gastrointestinal disorders	Dry mouth	1	1	0
2021	11	25	Investigations	Heart rate irregular	1	1	0
2021	11	25	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	25	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	25	Renal and urinary disorders	Microalbuminuria	1	1	0
2021	11	25	Reproductive system and breast disorders	Testicular pain	1	1	0
2021	11	26	Nervous system disorders	Headache	12	12	0
2021	11	26	Respiratory, thoracic and mediastinal disorders	Dyspnoea	11	10	0
2021	11	26	General disorders and administration site conditions	Chest pain	11	11	1
2021	11	26	General disorders and administration site conditions	Injection site reaction	8	8	0
2021	11	26	Musculoskeletal and connective tissue disorders	Myalgia	8	8	0
2021	11	26	Nervous system disorders	Dizziness	8	8	0
2021	11	26	General disorders and administration site conditions	Chest discomfort	8	7	0
2021	11	26	General disorders and administration site conditions	Fatigue	7	7	0
2021	11	26	Nervous system disorders	Lethargy	7	7	0
2021	11	26	Cardiac disorders	Palpitations	6	6	0
2021	11	26	Gastrointestinal disorders	Nausea	6	6	0
2021	11	26	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2021	11	26	General disorders and administration site conditions	Pyrexia	5	5	0
2021	11	26	Cardiac disorders	Tachycardia	4	4	0
2021	11	26	General disorders and administration site conditions	Influenza like illness	4	4	0
2021	11	26	General disorders and administration site conditions	Exercise tolerance decreased	3	3	0
2021	11	26	Nervous system disorders	Paraesthesia	3	3	0
2021	11	26	Metabolism and nutrition disorders	Decreased appetite	3	3	0
2021	11	26	Vascular disorders	Hypertension	3	3	0
2021	11	26	Nervous system disorders	Syncope	3	3	0
2021	11	26	General disorders and administration site conditions	Malaise	3	3	0
2021	11	26	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	11	26	General disorders and administration site conditions	Feeling of body temperature change	2	2	0
2021	11	26	Nervous system disorders	Tremor	2	2	0
2021	11	26	General disorders and administration site conditions	Injection site pain	2	2	0
2021	11	26	Psychiatric disorders	Confusional state	2	2	0
2021	11	26	Gastrointestinal disorders	Vomiting	2	2	0
2021	11	26	Eye disorders	Vision blurred	2	2	0
2021	11	26	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	11	26	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	11	26	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	11	26	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2021	11	26	Respiratory, thoracic and mediastinal disorders	Cough	2	2	1
2021	11	26	Investigations	Heart rate irregular	2	2	0
2021	11	26	Psychiatric disorders	Sleep disorder	2	2	0
2021	11	26	Hepatobiliary disorders	Hepatitis	1	1	0
2021	11	26	Investigations	Body temperature increased	1	1	0
2021	11	26	Musculoskeletal and connective tissue disorders	Musculoskeletal discomfort	1	1	0
2021	11	26	Nervous system disorders	Cerebral haemorrhage	1	1	0
2021	11	26	Vascular disorders	Deep vein thrombosis	1	1	0
2021	11	26	Investigations	Troponin	1	1	0
2021	11	26	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	11	26	Skin and subcutaneous tissue disorders	Piloerection	1	1	0
2021	11	26	Skin and subcutaneous tissue disorders	Skin sensitisation	1	1	0
2021	11	26	Investigations	Heart rate abnormal	1	1	0
2021	11	26	Reproductive system and breast disorders	Erection increased	1	1	0
2021	11	26	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	11	26	Investigations	Electrocardiogram	1	1	0
2021	11	26	Nervous system disorders	Coordination abnormal	1	1	0
2021	11	26	Nervous system disorders	Somnolence	1	1	0
2021	11	26	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2021	11	26	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	11	26	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	26	Musculoskeletal and connective tissue disorders	Spinal pain	1	0	0
2021	11	26	Psychiatric disorders	Panic attack	1	1	0
2021	11	26	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	11	26	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	26	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2021	11	26	General disorders and administration site conditions	Pain	1	1	0
2021	11	26	Infections and infestations	Urinary tract infection	1	1	0
2021	11	26	Musculoskeletal and connective tissue disorders	Muscle fatigue	1	1	0
2021	11	26	Nervous system disorders	Burning sensation	1	1	0
2021	11	26	Nervous system disorders	Electric shock sensation	1	1	0
2021	11	26	Nervous system disorders	Sensory overload	1	1	0
2021	11	26	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	11	26	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	11	26	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	11	26	Vascular disorders	Flushing	1	1	0
2021	11	26	Cardiac disorders	Myocarditis	1	1	0
2021	11	26	Eye disorders	Photophobia	1	1	0
2021	11	26	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	11	26	General disorders and administration site conditions	Injection site paraesthesia	1	1	0
2021	11	26	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2021	11	26	Immune system disorders	Hypersensitivity	1	1	0
2021	11	26	Nervous system disorders	Dysgeusia	1	1	0
2021	11	26	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	11	26	Respiratory, thoracic and mediastinal disorders	Pleural effusion	1	1	1
2021	11	26	Cardiac disorders	Pericardial effusion	1	1	0
2021	11	26	Cardiac disorders	Pericarditis	1	1	0
2021	11	26	Ear and labyrinth disorders	Vertigo	1	1	0
2021	11	26	Gastrointestinal disorders	Oesophageal spasm	1	0	0
2021	11	26	General disorders and administration site conditions	Feeling hot	1	1	0
2021	11	26	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	11	26	Nervous system disorders	Basal ganglia infarction	1	1	0
2021	11	26	Nervous system disorders	Migraine	1	1	0
2021	11	26	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	11	26	Nervous system disorders	Spinal cord compression	1	0	0
2021	11	26	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	11	26	Gastrointestinal disorders	Glossodynia	1	1	0
2021	11	26	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	11	26	General disorders and administration site conditions	Swelling face	1	1	0
2021	11	26	Investigations	Heart rate increased	1	1	0
2021	11	26	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	26	Nervous system disorders	Cerebrovascular accident	1	1	0
2021	11	26	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	11	26	General disorders and administration site conditions	Chills	1	1	0
2021	11	26	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	11	26	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	11	26	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2021	11	26	Investigations	Lymph node palpable	1	1	0
2021	11	26	Nervous system disorders	Balance disorder	1	1	0
2021	11	26	Nervous system disorders	Seizure	1	1	0
2021	11	26	Psychiatric disorders	Disorientation	1	1	0
2021	11	26	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	11	27	Gastrointestinal disorders	Nausea	5	5	0
2021	11	27	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2021	11	27	General disorders and administration site conditions	Pyrexia	5	5	0
2021	11	27	General disorders and administration site conditions	Fatigue	5	5	0
2021	11	27	Nervous system disorders	Headache	5	5	0
2021	11	27	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2021	11	27	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	11	27	General disorders and administration site conditions	Chest pain	4	4	0
2021	11	27	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2021	11	27	Gastrointestinal disorders	Vomiting	3	3	0
2021	11	27	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	11	27	Nervous system disorders	Dizziness	3	3	0
2021	11	27	Nervous system disorders	Paraesthesia	2	2	0
2021	11	27	Cardiac disorders	Palpitations	2	2	0
2021	11	27	General disorders and administration site conditions	Pain	2	2	0
2021	11	27	General disorders and administration site conditions	Malaise	2	2	0
2021	11	27	Musculoskeletal and connective tissue disorders	Neck pain	2	2	0
2021	11	27	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	11	27	Psychiatric disorders	Disorientation	1	1	0
2021	11	27	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	27	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	27	General disorders and administration site conditions	Chills	1	1	0
2021	11	27	Cardiac disorders	Cardiac flutter	1	1	0
2021	11	27	Investigations	Heart rate increased	1	1	0
2021	11	27	Vascular disorders	Hypertension	1	1	0
2021	11	27	Nervous system disorders	Lethargy	1	1	0
2021	11	27	Nervous system disorders	Memory impairment	1	1	0
2021	11	27	Respiratory, thoracic and mediastinal disorders	Pneumonitis	1	1	0
2021	11	27	Cardiac disorders	Cardiac arrest	1	1	0
2021	11	27	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	27	Nervous system disorders	Hypoaesthesia	1	1	0
2021	11	27	Psychiatric disorders	Emotional poverty	1	1	0
2021	11	27	Vascular disorders	Arteritis	1	1	0
2021	11	27	Investigations	Electrocardiogram abnormal	1	1	0
2021	11	27	Gastrointestinal disorders	Odynophagia	1	1	0
2021	11	27	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	27	Nervous system disorders	Migraine	1	1	0
2021	11	27	Eye disorders	Photophobia	1	1	0
2021	11	27	Nervous system disorders	Dysgeusia	1	1	0
2021	11	27	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	11	27	Cardiac disorders	Tachycardia	1	1	0
2021	11	27	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2021	11	28	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	11	28	General disorders and administration site conditions	Fatigue	3	3	0
2021	11	28	General disorders and administration site conditions	Pyrexia	2	2	0
2021	11	28	Nervous system disorders	Headache	2	2	0
2021	11	28	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	28	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	11	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2021	11	28	Nervous system disorders	Dysgeusia	2	2	0
2021	11	28	Gastrointestinal disorders	Nausea	2	2	0
2021	11	28	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	11	28	Cardiac disorders	Palpitations	1	1	0
2021	11	28	Nervous system disorders	Lethargy	1	1	0
2021	11	28	Gastrointestinal disorders	Vomiting	1	1	0
2021	11	28	General disorders and administration site conditions	Chest pain	1	1	0
2021	11	28	Social circumstances	Loss of personal independence in daily activities	1	1	0
2021	11	28	General disorders and administration site conditions	Hangover	1	1	0
2021	11	28	Nervous system disorders	Somnolence	1	1	0
2021	11	28	Reproductive system and breast disorders	Testicular swelling	1	1	0
2021	11	28	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	11	28	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	11	28	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	11	28	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	28	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2021	11	28	Respiratory, thoracic and mediastinal disorders	Sinus pain	1	1	0
2021	11	28	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	11	28	Immune system disorders	Immunosuppression	1	1	0
2021	11	28	General disorders and administration site conditions	Chills	1	1	0
2021	11	28	Immune system disorders	Anaphylactic reaction	1	1	0
2021	11	28	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	11	28	Nervous system disorders	Dizziness	1	1	0
2021	11	28	Infections and infestations	Herpes zoster	1	1	0
2021	11	29	General disorders and administration site conditions	Chest pain	20	20	0
2021	11	29	Nervous system disorders	Headache	18	18	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Dyspnoea	15	15	0
2021	11	29	Nervous system disorders	Paraesthesia	15	15	0
2021	11	29	General disorders and administration site conditions	Fatigue	13	13	0
2021	11	29	General disorders and administration site conditions	Pyrexia	12	12	0
2021	11	29	Skin and subcutaneous tissue disorders	Urticaria	11	11	0
2021	11	29	Nervous system disorders	Dizziness	11	11	0
2021	11	29	Skin and subcutaneous tissue disorders	Angioedema	10	10	0
2021	11	29	Gastrointestinal disorders	Nausea	10	10	0
2021	11	29	Skin and subcutaneous tissue disorders	Rash	10	10	0
2021	11	29	General disorders and administration site conditions	Chest discomfort	10	10	0
2021	11	29	Musculoskeletal and connective tissue disorders	Myalgia	9	9	0
2021	11	29	Gastrointestinal disorders	Vomiting	9	9	0
2021	11	29	Blood and lymphatic system disorders	Lymphadenopathy	9	9	0
2021	11	29	Cardiac disorders	Palpitations	9	9	0
2021	11	29	General disorders and administration site conditions	Injection site reaction	8	8	0
2021	11	29	Nervous system disorders	Syncope	7	7	0
2021	11	29	General disorders and administration site conditions	Concomitant disease aggravated	7	7	0
2021	11	29	Musculoskeletal and connective tissue disorders	Pain in extremity	7	7	0
2021	11	29	Musculoskeletal and connective tissue disorders	Arthralgia	7	7	0
2021	11	29	Cardiac disorders	Myocarditis	6	6	0
2021	11	29	Injury, poisoning and procedural complications	Vaccination error	6	6	0
2021	11	29	Cardiac disorders	Pericarditis	6	6	0
2021	11	29	Nervous system disorders	Hypoaesthesia	6	6	0
2021	11	29	Investigations	Troponin increased	5	5	0
2021	11	29	Cardiac disorders	Tachycardia	4	4	0
2021	11	29	Gastrointestinal disorders	Abdominal pain	4	4	0
2021	11	29	Musculoskeletal and connective tissue disorders	Muscular weakness	4	4	0
2021	11	29	Psychiatric disorders	Confusional state	4	4	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Cough	3	3	0
2021	11	29	Psychiatric disorders	Anxiety	3	3	0
2021	11	29	General disorders and administration site conditions	Oedema	2	2	0
2021	11	29	Nervous system disorders	Tremor	2	2	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	2	2	0
2021	11	29	Ear and labyrinth disorders	Ear pain	2	2	0
2021	11	29	Immune system disorders	Hypersensitivity	2	2	0
2021	11	29	Nervous system disorders	Migraine	2	2	0
2021	11	29	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	29	Infections and infestations	Herpes zoster	2	2	0
2021	11	29	Nervous system disorders	Balance disorder	2	2	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Throat tightness	2	2	0
2021	11	29	Skin and subcutaneous tissue disorders	Cold sweat	2	2	0
2021	11	29	General disorders and administration site conditions	Chills	2	2	0
2021	11	29	Nervous system disorders	Dysgeusia	2	2	0
2021	11	29	Nervous system disorders	Lethargy	2	2	0
2021	11	29	General disorders and administration site conditions	Swelling	2	2	0
2021	11	29	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	11	29	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2021	11	29	Renal and urinary disorders	Pollakiuria	2	2	0
2021	11	29	General disorders and administration site conditions	Pain	2	2	0
2021	11	29	Investigations	Heart rate irregular	2	2	0
2021	11	29	Nervous system disorders	Burning sensation	2	2	0
2021	11	29	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	29	General disorders and administration site conditions	Gait disturbance	2	2	0
2021	11	29	Immune system disorders	Anaphylactic reaction	2	2	0
2021	11	29	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	29	General disorders and administration site conditions	Malaise	2	2	0
2021	11	29	Skin and subcutaneous tissue disorders	Rash pruritic	2	2	0
2021	11	29	General disorders and administration site conditions	Injection site pain	1	1	0
2021	11	29	Investigations	Fibrin D dimer increased	1	1	0
2021	11	29	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	29	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	11	29	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	11	29	Gastrointestinal disorders	Abdominal distension	1	1	0
2021	11	29	Investigations	Troponin	1	1	0
2021	11	29	Nervous system disorders	Ageusia	1	1	0
2021	11	29	Nervous system disorders	Loss of consciousness	1	1	0
2021	11	29	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	11	29	Pregnancy, puerperium and perinatal conditions	Foetal hypokinesia	1	1	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Dry throat	1	1	0
2021	11	29	General disorders and administration site conditions	Inflammation	1	1	0
2021	11	29	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	11	29	Nervous system disorders	Dysaesthesia	1	1	0
2021	11	29	Nervous system disorders	Head discomfort	1	1	0
2021	11	29	Nervous system disorders	Transient ischaemic attack	1	1	0
2021	11	29	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2021	11	29	General disorders and administration site conditions	Discomfort	1	1	0
2021	11	29	Infections and infestations	Injection site abscess	1	1	0
2021	11	29	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2021	11	29	Investigations	Electrocardiogram abnormal	1	1	0
2021	11	29	Nervous system disorders	Coordination abnormal	1	1	0
2021	11	29	Psychiatric disorders	Mood swings	1	1	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2021	11	29	Vascular disorders	Hot flush	1	1	0
2021	11	29	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2021	11	29	Gastrointestinal disorders	Gastrointestinal pain	1	1	0
2021	11	29	Investigations	Blood creatine phosphokinase	1	1	0
2021	11	29	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Oropharyngeal swelling	1	1	0
2021	11	29	Skin and subcutaneous tissue disorders	Blister	1	1	0
2021	11	29	Skin and subcutaneous tissue disorders	Blood blister	1	1	0
2021	11	29	Cardiac disorders	Atrial tachycardia	1	1	0
2021	11	29	Gastrointestinal disorders	Swollen tongue	1	1	0
2021	11	29	Investigations	C-reactive protein increased	1	1	0
2021	11	29	Investigations	Echocardiogram	1	1	0
2021	11	29	Psychiatric disorders	Insomnia	1	1	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Pulmonary pain	1	1	0
2021	11	29	Endocrine disorders	Thyroid mass	1	1	0
2021	11	29	Eye disorders	Periorbital swelling	1	1	0
2021	11	29	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	11	29	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	29	Investigations	Pancreatic enzymes increased	1	1	0
2021	11	29	Nervous system disorders	Hyperaesthesia	1	1	0
2021	11	29	Nervous system disorders	Neuropathy peripheral	1	1	0
2021	11	29	Renal and urinary disorders	Renal pain	1	1	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	11	29	Vascular disorders	Internal haemorrhage	1	1	0
2021	11	29	Cardiac disorders	Myocardial infarction	1	1	0
2021	11	29	General disorders and administration site conditions	Asthenia	1	1	0
2021	11	29	Investigations	Echocardiogram normal	1	1	0
2021	11	29	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2021	11	29	Nervous system disorders	Fine motor skill dysfunction	1	1	0
2021	11	29	Nervous system disorders	Taste disorder	1	1	0
2021	11	29	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	11	29	Vascular disorders	Flushing	1	1	0
2021	11	29	Eye disorders	Vision blurred	1	1	0
2021	11	29	Nervous system disorders	Amnesia	1	1	0
2021	11	29	Nervous system disorders	Disturbance in attention	1	1	0
2021	11	29	Nervous system disorders	Seizure	1	1	0
2021	11	29	Psychiatric disorders	Disorientation	1	1	0
2021	11	29	Renal and urinary disorders	Urinary incontinence	1	1	0
2021	11	29	Reproductive system and breast disorders	Menopausal symptoms	1	1	0
2021	11	29	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	11	29	Cardiac disorders	Myocardial ischaemia	1	1	1
2021	11	29	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	29	Gastrointestinal disorders	Hypoaesthesia oral	1	1	0
2021	11	29	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	11	29	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	11	29	Nervous system disorders	Neuralgia	1	1	0
2021	11	29	Nervous system disorders	Tension headache	1	1	0
2021	11	29	Eye disorders	Blepharospasm	1	1	0
2021	11	29	General disorders and administration site conditions	Axillary pain	1	1	0
2021	11	29	Investigations	Cardiac murmur	1	1	0
2021	11	29	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	29	Nervous system disorders	Cognitive disorder	1	1	0
2021	11	29	Nervous system disorders	Facial paralysis	1	1	0
2021	11	29	Nervous system disorders	Presyncope	1	1	0
2021	11	29	Vascular disorders	Hypertension	1	1	0
2021	11	30	General disorders and administration site conditions	Injection site reaction	11	11	0
2021	11	30	General disorders and administration site conditions	Chest pain	9	9	0
2021	11	30	Nervous system disorders	Headache	8	8	0
2021	11	30	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	11	30	General disorders and administration site conditions	Pyrexia	8	8	0
2021	11	30	Nervous system disorders	Lethargy	7	7	0
2021	11	30	Cardiac disorders	Palpitations	6	6	0
2021	11	30	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2021	11	30	Gastrointestinal disorders	Nausea	6	6	0
2021	11	30	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2021	11	30	General disorders and administration site conditions	Chills	5	5	0
2021	11	30	General disorders and administration site conditions	Fatigue	5	5	0
2021	11	30	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2021	11	30	Gastrointestinal disorders	Vomiting	4	4	0
2021	11	30	Nervous system disorders	Paraesthesia	4	4	0
2021	11	30	General disorders and administration site conditions	Malaise	3	3	0
2021	11	30	Metabolism and nutrition disorders	Decreased appetite	3	3	0
2021	11	30	Skin and subcutaneous tissue disorders	Rash	3	3	0
2021	11	30	Nervous system disorders	Dizziness	3	3	0
2021	11	30	Nervous system disorders	Hypoaesthesia	3	3	0
2021	11	30	Cardiac disorders	Tachycardia	3	3	0
2021	11	30	Eye disorders	Vision blurred	2	2	0
2021	11	30	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	11	30	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	11	30	Investigations	Troponin increased	2	2	0
2021	11	30	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	11	30	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	11	30	General disorders and administration site conditions	Injection site pain	2	2	0
2021	11	30	Nervous system disorders	Migraine	2	2	0
2021	11	30	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	11	30	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	11	30	Infections and infestations	Injection site cellulitis	1	1	0
2021	11	30	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	11	30	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	11	30	Nervous system disorders	Disturbance in attention	1	1	0
2021	11	30	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	11	30	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	11	30	Eye disorders	Blepharospasm	1	1	0
2021	11	30	Nervous system disorders	Poor quality sleep	1	1	0
2021	11	30	Ear and labyrinth disorders	Ear pain	1	1	0
2021	11	30	Investigations	Heart rate increased	1	1	0
2021	11	30	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	11	30	Nervous system disorders	Presyncope	1	1	0
2021	11	30	Psychiatric disorders	Sleep disorder	1	1	0
2021	11	30	Hepatobiliary disorders	Hepatitis	1	1	0
2021	11	30	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	11	30	Nervous system disorders	Memory impairment	1	1	0
2021	11	30	Psychiatric disorders	Confusional state	1	1	0
2021	11	30	Skin and subcutaneous tissue disorders	Ecchymosis	1	1	0
2021	11	30	Nervous system disorders	Bell's palsy	1	1	0
2021	11	30	Nervous system disorders	Paralysis	1	1	0
2021	11	30	Cardiac disorders	Arrhythmia	1	1	0
2021	11	30	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	11	30	Metabolism and nutrition disorders	Fluid intake reduced	1	1	0
2021	11	30	Product issues	Electromagnetic interference	1	1	0
2021	11	30	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	11	30	Vascular disorders	Hypotension	1	1	0
2021	11	30	General disorders and administration site conditions	Pain	1	1	0
2021	11	30	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	11	30	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	11	30	Investigations	Pancreatic enzymes increased	1	1	0
2021	11	30	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	11	30	Psychiatric disorders	Poor quality sleep	1	1	0
2021	11	30	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	11	30	Cardiac disorders	Myocarditis	1	1	0
2021	11	30	Eye disorders	Photophobia	1	1	0
2021	11	30	Metabolism and nutrition disorders	Diabetic ketoacidosis	1	1	0
2021	11	30	Cardiac disorders	Pericardial effusion	1	1	0
2021	11	30	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	11	30	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	12	1	General disorders and administration site conditions	Injection site reaction	8	8	0
2021	12	1	Nervous system disorders	Headache	6	6	0
2021	12	1	Gastrointestinal disorders	Nausea	5	5	0
2021	12	1	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2021	12	1	Metabolism and nutrition disorders	Decreased appetite	3	3	0
2021	12	1	General disorders and administration site conditions	Chest pain	3	3	0
2021	12	1	General disorders and administration site conditions	Fatigue	3	3	0
2021	12	1	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	12	1	General disorders and administration site conditions	Pyrexia	3	3	0
2021	12	1	Psychiatric disorders	Sleep disorder	3	3	0
2021	12	1	Nervous system disorders	Lethargy	2	2	0
2021	12	1	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	12	1	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	1	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	12	1	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	12	1	Nervous system disorders	Dizziness	2	2	0
2021	12	1	Nervous system disorders	Hypoaesthesia	2	2	0
2021	12	1	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	12	1	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	12	1	General disorders and administration site conditions	Injection site pain	2	2	0
2021	12	1	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	12	1	Nervous system disorders	Migraine	2	2	0
2021	12	1	Cardiac disorders	Cardiac flutter	1	1	0
2021	12	1	General disorders and administration site conditions	Injection site pruritus	1	1	0
2021	12	1	General disorders and administration site conditions	Malaise	1	1	0
2021	12	1	General disorders and administration site conditions	Oedema peripheral	1	1	0
2021	12	1	Nervous system disorders	Facial paralysis	1	1	0
2021	12	1	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	1	General disorders and administration site conditions	Chills	1	1	0
2021	12	1	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	1	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2021	12	1	Cardiac disorders	Palpitations	1	1	0
2021	12	1	General disorders and administration site conditions	Injection site inflammation	1	1	0
2021	12	1	Nervous system disorders	Hemiparesis	1	1	0
2021	12	1	Reproductive system and breast disorders	Breast pain	1	1	0
2021	12	1	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	12	1	Nervous system disorders	Paralysis	1	1	0
2021	12	1	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2021	12	1	General disorders and administration site conditions	Injection site rash	1	1	0
2021	12	1	Investigations	Blood phosphorus decreased	1	1	0
2021	12	1	Nervous system disorders	Paraesthesia	1	1	0
2021	12	1	Nervous system disorders	Syncope	1	1	0
2021	12	1	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	1	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	1	Gastrointestinal disorders	Dysphagia	1	1	0
2021	12	1	Investigations	Blood potassium decreased	1	1	0
2021	12	1	Cardiac disorders	Tachycardia	1	1	0
2021	12	1	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	12	1	General disorders and administration site conditions	Asthenia	1	1	0
2021	12	1	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	1	Respiratory, thoracic and mediastinal disorders	Choking	1	1	0
2021	12	1	Gastrointestinal disorders	Retching	1	1	0
2021	12	1	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	12	1	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	12	2	General disorders and administration site conditions	Chest pain	12	11	0
2021	12	2	General disorders and administration site conditions	Fatigue	11	10	0
2021	12	2	Nervous system disorders	Headache	10	9	0
2021	12	2	Respiratory, thoracic and mediastinal disorders	Dyspnoea	9	8	0
2021	12	2	General disorders and administration site conditions	Injection site reaction	8	8	0
2021	12	2	Gastrointestinal disorders	Nausea	6	6	0
2021	12	2	Nervous system disorders	Dizziness	6	6	0
2021	12	2	General disorders and administration site conditions	Chest discomfort	5	4	0
2021	12	2	Cardiac disorders	Pericarditis	4	4	0
2021	12	2	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	12	2	Cardiac disorders	Palpitations	4	3	0
2021	12	2	General disorders and administration site conditions	Malaise	4	3	0
2021	12	2	General disorders and administration site conditions	Chills	3	3	0
2021	12	2	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2021	12	2	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	12	2	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2021	12	2	Nervous system disorders	Syncope	3	3	1
2021	12	2	Gastrointestinal disorders	Vomiting	3	3	0
2021	12	2	General disorders and administration site conditions	Concomitant disease aggravated	3	3	0
2021	12	2	General disorders and administration site conditions	Pyrexia	3	3	0
2021	12	2	Nervous system disorders	Migraine	3	3	0
2021	12	2	Eye disorders	Vision blurred	2	2	0
2021	12	2	Gastrointestinal disorders	Dysphagia	2	2	0
2021	12	2	General disorders and administration site conditions	Feeling abnormal	2	2	0
2021	12	2	General disorders and administration site conditions	Pain	2	1	0
2021	12	2	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	12	2	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	2	2	0
2021	12	2	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	12	2	Vascular disorders	Hot flush	2	2	0
2021	12	2	Nervous system disorders	Taste disorder	2	2	0
2021	12	2	General disorders and administration site conditions	Feeling of body temperature change	2	2	0
2021	12	2	General disorders and administration site conditions	Asthenia	2	2	0
2021	12	2	General disorders and administration site conditions	Injection site pain	2	2	0
2021	12	2	General disorders and administration site conditions	Axillary pain	1	1	0
2021	12	2	General disorders and administration site conditions	Oedema peripheral	1	1	0
2021	12	2	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	12	2	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	12	2	General disorders and administration site conditions	Swelling face	1	1	0
2021	12	2	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	2	Reproductive system and breast disorders	Breast enlargement	1	1	0
2021	12	2	Vascular disorders	Hypertension	1	1	0
2021	12	2	Vascular disorders	Pallor	1	1	0
2021	12	2	Blood and lymphatic system disorders	Immune thrombocytopenia	1	1	0
2021	12	2	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	2	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	2	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	2	Infections and infestations	Cellulitis	1	1	0
2021	12	2	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	2	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2021	12	2	Investigations	Fibrin D dimer increased	1	1	0
2021	12	2	Investigations	Troponin I	1	1	0
2021	12	2	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	12	2	Vascular disorders	Deep vein thrombosis	1	1	0
2021	12	2	Investigations	Troponin	1	1	0
2021	12	2	Renal and urinary disorders	Urinary retention	1	1	0
2021	12	2	Cardiac disorders	Myopericarditis	1	1	0
2021	12	2	Infections and infestations	Pneumonia	1	1	0
2021	12	2	Investigations	Electrocardiogram	1	1	0
2021	12	2	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	2	Nervous system disorders	Generalised tonic-clonic seizure	1	1	0
2021	12	2	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2021	12	2	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	2	Nervous system disorders	Hypoaesthesia	1	1	0
2021	12	2	Cardiac disorders	Tachycardia	1	1	0
2021	12	2	Gastrointestinal disorders	Constipation	1	1	0
2021	12	2	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	2	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	12	2	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	12	2	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	12	2	Nervous system disorders	Tremor	1	1	0
2021	12	2	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	12	2	Vascular disorders	Thrombosis	1	1	0
2021	12	2	Cardiac disorders	Myocarditis	1	1	0
2021	12	2	Nervous system disorders	Dysgeusia	1	1	0
2021	12	2	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	2	Injury, poisoning and procedural complications	Road traffic accident	1	1	1
2021	12	2	Metabolism and nutrition disorders	Polydipsia	1	1	0
2021	12	2	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	12	3	General disorders and administration site conditions	Chest pain	20	20	0
2021	12	3	Nervous system disorders	Headache	13	13	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Dyspnoea	11	11	0
2021	12	3	Cardiac disorders	Pericarditis	9	9	0
2021	12	3	Gastrointestinal disorders	Nausea	8	8	0
2021	12	3	Nervous system disorders	Lethargy	8	8	0
2021	12	3	Nervous system disorders	Dizziness	7	7	0
2021	12	3	Cardiac disorders	Palpitations	7	7	0
2021	12	3	General disorders and administration site conditions	Fatigue	5	5	0
2021	12	3	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2021	12	3	General disorders and administration site conditions	Chills	4	4	0
2021	12	3	Gastrointestinal disorders	Vomiting	4	4	0
2021	12	3	Nervous system disorders	Syncope	4	4	0
2021	12	3	Musculoskeletal and connective tissue disorders	Pain in extremity	4	3	0
2021	12	3	Gastrointestinal disorders	Diarrhoea	4	4	0
2021	12	3	Cardiac disorders	Myocarditis	4	4	0
2021	12	3	General disorders and administration site conditions	Influenza like illness	4	4	0
2021	12	3	General disorders and administration site conditions	Chest discomfort	4	4	0
2021	12	3	General disorders and administration site conditions	Pyrexia	4	4	0
2021	12	3	Nervous system disorders	Paraesthesia	4	3	0
2021	12	3	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	12	3	Investigations	Troponin increased	3	3	0
2021	12	3	Gastrointestinal disorders	Abdominal pain	3	3	0
2021	12	3	General disorders and administration site conditions	Injection site reaction	3	3	0
2021	12	3	General disorders and administration site conditions	Injection site swelling	3	3	0
2021	12	3	General disorders and administration site conditions	Malaise	3	3	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Throat tightness	3	3	0
2021	12	3	Eye disorders	Vision blurred	3	3	0
2021	12	3	Vascular disorders	Hypertension	3	3	0
2021	12	3	General disorders and administration site conditions	Injection site pain	2	2	0
2021	12	3	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	12	3	Psychiatric disorders	Confusional state	2	2	0
2021	12	3	Nervous system disorders	Tremor	2	2	0
2021	12	3	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	12	3	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2021	12	3	Cardiac disorders	Tachycardia	2	2	0
2021	12	3	Eye disorders	Ocular hyperaemia	2	2	0
2021	12	3	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	12	3	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	12	3	Immune system disorders	Anaphylactic reaction	2	2	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Epistaxis	2	2	0
2021	12	3	Cardiac disorders	Atrioventricular block first degree	1	1	0
2021	12	3	Injury, poisoning and procedural complications	Scar	1	1	0
2021	12	3	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2021	12	3	Skin and subcutaneous tissue disorders	Dermatitis	1	1	0
2021	12	3	Cardiac disorders	Cardiac arrest	1	1	0
2021	12	3	Infections and infestations	Diverticulitis	1	1	0
2021	12	3	Investigations	Respiratory rate increased	1	1	0
2021	12	3	Metabolism and nutrition disorders	Hyperglycaemia	1	1	0
2021	12	3	Psychiatric disorders	Suicidal ideation	1	1	0
2021	12	3	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	12	3	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	3	Nervous system disorders	Hypoaesthesia	1	1	0
2021	12	3	Psychiatric disorders	Hallucination, visual	1	1	0
2021	12	3	Reproductive system and breast disorders	Breast discomfort	1	1	0
2021	12	3	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	12	3	Cardiac disorders	Myopericarditis	1	1	0
2021	12	3	Infections and infestations	Septic shock	1	1	0
2021	12	3	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2021	12	3	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	3	Skin and subcutaneous tissue disorders	Skin discolouration	1	0	0
2021	12	3	Vascular disorders	Hot flush	1	1	0
2021	12	3	General disorders and administration site conditions	Illness	1	1	0
2021	12	3	General disorders and administration site conditions	Pain	1	1	0
2021	12	3	Nervous system disorders	Burning sensation	1	1	0
2021	12	3	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Stridor	1	1	0
2021	12	3	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	3	Eye disorders	Eye pain	1	1	0
2021	12	3	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	12	3	Psychiatric disorders	Panic attack	1	1	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	12	3	Blood and lymphatic system disorders	Sickle cell anaemia with crisis	1	1	0
2021	12	3	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2021	12	3	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	3	Nervous system disorders	Facial spasm	1	1	0
2021	12	3	Nervous system disorders	Migraine	1	1	0
2021	12	3	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2021	12	3	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	12	3	General disorders and administration site conditions	Injection site urticaria	1	1	0
2021	12	3	Infections and infestations	Pharyngitis	1	1	0
2021	12	3	Investigations	Echocardiogram	1	1	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Bronchospasm	1	1	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	3	Blood and lymphatic system disorders	Immune thrombocytopenia	1	1	0
2021	12	3	Eye disorders	Visual impairment	1	1	0
2021	12	3	Nervous system disorders	Aphasia	1	1	0
2021	12	3	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Haemoptysis	1	1	0
2021	12	3	Cardiac disorders	Pericardial rub	1	1	0
2021	12	3	Investigations	Electrocardiogram normal	1	1	0
2021	12	3	Metabolism and nutrition disorders	Dehydration	1	1	0
2021	12	3	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	12	3	Respiratory, thoracic and mediastinal disorders	Tachypnoea	1	1	0
2021	12	3	Skin and subcutaneous tissue disorders	Acne	1	1	0
2021	12	3	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	12	3	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	12	3	Investigations	Electrocardiogram T wave inversion	1	1	0
2021	12	3	Investigations	Weight increased	1	1	0
2021	12	3	Nervous system disorders	Presyncope	1	1	0
2021	12	3	Psychiatric disorders	Depressed mood	1	1	0
2021	12	3	Reproductive system and breast disorders	Breast enlargement	1	1	0
2021	12	3	Vascular disorders	Pallor	1	1	0
2021	12	3	Cardiac disorders	Cardiac flutter	1	1	0
2021	12	3	General disorders and administration site conditions	Gait inability	1	1	0
2021	12	3	Reproductive system and breast disorders	Breast discharge	1	1	0
2021	12	4	General disorders and administration site conditions	Fatigue	4	4	0
2021	12	4	General disorders and administration site conditions	Chest pain	4	3	0
2021	12	4	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2021	12	4	Cardiac disorders	Pericarditis	2	1	0
2021	12	4	Gastrointestinal disorders	Nausea	2	2	0
2021	12	4	Nervous system disorders	Dizziness	2	2	0
2021	12	4	General disorders and administration site conditions	Pyrexia	2	2	0
2021	12	4	Eye disorders	Vision blurred	1	1	0
2021	12	4	Nervous system disorders	Amnesia	1	1	0
2021	12	4	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	4	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	12	4	General disorders and administration site conditions	Chills	1	1	0
2021	12	4	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2021	12	4	Investigations	Electrocardiogram abnormal	1	0	0
2021	12	4	Vascular disorders	Capillary leak syndrome	1	1	0
2021	12	4	Skin and subcutaneous tissue disorders	Nail bed bleeding	1	1	0
2021	12	4	Gastrointestinal disorders	Gingival bleeding	1	1	0
2021	12	4	Nervous system disorders	Paraesthesia	1	1	0
2021	12	4	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	4	Investigations	Electrocardiogram ST segment elevation	1	0	0
2021	12	4	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	12	4	Musculoskeletal and connective tissue disorders	Flank pain	1	1	0
2021	12	4	Renal and urinary disorders	Haematuria	1	1	0
2021	12	4	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	12	4	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	4	Eye disorders	Eye swelling	1	1	0
2021	12	4	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	12	4	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	12	4	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	12	4	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	12	4	Psychiatric disorders	Panic attack	1	1	0
2021	12	4	Cardiac disorders	Palpitations	1	1	0
2021	12	4	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	12	4	Nervous system disorders	Headache	1	1	0
2021	12	4	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	4	Nervous system disorders	Hypoaesthesia	1	1	0
2021	12	5	Nervous system disorders	Headache	5	5	0
2021	12	5	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2021	12	5	Nervous system disorders	Lethargy	4	4	0
2021	12	5	Respiratory, thoracic and mediastinal disorders	Cough	3	3	0
2021	12	5	General disorders and administration site conditions	Pyrexia	3	3	0
2021	12	5	Nervous system disorders	Dizziness	3	3	0
2021	12	5	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	5	Gastrointestinal disorders	Nausea	2	2	0
2021	12	5	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	12	5	General disorders and administration site conditions	Injection site pain	2	2	0
2021	12	5	Gastrointestinal disorders	Abdominal pain upper	2	2	0
2021	12	5	Investigations	Heart rate increased	2	2	0
2021	12	5	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	5	Respiratory, thoracic and mediastinal disorders	Choking sensation	1	1	0
2021	12	5	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	12	5	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	5	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	12	5	Cardiac disorders	Palpitations	1	1	0
2021	12	5	Investigations	Body temperature increased	1	1	0
2021	12	5	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	12	5	Nervous system disorders	Memory impairment	1	1	0
2021	12	5	Psychiatric disorders	Confusional state	1	1	0
2021	12	5	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	5	Cardiac disorders	Pericarditis	1	1	0
2021	12	5	General disorders and administration site conditions	Swelling	1	1	0
2021	12	5	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	12	5	General disorders and administration site conditions	Fatigue	1	1	0
2021	12	5	Nervous system disorders	Paraesthesia	1	1	0
2021	12	5	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	5	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	12	5	Gastrointestinal disorders	Constipation	1	1	0
2021	12	5	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	12	6	General disorders and administration site conditions	Chest pain	15	15	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Dyspnoea	11	11	0
2021	12	6	Nervous system disorders	Headache	9	9	0
2021	12	6	General disorders and administration site conditions	Injection site reaction	9	9	0
2021	12	6	General disorders and administration site conditions	Pyrexia	8	8	0
2021	12	6	General disorders and administration site conditions	Chest discomfort	6	6	0
2021	12	6	Cardiac disorders	Palpitations	6	6	0
2021	12	6	Skin and subcutaneous tissue disorders	Rash	6	6	0
2021	12	6	Gastrointestinal disorders	Nausea	5	5	0
2021	12	6	General disorders and administration site conditions	Fatigue	4	4	0
2021	12	6	General disorders and administration site conditions	Malaise	4	4	0
2021	12	6	Nervous system disorders	Tremor	4	4	0
2021	12	6	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	12	6	Cardiac disorders	Pericarditis	3	3	0
2021	12	6	General disorders and administration site conditions	Injection site pain	3	3	0
2021	12	6	Investigations	Troponin	3	2	0
2021	12	6	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	12	6	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	12	6	Cardiac disorders	Myopericarditis	2	2	0
2021	12	6	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	12	6	Psychiatric disorders	Sleep disorder	2	2	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	12	6	Cardiac disorders	Myocarditis	2	2	0
2021	12	6	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	6	Nervous system disorders	Dizziness	2	2	0
2021	12	6	Cardiac disorders	Tachycardia	2	2	0
2021	12	6	Nervous system disorders	Lethargy	2	2	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	2	2	0
2021	12	6	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	12	6	General disorders and administration site conditions	Asthenia	2	2	0
2021	12	6	Nervous system disorders	Migraine	2	2	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Wheezing	2	2	0
2021	12	6	Psychiatric disorders	Panic attack	2	2	0
2021	12	6	Gastrointestinal disorders	Lip swelling	1	1	0
2021	12	6	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	6	Psychiatric disorders	Disorientation	1	1	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	12	6	Cardiac disorders	Atrial fibrillation	1	1	0
2021	12	6	Cardiac disorders	Atrioventricular block	1	0	0
2021	12	6	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	12	6	Infections and infestations	Cellulitis	1	1	0
2021	12	6	Investigations	Electrocardiogram normal	1	1	0
2021	12	6	Metabolism and nutrition disorders	Dehydration	1	1	0
2021	12	6	Psychiatric disorders	Anxiety	1	1	0
2021	12	6	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	12	6	General disorders and administration site conditions	Oedema peripheral	1	1	0
2021	12	6	Infections and infestations	Herpes zoster	1	1	0
2021	12	6	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	12	6	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	12	6	General disorders and administration site conditions	Swelling face	1	1	0
2021	12	6	Vascular disorders	Hypertension	1	1	0
2021	12	6	Eye disorders	Eye swelling	1	1	0
2021	12	6	Gastrointestinal disorders	Retching	1	1	0
2021	12	6	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	12	6	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	12	6	Investigations	Echocardiogram normal	1	1	0
2021	12	6	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	6	Nervous system disorders	Dysgeusia	1	1	0
2021	12	6	Nervous system disorders	Syncope	1	1	0
2021	12	6	Psychiatric disorders	Insomnia	1	1	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Sneezing	1	1	0
2021	12	6	Skin and subcutaneous tissue disorders	Rash vesicular	1	1	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2021	12	6	Cardiac disorders	Bradycardia	1	1	0
2021	12	6	Investigations	Heart rate irregular	1	1	0
2021	12	6	Nervous system disorders	Hypoaesthesia	1	1	0
2021	12	6	General disorders and administration site conditions	Discomfort	1	1	0
2021	12	6	Psychiatric disorders	Dysphemia	1	1	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	12	6	Cardiac disorders	Bundle branch block left	1	0	0
2021	12	6	Immune system disorders	Amyloidosis	1	0	0
2021	12	6	Psychiatric disorders	Confusional state	1	1	0
2021	12	6	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	12	6	Respiratory, thoracic and mediastinal disorders	Oropharyngeal discomfort	1	1	0
2021	12	6	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	12	6	Vascular disorders	Deep vein thrombosis	1	1	0
2021	12	6	Cardiac disorders	Cardiac disorder	1	0	0
2021	12	6	Injury, poisoning and procedural complications	Maternal exposure during breast feeding	1	1	0
2021	12	6	Investigations	Oxygen saturation decreased	1	1	0
2021	12	6	Psychiatric disorders	Emotional distress	1	1	0
2021	12	7	General disorders and administration site conditions	Chest pain	11	11	0
2021	12	7	Musculoskeletal and connective tissue disorders	Myalgia	8	8	0
2021	12	7	Nervous system disorders	Paraesthesia	7	7	0
2021	12	7	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2021	12	7	General disorders and administration site conditions	Pyrexia	7	7	0
2021	12	7	General disorders and administration site conditions	Injection site reaction	6	6	0
2021	12	7	Nervous system disorders	Headache	6	6	0
2021	12	7	General disorders and administration site conditions	Fatigue	6	6	0
2021	12	7	Cardiac disorders	Pericarditis	5	5	0
2021	12	7	Gastrointestinal disorders	Nausea	5	5	0
2021	12	7	General disorders and administration site conditions	Chest discomfort	5	5	0
2021	12	7	Nervous system disorders	Dizziness	4	4	0
2021	12	7	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2021	12	7	Cardiac disorders	Palpitations	4	4	0
2021	12	7	Gastrointestinal disorders	Vomiting	4	4	0
2021	12	7	General disorders and administration site conditions	Chills	3	3	0
2021	12	7	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2021	12	7	Nervous system disorders	Syncope	3	3	0
2021	12	7	Nervous system disorders	Tremor	2	2	0
2021	12	7	Gastrointestinal disorders	Gastrooesophageal reflux disease	2	2	0
2021	12	7	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	12	7	Nervous system disorders	Amnesia	2	2	0
2021	12	7	Nervous system disorders	Hypoaesthesia	2	2	0
2021	12	7	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	12	7	Nervous system disorders	Lethargy	2	2	0
2021	12	7	Investigations	Heart rate irregular	2	2	0
2021	12	7	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	12	7	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	12	7	Psychiatric disorders	Sleep disorder	2	2	0
2021	12	7	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2021	12	7	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	12	7	Infections and infestations	Cystitis	1	1	0
2021	12	7	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	12	7	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	12	7	Blood and lymphatic system disorders	Neutropenia	1	1	0
2021	12	7	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	12	7	Investigations	Blood pressure systolic increased	1	1	0
2021	12	7	Reproductive system and breast disorders	Abnormal uterine bleeding	1	1	0
2021	12	7	Gastrointestinal disorders	Glossitis	1	1	0
2021	12	7	General disorders and administration site conditions	Injection site rash	1	1	0
2021	12	7	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	12	7	Investigations	Electrocardiogram	1	1	0
2021	12	7	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2021	12	7	Vascular disorders	Hot flush	1	1	0
2021	12	7	Vascular disorders	Hypotension	1	1	0
2021	12	7	Eye disorders	Eye pain	1	1	0
2021	12	7	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	7	Investigations	White blood cell count decreased	1	1	0
2021	12	7	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	12	7	Gastrointestinal disorders	Tongue haemorrhage	1	1	0
2021	12	7	General disorders and administration site conditions	Pain	1	1	0
2021	12	7	Investigations	Blood creatine phosphokinase increased	1	1	0
2021	12	7	Investigations	Weight decreased	1	1	0
2021	12	7	Psychiatric disorders	Confusional state	1	0	0
2021	12	7	Vascular disorders	Flushing	1	1	0
2021	12	7	Eye disorders	Photophobia	1	1	0
2021	12	7	Nervous system disorders	Dysgeusia	1	1	0
2021	12	7	Renal and urinary disorders	Pollakiuria	1	1	0
2021	12	7	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2021	12	7	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	7	Gastrointestinal disorders	Dysphagia	1	1	0
2021	12	7	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	12	7	Reproductive system and breast disorders	Pelvic pain	1	1	0
2021	12	7	General disorders and administration site conditions	Malaise	1	1	0
2021	12	7	General disorders and administration site conditions	Thirst	1	1	0
2021	12	7	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	12	7	Gastrointestinal disorders	Glossodynia	1	1	0
2021	12	7	Respiratory, thoracic and mediastinal disorders	Nasal ulcer	1	1	0
2021	12	7	Vascular disorders	Hypertension	1	1	0
2021	12	7	Vascular disorders	Pallor	1	1	0
2021	12	7	Cardiac disorders	Cardiomegaly	1	1	0
2021	12	7	Eye disorders	Blindness	1	1	0
2021	12	7	Gastrointestinal disorders	Gingival pain	1	1	0
2021	12	7	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	7	Eye disorders	Vision blurred	1	1	0
2021	12	7	Eye disorders	Visual impairment	1	1	0
2021	12	7	Nervous system disorders	Balance disorder	1	1	0
2021	12	7	Nervous system disorders	Seizure	1	1	0
2021	12	7	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	8	General disorders and administration site conditions	Chest pain	14	14	0
2021	12	8	Nervous system disorders	Headache	9	9	0
2021	12	8	Respiratory, thoracic and mediastinal disorders	Dyspnoea	9	9	0
2021	12	8	Musculoskeletal and connective tissue disorders	Myalgia	7	7	0
2021	12	8	General disorders and administration site conditions	Injection site reaction	7	7	0
2021	12	8	Nervous system disorders	Lethargy	6	6	0
2021	12	8	General disorders and administration site conditions	Fatigue	6	6	0
2021	12	8	Cardiac disorders	Pericarditis	5	5	0
2021	12	8	General disorders and administration site conditions	Pyrexia	5	5	0
2021	12	8	Injury, poisoning and procedural complications	Vaccination error	4	4	0
2021	12	8	Nervous system disorders	Dizziness	4	4	0
2021	12	8	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2021	12	8	Nervous system disorders	Tremor	4	4	0
2021	12	8	Gastrointestinal disorders	Nausea	3	3	0
2021	12	8	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	12	8	Respiratory, thoracic and mediastinal disorders	Cough	3	3	0
2021	12	8	Psychiatric disorders	Confusional state	2	2	0
2021	12	8	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	2	2	0
2021	12	8	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	12	8	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	12	8	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	12	8	General disorders and administration site conditions	Feeling hot	2	2	0
2021	12	8	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2021	12	8	Nervous system disorders	Balance disorder	2	2	0
2021	12	8	Skin and subcutaneous tissue disorders	Cold sweat	2	2	0
2021	12	8	General disorders and administration site conditions	Chills	2	2	0
2021	12	8	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	12	8	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	12	8	Cardiac disorders	Palpitations	2	2	0
2021	12	8	Nervous system disorders	Burning sensation	2	2	0
2021	12	8	Gastrointestinal disorders	Dry mouth	1	1	0
2021	12	8	Gastrointestinal disorders	Mouth ulceration	1	1	0
2021	12	8	Injury, poisoning and procedural complications	Expired product administered	1	1	0
2021	12	8	Investigations	Heart rate irregular	1	1	0
2021	12	8	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	8	Nervous system disorders	Hypoaesthesia	1	1	0
2021	12	8	Cardiac disorders	Myopericarditis	1	1	0
2021	12	8	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2021	12	8	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	12	8	Endocrine disorders	Autoimmune thyroiditis	1	1	0
2021	12	8	Gastrointestinal disorders	Frequent bowel movements	1	1	0
2021	12	8	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	8	Injury, poisoning and procedural complications	Product storage error	1	1	0
2021	12	8	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	12	8	Cardiac disorders	Tachycardia	1	1	0
2021	12	8	Gastrointestinal disorders	Mouth haemorrhage	1	1	0
2021	12	8	Gastrointestinal disorders	Rectal haemorrhage	1	1	0
2021	12	8	Nervous system disorders	Hypersomnia	1	1	0
2021	12	8	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	8	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	12	8	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	8	Cardiac disorders	Cardiac arrest	1	1	1
2021	12	8	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	8	General disorders and administration site conditions	Multiple organ dysfunction syndrome	1	1	1
2021	12	8	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	12	8	Investigations	Electrocardiogram PR segment depression	1	1	0
2021	12	8	Reproductive system and breast disorders	Breast tenderness	1	1	0
2021	12	8	Cardiac disorders	Myocarditis	1	1	0
2021	12	8	Gastrointestinal disorders	Swollen tongue	1	1	0
2021	12	8	Immune system disorders	Hypersensitivity	1	1	0
2021	12	8	Nervous system disorders	Dysgeusia	1	1	0
2021	12	8	Nervous system disorders	Syncope	1	1	0
2021	12	8	Psychiatric disorders	Insomnia	1	1	0
2021	12	8	Blood and lymphatic system disorders	Immune thrombocytopenia	1	1	0
2021	12	8	Eye disorders	Visual impairment	1	1	0
2021	12	8	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	8	Investigations	Blood thyroid stimulating hormone increased	1	1	0
2021	12	8	Nervous system disorders	Disturbance in attention	1	1	0
2021	12	8	Nervous system disorders	Ischaemic stroke	1	1	0
2021	12	8	Nervous system disorders	Sensory disturbance	1	1	0
2021	12	8	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	8	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	12	8	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	8	Cardiac disorders	Cardiomegaly	1	1	0
2021	12	8	Eye disorders	Retinoschisis	1	1	0
2021	12	8	Gastrointestinal disorders	Hypoaesthesia oral	1	1	0
2021	12	8	Infections and infestations	Injection site cellulitis	1	1	0
2021	12	8	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2021	12	8	Psychiatric disorders	Anxiety	1	1	0
2021	12	8	Cardiac disorders	Acute myocardial infarction	1	1	1
2021	12	8	Cardiac disorders	Atrial flutter	1	1	0
2021	12	8	Ear and labyrinth disorders	Ear pain	1	1	0
2021	12	8	Nervous system disorders	Presyncope	1	1	0
2021	12	8	General disorders and administration site conditions	Malaise	1	1	0
2021	12	8	Infections and infestations	Herpes zoster meningitis	1	1	0
2021	12	9	General disorders and administration site conditions	Chest pain	11	11	0
2021	12	9	General disorders and administration site conditions	Pyrexia	8	8	0
2021	12	9	Nervous system disorders	Headache	7	7	0
2021	12	9	General disorders and administration site conditions	Injection site reaction	7	7	0
2021	12	9	Gastrointestinal disorders	Vomiting	6	6	0
2021	12	9	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2021	12	9	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2021	12	9	General disorders and administration site conditions	Chest discomfort	5	5	0
2021	12	9	Blood and lymphatic system disorders	Lymphadenopathy	5	5	0
2021	12	9	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2021	12	9	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	12	9	Gastrointestinal disorders	Nausea	4	4	0
2021	12	9	Cardiac disorders	Palpitations	4	4	0
2021	12	9	Skin and subcutaneous tissue disorders	Rash	4	4	0
2021	12	9	Gastrointestinal disorders	Diarrhoea	3	3	0
2021	12	9	General disorders and administration site conditions	Injection site swelling	3	3	0
2021	12	9	General disorders and administration site conditions	Swelling	3	3	0
2021	12	9	General disorders and administration site conditions	Fatigue	3	3	0
2021	12	9	Cardiac disorders	Pericarditis	2	2	0
2021	12	9	General disorders and administration site conditions	Injection site rash	2	2	0
2021	12	9	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	12	9	Musculoskeletal and connective tissue disorders	Mobility decreased	2	2	0
2021	12	9	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	2	2	0
2021	12	9	Nervous system disorders	Migraine	2	2	0
2021	12	9	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	12	9	Investigations	Troponin increased	2	2	0
2021	12	9	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	12	9	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	12	9	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2021	12	9	Nervous system disorders	Paraesthesia	2	2	0
2021	12	9	Nervous system disorders	Dizziness	2	2	0
2021	12	9	Nervous system disorders	Hypoaesthesia	2	2	0
2021	12	9	General disorders and administration site conditions	Chills	2	2	0
2021	12	9	Nervous system disorders	Lethargy	2	2	0
2021	12	9	Gastrointestinal disorders	Retching	1	1	0
2021	12	9	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	12	9	General disorders and administration site conditions	Generalised oedema	1	1	0
2021	12	9	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	12	9	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	12	9	Nervous system disorders	Tremor	1	1	0
2021	12	9	Renal and urinary disorders	Renal pain	1	1	0
2021	12	9	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	12	9	Skin and subcutaneous tissue disorders	Rash papular	1	1	0
2021	12	9	Cardiac disorders	Tachycardia	1	1	0
2021	12	9	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	12	9	Gastrointestinal disorders	Oral discomfort	1	1	0
2021	12	9	General disorders and administration site conditions	Asthenia	1	1	0
2021	12	9	General disorders and administration site conditions	Injection site haemorrhage	1	1	0
2021	12	9	Infections and infestations	Tonsillitis	1	1	0
2021	12	9	Vascular disorders	Flushing	1	1	0
2021	12	9	Cardiac disorders	Myocarditis	1	1	0
2021	12	9	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	12	9	General disorders and administration site conditions	Injection site paraesthesia	1	1	0
2021	12	9	Infections and infestations	Ear infection	1	1	0
2021	12	9	Investigations	C-reactive protein increased	1	1	0
2021	12	9	Nervous system disorders	Dysgeusia	1	1	0
2021	12	9	Skin and subcutaneous tissue disorders	Skin burning sensation	1	1	0
2021	12	9	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	9	General disorders and administration site conditions	Feeling hot	1	1	0
2021	12	9	Investigations	Electrocardiogram ST segment depression	1	1	0
2021	12	9	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2021	12	9	General disorders and administration site conditions	Injection site pain	1	1	0
2021	12	9	Investigations	Body temperature increased	1	1	0
2021	12	9	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2021	12	9	Psychiatric disorders	Confusional state	1	1	0
2021	12	9	Reproductive system and breast disorders	Breast pain	1	1	0
2021	12	9	Musculoskeletal and connective tissue disorders	Rhabdomyolysis	1	1	0
2021	12	9	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	12	9	Cardiac disorders	Myopericarditis	1	1	0
2021	12	9	Gastrointestinal disorders	Tongue disorder	1	1	0
2021	12	9	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2021	12	9	Investigations	Electrocardiogram	1	1	0
2021	12	9	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	12	9	Cardiac disorders	Cardiomyopathy	1	1	0
2021	12	9	General disorders and administration site conditions	Cyst	1	1	0
2021	12	9	General disorders and administration site conditions	Malaise	1	1	0
2021	12	9	Infections and infestations	Herpes zoster	1	1	0
2021	12	9	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	12	9	Ear and labyrinth disorders	Ear pain	1	1	0
2021	12	9	General disorders and administration site conditions	Swelling face	1	1	0
2021	12	9	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	9	Nervous system disorders	Presyncope	1	1	0
2021	12	9	Vascular disorders	Hypertension	1	1	0
2021	12	9	Cardiac disorders	Atrial fibrillation	1	1	0
2021	12	9	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	12	9	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2021	12	9	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	12	9	Investigations	Red blood cell sedimentation rate increased	1	1	0
2021	12	9	Investigations	Troponin I increased	1	1	0
2021	12	9	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	12	9	Nervous system disorders	Neuralgia	1	1	0
2021	12	9	Eye disorders	Vision blurred	1	1	0
2021	12	9	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	9	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Uterine cancer	1	1	0
2021	12	9	Respiratory, thoracic and mediastinal disorders	Haemoptysis	1	1	0
2021	12	9	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	12	10	Respiratory, thoracic and mediastinal disorders	Dyspnoea	11	11	0
2021	12	10	General disorders and administration site conditions	Chest pain	11	11	0
2021	12	10	Nervous system disorders	Headache	7	6	0
2021	12	10	General disorders and administration site conditions	Fatigue	6	6	0
2021	12	10	General disorders and administration site conditions	Chest discomfort	6	6	0
2021	12	10	General disorders and administration site conditions	Pyrexia	6	5	0
2021	12	10	Cardiac disorders	Palpitations	6	6	0
2021	12	10	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2021	12	10	General disorders and administration site conditions	Injection site reaction	5	5	0
2021	12	10	Gastrointestinal disorders	Nausea	3	3	0
2021	12	10	Cardiac disorders	Myopericarditis	3	3	0
2021	12	10	Nervous system disorders	Lethargy	3	3	0
2021	12	10	Nervous system disorders	Dizziness	3	3	0
2021	12	10	Cardiac disorders	Myocarditis	3	3	0
2021	12	10	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	12	10	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	10	Nervous system disorders	Paraesthesia	2	2	0
2021	12	10	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	12	10	Nervous system disorders	Syncope	2	2	0
2021	12	10	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	12	10	General disorders and administration site conditions	Malaise	2	2	0
2021	12	10	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	12	10	General disorders and administration site conditions	Asthenia	2	2	0
2021	12	10	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	12	10	Investigations	Heart rate increased	2	2	0
2021	12	10	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	12	10	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	12	10	Skin and subcutaneous tissue disorders	Skin ulcer	1	1	0
2021	12	10	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	10	Nervous system disorders	Seizure	1	1	0
2021	12	10	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	10	Skin and subcutaneous tissue disorders	Skin exfoliation	1	1	0
2021	12	10	Ear and labyrinth disorders	Hyperacusis	1	1	0
2021	12	10	Investigations	Troponin	1	1	0
2021	12	10	Investigations	Troponin increased	1	1	0
2021	12	10	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	12	10	Nervous system disorders	Ageusia	1	1	0
2021	12	10	General disorders and administration site conditions	Injection site pain	1	1	0
2021	12	10	Hepatobiliary disorders	Hepatitis	1	1	0
2021	12	10	Investigations	Fibrin D dimer increased	1	1	0
2021	12	10	Reproductive system and breast disorders	Breast pain	1	1	0
2021	12	10	Skin and subcutaneous tissue disorders	Ecchymosis	1	1	0
2021	12	10	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	10	Reproductive system and breast disorders	Testicular pain	1	1	0
2021	12	10	Investigations	Electrocardiogram	1	1	0
2021	12	10	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	10	Eye disorders	Photophobia	1	1	0
2021	12	10	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	12	10	Investigations	Blood urea increased	1	1	0
2021	12	10	Nervous system disorders	Facial spasm	1	1	0
2021	12	10	Nervous system disorders	Migraine	1	1	0
2021	12	10	Product issues	Syringe issue	1	1	0
2021	12	10	Reproductive system and breast disorders	Pelvic pain	1	1	0
2021	12	10	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2021	12	10	Nervous system disorders	Burning sensation	1	1	0
2021	12	10	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	10	Skin and subcutaneous tissue disorders	Sensitive skin	1	1	0
2021	12	10	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	12	10	Nervous system disorders	Hyperaesthesia	1	1	0
2021	12	10	Reproductive system and breast disorders	Breast swelling	1	1	0
2021	12	11	General disorders and administration site conditions	Pyrexia	3	3	0
2021	12	11	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	12	11	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	12	11	Cardiac disorders	Pericarditis	2	2	0
2021	12	11	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	12	11	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	11	General disorders and administration site conditions	Chills	1	1	0
2021	12	11	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	11	Reproductive system and breast disorders	Haematospermia	1	1	0
2021	12	11	Cardiac disorders	Cardiac flutter	1	1	0
2021	12	11	General disorders and administration site conditions	Malaise	1	1	0
2021	12	11	Gastrointestinal disorders	Gingival bleeding	1	1	0
2021	12	11	General disorders and administration site conditions	Fatigue	1	1	0
2021	12	11	General disorders and administration site conditions	Feeling cold	1	1	0
2021	12	11	General disorders and administration site conditions	Injection site mass	1	1	0
2021	12	11	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	12	11	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	12	11	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	11	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	12	11	General disorders and administration site conditions	Pain	1	1	0
2021	12	11	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	11	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	12	11	General disorders and administration site conditions	Chest pain	1	1	0
2021	12	11	Investigations	Heart rate irregular	1	1	0
2021	12	11	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	12	11	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	11	General disorders and administration site conditions	Injection site inflammation	1	1	0
2021	12	11	General disorders and administration site conditions	Injection site pain	1	1	0
2021	12	11	Nervous system disorders	Headache	1	1	0
2021	12	11	Nervous system disorders	Lethargy	1	1	0
2021	12	11	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	12	12	Nervous system disorders	Headache	6	6	0
2021	12	12	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2021	12	12	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	12	12	General disorders and administration site conditions	Fatigue	4	4	0
2021	12	12	General disorders and administration site conditions	Pyrexia	4	4	0
2021	12	12	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	12	12	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	12	12	General disorders and administration site conditions	Injection site reaction	3	3	0
2021	12	12	General disorders and administration site conditions	Chest pain	3	3	0
2021	12	12	General disorders and administration site conditions	Injection site pain	2	2	0
2021	12	12	Nervous system disorders	Dizziness	2	2	0
2021	12	12	Nervous system disorders	Lethargy	2	2	0
2021	12	12	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	12	12	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	12	12	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	12	12	Gastrointestinal disorders	Nausea	1	1	0
2021	12	12	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	12	Investigations	C-reactive protein	1	1	0
2021	12	12	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	12	12	Investigations	Electrocardiogram	1	1	0
2021	12	12	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2021	12	12	Vascular disorders	Hypotension	1	1	0
2021	12	12	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	12	12	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	12	12	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2021	12	12	Psychiatric disorders	Panic attack	1	1	0
2021	12	12	Renal and urinary disorders	Renal pain	1	1	0
2021	12	12	General disorders and administration site conditions	Asthenia	1	1	0
2021	12	12	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	12	Cardiac disorders	Myocarditis	1	1	0
2021	12	12	Nervous system disorders	Dysgeusia	1	1	0
2021	12	12	Nervous system disorders	Sciatica	1	1	0
2021	12	12	Investigations	Electrocardiogram ST segment depression	1	1	0
2021	12	12	Investigations	Heart rate decreased	1	1	0
2021	12	12	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	12	12	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	12	12	Vascular disorders	Pallor	1	1	0
2021	12	12	Gastrointestinal disorders	Gastrooesophageal reflux disease	1	1	0
2021	12	12	Investigations	Troponin I increased	1	1	0
2021	12	12	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	12	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	12	Vascular disorders	Blood pressure fluctuation	1	1	0
2021	12	13	General disorders and administration site conditions	Chest pain	13	13	0
2021	12	13	Respiratory, thoracic and mediastinal disorders	Dyspnoea	11	10	0
2021	12	13	Nervous system disorders	Headache	7	7	0
2021	12	13	Nervous system disorders	Dizziness	6	6	0
2021	12	13	Musculoskeletal and connective tissue disorders	Arthralgia	6	6	0
2021	12	13	General disorders and administration site conditions	Chills	5	5	0
2021	12	13	Gastrointestinal disorders	Nausea	5	5	0
2021	12	13	General disorders and administration site conditions	Pyrexia	5	5	0
2021	12	13	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2021	12	13	Cardiac disorders	Palpitations	4	4	0
2021	12	13	General disorders and administration site conditions	Injection site reaction	4	4	0
2021	12	13	Gastrointestinal disorders	Diarrhoea	3	3	0
2021	12	13	Nervous system disorders	Lethargy	3	3	0
2021	12	13	Gastrointestinal disorders	Vomiting	3	3	0
2021	12	13	General disorders and administration site conditions	Fatigue	2	2	0
2021	12	13	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2021	12	13	Nervous system disorders	Paraesthesia	2	2	0
2021	12	13	Nervous system disorders	Seizure	2	2	0
2021	12	13	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	12	13	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	12	13	Nervous system disorders	Presyncope	2	2	0
2021	12	13	Cardiac disorders	Myopericarditis	2	2	0
2021	12	13	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	12	13	General disorders and administration site conditions	Injection site rash	2	2	0
2021	12	13	Nervous system disorders	Tremor	2	2	0
2021	12	13	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	12	13	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	13	Vascular disorders	Hypertension	1	1	0
2021	12	13	General disorders and administration site conditions	Malaise	1	1	0
2021	12	13	Investigations	Oxygen saturation decreased	1	0	0
2021	12	13	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2021	12	13	Ear and labyrinth disorders	Vertigo positional	1	1	0
2021	12	13	Eye disorders	Vision blurred	1	1	0
2021	12	13	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	13	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	13	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	12	13	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	13	Skin and subcutaneous tissue disorders	Skin exfoliation	1	1	0
2021	12	13	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	12	13	Musculoskeletal and connective tissue disorders	Arthritis	1	1	0
2021	12	13	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2021	12	13	Hepatobiliary disorders	Hypertransaminasaemia	1	1	0
2021	12	13	Psychiatric disorders	Confusional state	1	1	0
2021	12	13	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	12	13	Eye disorders	Eye disorder	1	1	0
2021	12	13	Investigations	Troponin increased	1	1	0
2021	12	13	Nervous system disorders	Ageusia	1	1	0
2021	12	13	Nervous system disorders	Bell's palsy	1	1	0
2021	12	13	Cardiac disorders	Left atrial enlargement	1	1	0
2021	12	13	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	12	13	Immune system disorders	Hypersensitivity	1	0	0
2021	12	13	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	13	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	13	Nervous system disorders	Somnolence	1	1	0
2021	12	13	Nervous system disorders	Tonic clonic movements	1	1	0
2021	12	13	Skin and subcutaneous tissue disorders	Vasculitic rash	1	1	0
2021	12	13	Nervous system disorders	Anosmia	1	1	0
2021	12	13	Nervous system disorders	Syncope	1	1	0
2021	12	13	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	12	13	Cardiac disorders	Pericarditis	1	1	0
2021	12	13	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	13	Hepatobiliary disorders	Ocular icterus	1	1	0
2021	12	13	Infections and infestations	Bacterial infection	1	1	0
2021	12	13	Investigations	Echocardiogram abnormal	1	1	0
2021	12	13	Investigations	International normalised ratio increased	1	1	0
2021	12	13	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	12	13	Nervous system disorders	Migraine	1	1	0
2021	12	13	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	12	13	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	13	Hepatobiliary disorders	Jaundice	1	1	0
2021	12	13	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2021	12	13	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	12	13	Cardiac disorders	Tachycardia	1	1	0
2021	12	13	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	12	13	Gastrointestinal disorders	Swollen tongue	1	0	0
2021	12	13	Infections and infestations	Herpes simplex	1	1	0
2021	12	13	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2021	12	13	Renal and urinary disorders	Chromaturia	1	1	0
2021	12	13	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	13	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	14	General disorders and administration site conditions	Chest pain	12	12	0
2021	12	14	Musculoskeletal and connective tissue disorders	Arthralgia	9	8	0
2021	12	14	Nervous system disorders	Headache	8	7	0
2021	12	14	Gastrointestinal disorders	Vomiting	8	8	0
2021	12	14	General disorders and administration site conditions	Injection site reaction	8	8	0
2021	12	14	Gastrointestinal disorders	Nausea	7	6	0
2021	12	14	Musculoskeletal and connective tissue disorders	Myalgia	6	5	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2021	12	14	General disorders and administration site conditions	Pyrexia	6	5	0
2021	12	14	Nervous system disorders	Lethargy	6	6	0
2021	12	14	General disorders and administration site conditions	Chest discomfort	5	5	0
2021	12	14	General disorders and administration site conditions	Fatigue	5	4	0
2021	12	14	General disorders and administration site conditions	Injection site pain	4	3	0
2021	12	14	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2021	12	14	General disorders and administration site conditions	Peripheral swelling	3	3	0
2021	12	14	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2021	12	14	Nervous system disorders	Seizure	2	2	0
2021	12	14	Nervous system disorders	Hypoaesthesia	2	2	0
2021	12	14	Gastrointestinal disorders	Abdominal pain	2	2	0
2021	12	14	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	12	14	Cardiac disorders	Palpitations	2	2	0
2021	12	14	General disorders and administration site conditions	Pain	2	2	0
2021	12	14	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2021	12	14	General disorders and administration site conditions	Malaise	2	2	0
2021	12	14	General disorders and administration site conditions	Axillary pain	2	1	0
2021	12	14	Psychiatric disorders	Confusional state	2	2	0
2021	12	14	Cardiac disorders	Pericarditis	2	2	0
2021	12	14	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	12	14	General disorders and administration site conditions	Chills	1	1	0
2021	12	14	Investigations	Troponin I normal	1	1	0
2021	12	14	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	14	Psychiatric disorders	Anxiety	1	1	0
2021	12	14	Eye disorders	Vision blurred	1	1	0
2021	12	14	Eye disorders	Visual impairment	1	1	0
2021	12	14	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	14	Nervous system disorders	Paraesthesia	1	0	0
2021	12	14	Psychiatric disorders	Disorientation	1	1	0
2021	12	14	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Painful respiration	1	1	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	12	14	Metabolism and nutrition disorders	Decreased appetite	1	0	0
2021	12	14	Hepatobiliary disorders	Liver injury	1	1	0
2021	12	14	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	14	Skin and subcutaneous tissue disorders	Skin discolouration	1	1	0
2021	12	14	General disorders and administration site conditions	Injection site cyst	1	1	0
2021	12	14	Hepatobiliary disorders	Hepatitis	1	1	0
2021	12	14	Nervous system disorders	Memory impairment	1	1	0
2021	12	14	Cardiac disorders	Cyanosis	1	1	0
2021	12	14	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	12	14	Investigations	Troponin increased	1	1	0
2021	12	14	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	12	14	Investigations	Liver function test abnormal	1	1	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2021	12	14	Vascular disorders	Cyanosis	1	1	0
2021	12	14	Cardiac disorders	Myopericarditis	1	1	0
2021	12	14	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2021	12	14	Cardiac disorders	Tachycardia	1	1	0
2021	12	14	Infections and infestations	Nasopharyngitis	1	1	0
2021	12	14	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	12	14	Cardiac disorders	Myocarditis	1	1	0
2021	12	14	Immune system disorders	Hypersensitivity	1	1	0
2021	12	14	Nervous system disorders	Dysgeusia	1	1	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	14	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	14	Gastrointestinal disorders	Dysphagia	1	1	0
2021	12	14	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	12	14	Respiratory, thoracic and mediastinal disorders	Aphonia	1	1	0
2021	12	14	Social circumstances	Bedridden	1	1	0
2021	12	15	General disorders and administration site conditions	Chest pain	17	16	0
2021	12	15	Injury, poisoning and procedural complications	Vaccination error	16	16	0
2021	12	15	Respiratory, thoracic and mediastinal disorders	Dyspnoea	15	15	0
2021	12	15	Injury, poisoning and procedural complications	Incorrect dose administered	15	15	0
2021	12	15	General disorders and administration site conditions	Injection site reaction	12	12	0
2021	12	15	Nervous system disorders	Headache	12	12	0
2021	12	15	General disorders and administration site conditions	Fatigue	12	12	0
2021	12	15	Musculoskeletal and connective tissue disorders	Myalgia	11	11	0
2021	12	15	Cardiac disorders	Pericarditis	10	10	0
2021	12	15	Cardiac disorders	Palpitations	9	9	0
2021	12	15	General disorders and administration site conditions	Chest discomfort	8	7	0
2021	12	15	Nervous system disorders	Dizziness	8	8	0
2021	12	15	Musculoskeletal and connective tissue disorders	Arthralgia	7	7	0
2021	12	15	Gastrointestinal disorders	Abdominal pain	6	6	0
2021	12	15	Gastrointestinal disorders	Nausea	6	6	0
2021	12	15	General disorders and administration site conditions	Pyrexia	6	6	0
2021	12	15	Nervous system disorders	Lethargy	6	6	0
2021	12	15	Nervous system disorders	Paraesthesia	4	4	0
2021	12	15	Nervous system disorders	Presyncope	3	3	0
2021	12	15	General disorders and administration site conditions	Malaise	3	3	0
2021	12	15	Skin and subcutaneous tissue disorders	Rash	3	3	0
2021	12	15	General disorders and administration site conditions	Chills	3	3	0
2021	12	15	General disorders and administration site conditions	Injection site pain	3	3	0
2021	12	15	Nervous system disorders	Syncope	3	3	0
2021	12	15	General disorders and administration site conditions	Injection site rash	3	3	0
2021	12	15	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	15	General disorders and administration site conditions	Feeling abnormal	2	2	0
2021	12	15	Gastrointestinal disorders	Swollen tongue	2	2	0
2021	12	15	Cardiac disorders	Myopericarditis	2	2	0
2021	12	15	Nervous system disorders	Head discomfort	2	2	0
2021	12	15	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	12	15	Vascular disorders	Hypotension	2	2	0
2021	12	15	Gastrointestinal disorders	Abdominal discomfort	2	2	0
2021	12	15	Injury, poisoning and procedural complications	Incorrect dosage administered	2	2	0
2021	12	15	Nervous system disorders	Migraine	2	2	0
2021	12	15	Ear and labyrinth disorders	Tinnitus	2	2	0
2021	12	15	Blood and lymphatic system disorders	Immune thrombocytopenia	1	1	0
2021	12	15	Eye disorders	Vision blurred	1	1	0
2021	12	15	Gastrointestinal disorders	Lip swelling	1	1	0
2021	12	15	Nervous system disorders	Amnesia	1	1	0
2021	12	15	Psychiatric disorders	Disorientation	1	1	0
2021	12	15	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	15	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	15	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	12	15	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	12	15	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	12	15	Cardiac disorders	Cardiomegaly	1	1	0
2021	12	15	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	12	15	Investigations	Magnetic resonance imaging abnormal	1	1	0
2021	12	15	Investigations	Red blood cell sedimentation rate increased	1	1	0
2021	12	15	Nervous system disorders	Dysarthria	1	1	0
2021	12	15	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2021	12	15	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	12	15	General disorders and administration site conditions	Oedema peripheral	1	1	0
2021	12	15	Infections and infestations	Herpes zoster	1	1	0
2021	12	15	Nervous system disorders	Incoherent	1	1	0
2021	12	15	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	12	15	Ear and labyrinth disorders	Ear pain	1	1	0
2021	12	15	General disorders and administration site conditions	Swelling face	1	1	0
2021	12	15	Nervous system disorders	Facial paralysis	1	1	0
2021	12	15	Vascular disorders	Hypertension	1	1	0
2021	12	15	Vascular disorders	Pallor	1	1	0
2021	12	15	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	12	15	Nervous system disorders	Ageusia	1	1	0
2021	12	15	Nervous system disorders	Bell's palsy	1	1	0
2021	12	15	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	12	15	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2021	12	15	Psychiatric disorders	Confusional state	1	1	0
2021	12	15	Infections and infestations	Nasopharyngitis	1	0	0
2021	12	15	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	15	Cardiac disorders	Arrhythmia	1	1	0
2021	12	15	Infections and infestations	Appendicitis	1	1	0
2021	12	15	Investigations	Heart rate irregular	1	1	0
2021	12	15	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	15	Cardiac disorders	Myocarditis	1	1	0
2021	12	15	Infections and infestations	Ear infection	1	1	0
2021	12	15	Investigations	Echocardiogram	1	1	0
2021	12	15	Nervous system disorders	Anosmia	1	1	0
2021	12	15	Psychiatric disorders	Insomnia	1	1	0
2021	12	15	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	12	15	Musculoskeletal and connective tissue disorders	Flank pain	1	1	0
2021	12	15	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	12	15	Eye disorders	Diplopia	1	1	0
2021	12	15	General disorders and administration site conditions	Asthenia	1	1	0
2021	12	15	General disorders and administration site conditions	Pain	1	1	0
2021	12	15	Nervous system disorders	Demyelination	1	1	0
2021	12	15	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	15	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	15	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	12	15	Nervous system disorders	Tremor	1	1	0
2021	12	15	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	12	15	Vascular disorders	Thrombosis	1	1	0
2021	12	16	Musculoskeletal and connective tissue disorders	Myalgia	8	8	0
2021	12	16	Nervous system disorders	Headache	8	8	0
2021	12	16	General disorders and administration site conditions	Chest pain	8	8	0
2021	12	16	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	6	0
2021	12	16	Cardiac disorders	Pericarditis	6	5	0
2021	12	16	General disorders and administration site conditions	Injection site reaction	6	6	0
2021	12	16	General disorders and administration site conditions	Pyrexia	6	6	0
2021	12	16	Gastrointestinal disorders	Nausea	5	5	0
2021	12	16	General disorders and administration site conditions	Fatigue	4	4	0
2021	12	16	Nervous system disorders	Lethargy	4	4	0
2021	12	16	General disorders and administration site conditions	Malaise	3	3	0
2021	12	16	General disorders and administration site conditions	Chills	3	3	0
2021	12	16	General disorders and administration site conditions	Injection site pain	3	3	0
2021	12	16	General disorders and administration site conditions	Chest discomfort	3	3	0
2021	12	16	Nervous system disorders	Dizziness	3	3	0
2021	12	16	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2021	12	16	Cardiac disorders	Palpitations	2	2	0
2021	12	16	Gastrointestinal disorders	Hypoaesthesia oral	2	2	0
2021	12	16	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2021	12	16	Psychiatric disorders	Anxiety	2	2	0
2021	12	16	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	12	16	General disorders and administration site conditions	Feeling of body temperature change	2	2	0
2021	12	16	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	12	16	General disorders and administration site conditions	Injection site rash	2	2	0
2021	12	16	Respiratory, thoracic and mediastinal disorders	Sneezing	2	2	0
2021	12	16	Eye disorders	Vision blurred	1	1	0
2021	12	16	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2021	12	16	Nervous system disorders	Seizure	1	1	0
2021	12	16	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	16	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	12	16	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	12	16	Infections and infestations	Injection site cellulitis	1	1	0
2021	12	16	Injury, poisoning and procedural complications	Contusion	1	1	0
2021	12	16	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	12	16	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	16	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2021	12	16	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	12	16	Respiratory, thoracic and mediastinal disorders	Yawning	1	1	0
2021	12	16	General disorders and administration site conditions	Axillary pain	1	1	0
2021	12	16	Metabolism and nutrition disorders	Hyperkalaemia	1	1	0
2021	12	16	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	12	16	General disorders and administration site conditions	Swelling face	1	1	0
2021	12	16	Investigations	Heart rate increased	1	1	0
2021	12	16	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	16	Vascular disorders	Hypertension	1	1	0
2021	12	16	Cardiac disorders	Myocarditis	1	1	0
2021	12	16	Nervous system disorders	Paraesthesia	1	1	0
2021	12	16	Psychiatric disorders	Insomnia	1	1	0
2021	12	16	Gastrointestinal disorders	Dysphagia	1	1	0
2021	12	16	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2021	12	16	Nervous system disorders	Migraine	1	1	0
2021	12	16	Reproductive system and breast disorders	Breast disorder female	1	1	0
2021	12	16	Reproductive system and breast disorders	Breast tenderness	1	1	0
2021	12	16	Immune system disorders	Anaphylactic shock	1	1	0
2021	12	16	Nervous system disorders	Tremor	1	1	0
2021	12	16	Reproductive system and breast disorders	Breast engorgement	1	1	0
2021	12	16	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	12	16	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	12	16	Infections and infestations	Cystitis	1	0	0
2021	12	16	Infections and infestations	Tonsillitis	1	1	0
2021	12	16	Nervous system disorders	Burning sensation	1	1	0
2021	12	16	Nervous system disorders	Dysstasia	1	1	0
2021	12	16	Respiratory, thoracic and mediastinal disorders	Pneumothorax	1	0	0
2021	12	16	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	16	Infections and infestations	Appendicitis	1	1	0
2021	12	16	Investigations	Heart rate irregular	1	1	0
2021	12	16	Nervous system disorders	Hypoaesthesia	1	1	0
2021	12	16	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	12	16	Infections and infestations	Sinusitis	1	1	0
2021	12	16	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	16	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	16	Investigations	Fibrin D dimer increased	1	0	0
2021	12	16	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	12	16	Musculoskeletal and connective tissue disorders	Muscle disorder	1	1	0
2021	12	16	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2021	12	16	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	12	16	General disorders and administration site conditions	Injection site nodule	1	1	0
2021	12	17	General disorders and administration site conditions	Chest pain	7	7	0
2021	12	17	General disorders and administration site conditions	Injection site reaction	4	4	0
2021	12	17	General disorders and administration site conditions	Chest discomfort	4	4	0
2021	12	17	Nervous system disorders	Dizziness	4	4	0
2021	12	17	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	12	17	Cardiac disorders	Palpitations	4	3	0
2021	12	17	Cardiac disorders	Pericarditis	3	3	0
2021	12	17	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2021	12	17	Nervous system disorders	Paraesthesia	3	3	0
2021	12	17	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	12	17	Nervous system disorders	Hypoaesthesia	2	2	0
2021	12	17	Gastrointestinal disorders	Nausea	2	2	0
2021	12	17	General disorders and administration site conditions	Pain	2	2	0
2021	12	17	Nervous system disorders	Headache	2	2	0
2021	12	17	General disorders and administration site conditions	Pyrexia	1	1	0
2021	12	17	Musculoskeletal and connective tissue disorders	Bursitis	1	1	0
2021	12	17	Nervous system disorders	Balance disorder	1	1	0
2021	12	17	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	12	17	Gastrointestinal disorders	Hypoaesthesia oral	1	1	0
2021	12	17	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	17	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	12	17	General disorders and administration site conditions	Axillary pain	1	1	0
2021	12	17	General disorders and administration site conditions	Malaise	1	1	0
2021	12	17	Surgical and medical procedures	Axillary lymphadenectomy	1	1	0
2021	12	17	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	12	17	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	12	17	Gastrointestinal disorders	Frequent bowel movements	1	1	0
2021	12	17	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	17	Nervous system disorders	Nervous system disorder	1	1	0
2021	12	17	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	12	17	Nervous system disorders	Lethargy	1	1	0
2021	12	17	Cardiac disorders	Myocarditis	1	1	0
2021	12	17	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2021	12	17	General disorders and administration site conditions	Fatigue	1	1	0
2021	12	17	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2021	12	17	Nervous system disorders	Syncope	1	1	0
2021	12	17	Psychiatric disorders	Insomnia	1	1	0
2021	12	17	Gastrointestinal disorders	Dysphagia	1	1	0
2021	12	17	Musculoskeletal and connective tissue disorders	Flank pain	1	1	0
2021	12	17	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	12	17	Gastrointestinal disorders	Abdominal pain lower	1	1	0
2021	12	17	General disorders and administration site conditions	Asthenia	1	1	0
2021	12	17	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	12	17	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	18	General disorders and administration site conditions	Injection site reaction	3	2	0
2021	12	18	General disorders and administration site conditions	Fatigue	3	2	0
2021	12	18	Musculoskeletal and connective tissue disorders	Myalgia	3	2	0
2021	12	18	Eye disorders	Vision blurred	3	3	0
2021	12	18	Blood and lymphatic system disorders	Lymphadenopathy	3	2	0
2021	12	18	Nervous system disorders	Headache	3	3	0
2021	12	18	General disorders and administration site conditions	Pyrexia	2	2	0
2021	12	18	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	12	18	Cardiac disorders	Palpitations	2	2	0
2021	12	18	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	12	18	General disorders and administration site conditions	Chills	2	1	0
2021	12	18	Nervous system disorders	Dizziness	2	2	0
2021	12	18	General disorders and administration site conditions	Pain	1	1	0
2021	12	18	Infections and infestations	Nasopharyngitis	1	1	0
2021	12	18	Infections and infestations	Tonsillitis	1	1	0
2021	12	18	Injury, poisoning and procedural complications	Product administered at inappropriate site	1	0	0
2021	12	18	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	12	18	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	12	18	Eye disorders	Eye swelling	1	1	0
2021	12	18	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	12	18	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	12	18	General disorders and administration site conditions	Chest pain	1	1	0
2021	12	18	Gastrointestinal disorders	Nausea	1	1	0
2021	12	18	Investigations	Heart rate	1	1	0
2021	12	18	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	12	18	General disorders and administration site conditions	Axillary pain	1	0	0
2021	12	18	General disorders and administration site conditions	Injection site pain	1	1	0
2021	12	18	Infections and infestations	Lower respiratory tract infection	1	1	0
2021	12	18	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2021	12	18	Nervous system disorders	Lethargy	1	1	0
2021	12	18	Renal and urinary disorders	Dysuria	1	1	0
2021	12	18	Skin and subcutaneous tissue disorders	Petechiae	1	0	0
2021	12	18	Eye disorders	Retinal haemorrhage	1	1	0
2021	12	18	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	12	18	General disorders and administration site conditions	Malaise	1	1	0
2021	12	18	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	12	18	Ear and labyrinth disorders	Ear pain	1	1	0
2021	12	18	General disorders and administration site conditions	Swelling face	1	1	0
2021	12	18	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	18	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	18	Eye disorders	Blindness	1	1	0
2021	12	18	Infections and infestations	Sepsis	1	1	0
2021	12	18	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2021	12	19	General disorders and administration site conditions	Fatigue	6	5	0
2021	12	19	Nervous system disorders	Headache	6	5	0
2021	12	19	General disorders and administration site conditions	Chills	3	2	0
2021	12	19	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	2	0
2021	12	19	Nervous system disorders	Dizziness	3	2	0
2021	12	19	Gastrointestinal disorders	Nausea	3	3	0
2021	12	19	General disorders and administration site conditions	Pyrexia	3	2	0
2021	12	19	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	12	19	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	12	19	General disorders and administration site conditions	Chest pain	2	2	0
2021	12	19	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	12	19	General disorders and administration site conditions	Chest discomfort	2	1	0
2021	12	19	Nervous system disorders	Balance disorder	1	1	0
2021	12	19	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	19	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	19	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	12	19	General disorders and administration site conditions	Malaise	1	1	0
2021	12	19	Investigations	Heart rate increased	1	1	0
2021	12	19	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	19	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	19	Cardiac disorders	Myopericarditis	1	1	0
2021	12	19	Cardiac disorders	Pericarditis	1	0	0
2021	12	19	General disorders and administration site conditions	Injection site nodule	1	1	0
2021	12	19	Investigations	Electrocardiogram	1	0	0
2021	12	19	Psychiatric disorders	Confusional state	1	1	0
2021	12	19	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	19	Investigations	Troponin increased	1	1	0
2021	12	19	Psychiatric disorders	Suicidal ideation	1	1	0
2021	12	19	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	12	19	Investigations	Grip strength decreased	1	1	0
2021	12	19	Nervous system disorders	Migraine	1	1	0
2021	12	19	Nervous system disorders	Paraesthesia	1	1	0
2021	12	19	Renal and urinary disorders	Pollakiuria	1	1	0
2021	12	19	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	12	19	General disorders and administration site conditions	Asthenia	1	1	0
2021	12	19	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	12	19	Respiratory, thoracic and mediastinal disorders	Pleural rub	1	1	0
2021	12	19	Cardiac disorders	Arrhythmia	1	0	0
2021	12	19	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	12	19	Nervous system disorders	Tremor	1	1	0
2021	12	19	Renal and urinary disorders	Renal pain	1	1	0
2021	12	20	General disorders and administration site conditions	Injection site reaction	15	15	0
2021	12	20	General disorders and administration site conditions	Chest pain	14	14	0
2021	12	20	Nervous system disorders	Headache	11	11	0
2021	12	20	Nervous system disorders	Lethargy	9	8	0
2021	12	20	General disorders and administration site conditions	Pyrexia	8	8	0
2021	12	20	Gastrointestinal disorders	Nausea	8	8	0
2021	12	20	Blood and lymphatic system disorders	Lymphadenopathy	7	7	0
2021	12	20	General disorders and administration site conditions	Fatigue	7	7	0
2021	12	20	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	6	0
2021	12	20	Musculoskeletal and connective tissue disorders	Arthralgia	6	5	0
2021	12	20	Nervous system disorders	Paraesthesia	6	6	0
2021	12	20	Musculoskeletal and connective tissue disorders	Myalgia	5	4	0
2021	12	20	General disorders and administration site conditions	Chest discomfort	5	5	0
2021	12	20	General disorders and administration site conditions	Chills	5	5	0
2021	12	20	Cardiac disorders	Pericarditis	5	5	0
2021	12	20	General disorders and administration site conditions	Malaise	4	4	0
2021	12	20	Cardiac disorders	Palpitations	4	4	0
2021	12	20	General disorders and administration site conditions	Influenza like illness	3	3	0
2021	12	20	Nervous system disorders	Dizziness	3	3	0
2021	12	20	General disorders and administration site conditions	Pain	3	3	0
2021	12	20	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2021	12	20	General disorders and administration site conditions	Feeling abnormal	3	3	0
2021	12	20	Nervous system disorders	Syncope	3	3	0
2021	12	20	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	3	3	0
2021	12	20	Skin and subcutaneous tissue disorders	Rash	3	3	0
2021	12	20	Musculoskeletal and connective tissue disorders	Pain in extremity	3	2	0
2021	12	20	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2021	12	20	Nervous system disorders	Facial paralysis	2	2	0
2021	12	20	Nervous system disorders	Tonic clonic movements	2	2	0
2021	12	20	Investigations	Troponin increased	2	2	0
2021	12	20	Cardiac disorders	Myopericarditis	2	2	0
2021	12	20	Skin and subcutaneous tissue disorders	Rash pruritic	2	2	0
2021	12	20	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2021	12	20	Psychiatric disorders	Anxiety	2	2	0
2021	12	20	Cardiac disorders	Tachycardia	2	2	0
2021	12	20	Musculoskeletal and connective tissue disorders	Back pain	2	1	0
2021	12	20	Eye disorders	Vision blurred	2	2	0
2021	12	20	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2021	12	20	Nervous system disorders	Migraine	1	1	0
2021	12	20	Cardiac disorders	Myocarditis	1	1	0
2021	12	20	Investigations	Echocardiogram	1	1	0
2021	12	20	Psychiatric disorders	Insomnia	1	1	0
2021	12	20	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2021	12	20	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	12	20	Gastrointestinal disorders	Abdominal pain lower	1	1	0
2021	12	20	Investigations	Blood pressure abnormal	1	1	0
2021	12	20	Nervous system disorders	Burning sensation	1	1	0
2021	12	20	Eye disorders	Ocular discomfort	1	1	0
2021	12	20	Gastrointestinal disorders	Toothache	1	1	0
2021	12	20	General disorders and administration site conditions	Injection site swelling	1	1	0
2021	12	20	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	12	20	Infections and infestations	Rhinitis	1	1	0
2021	12	20	Hepatobiliary disorders	Hepatitis	1	1	0
2021	12	20	Investigations	Chest X-ray	1	1	0
2021	12	20	Metabolism and nutrition disorders	Diabetes mellitus	1	1	0
2021	12	20	Psychiatric disorders	Hallucination	1	1	0
2021	12	20	Renal and urinary disorders	Dysuria	1	1	0
2021	12	20	Respiratory, thoracic and mediastinal disorders	Oropharyngeal discomfort	1	1	0
2021	12	20	Vascular disorders	Deep vein thrombosis	1	1	0
2021	12	20	Gastrointestinal disorders	Dyspepsia	1	1	0
2021	12	20	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	20	General disorders and administration site conditions	Exercise tolerance decreased	1	0	0
2021	12	20	Cardiac disorders	Systolic dysfunction	1	1	0
2021	12	20	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	12	20	Investigations	Liver function test abnormal	1	1	0
2021	12	20	Nervous system disorders	Head discomfort	1	1	0
2021	12	20	Nervous system disorders	Hypoaesthesia	1	1	0
2021	12	20	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	12	20	General disorders and administration site conditions	Injection site rash	1	1	0
2021	12	20	Infections and infestations	Pneumonia	1	1	0
2021	12	20	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2021	12	20	Investigations	Electrocardiogram	1	1	0
2021	12	20	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	20	Vascular disorders	Hot flush	1	1	0
2021	12	20	Ear and labyrinth disorders	Hypoacusis	1	1	0
2021	12	20	Psychiatric disorders	Mood altered	1	1	0
2021	12	20	Investigations	Stress echocardiogram	1	1	0
2021	12	20	Eye disorders	Visual impairment	1	1	0
2021	12	20	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	20	Nervous system disorders	Balance disorder	1	1	0
2021	12	20	Nervous system disorders	Disturbance in attention	1	1	0
2021	12	20	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	20	Respiratory, thoracic and mediastinal disorders	Productive cough	1	1	0
2021	12	20	Eye disorders	Ocular hyperaemia	1	1	0
2021	12	20	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	12	20	General disorders and administration site conditions	Injection site discomfort	1	1	0
2021	12	20	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	12	20	Musculoskeletal and connective tissue disorders	Periarthritis	1	1	0
2021	12	20	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	12	21	General disorders and administration site conditions	Chest pain	10	10	0
2021	12	21	Nervous system disorders	Headache	9	9	0
2021	12	21	Musculoskeletal and connective tissue disorders	Myalgia	9	9	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	12	21	Gastrointestinal disorders	Nausea	7	7	0
2021	12	21	General disorders and administration site conditions	Pyrexia	7	7	0
2021	12	21	General disorders and administration site conditions	Fatigue	6	6	0
2021	12	21	General disorders and administration site conditions	Chest discomfort	6	6	0
2021	12	21	General disorders and administration site conditions	Injection site reaction	5	5	0
2021	12	21	Nervous system disorders	Dizziness	4	4	0
2021	12	21	General disorders and administration site conditions	Malaise	4	4	0
2021	12	21	Investigations	Troponin increased	3	3	0
2021	12	21	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	12	21	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	12	21	Cardiac disorders	Palpitations	2	2	0
2021	12	21	Nervous system disorders	Burning sensation	2	2	0
2021	12	21	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2021	12	21	Cardiac disorders	Myopericarditis	2	2	0
2021	12	21	General disorders and administration site conditions	Influenza like illness	2	2	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	12	21	Nervous system disorders	Lethargy	2	2	0
2021	12	21	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	21	Nervous system disorders	Hypoaesthesia	2	2	0
2021	12	21	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	12	21	Investigations	Electrocardiogram abnormal	2	2	0
2021	12	21	Cardiac disorders	Pericarditis	2	2	0
2021	12	21	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2021	12	21	Nervous system disorders	Migraine	2	2	0
2021	12	21	Reproductive system and breast disorders	Menstruation irregular	2	2	0
2021	12	21	Psychiatric disorders	Sleep disorder	1	1	0
2021	12	21	Eye disorders	Vision blurred	1	1	0
2021	12	21	Gastrointestinal disorders	Flatulence	1	1	0
2021	12	21	Musculoskeletal and connective tissue disorders	Bursitis	1	1	0
2021	12	21	Nervous system disorders	Disturbance in attention	1	1	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	12	21	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	21	General disorders and administration site conditions	Chills	1	1	0
2021	12	21	General disorders and administration site conditions	Injection site discomfort	1	1	0
2021	12	21	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	12	21	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	21	Nervous system disorders	Neuralgia	1	1	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2021	12	21	Cardiac disorders	Myocarditis	1	1	0
2021	12	21	General disorders and administration site conditions	Gait disturbance	1	1	0
2021	12	21	Nervous system disorders	Dysgeusia	1	1	0
2021	12	21	Nervous system disorders	Paraesthesia	1	1	0
2021	12	21	Nervous system disorders	Syncope	1	1	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	21	Cardiac disorders	Acute myocardial infarction	1	1	0
2021	12	21	Cardiac disorders	Pericardial effusion	1	1	0
2021	12	21	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	21	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	12	21	Nervous system disorders	Tremor	1	1	0
2021	12	21	Investigations	Echocardiogram normal	1	1	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	12	21	General disorders and administration site conditions	Injection site pain	1	1	0
2021	12	21	Infections and infestations	Lower respiratory tract infection	1	1	0
2021	12	21	Investigations	Fibrin D dimer increased	1	1	0
2021	12	21	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Oropharyngeal discomfort	1	1	0
2021	12	21	Vascular disorders	Deep vein thrombosis	1	1	0
2021	12	21	Ear and labyrinth disorders	Ear congestion	1	1	0
2021	12	21	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	12	21	Psychiatric disorders	Autoscopy	1	1	0
2021	12	21	Cardiac disorders	Cardiovascular disorder	1	1	0
2021	12	21	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	12	22	General disorders and administration site conditions	Chest pain	20	20	0
2021	12	22	Nervous system disorders	Headache	17	17	0
2021	12	22	General disorders and administration site conditions	Fatigue	17	17	0
2021	12	22	General disorders and administration site conditions	Injection site reaction	16	16	0
2021	12	22	General disorders and administration site conditions	Pyrexia	12	12	0
2021	12	22	Gastrointestinal disorders	Nausea	11	11	0
2021	12	22	Musculoskeletal and connective tissue disorders	Myalgia	11	11	0
2021	12	22	Musculoskeletal and connective tissue disorders	Arthralgia	10	10	0
2021	12	22	General disorders and administration site conditions	Chills	9	9	0
2021	12	22	Nervous system disorders	Dizziness	9	9	0
2021	12	22	Injury, poisoning and procedural complications	Vaccination error	8	8	0
2021	12	22	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	8	0
2021	12	22	General disorders and administration site conditions	Influenza like illness	6	6	0
2021	12	22	Cardiac disorders	Pericarditis	6	6	0
2021	12	22	Cardiac disorders	Palpitations	6	6	0
2021	12	22	General disorders and administration site conditions	Injection site pain	5	5	0
2021	12	22	Musculoskeletal and connective tissue disorders	Pain in extremity	5	5	0
2021	12	22	General disorders and administration site conditions	Chest discomfort	4	4	0
2021	12	22	Nervous system disorders	Tremor	4	4	0
2021	12	22	General disorders and administration site conditions	Malaise	4	4	0
2021	12	22	Skin and subcutaneous tissue disorders	Rash	4	4	0
2021	12	22	Nervous system disorders	Lethargy	4	4	0
2021	12	22	Metabolism and nutrition disorders	Decreased appetite	3	3	0
2021	12	22	Cardiac disorders	Tachycardia	3	3	0
2021	12	22	Gastrointestinal disorders	Abdominal pain	3	3	0
2021	12	22	Musculoskeletal and connective tissue disorders	Muscle spasms	3	3	0
2021	12	22	Gastrointestinal disorders	Vomiting	3	3	0
2021	12	22	Investigations	Troponin increased	3	3	0
2021	12	22	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2021	12	22	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2021	12	22	Cardiac disorders	Myopericarditis	3	3	0
2021	12	22	Eye disorders	Eye pain	3	3	0
2021	12	22	Cardiac disorders	Myocarditis	2	2	0
2021	12	22	General disorders and administration site conditions	Pain	2	2	0
2021	12	22	Investigations	Echocardiogram	2	2	0
2021	12	22	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	12	22	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2021	12	22	General disorders and administration site conditions	Feeling abnormal	2	2	0
2021	12	22	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2021	12	22	Psychiatric disorders	Disorientation	2	2	0
2021	12	22	General disorders and administration site conditions	Asthenia	2	2	0
2021	12	22	Reproductive system and breast disorders	Menstruation irregular	2	2	0
2021	12	22	Ear and labyrinth disorders	Tinnitus	2	2	0
2021	12	22	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	12	22	Musculoskeletal and connective tissue disorders	Neck pain	2	2	0
2021	12	22	Nervous system disorders	Parosmia	2	2	0
2021	12	22	Skin and subcutaneous tissue disorders	Night sweats	2	2	0
2021	12	22	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2021	12	22	Investigations	Electrocardiogram ST segment elevation	1	1	0
2021	12	22	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2021	12	22	Nervous system disorders	Neuralgia	1	1	0
2021	12	22	Eye disorders	Vision blurred	1	1	0
2021	12	22	Investigations	Blood urine present	1	1	0
2021	12	22	Nervous system disorders	Disturbance in attention	1	1	0
2021	12	22	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	22	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	12	22	Eye disorders	Eyelid oedema	1	1	0
2021	12	22	General disorders and administration site conditions	Axillary pain	1	1	0
2021	12	22	Infections and infestations	Herpes zoster	1	1	0
2021	12	22	Metabolism and nutrition disorders	Fluid retention	1	1	0
2021	12	22	Ear and labyrinth disorders	Ear pain	1	1	0
2021	12	22	Psychiatric disorders	Sleep disorder	1	1	0
2021	12	22	Eye disorders	Photophobia	1	1	0
2021	12	22	Gastrointestinal disorders	Gingival bleeding	1	1	0
2021	12	22	Investigations	Body temperature fluctuation	1	1	0
2021	12	22	Nervous system disorders	Muscle contractions involuntary	1	1	0
2021	12	22	Nervous system disorders	Paraesthesia	1	1	0
2021	12	22	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	22	Respiratory, thoracic and mediastinal disorders	Sneezing	1	1	0
2021	12	22	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	22	General disorders and administration site conditions	Feeling hot	1	1	0
2021	12	22	Nervous system disorders	Migraine	1	1	0
2021	12	22	Reproductive system and breast disorders	Polymenorrhoea	1	1	0
2021	12	22	Social circumstances	Bedridden	1	1	0
2021	12	22	Eye disorders	Ocular discomfort	1	1	0
2021	12	22	Eye disorders	Orbital oedema	1	1	0
2021	12	22	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	12	22	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2021	12	22	Nervous system disorders	Taste disorder	1	1	0
2021	12	22	Renal and urinary disorders	Chromaturia	1	1	0
2021	12	22	Reproductive system and breast disorders	Amenorrhoea	1	1	0
2021	12	22	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2021	12	22	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2021	12	22	Vascular disorders	Flushing	1	1	0
2021	12	22	Investigations	Chest X-ray	1	1	0
2021	12	22	Investigations	Chest X-ray normal	1	1	0
2021	12	22	Psychiatric disorders	Confusional state	1	1	0
2021	12	22	Investigations	Troponin	1	1	0
2021	12	22	Cardiac disorders	Arrhythmia	1	1	0
2021	12	22	Gastrointestinal disorders	Dry mouth	1	1	0
2021	12	22	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	12	22	Investigations	Heart rate irregular	1	1	0
2021	12	22	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2021	12	22	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	12	22	Investigations	Electrocardiogram	1	1	0
2021	12	22	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2021	12	23	General disorders and administration site conditions	Chest pain	23	23	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Dyspnoea	13	13	0
2021	12	23	Nervous system disorders	Headache	12	12	0
2021	12	23	Cardiac disorders	Palpitations	11	11	0
2021	12	23	General disorders and administration site conditions	Injection site reaction	11	11	0
2021	12	23	Nervous system disorders	Dizziness	9	9	0
2021	12	23	General disorders and administration site conditions	Fatigue	8	8	0
2021	12	23	Gastrointestinal disorders	Nausea	7	7	0
2021	12	23	General disorders and administration site conditions	Chest discomfort	7	7	0
2021	12	23	Musculoskeletal and connective tissue disorders	Myalgia	7	7	0
2021	12	23	Cardiac disorders	Pericarditis	6	6	0
2021	12	23	Cardiac disorders	Myocarditis	6	6	0
2021	12	23	Skin and subcutaneous tissue disorders	Hyperhidrosis	5	5	0
2021	12	23	General disorders and administration site conditions	Concomitant disease aggravated	4	4	0
2021	12	23	Gastrointestinal disorders	Abdominal pain	4	4	0
2021	12	23	Investigations	Troponin	4	4	0
2021	12	23	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2021	12	23	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2021	12	23	Gastrointestinal disorders	Vomiting	4	4	0
2021	12	23	General disorders and administration site conditions	Malaise	4	4	0
2021	12	23	General disorders and administration site conditions	Peripheral swelling	3	3	0
2021	12	23	Investigations	Electrocardiogram	3	3	0
2021	12	23	Nervous system disorders	Paraesthesia	3	3	0
2021	12	23	Cardiac disorders	Tachycardia	3	3	0
2021	12	23	General disorders and administration site conditions	Pyrexia	3	3	0
2021	12	23	General disorders and administration site conditions	Pain	3	3	0
2021	12	23	Skin and subcutaneous tissue disorders	Urticaria	3	3	0
2021	12	23	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2021	12	23	Nervous system disorders	Syncope	3	3	0
2021	12	23	Gastrointestinal disorders	Abdominal pain upper	2	2	0
2021	12	23	General disorders and administration site conditions	Injection site pain	2	2	0
2021	12	23	Psychiatric disorders	Confusional state	2	2	0
2021	12	23	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	12	23	Infections and infestations	Nasopharyngitis	2	2	0
2021	12	23	Skin and subcutaneous tissue disorders	Swelling face	2	2	0
2021	12	23	Cardiac disorders	Pericardial effusion	2	2	0
2021	12	23	Investigations	Echocardiogram	2	2	0
2021	12	23	Investigations	Echocardiogram abnormal	2	2	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	2	2	0
2021	12	23	Gastrointestinal disorders	Swollen tongue	2	2	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Productive cough	2	2	0
2021	12	23	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2021	12	23	Investigations	Fibrin D dimer	2	2	0
2021	12	23	Nervous system disorders	Neuropathy peripheral	2	2	0
2021	12	23	Nervous system disorders	Presyncope	2	2	0
2021	12	23	General disorders and administration site conditions	Chills	2	2	0
2021	12	23	General disorders and administration site conditions	Injection site erythema	2	2	0
2021	12	23	General disorders and administration site conditions	Swelling	2	2	0
2021	12	23	General disorders and administration site conditions	Swelling face	2	2	0
2021	12	23	Nervous system disorders	Hypoaesthesia	2	2	0
2021	12	23	Cardiac disorders	Eosinophilic myocarditis	1	1	0
2021	12	23	General disorders and administration site conditions	Injection site mass	1	1	0
2021	12	23	Investigations	C-reactive protein increased	1	1	0
2021	12	23	Psychiatric disorders	Insomnia	1	1	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	23	General disorders and administration site conditions	Feeling hot	1	1	0
2021	12	23	Investigations	Electrocardiogram ST segment depression	1	1	0
2021	12	23	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2021	12	23	Skin and subcutaneous tissue disorders	Blister	1	1	0
2021	12	23	Skin and subcutaneous tissue disorders	Skin lesion	1	1	0
2021	12	23	Eye disorders	Eye swelling	1	1	0
2021	12	23	Eye disorders	Ocular discomfort	1	1	0
2021	12	23	General disorders and administration site conditions	Feeling abnormal	1	1	0
2021	12	23	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	23	Infections and infestations	Rhinovirus infection	1	1	0
2021	12	23	Nervous system disorders	Parosmia	1	1	0
2021	12	23	Psychiatric disorders	Poor quality sleep	1	1	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	12	23	Skin and subcutaneous tissue disorders	Rash papular	1	1	0
2021	12	23	Cardiac disorders	Hypertensive cardiomyopathy	1	1	0
2021	12	23	Gastrointestinal disorders	Abdominal pain lower	1	1	0
2021	12	23	Investigations	Echocardiogram normal	1	1	0
2021	12	23	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	1	1	0
2021	12	23	Nervous system disorders	Burning sensation	1	1	0
2021	12	23	Nervous system disorders	Taste disorder	1	1	0
2021	12	23	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	23	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2021	12	23	Cardiac disorders	Left ventricular failure	1	1	0
2021	12	23	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	12	23	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2021	12	23	Investigations	Angiogram	1	1	0
2021	12	23	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Respiratory distress	1	1	0
2021	12	23	Cardiac disorders	Myopericarditis	1	1	0
2021	12	23	Investigations	Electrocardiogram abnormal	1	1	0
2021	12	23	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2021	12	23	Skin and subcutaneous tissue disorders	Dry skin	1	1	0
2021	12	23	Vascular disorders	Hot flush	1	1	0
2021	12	23	General disorders and administration site conditions	Ulcer	1	1	0
2021	12	23	Investigations	Troponin increased	1	1	0
2021	12	23	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	12	23	Musculoskeletal and connective tissue disorders	Joint stiffness	1	1	0
2021	12	23	Nervous system disorders	Ageusia	1	1	0
2021	12	23	Cardiac disorders	Atrioventricular block first degree	1	1	0
2021	12	23	Investigations	Fibrin D dimer increased	1	1	0
2021	12	23	Investigations	Troponin I	1	1	0
2021	12	23	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2021	12	23	Nervous system disorders	Lethargy	1	1	0
2021	12	23	Vascular disorders	Thrombophlebitis	1	1	0
2021	12	23	Cardiac disorders	Atrial fibrillation	1	1	0
2021	12	23	Eye disorders	Blindness	1	1	0
2021	12	23	Gastrointestinal disorders	Gingival pain	1	1	0
2021	12	23	Investigations	Electrocardiogram normal	1	1	0
2021	12	23	Investigations	Troponin I increased	1	1	0
2021	12	23	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	23	Eye disorders	Blepharitis	1	1	0
2021	12	23	Eye disorders	Vision blurred	1	1	0
2021	12	23	Eye disorders	Visual impairment	1	1	0
2021	12	23	Hepatobiliary disorders	Hepatic pain	1	1	0
2021	12	23	Infections and infestations	Bronchitis	1	1	0
2021	12	23	Nervous system disorders	Balance disorder	1	1	0
2021	12	23	Nervous system disorders	Seizure	1	1	0
2021	12	23	Psychiatric disorders	Disorientation	1	1	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	12	23	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	12	23	Skin and subcutaneous tissue disorders	Skin exfoliation	1	1	0
2021	12	23	Eye disorders	Eyelid oedema	1	1	0
2021	12	23	General disorders and administration site conditions	Axillary pain	1	1	0
2021	12	23	Immune system disorders	Eosinophilic granulomatosis with polyangiitis	1	1	0
2021	12	23	Nervous system disorders	Poor quality sleep	1	1	0
2021	12	23	Cardiac disorders	Angina pectoris	1	1	0
2021	12	23	Ear and labyrinth disorders	Ear pain	1	1	0
2021	12	23	Investigations	Troponin abnormal	1	1	0
2021	12	23	Psychiatric disorders	Sleep disorder	1	1	0
2021	12	23	Vascular disorders	Pallor	1	1	0
2021	12	24	General disorders and administration site conditions	Pyrexia	12	12	0
2021	12	24	Gastrointestinal disorders	Nausea	8	8	0
2021	12	24	General disorders and administration site conditions	Chest pain	7	7	0
2021	12	24	Nervous system disorders	Dizziness	5	5	0
2021	12	24	Nervous system disorders	Hypoaesthesia	5	5	0
2021	12	24	General disorders and administration site conditions	Fatigue	4	4	0
2021	12	24	Nervous system disorders	Headache	4	4	0
2021	12	24	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2021	12	24	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2021	12	24	Nervous system disorders	Lethargy	3	3	0
2021	12	24	Gastrointestinal disorders	Vomiting	3	3	0
2021	12	24	Nervous system disorders	Syncope	3	3	0
2021	12	24	Nervous system disorders	Tremor	2	2	0
2021	12	24	General disorders and administration site conditions	Injection site pain	2	2	0
2021	12	24	Gastrointestinal disorders	Diarrhoea	2	2	0
2021	12	24	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2021	12	24	Renal and urinary disorders	Renal pain	2	2	0
2021	12	24	Cardiac disorders	Pericarditis	2	2	0
2021	12	24	General disorders and administration site conditions	Injection site rash	2	2	0
2021	12	24	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2021	12	24	General disorders and administration site conditions	Chills	2	2	0
2021	12	24	Skin and subcutaneous tissue disorders	Rash	2	2	0
2021	12	24	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2021	12	24	Cardiac disorders	Palpitations	2	2	0
2021	12	24	General disorders and administration site conditions	Malaise	2	2	0
2021	12	24	Infections and infestations	Sinusitis	2	2	0
2021	12	24	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	12	24	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	12	24	Investigations	Fibrin D dimer increased	1	1	0
2021	12	24	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	12	24	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	12	24	Cardiac disorders	Bradycardia	1	1	0
2021	12	24	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	12	24	Investigations	Heart rate irregular	1	1	0
2021	12	24	Vascular disorders	Hypotension	1	1	0
2021	12	24	Cardiac disorders	Myocarditis	1	1	0
2021	12	24	Immune system disorders	Hypersensitivity	1	1	0
2021	12	24	Nervous system disorders	Paraesthesia	1	1	0
2021	12	24	Psychiatric disorders	Insomnia	1	1	0
2021	12	24	Renal and urinary disorders	Pollakiuria	1	1	0
2021	12	24	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	24	General disorders and administration site conditions	Feeling hot	1	1	0
2021	12	24	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	12	24	Nervous system disorders	Migraine	1	1	0
2021	12	24	General disorders and administration site conditions	Adverse food reaction	1	1	0
2021	12	24	General disorders and administration site conditions	Asthenia	1	1	0
2021	12	24	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	1	1	0
2021	12	24	Skin and subcutaneous tissue disorders	Nail discolouration	1	1	0
2021	12	24	Skin and subcutaneous tissue disorders	Sensitive skin	1	1	0
2021	12	24	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2021	12	24	Gastrointestinal disorders	Colitis	1	1	0
2021	12	24	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	12	24	General disorders and administration site conditions	Injection site warmth	1	1	0
2021	12	24	Eye disorders	Vision blurred	1	1	0
2021	12	24	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	24	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	24	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2021	12	24	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	12	24	Eye disorders	Ocular hyperaemia	1	1	0
2021	12	24	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	12	24	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2021	12	24	General disorders and administration site conditions	Injection site pruritus	1	1	0
2021	12	24	Infections and infestations	Herpes zoster	1	1	0
2021	12	24	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	12	24	General disorders and administration site conditions	Temperature regulation disorder	1	1	0
2021	12	24	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	24	Psychiatric disorders	Depressed mood	1	1	0
2021	12	24	Vascular disorders	Pallor	1	1	0
2021	12	25	Immune system disorders	Hypersensitivity	2	1	0
2021	12	25	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	25	Nervous system disorders	Dizziness	1	0	0
2021	12	25	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	0	0
2021	12	25	Gastrointestinal disorders	Lip swelling	1	1	0
2021	12	25	General disorders and administration site conditions	Pyrexia	1	1	0
2021	12	25	Immune system disorders	Anaphylactic reaction	1	1	0
2021	12	25	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2021	12	25	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	12	25	Gastrointestinal disorders	Swollen tongue	1	1	0
2021	12	25	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2021	12	25	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	12	25	Skin and subcutaneous tissue disorders	Rash	1	0	0
2021	12	25	General disorders and administration site conditions	Chest pain	1	0	0
2021	12	25	General disorders and administration site conditions	Injection site pain	1	1	0
2021	12	25	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2021	12	26	General disorders and administration site conditions	Pyrexia	3	3	0
2021	12	26	General disorders and administration site conditions	Pain	3	3	0
2021	12	26	General disorders and administration site conditions	Fatigue	3	3	0
2021	12	26	Nervous system disorders	Headache	2	2	0
2021	12	26	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	12	26	Investigations	Body temperature increased	2	2	0
2021	12	26	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	12	26	Nervous system disorders	Dizziness	2	2	0
2021	12	26	Nervous system disorders	Paraesthesia	1	1	0
2021	12	26	General disorders and administration site conditions	Swelling	1	1	0
2021	12	26	Musculoskeletal and connective tissue disorders	Limb mass	1	1	0
2021	12	26	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	12	26	Gastrointestinal disorders	Abdominal pain	1	1	0
2021	12	26	General disorders and administration site conditions	Injection site rash	1	1	0
2021	12	26	General disorders and administration site conditions	Chest discomfort	1	1	0
2021	12	26	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	12	26	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	26	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	12	26	Gastrointestinal disorders	Nausea	1	1	0
2021	12	26	General disorders and administration site conditions	Injection site pain	1	1	0
2021	12	26	Nervous system disorders	Lethargy	1	1	0
2021	12	26	Psychiatric disorders	Confusional state	1	1	0
2021	12	26	General disorders and administration site conditions	Malaise	1	1	0
2021	12	26	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2021	12	26	General disorders and administration site conditions	Chills	1	1	0
2021	12	26	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2021	12	26	Vascular disorders	Poor peripheral circulation	1	1	0
2021	12	27	Injury, poisoning and procedural complications	Incorrect dose administered	10	10	0
2021	12	27	Injury, poisoning and procedural complications	Vaccination error	10	10	0
2021	12	27	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2021	12	27	General disorders and administration site conditions	Pyrexia	5	5	0
2021	12	27	General disorders and administration site conditions	Injection site pain	2	2	1
2021	12	27	General disorders and administration site conditions	Injection site reaction	2	2	0
2021	12	27	Nervous system disorders	Headache	2	2	0
2021	12	27	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	27	Psychiatric disorders	Confusional state	2	2	1
2021	12	27	General disorders and administration site conditions	Fatigue	2	2	0
2021	12	27	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	12	27	Cardiac disorders	Tachycardia	1	1	0
2021	12	27	Infections and infestations	Pneumonia	1	1	1
2021	12	27	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	27	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	27	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	12	27	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2021	12	27	General disorders and administration site conditions	Injection site mass	1	1	0
2021	12	27	Nervous system disorders	Facial paresis	1	1	0
2021	12	27	Nervous system disorders	Paraesthesia	1	1	0
2021	12	27	Nervous system disorders	Syncope	1	1	0
2021	12	27	Cardiac disorders	Bradycardia	1	1	0
2021	12	27	General disorders and administration site conditions	Chest pain	1	1	0
2021	12	27	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	27	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2021	12	27	General disorders and administration site conditions	Injection site rash	1	1	0
2021	12	27	Vascular disorders	Hot flush	1	1	0
2021	12	27	Gastrointestinal disorders	Nausea	1	1	0
2021	12	27	Cardiac disorders	Palpitations	1	1	0
2021	12	27	Nervous system disorders	Hemiparesis	1	1	0
2021	12	27	Nervous system disorders	Lethargy	1	1	0
2021	12	27	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	12	27	Eye disorders	Vision blurred	1	1	0
2021	12	27	Nervous system disorders	Amnesia	1	1	0
2021	12	27	Nervous system disorders	Seizure	1	1	0
2021	12	27	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2021	12	27	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	12	27	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	12	27	Respiratory, thoracic and mediastinal disorders	Productive cough	1	1	0
2021	12	27	General disorders and administration site conditions	Chills	1	1	0
2021	12	27	General disorders and administration site conditions	Tenderness	1	1	0
2021	12	27	Infections and infestations	Injection site cellulitis	1	1	0
2021	12	27	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	12	27	Gastrointestinal disorders	Diarrhoea	1	1	0
2021	12	27	General disorders and administration site conditions	Axillary pain	1	1	0
2021	12	28	Nervous system disorders	Paraesthesia	3	3	0
2021	12	28	General disorders and administration site conditions	Chest pain	3	3	0
2021	12	28	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	28	General disorders and administration site conditions	Fatigue	2	2	0
2021	12	28	General disorders and administration site conditions	Influenza like illness	1	1	0
2021	12	28	General disorders and administration site conditions	Injection site reaction	1	1	0
2021	12	28	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2021	12	28	Cardiac disorders	Tachycardia	1	1	0
2021	12	28	Nervous system disorders	Taste disorder	1	1	0
2021	12	28	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	28	Cardiac disorders	Pericarditis	1	1	0
2021	12	28	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2021	12	28	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	28	Gastrointestinal disorders	Nausea	1	1	0
2021	12	28	Cardiac disorders	Palpitations	1	1	0
2021	12	28	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	12	28	Nervous system disorders	Headache	1	1	0
2021	12	28	Cardiac disorders	Atrial fibrillation	1	1	0
2021	12	28	General disorders and administration site conditions	Chills	1	1	0
2021	12	28	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2021	12	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2021	12	28	General disorders and administration site conditions	Pyrexia	1	1	0
2021	12	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2021	12	28	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	12	28	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	12	28	Investigations	Urine output decreased	1	1	0
2021	12	28	Nervous system disorders	Dizziness	1	1	0
2021	12	28	Cardiac disorders	Extrasystoles	1	1	0
2021	12	28	General disorders and administration site conditions	Thirst	1	1	0
2021	12	29	Injury, poisoning and procedural complications	Vaccination error	7	7	0
2021	12	29	Injury, poisoning and procedural complications	Incorrect dose administered	7	7	0
2021	12	29	General disorders and administration site conditions	Chest pain	5	5	0
2021	12	29	General disorders and administration site conditions	Pyrexia	5	5	0
2021	12	29	General disorders and administration site conditions	Fatigue	5	5	0
2021	12	29	Nervous system disorders	Headache	5	4	0
2021	12	29	General disorders and administration site conditions	Chest discomfort	5	5	0
2021	12	29	Musculoskeletal and connective tissue disorders	Pain in extremity	5	5	0
2021	12	29	Gastrointestinal disorders	Nausea	4	4	0
2021	12	29	Musculoskeletal and connective tissue disorders	Arthralgia	4	3	0
2021	12	29	Nervous system disorders	Paraesthesia	4	4	0
2021	12	29	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2021	12	29	General disorders and administration site conditions	Pain	2	1	0
2021	12	29	General disorders and administration site conditions	Malaise	2	1	0
2021	12	29	General disorders and administration site conditions	Injection site pruritus	1	1	0
2021	12	29	Investigations	Cardiac murmur	1	1	0
2021	12	29	Nervous system disorders	Dizziness	1	1	0
2021	12	29	Vascular disorders	Pallor	1	1	0
2021	12	29	Ear and labyrinth disorders	Tinnitus	1	1	0
2021	12	29	General disorders and administration site conditions	Asthenia	1	0	0
2021	12	29	General disorders and administration site conditions	Chills	1	1	0
2021	12	29	Gastrointestinal disorders	Diarrhoea	1	0	0
2021	12	29	Nervous system disorders	Seizure	1	1	0
2021	12	29	Investigations	C-reactive protein increased	1	1	0
2021	12	29	Ear and labyrinth disorders	Vertigo	1	1	0
2021	12	29	Nervous system disorders	Migraine	1	1	0
2021	12	29	Gastrointestinal disorders	Abdominal distension	1	0	0
2021	12	29	Gastrointestinal disorders	Abdominal pain lower	1	0	0
2021	12	29	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2021	12	29	Infections and infestations	Diverticulitis	1	0	0
2021	12	29	Renal and urinary disorders	Renal pain	1	1	0
2021	12	29	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2021	12	29	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	1	1	0
2021	12	29	Nervous system disorders	Somnolence	1	1	0
2021	12	29	Cardiac disorders	Palpitations	1	1	0
2021	12	29	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2021	12	29	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	29	Nervous system disorders	Loss of consciousness	1	1	0
2021	12	29	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2021	12	30	General disorders and administration site conditions	Fatigue	10	10	0
2021	12	30	Nervous system disorders	Headache	10	10	0
2021	12	30	General disorders and administration site conditions	Pyrexia	10	10	0
2021	12	30	Nervous system disorders	Lethargy	9	9	0
2021	12	30	Musculoskeletal and connective tissue disorders	Myalgia	9	9	0
2021	12	30	General disorders and administration site conditions	Injection site reaction	7	7	0
2021	12	30	General disorders and administration site conditions	Chest pain	7	7	0
2021	12	30	Nervous system disorders	Dizziness	7	7	0
2021	12	30	Musculoskeletal and connective tissue disorders	Arthralgia	6	6	0
2021	12	30	Blood and lymphatic system disorders	Lymphadenopathy	6	6	0
2021	12	30	Gastrointestinal disorders	Nausea	6	6	0
2021	12	30	General disorders and administration site conditions	Injection site pain	5	5	0
2021	12	30	Gastrointestinal disorders	Diarrhoea	5	5	0
2021	12	30	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2021	12	30	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2021	12	30	General disorders and administration site conditions	Feeling hot	3	3	0
2021	12	30	Metabolism and nutrition disorders	Decreased appetite	3	3	0
2021	12	30	Gastrointestinal disorders	Abdominal pain	3	3	0
2021	12	30	General disorders and administration site conditions	Injection site rash	3	3	0
2021	12	30	Psychiatric disorders	Confusional state	3	3	0
2021	12	30	Cardiac disorders	Palpitations	2	2	0
2021	12	30	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	12	30	General disorders and administration site conditions	Malaise	2	2	0
2021	12	30	Nervous system disorders	Ageusia	2	2	0
2021	12	30	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2021	12	30	Gastrointestinal disorders	Vomiting	2	2	0
2021	12	30	Ear and labyrinth disorders	Vertigo	2	2	0
2021	12	30	Psychiatric disorders	Insomnia	2	2	0
2021	12	30	General disorders and administration site conditions	Asthenia	2	2	0
2021	12	30	Metabolism and nutrition disorders	Dehydration	2	2	0
2021	12	30	Gastrointestinal disorders	Abdominal pain upper	2	2	0
2021	12	30	Musculoskeletal and connective tissue disorders	Neck pain	2	2	0
2021	12	30	Vascular disorders	Hypertension	2	2	0
2021	12	30	General disorders and administration site conditions	Injection site swelling	2	2	0
2021	12	30	Nervous system disorders	Balance disorder	2	2	0
2021	12	30	Nervous system disorders	Somnolence	2	2	0
2021	12	30	Skin and subcutaneous tissue disorders	Cold sweat	2	2	0
2021	12	30	General disorders and administration site conditions	Injection site dermatitis	1	1	0
2021	12	30	Psychiatric disorders	Disorientation	1	1	0
2021	12	30	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2021	12	30	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	12	30	General disorders and administration site conditions	Chills	1	1	0
2021	12	30	Investigations	White blood cell count increased	1	1	0
2021	12	30	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2021	12	30	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2021	12	30	General disorders and administration site conditions	Injection site erythema	1	1	0
2021	12	30	General disorders and administration site conditions	Swelling face	1	1	0
2021	12	30	Psychiatric disorders	Sleep disorder	1	1	0
2021	12	30	Eye disorders	Eyelid oedema	1	1	0
2021	12	30	Psychiatric disorders	Mood altered	1	1	0
2021	12	30	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2021	12	30	Nervous system disorders	Tremor	1	1	0
2021	12	30	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2021	12	30	Cardiac disorders	Tachycardia	1	1	0
2021	12	30	Gastrointestinal disorders	Abdominal pain lower	1	1	0
2021	12	30	General disorders and administration site conditions	Pain	1	1	0
2021	12	30	Infections and infestations	Nasopharyngitis	1	1	0
2021	12	30	Nervous system disorders	Burning sensation	1	1	0
2021	12	30	Nervous system disorders	Movement disorder	1	1	0
2021	12	30	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2021	12	30	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2021	12	30	Skin and subcutaneous tissue disorders	Rash	1	1	0
2021	12	30	Vascular disorders	Flushing	1	1	0
2021	12	30	Cardiac disorders	Pericardial effusion	1	1	0
2021	12	30	General disorders and administration site conditions	Swelling	1	1	0
2021	12	30	Gastrointestinal disorders	Reflux gastritis	1	1	0
2021	12	30	General disorders and administration site conditions	Mass	1	1	0
2021	12	30	Nervous system disorders	Anosmia	1	1	0
2021	12	30	Nervous system disorders	Dysgeusia	1	1	0
2021	12	30	Nervous system disorders	Paraesthesia	1	1	0
2021	12	30	Psychiatric disorders	Nightmare	1	1	0
2021	12	30	Renal and urinary disorders	Pollakiuria	1	1	0
2021	12	30	General disorders and administration site conditions	Secretion discharge	1	1	0
2021	12	30	Investigations	Respiratory rate increased	1	1	0
2021	12	30	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2021	12	30	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2021	12	30	Injury, poisoning and procedural complications	Expired product administered	1	1	0
2021	12	30	Investigations	Computerised tomogram thorax	1	1	0
2021	12	30	Nervous system disorders	Hypoaesthesia	1	1	0
2021	12	30	Psychiatric disorders	Affect lability	1	1	0
2021	12	30	Psychiatric disorders	Autoscopy	1	1	0
2021	12	30	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2021	12	30	Social circumstances	Loss of personal independence in daily activities	1	1	0
2021	12	30	Infections and infestations	Pneumonia	1	1	0
2021	12	30	Infections and infestations	Sinusitis	1	1	0
2021	12	31	General disorders and administration site conditions	Injection site reaction	5	5	0
2021	12	31	General disorders and administration site conditions	Fatigue	4	4	0
2021	12	31	General disorders and administration site conditions	Pyrexia	3	3	0
2021	12	31	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2021	12	31	General disorders and administration site conditions	Chest discomfort	2	2	0
2021	12	31	Gastrointestinal disorders	Nausea	2	2	0
2021	12	31	General disorders and administration site conditions	Chest pain	2	2	0
2021	12	31	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2021	12	31	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2021	12	31	Nervous system disorders	Headache	2	2	0
2021	12	31	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2021	12	31	General disorders and administration site conditions	Chills	1	1	0
2021	12	31	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2021	12	31	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2021	12	31	General disorders and administration site conditions	Malaise	1	1	0
2021	12	31	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2021	12	31	Nervous system disorders	Dizziness	1	1	0
2021	12	31	Respiratory, thoracic and mediastinal disorders	Hypopnoea	1	1	0
2021	12	31	Vascular disorders	Pallor	1	1	0
2021	12	31	Gastrointestinal disorders	Vomiting	1	1	0
2021	12	31	Cardiac disorders	Palpitations	1	1	0
2021	12	31	General disorders and administration site conditions	Injection site pain	1	1	0
2021	12	31	Nervous system disorders	Lethargy	1	1	0
2021	12	31	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2021	12	31	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2021	12	31	Nervous system disorders	Head discomfort	1	1	0
2021	12	31	Cardiac disorders	Myopericarditis	1	1	0
2021	12	31	Investigations	Electrocardiogram	1	1	0
2021	12	31	Nervous system disorders	Sensory loss	1	1	0
2021	12	31	Nervous system disorders	Somnolence	1	1	0
2021	12	31	Gastrointestinal disorders	Dysphagia	1	1	0
2021	12	31	General disorders and administration site conditions	Swelling	1	1	0
2021	12	31	Nervous system disorders	Migraine	1	1	0
2021	12	31	Nervous system disorders	Paraesthesia	1	1	0
2021	12	31	Nervous system disorders	Syncope	1	1	0
2021	12	31	Eye disorders	Eye pain	1	1	0
2021	12	31	General disorders and administration site conditions	Peripheral swelling	1	1	0
2021	12	31	Nervous system disorders	Hyperaesthesia	1	1	0
2021	12	31	General disorders and administration site conditions	Pain	1	1	0
2021	12	31	Nervous system disorders	Burning sensation	1	1	0
2021	12	31	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	1	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	1	1	Nervous system disorders	Dizziness	2	2	0
2022	1	1	Gastrointestinal disorders	Nausea	2	2	0
2022	1	1	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	1	1	General disorders and administration site conditions	Pyrexia	2	2	0
2022	1	1	Blood and lymphatic system disorders	Lymphadenitis	1	1	0
2022	1	1	General disorders and administration site conditions	Chills	1	1	0
2022	1	1	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	1	1	Nervous system disorders	Presyncope	1	1	0
2022	1	1	Skin and subcutaneous tissue disorders	Rash maculo-papular	1	1	0
2022	1	1	Cardiac disorders	Palpitations	1	1	0
2022	1	1	Nervous system disorders	Headache	1	1	0
2022	1	1	Investigations	Electrocardiogram	1	1	0
2022	1	1	General disorders and administration site conditions	Fatigue	1	1	0
2022	1	1	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	1	1	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	1	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	1	1	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	1	2	General disorders and administration site conditions	Fatigue	5	5	0
2022	1	2	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2022	1	2	Nervous system disorders	Headache	3	3	0
2022	1	2	Nervous system disorders	Dizziness	3	3	0
2022	1	2	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	1	2	Gastrointestinal disorders	Nausea	3	3	0
2022	1	2	General disorders and administration site conditions	Malaise	2	2	0
2022	1	2	Nervous system disorders	Paraesthesia	2	2	0
2022	1	2	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	1	2	General disorders and administration site conditions	Pyrexia	2	2	0
2022	1	2	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	1	2	General disorders and administration site conditions	Chest pain	2	2	0
2022	1	2	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	1	2	Nervous system disorders	Presyncope	1	1	0
2022	1	2	Nervous system disorders	Restless legs syndrome	1	1	0
2022	1	2	Eye disorders	Vision blurred	1	1	0
2022	1	2	Nervous system disorders	Disturbance in attention	1	1	0
2022	1	2	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	2	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	2	Nervous system disorders	Syncope	1	1	0
2022	1	2	Psychiatric disorders	Insomnia	1	1	0
2022	1	2	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	1	2	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	2	Musculoskeletal and connective tissue disorders	Hand deformity	1	1	0
2022	1	2	Cardiac disorders	Tachycardia	1	1	0
2022	1	2	Cardiac disorders	Palpitations	1	1	0
2022	1	2	General disorders and administration site conditions	Injection site pain	1	1	0
2022	1	2	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	2	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	2	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	1	3	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	5	0
2022	1	3	Musculoskeletal and connective tissue disorders	Arthralgia	4	3	0
2022	1	3	General disorders and administration site conditions	Fatigue	4	2	0
2022	1	3	Nervous system disorders	Headache	4	3	0
2022	1	3	Gastrointestinal disorders	Diarrhoea	4	4	0
2022	1	3	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	1	3	Nervous system disorders	Lethargy	3	3	0
2022	1	3	General disorders and administration site conditions	Pyrexia	3	2	0
2022	1	3	Nervous system disorders	Dizziness	3	2	0
2022	1	3	Cardiac disorders	Pericarditis	3	3	0
2022	1	3	General disorders and administration site conditions	Chest pain	3	3	0
2022	1	3	General disorders and administration site conditions	Malaise	2	1	0
2022	1	3	Gastrointestinal disorders	Nausea	2	2	0
2022	1	3	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	1	3	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	1	3	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2022	1	3	General disorders and administration site conditions	Chills	2	2	0
2022	1	3	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	1	3	General disorders and administration site conditions	Swelling	1	1	0
2022	1	3	Cardiac disorders	Myocarditis	1	1	0
2022	1	3	General disorders and administration site conditions	Injection site rash	1	0	0
2022	1	3	Infections and infestations	Injection site infection	1	0	0
2022	1	3	Nervous system disorders	Paraesthesia	1	1	0
2022	1	3	Nervous system disorders	Syncope	1	1	0
2022	1	3	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	1	3	Investigations	Breath sounds abnormal	1	1	0
2022	1	3	Ear and labyrinth disorders	Vertigo	1	0	0
2022	1	3	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	1	3	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2022	1	3	Reproductive system and breast disorders	Nipple pain	1	1	0
2022	1	3	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	1	3	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	3	Psychiatric disorders	Confusional state	1	1	0
2022	1	3	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	3	Cardiac disorders	Palpitations	1	0	0
2022	1	3	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	1	3	Investigations	Body temperature increased	1	0	0
2022	1	3	Skin and subcutaneous tissue disorders	Erythema multiforme	1	1	0
2022	1	3	General disorders and administration site conditions	Influenza like illness	1	0	0
2022	1	3	Investigations	Heart rate increased	1	1	0
2022	1	3	Musculoskeletal and connective tissue disorders	Pain in extremity	1	0	0
2022	1	3	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	1	3	General disorders and administration site conditions	Asthenia	1	0	0
2022	1	3	Infections and infestations	Cellulitis	1	1	0
2022	1	3	Eye disorders	Vision blurred	1	1	0
2022	1	3	Nervous system disorders	Seizure	1	1	0
2022	1	4	Blood and lymphatic system disorders	Lymphadenopathy	6	6	0
2022	1	4	General disorders and administration site conditions	Fatigue	5	4	0
2022	1	4	General disorders and administration site conditions	Pyrexia	5	5	0
2022	1	4	General disorders and administration site conditions	Malaise	4	3	0
2022	1	4	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2022	1	4	General disorders and administration site conditions	Chest pain	4	4	0
2022	1	4	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	1	4	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2022	1	4	Gastrointestinal disorders	Nausea	3	3	0
2022	1	4	Gastrointestinal disorders	Vomiting	3	3	0
2022	1	4	General disorders and administration site conditions	Pain	3	2	0
2022	1	4	General disorders and administration site conditions	Injection site pain	3	3	0
2022	1	4	Respiratory, thoracic and mediastinal disorders	Cough	3	3	0
2022	1	4	Nervous system disorders	Headache	3	3	0
2022	1	4	Cardiac disorders	Pericarditis	2	2	0
2022	1	4	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	1	4	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	2	2	0
2022	1	4	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	1	4	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	1	4	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	1	4	Respiratory, thoracic and mediastinal disorders	Productive cough	2	2	0
2022	1	4	Cardiac disorders	Palpitations	2	2	0
2022	1	4	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	1	4	Reproductive system and breast disorders	Suppressed lactation	1	1	0
2022	1	4	Reproductive system and breast disorders	Testicular pain	1	1	0
2022	1	4	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2022	1	4	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	1	4	Cardiac disorders	Myopericarditis	1	1	0
2022	1	4	Gastrointestinal disorders	Lip disorder	1	1	0
2022	1	4	General disorders and administration site conditions	Injection site rash	1	1	0
2022	1	4	Nervous system disorders	Somnolence	1	1	0
2022	1	4	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2022	1	4	Investigations	Body temperature increased	1	1	0
2022	1	4	Renal and urinary disorders	Dysuria	1	1	0
2022	1	4	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	1	4	Investigations	Troponin increased	1	1	0
2022	1	4	General disorders and administration site conditions	Injection site mass	1	1	0
2022	1	4	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2022	1	4	Nervous system disorders	Paraesthesia	1	1	0
2022	1	4	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2022	1	4	General disorders and administration site conditions	Swelling	1	1	0
2022	1	4	Musculoskeletal and connective tissue disorders	Flank pain	1	1	0
2022	1	4	Musculoskeletal and connective tissue disorders	Pain in jaw	1	0	0
2022	1	4	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	1	4	Gastrointestinal disorders	Retching	1	1	0
2022	1	4	Nervous system disorders	Tremor	1	1	0
2022	1	4	Cardiac disorders	Tachycardia	1	1	0
2022	1	4	Gastrointestinal disorders	Abdominal pain lower	1	1	0
2022	1	4	Investigations	Blood testosterone decreased	1	1	0
2022	1	4	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	1	4	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	1	4	General disorders and administration site conditions	Influenza like illness	1	0	0
2022	1	4	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	4	Investigations	Heart rate increased	1	1	0
2022	1	4	Nervous system disorders	Dizziness	1	1	0
2022	1	4	Reproductive system and breast disorders	Postmenopausal haemorrhage	1	1	0
2022	1	4	Eye disorders	Eye oedema	1	1	0
2022	1	4	Infections and infestations	Herpes zoster	1	1	0
2022	1	4	Gastrointestinal disorders	Lip swelling	1	1	0
2022	1	4	Gastrointestinal disorders	Toothache	1	0	0
2022	1	4	Investigations	Blood urine present	1	1	0
2022	1	4	Nervous system disorders	Monoplegia	1	1	0
2022	1	4	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	4	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	1	4	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2022	1	4	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2022	1	4	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2022	1	5	General disorders and administration site conditions	Pyrexia	11	11	0
2022	1	5	Nervous system disorders	Headache	10	7	0
2022	1	5	General disorders and administration site conditions	Chest pain	10	9	0
2022	1	5	Musculoskeletal and connective tissue disorders	Myalgia	10	9	0
2022	1	5	General disorders and administration site conditions	Fatigue	9	8	0
2022	1	5	General disorders and administration site conditions	Injection site reaction	9	9	0
2022	1	5	Musculoskeletal and connective tissue disorders	Arthralgia	7	6	0
2022	1	5	Nervous system disorders	Paraesthesia	6	5	0
2022	1	5	Nervous system disorders	Dizziness	5	5	0
2022	1	5	General disorders and administration site conditions	Malaise	5	2	0
2022	1	5	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2022	1	5	Blood and lymphatic system disorders	Lymphadenopathy	4	3	0
2022	1	5	General disorders and administration site conditions	Injection site pain	4	2	0
2022	1	5	Cardiac disorders	Palpitations	4	4	0
2022	1	5	Nervous system disorders	Lethargy	3	3	0
2022	1	5	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	1	5	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	2	0
2022	1	5	Skin and subcutaneous tissue disorders	Rash	3	3	0
2022	1	5	Musculoskeletal and connective tissue disorders	Pain in extremity	3	2	0
2022	1	5	Nervous system disorders	Presyncope	3	3	0
2022	1	5	Ear and labyrinth disorders	Tinnitus	2	2	0
2022	1	5	General disorders and administration site conditions	Chills	2	2	0
2022	1	5	General disorders and administration site conditions	Injected limb mobility decreased	2	2	0
2022	1	5	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	1	5	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2022	1	5	Ear and labyrinth disorders	Vertigo	2	0	0
2022	1	5	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	1	5	Investigations	Body temperature increased	1	1	0
2022	1	5	Psychiatric disorders	Confusional state	1	1	0
2022	1	5	Psychiatric disorders	Hallucination	1	1	0
2022	1	5	Ear and labyrinth disorders	Hyperacusis	1	1	0
2022	1	5	Gastrointestinal disorders	Dyspepsia	1	1	0
2022	1	5	Gastrointestinal disorders	Nausea	1	1	0
2022	1	5	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	5	Investigations	Troponin	1	1	0
2022	1	5	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	5	Nervous system disorders	Loss of consciousness	1	1	0
2022	1	5	Reproductive system and breast disorders	Breast cyst	1	1	0
2022	1	5	General disorders and administration site conditions	Inflammation	1	0	0
2022	1	5	General disorders and administration site conditions	Injection site necrosis	1	0	0
2022	1	5	General disorders and administration site conditions	Injection site rash	1	1	0
2022	1	5	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	1	5	Vascular disorders	Hot flush	1	1	0
2022	1	5	Cardiac disorders	Bradycardia	1	1	0
2022	1	5	Gastrointestinal disorders	Dry mouth	1	1	0
2022	1	5	Gastrointestinal disorders	Mouth ulceration	1	1	0
2022	1	5	Immune system disorders	Immune system disorder	1	1	0
2022	1	5	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	5	Investigations	Heart rate irregular	1	1	0
2022	1	5	Nervous system disorders	Anosmia	1	1	0
2022	1	5	Nervous system disorders	Syncope	1	1	0
2022	1	5	Psychiatric disorders	Listless	1	1	0
2022	1	5	Cardiac disorders	Pericarditis	1	1	0
2022	1	5	Nervous system disorders	Migraine	1	1	0
2022	1	5	Cardiac disorders	Supraventricular tachycardia	1	1	0
2022	1	5	Cardiac disorders	Tachycardia	1	1	0
2022	1	5	Eye disorders	Diplopia	1	1	0
2022	1	5	Nervous system disorders	Taste disorder	1	1	0
2022	1	5	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	5	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	1	5	Eye disorders	Eye pain	1	1	0
2022	1	5	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	1	5	Eye disorders	Photophobia	1	0	0
2022	1	5	Eye disorders	Vision blurred	1	1	0
2022	1	5	Investigations	Blood pressure decreased	1	1	0
2022	1	5	Psychiatric disorders	Libido decreased	1	0	0
2022	1	5	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	1	5	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	1	5	Ear and labyrinth disorders	Deafness	1	1	0
2022	1	5	General disorders and administration site conditions	Asthenia	1	0	0
2022	1	5	Nervous system disorders	Dysarthria	1	1	0
2022	1	5	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	1	5	Infections and infestations	Herpes zoster	1	1	0
2022	1	5	Metabolism and nutrition disorders	Decreased appetite	1	0	0
2022	1	5	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	1	5	General disorders and administration site conditions	Swelling face	1	1	0
2022	1	5	Investigations	Heart rate increased	1	1	0
2022	1	6	Nervous system disorders	Headache	17	15	0
2022	1	6	General disorders and administration site conditions	Chest pain	14	13	0
2022	1	6	General disorders and administration site conditions	Pyrexia	14	14	0
2022	1	6	Musculoskeletal and connective tissue disorders	Myalgia	10	9	0
2022	1	6	Gastrointestinal disorders	Nausea	9	7	0
2022	1	6	Gastrointestinal disorders	Vomiting	9	8	0
2022	1	6	General disorders and administration site conditions	Fatigue	9	9	0
2022	1	6	Blood and lymphatic system disorders	Lymphadenopathy	8	8	0
2022	1	6	Nervous system disorders	Dizziness	7	6	0
2022	1	6	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	6	0
2022	1	6	General disorders and administration site conditions	Chills	6	5	0
2022	1	6	Nervous system disorders	Lethargy	6	6	0
2022	1	6	Cardiac disorders	Palpitations	6	6	0
2022	1	6	Gastrointestinal disorders	Diarrhoea	5	4	0
2022	1	6	Musculoskeletal and connective tissue disorders	Pain in extremity	5	5	0
2022	1	6	General disorders and administration site conditions	Chest discomfort	5	4	0
2022	1	6	Cardiac disorders	Pericarditis	5	5	0
2022	1	6	General disorders and administration site conditions	Malaise	4	4	0
2022	1	6	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	1	6	Cardiac disorders	Myocarditis	4	3	0
2022	1	6	Eye disorders	Vision blurred	4	4	0
2022	1	6	Gastrointestinal disorders	Abdominal pain	4	4	0
2022	1	6	General disorders and administration site conditions	Injection site pain	4	3	0
2022	1	6	Musculoskeletal and connective tissue disorders	Arthralgia	4	3	0
2022	1	6	Investigations	Heart rate increased	3	2	0
2022	1	6	Skin and subcutaneous tissue disorders	Rash	3	3	0
2022	1	6	General disorders and administration site conditions	Pain	3	3	0
2022	1	6	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2022	1	6	Investigations	Fibrin D dimer increased	3	3	0
2022	1	6	Nervous system disorders	Paraesthesia	3	3	0
2022	1	6	Cardiac disorders	Tachycardia	3	3	0
2022	1	6	General disorders and administration site conditions	Injection site extravasation	2	2	0
2022	1	6	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2022	1	6	Musculoskeletal and connective tissue disorders	Muscle spasms	2	1	0
2022	1	6	Nervous system disorders	Disturbance in attention	2	2	0
2022	1	6	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	1	6	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	2	1	0
2022	1	6	Investigations	Heart rate irregular	2	2	0
2022	1	6	Investigations	Troponin increased	2	2	0
2022	1	6	Psychiatric disorders	Confusional state	2	2	0
2022	1	6	Skin and subcutaneous tissue disorders	Skin exfoliation	2	2	0
2022	1	6	Nervous system disorders	Tremor	2	2	0
2022	1	6	Investigations	Electrocardiogram	2	2	0
2022	1	6	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2022	1	6	Skin and subcutaneous tissue disorders	Cold sweat	2	2	0
2022	1	6	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2022	1	6	General disorders and administration site conditions	Feeling hot	2	2	0
2022	1	6	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	1	6	Eye disorders	Ocular hyperaemia	1	1	0
2022	1	6	Gastrointestinal disorders	Gingival pain	1	1	0
2022	1	6	Infections and infestations	Vestibular neuronitis	1	1	0
2022	1	6	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	1	6	Psychiatric disorders	Anxiety	1	1	0
2022	1	6	Ear and labyrinth disorders	Ear inflammation	1	1	0
2022	1	6	Hepatobiliary disorders	Hepatomegaly	1	0	0
2022	1	6	Musculoskeletal and connective tissue disorders	Limb discomfort	1	0	0
2022	1	6	Psychiatric disorders	Enuresis	1	1	0
2022	1	6	Renal and urinary disorders	Urinary incontinence	1	1	0
2022	1	6	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	1	6	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	6	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	6	General disorders and administration site conditions	Swelling face	1	1	0
2022	1	6	Investigations	Electrocardiogram abnormal	1	0	0
2022	1	6	Investigations	Electrocardiogram T wave inversion	1	1	0
2022	1	6	Nervous system disorders	Facial paralysis	1	1	0
2022	1	6	Cardiac disorders	Atrial fibrillation	1	0	0
2022	1	6	Infections and infestations	Herpes zoster	1	1	0
2022	1	6	Nervous system disorders	Poor quality sleep	1	1	0
2022	1	6	Psychiatric disorders	Suicidal behaviour	1	1	0
2022	1	6	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	1	6	Investigations	C-reactive protein	1	1	0
2022	1	6	Investigations	Troponin	1	1	0
2022	1	6	Psychiatric disorders	Psychotic behaviour	1	1	0
2022	1	6	Psychiatric disorders	Suicidal ideation	1	1	0
2022	1	6	Renal and urinary disorders	Haemorrhage urinary tract	1	1	0
2022	1	6	Renal and urinary disorders	Urinary retention	1	1	0
2022	1	6	Cardiac disorders	Heart valve incompetence	1	1	0
2022	1	6	Investigations	Body temperature increased	1	1	0
2022	1	6	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	1	6	Cardiac disorders	Arrhythmia	1	1	0
2022	1	6	Injury, poisoning and procedural complications	Muscle strain	1	1	0
2022	1	6	Investigations	Heart rate abnormal	1	1	0
2022	1	6	Investigations	Troponin I increased	1	0	0
2022	1	6	Nervous system disorders	Depressed level of consciousness	1	1	0
2022	1	6	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	6	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	0	0
2022	1	6	Respiratory, thoracic and mediastinal disorders	Sinus congestion	1	1	0
2022	1	6	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2022	1	6	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	1	6	Cardiac disorders	Myopericarditis	1	1	0
2022	1	6	Ear and labyrinth disorders	Ear swelling	1	1	0
2022	1	6	Gastrointestinal disorders	Gingival swelling	1	1	0
2022	1	6	Hepatobiliary disorders	Hepatic steatosis	1	0	0
2022	1	6	Nervous system disorders	Electric shock sensation	1	0	0
2022	1	6	Nervous system disorders	Somnolence	1	1	0
2022	1	6	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2022	1	6	Vascular disorders	Hypotension	1	1	0
2022	1	6	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	1	6	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	1	6	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	6	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	1	6	Psychiatric disorders	Poor quality sleep	1	1	0
2022	1	6	Eye disorders	Diplopia	1	1	0
2022	1	6	Eye disorders	Foreign body sensation in eyes	1	1	0
2022	1	6	Gastrointestinal disorders	Rectal haemorrhage	1	1	0
2022	1	6	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	6	Investigations	Hormone level abnormal	1	1	0
2022	1	6	Investigations	Weight decreased	1	1	0
2022	1	6	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2022	1	6	Nervous system disorders	Burning sensation	1	1	0
2022	1	6	Reproductive system and breast disorders	Amenorrhoea	1	1	0
2022	1	6	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	1	6	Respiratory, thoracic and mediastinal disorders	Pneumothorax	1	0	0
2022	1	6	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	6	Reproductive system and breast disorders	Pelvic pain	1	1	0
2022	1	6	Skin and subcutaneous tissue disorders	Blister	1	1	0
2022	1	6	Social circumstances	Bedridden	1	1	0
2022	1	6	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	1	6	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	1	6	General disorders and administration site conditions	Feeling cold	1	1	0
2022	1	6	General disorders and administration site conditions	Injection site mass	1	1	0
2022	1	6	Musculoskeletal and connective tissue disorders	Spinal pain	1	1	0
2022	1	6	Nervous system disorders	Syncope	1	1	0
2022	1	6	Respiratory, thoracic and mediastinal disorders	Nasal inflammation	1	1	0
2022	1	6	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	1	7	General disorders and administration site conditions	Chest pain	9	9	0
2022	1	7	General disorders and administration site conditions	Fatigue	8	8	0
2022	1	7	Nervous system disorders	Headache	8	8	0
2022	1	7	General disorders and administration site conditions	Pyrexia	8	8	0
2022	1	7	Gastrointestinal disorders	Nausea	7	6	0
2022	1	7	Nervous system disorders	Dizziness	5	5	0
2022	1	7	General disorders and administration site conditions	Injection site reaction	5	5	0
2022	1	7	Musculoskeletal and connective tissue disorders	Myalgia	4	3	0
2022	1	7	General disorders and administration site conditions	Injection site pain	4	4	0
2022	1	7	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2022	1	7	Nervous system disorders	Lethargy	4	4	0
2022	1	7	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2022	1	7	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	2	0
2022	1	7	Cardiac disorders	Palpitations	3	3	0
2022	1	7	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	1	7	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	1	7	Nervous system disorders	Disturbance in attention	2	2	0
2022	1	7	Nervous system disorders	Paraesthesia	2	2	0
2022	1	7	Eye disorders	Vision blurred	2	2	0
2022	1	7	General disorders and administration site conditions	Feeling cold	2	1	0
2022	1	7	Nervous system disorders	Hypoaesthesia	2	2	0
2022	1	7	Nervous system disorders	Syncope	2	1	0
2022	1	7	General disorders and administration site conditions	Malaise	2	2	0
2022	1	7	General disorders and administration site conditions	Asthenia	2	2	0
2022	1	7	Cardiac disorders	Pericarditis	2	2	0
2022	1	7	Vascular disorders	Hypertension	2	2	0
2022	1	7	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	1	7	Eye disorders	Blindness	1	1	0
2022	1	7	General disorders and administration site conditions	Chills	1	1	0
2022	1	7	Infections and infestations	Cellulitis	1	1	0
2022	1	7	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2022	1	7	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	1	7	Nervous system disorders	Neuralgia	1	1	0
2022	1	7	Nervous system disorders	Monoplegia	1	1	0
2022	1	7	Nervous system disorders	Seizure	1	1	0
2022	1	7	Eye disorders	Lacrimation increased	1	1	0
2022	1	7	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	1	7	Investigations	Heart rate increased	1	1	0
2022	1	7	Investigations	Body temperature increased	1	1	0
2022	1	7	Musculoskeletal and connective tissue disorders	Flank pain	1	0	0
2022	1	7	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	7	Skin and subcutaneous tissue disorders	Trichodynia	1	1	0
2022	1	7	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	7	General disorders and administration site conditions	Injection site hypoaesthesia	1	1	0
2022	1	7	Eye disorders	Eye irritation	1	1	0
2022	1	7	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	7	Investigations	Heart rate irregular	1	1	0
2022	1	7	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	1	7	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	1	7	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	1	7	General disorders and administration site conditions	Discomfort	1	1	0
2022	1	7	Infections and infestations	Pneumonia	1	1	0
2022	1	7	Investigations	Electrocardiogram abnormal	1	1	0
2022	1	7	Ear and labyrinth disorders	Deafness neurosensory	1	1	0
2022	1	7	Immune system disorders	Hypersensitivity	1	1	0
2022	1	7	Nervous system disorders	Burning feet syndrome	1	1	0
2022	1	7	Nervous system disorders	Dysgeusia	1	1	0
2022	1	7	Psychiatric disorders	Insomnia	1	1	0
2022	1	7	Renal and urinary disorders	Pollakiuria	1	1	0
2022	1	7	Blood and lymphatic system disorders	Anaemia	1	1	0
2022	1	7	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	7	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	7	Nervous system disorders	Migraine	1	1	0
2022	1	7	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	1	7	Cardiac disorders	Tachycardia	1	1	0
2022	1	7	Investigations	Blood creatine phosphokinase increased	1	1	0
2022	1	7	Investigations	Liver function test increased	1	1	0
2022	1	7	Nervous system disorders	Burning sensation	1	1	0
2022	1	7	Nervous system disorders	Taste disorder	1	1	0
2022	1	7	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2022	1	7	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	7	Eye disorders	Eyelid disorder	1	1	0
2022	1	7	Investigations	Inflammatory marker increased	1	1	0
2022	1	7	Investigations	White blood cell count decreased	1	1	0
2022	1	7	Vascular disorders	Pallor	1	0	0
2022	1	8	Nervous system disorders	Headache	5	4	0
2022	1	8	General disorders and administration site conditions	Fatigue	4	3	0
2022	1	8	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	1	8	General disorders and administration site conditions	Malaise	3	3	0
2022	1	8	General disorders and administration site conditions	Chest pain	3	3	0
2022	1	8	Gastrointestinal disorders	Nausea	3	3	0
2022	1	8	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	1	8	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	1	8	Nervous system disorders	Lethargy	3	3	0
2022	1	8	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	1	8	General disorders and administration site conditions	Chills	2	2	0
2022	1	8	Psychiatric disorders	Insomnia	2	2	0
2022	1	8	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	1	8	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2022	1	8	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	1	8	General disorders and administration site conditions	Pyrexia	2	2	0
2022	1	8	Investigations	Heart rate increased	1	1	0
2022	1	8	Skin and subcutaneous tissue disorders	Skin discolouration	1	1	0
2022	1	8	General disorders and administration site conditions	Axillary pain	1	1	0
2022	1	8	Investigations	Electrocardiogram	1	1	0
2022	1	8	Cardiac disorders	Palpitations	1	0	0
2022	1	8	Musculoskeletal and connective tissue disorders	Groin pain	1	1	0
2022	1	8	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	8	Investigations	Chest X-ray	1	1	0
2022	1	8	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	8	Investigations	Troponin increased	1	1	0
2022	1	8	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	8	Skin and subcutaneous tissue disorders	Rash papular	1	1	0
2022	1	8	Nervous system disorders	Burning sensation	1	1	0
2022	1	8	Cardiac disorders	Myocarditis	1	1	0
2022	1	8	General disorders and administration site conditions	Feeling cold	1	1	0
2022	1	8	Nervous system disorders	Paraesthesia	1	1	0
2022	1	8	Nervous system disorders	Syncope	1	1	0
2022	1	8	Cardiac disorders	Pericarditis	1	1	0
2022	1	8	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	1	8	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	9	General disorders and administration site conditions	Pyrexia	4	4	0
2022	1	9	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	1	9	General disorders and administration site conditions	Fatigue	3	3	0
2022	1	9	Nervous system disorders	Headache	2	2	0
2022	1	9	Gastrointestinal disorders	Vomiting	2	2	0
2022	1	9	General disorders and administration site conditions	Chills	2	2	0
2022	1	9	General disorders and administration site conditions	Injection site nodule	2	2	0
2022	1	9	Musculoskeletal and connective tissue disorders	Groin pain	1	1	0
2022	1	9	Ear and labyrinth disorders	Ear congestion	1	1	0
2022	1	9	Gastrointestinal disorders	Nausea	1	1	0
2022	1	9	General disorders and administration site conditions	Injection site pain	1	1	0
2022	1	9	Nervous system disorders	Lethargy	1	1	0
2022	1	9	Psychiatric disorders	Hallucination	1	1	0
2022	1	9	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	1	9	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	1	9	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	1	9	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	1	9	Nervous system disorders	Tremor	1	1	0
2022	1	9	Renal and urinary disorders	Renal pain	1	1	0
2022	1	9	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	1	9	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	9	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	1	9	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	9	Nervous system disorders	Syncope	1	1	0
2022	1	9	Psychiatric disorders	Insomnia	1	1	0
2022	1	9	Eye disorders	Vision blurred	1	1	0
2022	1	9	Musculoskeletal and connective tissue disorders	Bursitis	1	1	0
2022	1	9	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	1	9	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	9	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	1	9	Infections and infestations	Herpes zoster	1	1	0
2022	1	10	General disorders and administration site conditions	Pyrexia	11	10	0
2022	1	10	General disorders and administration site conditions	Chest pain	10	9	0
2022	1	10	Nervous system disorders	Headache	10	9	0
2022	1	10	Gastrointestinal disorders	Nausea	7	7	0
2022	1	10	General disorders and administration site conditions	Chest discomfort	6	6	0
2022	1	10	Nervous system disorders	Paraesthesia	5	5	0
2022	1	10	Musculoskeletal and connective tissue disorders	Myalgia	5	4	0
2022	1	10	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2022	1	10	Cardiac disorders	Palpitations	4	3	0
2022	1	10	Nervous system disorders	Lethargy	4	3	0
2022	1	10	Skin and subcutaneous tissue disorders	Rash	4	4	0
2022	1	10	General disorders and administration site conditions	Fatigue	4	4	0
2022	1	10	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2022	1	10	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2022	1	10	Gastrointestinal disorders	Diarrhoea	3	3	0
2022	1	10	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	1	10	Musculoskeletal and connective tissue disorders	Pain in extremity	3	2	0
2022	1	10	General disorders and administration site conditions	Malaise	3	3	0
2022	1	10	General disorders and administration site conditions	Injection site pain	3	2	0
2022	1	10	Immune system disorders	Hypersensitivity	2	2	0
2022	1	10	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	1	10	Nervous system disorders	Bell's palsy	2	1	0
2022	1	10	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2022	1	10	Gastrointestinal disorders	Vomiting	2	2	0
2022	1	10	Nervous system disorders	Dizziness	2	1	0
2022	1	10	General disorders and administration site conditions	Pain	2	2	0
2022	1	10	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	10	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	1	10	Cardiac disorders	Myopericarditis	1	1	0
2022	1	10	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2022	1	10	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	1	10	Vascular disorders	Hypotension	1	1	0
2022	1	10	Infections and infestations	Viral infection	1	1	0
2022	1	10	Investigations	Troponin increased	1	1	0
2022	1	10	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	10	Nervous system disorders	Myelitis transverse	1	1	0
2022	1	10	Infections and infestations	Oral herpes	1	1	0
2022	1	10	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	1	10	Cardiac disorders	Pericarditis	1	1	0
2022	1	10	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	10	General disorders and administration site conditions	Feeling hot	1	1	0
2022	1	10	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	1	10	Cardiac disorders	Myocarditis	1	1	0
2022	1	10	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	1	10	Immune system disorders	Anaphylactic reaction	1	0	0
2022	1	10	Nervous system disorders	Syncope	1	1	0
2022	1	10	Psychiatric disorders	Insomnia	1	1	0
2022	1	10	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	1	10	Gastrointestinal disorders	Retching	1	1	0
2022	1	10	Cardiac disorders	Tachycardia	1	1	0
2022	1	10	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	1	10	Infections and infestations	Herpes simplex	1	1	0
2022	1	10	Nervous system disorders	Muscle spasticity	1	1	0
2022	1	10	Nervous system disorders	Restless legs syndrome	1	0	0
2022	1	10	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	10	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	1	10	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	1	10	Skin and subcutaneous tissue disorders	Sensitive skin	1	1	0
2022	1	10	Eye disorders	Vision blurred	1	1	0
2022	1	10	Eye disorders	Visual impairment	1	1	0
2022	1	10	Gastrointestinal disorders	Flatulence	1	1	0
2022	1	10	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Testis cancer	1	1	0
2022	1	10	Nervous system disorders	Sensory disturbance	1	1	0
2022	1	10	Pregnancy, puerperium and perinatal conditions	Foetal death	1	1	0
2022	1	10	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	1	10	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	10	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	1	10	General disorders and administration site conditions	Chills	1	1	0
2022	1	10	General disorders and administration site conditions	Injected limb mobility decreased	1	0	0
2022	1	10	Infections and infestations	Injection site cellulitis	1	1	0
2022	1	10	Metabolism and nutrition disorders	Dehydration	1	1	0
2022	1	10	General disorders and administration site conditions	Influenza like illness	1	0	0
2022	1	10	Nervous system disorders	Presyncope	1	1	0
2022	1	10	Psychiatric disorders	Sleep disorder	1	1	0
2022	1	10	Cardiac disorders	Cardiac flutter	1	1	0
2022	1	10	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	1	10	General disorders and administration site conditions	Injection site movement impairment	1	1	0
2022	1	10	Infections and infestations	Herpes zoster	1	1	0
2022	1	11	General disorders and administration site conditions	Chest pain	20	20	0
2022	1	11	Nervous system disorders	Headache	12	12	0
2022	1	11	Respiratory, thoracic and mediastinal disorders	Dyspnoea	12	12	0
2022	1	11	Gastrointestinal disorders	Nausea	10	10	0
2022	1	11	General disorders and administration site conditions	Fatigue	9	9	0
2022	1	11	General disorders and administration site conditions	Pyrexia	9	9	0
2022	1	11	Musculoskeletal and connective tissue disorders	Myalgia	7	7	0
2022	1	11	General disorders and administration site conditions	Injection site reaction	6	6	0
2022	1	11	General disorders and administration site conditions	Chest discomfort	6	6	0
2022	1	11	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2022	1	11	Nervous system disorders	Paraesthesia	5	5	0
2022	1	11	Respiratory, thoracic and mediastinal disorders	Cough	4	4	0
2022	1	11	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	1	11	Nervous system disorders	Syncope	4	4	0
2022	1	11	Cardiac disorders	Pericarditis	3	3	0
2022	1	11	General disorders and administration site conditions	Malaise	3	3	0
2022	1	11	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2022	1	11	Nervous system disorders	Dizziness	3	3	0
2022	1	11	Ear and labyrinth disorders	Vertigo	2	2	0
2022	1	11	General disorders and administration site conditions	Chills	2	2	0
2022	1	11	Nervous system disorders	Lethargy	2	2	0
2022	1	11	Cardiac disorders	Cardiac discomfort	2	2	0
2022	1	11	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	1	11	Eye disorders	Vision blurred	2	2	0
2022	1	11	Gastrointestinal disorders	Vomiting	2	2	0
2022	1	11	Cardiac disorders	Myocarditis	2	2	0
2022	1	11	Investigations	Troponin increased	2	2	0
2022	1	11	Investigations	Heart rate increased	2	2	0
2022	1	11	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2022	1	11	General disorders and administration site conditions	Asthenia	2	2	0
2022	1	11	General disorders and administration site conditions	Injection site pain	2	2	0
2022	1	11	Cardiac disorders	Carditis	2	2	0
2022	1	11	Injury, poisoning and procedural complications	Adverse event following immunisation	2	2	0
2022	1	11	Cardiac disorders	Cardiac disorder	1	1	0
2022	1	11	Cardiac disorders	Cardiomegaly	1	1	0
2022	1	11	Eye disorders	Blindness	1	1	0
2022	1	11	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	1	11	Investigations	White blood cell count increased	1	1	0
2022	1	11	Psychiatric disorders	Anxiety	1	1	0
2022	1	11	Skin and subcutaneous tissue disorders	Skin mass	1	1	0
2022	1	11	Eye disorders	Visual impairment	1	1	0
2022	1	11	Gastrointestinal disorders	Lip swelling	1	1	0
2022	1	11	Nervous system disorders	Balance disorder	1	1	0
2022	1	11	Pregnancy, puerperium and perinatal conditions	Foetal death	1	1	0
2022	1	11	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2022	1	11	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	11	Skin and subcutaneous tissue disorders	Skin exfoliation	1	1	0
2022	1	11	General disorders and administration site conditions	Axillary pain	1	1	0
2022	1	11	Infections and infestations	Hepatitis C	1	1	0
2022	1	11	Investigations	Cardiac murmur	1	1	0
2022	1	11	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	1	11	Nervous system disorders	Presyncope	1	1	0
2022	1	11	Reproductive system and breast disorders	Haematospermia	1	1	0
2022	1	11	Cardiac disorders	Heart valve incompetence	1	1	0
2022	1	11	Cardiac disorders	Palpitations	1	1	0
2022	1	11	Eye disorders	Uveitis	1	1	0
2022	1	11	General disorders and administration site conditions	Facial pain	1	1	0
2022	1	11	Infections and infestations	Lower respiratory tract infection	1	1	0
2022	1	11	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	11	Psychiatric disorders	Confusional state	1	1	0
2022	1	11	Psychiatric disorders	Restlessness	1	1	0
2022	1	11	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	1	11	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	11	Investigations	Romberg test positive	1	1	0
2022	1	11	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	1	11	Nervous system disorders	Cerebral disorder	1	1	0
2022	1	11	Nervous system disorders	Depressed level of consciousness	1	1	0
2022	1	11	Psychiatric disorders	Mental disorder	1	1	0
2022	1	11	General disorders and administration site conditions	Injection site rash	1	1	0
2022	1	11	Investigations	Electrocardiogram	1	1	0
2022	1	11	Investigations	Electrocardiogram abnormal	1	1	0
2022	1	11	Nervous system disorders	Mononeuritis	1	1	0
2022	1	11	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2022	1	11	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	1	11	Vascular disorders	Hypotension	1	1	0
2022	1	11	Cardiac disorders	Pericardial effusion	1	1	0
2022	1	11	Infections and infestations	Bacterial infection	1	1	0
2022	1	11	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	1	11	Investigations	Grip strength decreased	1	1	0
2022	1	11	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	1	11	Reproductive system and breast disorders	Polymenorrhoea	1	1	0
2022	1	11	Blood and lymphatic system disorders	Pancytopenia	1	1	0
2022	1	11	Eye disorders	Photophobia	1	1	0
2022	1	11	Gastrointestinal disorders	Gingival bleeding	1	1	0
2022	1	11	Psychiatric disorders	Insomnia	1	1	0
2022	1	11	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	1	11	Respiratory, thoracic and mediastinal disorders	Sneezing	1	1	0
2022	1	11	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	1	11	General disorders and administration site conditions	Pain	1	1	0
2022	1	11	Infections and infestations	Tonsillitis	1	1	0
2022	1	11	Investigations	Blood pressure increased	1	1	0
2022	1	11	Investigations	Echocardiogram normal	1	1	0
2022	1	11	Investigations	Eosinophil count increased	1	1	0
2022	1	11	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	11	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	1	11	Cardiac disorders	Sinus tachycardia	1	1	0
2022	1	11	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	1	11	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	12	General disorders and administration site conditions	Fatigue	8	8	0
2022	1	12	General disorders and administration site conditions	Chest pain	8	8	0
2022	1	12	Nervous system disorders	Headache	7	7	0
2022	1	12	General disorders and administration site conditions	Pyrexia	6	6	0
2022	1	12	Skin and subcutaneous tissue disorders	Rash	6	6	0
2022	1	12	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2022	1	12	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2022	1	12	General disorders and administration site conditions	Injection site reaction	5	5	0
2022	1	12	General disorders and administration site conditions	Pain	4	4	0
2022	1	12	Skin and subcutaneous tissue disorders	Hyperhidrosis	4	4	0
2022	1	12	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2022	1	12	General disorders and administration site conditions	Injection site pain	3	3	0
2022	1	12	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	2	0
2022	1	12	Cardiac disorders	Pericarditis	3	3	0
2022	1	12	General disorders and administration site conditions	Asthenia	3	3	0
2022	1	12	Gastrointestinal disorders	Vomiting	3	3	0
2022	1	12	Nervous system disorders	Dizziness	3	3	0
2022	1	12	Gastrointestinal disorders	Nausea	3	3	0
2022	1	12	Reproductive system and breast disorders	Heavy menstrual bleeding	3	3	0
2022	1	12	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2022	1	12	Psychiatric disorders	Confusional state	3	2	0
2022	1	12	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	1	12	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2022	1	12	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	1	12	Eye disorders	Visual impairment	2	1	0
2022	1	12	Vascular disorders	Hot flush	2	2	0
2022	1	12	Nervous system disorders	Paraesthesia	2	2	0
2022	1	12	General disorders and administration site conditions	Injection site swelling	2	2	0
2022	1	12	Nervous system disorders	Migraine	2	2	0
2022	1	12	Reproductive system and breast disorders	Menstruation irregular	2	2	0
2022	1	12	Endocrine disorders	Thyroiditis	1	1	0
2022	1	12	Nervous system disorders	Poor quality sleep	1	1	0
2022	1	12	General disorders and administration site conditions	Condition aggravated	1	1	0
2022	1	12	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	12	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	1	0
2022	1	12	Investigations	Electrocardiogram T wave inversion	1	1	0
2022	1	12	Investigations	Heart rate increased	1	1	0
2022	1	12	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	1	12	Psychiatric disorders	Sleep disorder	1	1	0
2022	1	12	Investigations	Pulse pressure increased	1	1	0
2022	1	12	Nervous system disorders	Seizure	1	1	0
2022	1	12	Psychiatric disorders	Disorientation	1	1	0
2022	1	12	Cardiac disorders	Atrial fibrillation	1	1	0
2022	1	12	Cardiac disorders	Pericardial rub	1	1	0
2022	1	12	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	1	12	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	1	12	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	1	12	Investigations	White blood cell count increased	1	1	0
2022	1	12	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	1	12	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	1	12	Nervous system disorders	Dysarthria	1	1	0
2022	1	12	Nervous system disorders	Neuralgia	1	1	0
2022	1	12	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2022	1	12	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2022	1	12	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	12	Eye disorders	Ocular discomfort	1	0	0
2022	1	12	Gastrointestinal disorders	Defaecation urgency	1	1	0
2022	1	12	General disorders and administration site conditions	Feeling hot	1	1	0
2022	1	12	Investigations	Blood glucose decreased	1	1	0
2022	1	12	Cardiac disorders	Myocarditis	1	1	0
2022	1	12	Nervous system disorders	Anosmia	1	1	0
2022	1	12	Nervous system disorders	Syncope	1	1	0
2022	1	12	Cardiac disorders	Tachycardia	1	1	0
2022	1	12	Gastrointestinal disorders	Constipation	1	1	0
2022	1	12	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	1	12	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	1	12	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	1	12	Gastrointestinal disorders	Retching	1	1	0
2022	1	12	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	1	12	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	12	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	1	12	Nervous system disorders	Tremor	1	1	0
2022	1	12	Psychiatric disorders	Poor quality sleep	1	1	0
2022	1	12	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2022	1	12	Cardiac disorders	Atrioventricular block first degree	1	1	0
2022	1	12	Cardiac disorders	Palpitations	1	1	0
2022	1	12	General disorders and administration site conditions	Injection site nodule	1	1	0
2022	1	12	Infections and infestations	Meningitis bacterial	1	1	0
2022	1	12	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	12	Nervous system disorders	Lethargy	1	1	0
2022	1	12	Psychiatric disorders	Depressed mood	1	0	0
2022	1	12	Psychiatric disorders	Hallucination, visual	1	0	0
2022	1	12	Psychiatric disorders	Restlessness	1	1	0
2022	1	12	Cardiac disorders	Carditis	1	1	0
2022	1	12	General disorders and administration site conditions	Vaccination failure	1	1	0
2022	1	12	Investigations	Troponin	1	1	0
2022	1	12	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	12	Nervous system disorders	Ageusia	1	1	0
2022	1	12	Nervous system disorders	Nervous system disorder	1	1	0
2022	1	12	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	1	12	Gastrointestinal disorders	Mouth ulceration	1	1	0
2022	1	12	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	1	12	General disorders and administration site conditions	Feeling abnormal	1	0	0
2022	1	12	General disorders and administration site conditions	Inflammation	1	1	0
2022	1	12	Nervous system disorders	Head discomfort	1	1	0
2022	1	12	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	12	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	1	12	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	1	12	Nervous system disorders	Intracranial aneurysm	1	1	0
2022	1	12	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2022	1	13	Musculoskeletal and connective tissue disorders	Myalgia	9	9	0
2022	1	13	General disorders and administration site conditions	Pyrexia	8	7	0
2022	1	13	General disorders and administration site conditions	Fatigue	8	7	0
2022	1	13	Nervous system disorders	Headache	8	7	0
2022	1	13	Nervous system disorders	Dizziness	7	6	0
2022	1	13	General disorders and administration site conditions	Injection site reaction	6	4	0
2022	1	13	Gastrointestinal disorders	Vomiting	5	4	0
2022	1	13	Nervous system disorders	Syncope	4	4	0
2022	1	13	General disorders and administration site conditions	Chills	4	4	0
2022	1	13	Skin and subcutaneous tissue disorders	Hyperhidrosis	4	4	0
2022	1	13	General disorders and administration site conditions	Chest pain	4	2	0
2022	1	13	Gastrointestinal disorders	Nausea	4	4	0
2022	1	13	Cardiac disorders	Palpitations	4	2	0
2022	1	13	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	1	13	General disorders and administration site conditions	Concomitant disease aggravated	3	3	0
2022	1	13	Cardiac disorders	Myocarditis	3	3	0
2022	1	13	General disorders and administration site conditions	Influenza like illness	3	2	0
2022	1	13	General disorders and administration site conditions	Injection site pain	3	3	0
2022	1	13	General disorders and administration site conditions	Malaise	3	1	0
2022	1	13	Musculoskeletal and connective tissue disorders	Pain in extremity	3	2	0
2022	1	13	Blood and lymphatic system disorders	Lymphadenopathy	3	2	0
2022	1	13	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2022	1	13	Musculoskeletal and connective tissue disorders	Arthralgia	2	1	0
2022	1	13	Nervous system disorders	Tremor	2	2	0
2022	1	13	General disorders and administration site conditions	Asthenia	2	2	0
2022	1	13	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2022	1	13	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2022	1	13	Nervous system disorders	Paraesthesia	2	2	0
2022	1	13	Nervous system disorders	Lethargy	2	2	0
2022	1	13	Blood and lymphatic system disorders	Thrombocytopenia	2	2	0
2022	1	13	Cardiac disorders	Pericarditis	1	0	0
2022	1	13	General disorders and administration site conditions	Axillary pain	1	0	0
2022	1	13	Investigations	Chest X-ray	1	1	0
2022	1	13	Nervous system disorders	Hemiparesis	1	1	0
2022	1	13	Nervous system disorders	Memory impairment	1	1	0
2022	1	13	Psychiatric disorders	Confusional state	1	1	0
2022	1	13	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	1	13	Eye disorders	Asthenopia	1	1	0
2022	1	13	Investigations	Electrocardiogram T wave inversion	1	0	0
2022	1	13	Nervous system disorders	Hemiparaesthesia	1	1	0
2022	1	13	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	0	0
2022	1	13	Investigations	Electrocardiogram	1	1	0
2022	1	13	Vascular disorders	Hot flush	1	1	0
2022	1	13	General disorders and administration site conditions	Inflammation	1	1	0
2022	1	13	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	13	Musculoskeletal and connective tissue disorders	Groin pain	1	1	0
2022	1	13	Nervous system disorders	Formication	1	1	0
2022	1	13	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2022	1	13	Eye disorders	Eye pain	1	1	0
2022	1	13	General disorders and administration site conditions	Pain	1	0	0
2022	1	13	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	13	Cardiac disorders	Tachycardia	1	1	0
2022	1	13	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	1	13	Gastrointestinal disorders	Mouth haemorrhage	1	1	0
2022	1	13	Investigations	Weight decreased	1	1	0
2022	1	13	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	1	13	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	13	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	1	13	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	1	13	General disorders and administration site conditions	Swelling	1	1	0
2022	1	13	Nervous system disorders	Migraine	1	1	0
2022	1	13	General disorders and administration site conditions	Injection site mass	1	1	0
2022	1	13	Investigations	Echocardiogram	1	1	0
2022	1	13	Psychiatric disorders	Nightmare	1	1	0
2022	1	13	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	1	13	Nervous system disorders	Presyncope	1	1	0
2022	1	13	Vascular disorders	Pallor	1	1	0
2022	1	13	Blood and lymphatic system disorders	Lymph node pain	1	0	0
2022	1	13	Injury, poisoning and procedural complications	Incorrect dosage administered	1	1	0
2022	1	13	Musculoskeletal and connective tissue disorders	Bursitis	1	1	0
2022	1	13	Nervous system disorders	Aphasia	1	1	0
2022	1	13	Nervous system disorders	Balance disorder	1	1	0
2022	1	13	Nervous system disorders	Disturbance in attention	1	1	0
2022	1	13	Psychiatric disorders	Disorientation	1	1	0
2022	1	13	Eye disorders	Blindness	1	1	0
2022	1	13	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	1	13	Gastrointestinal disorders	Lip haemorrhage	1	1	0
2022	1	13	General disorders and administration site conditions	Injected limb mobility decreased	1	0	0
2022	1	13	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	1	13	Nervous system disorders	Neuralgia	1	1	0
2022	1	13	Psychiatric disorders	Flat affect	1	1	0
2022	1	14	General disorders and administration site conditions	Pyrexia	9	9	0
2022	1	14	General disorders and administration site conditions	Chest pain	8	8	0
2022	1	14	Gastrointestinal disorders	Nausea	5	5	0
2022	1	14	Blood and lymphatic system disorders	Lymphadenopathy	5	5	0
2022	1	14	General disorders and administration site conditions	Fatigue	5	5	0
2022	1	14	Nervous system disorders	Headache	4	4	0
2022	1	14	General disorders and administration site conditions	Pain	3	3	0
2022	1	14	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	1	14	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	1	14	Nervous system disorders	Dizziness	3	3	0
2022	1	14	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	1	14	Nervous system disorders	Paraesthesia	3	3	0
2022	1	14	General disorders and administration site conditions	Injection site pain	3	3	0
2022	1	14	Nervous system disorders	Syncope	3	3	0
2022	1	14	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	1	14	Immune system disorders	Hypersensitivity	2	2	0
2022	1	14	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	1	14	Gastrointestinal disorders	Vomiting	2	2	0
2022	1	14	Eye disorders	Visual impairment	2	2	0
2022	1	14	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	1	14	Nervous system disorders	Hypoaesthesia	2	2	0
2022	1	14	General disorders and administration site conditions	Chills	2	2	0
2022	1	14	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	1	14	Cardiac disorders	Palpitations	2	2	0
2022	1	14	Nervous system disorders	Presyncope	2	2	0
2022	1	14	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	1	14	General disorders and administration site conditions	Malaise	2	2	0
2022	1	14	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	14	Nervous system disorders	Lethargy	1	1	0
2022	1	14	Psychiatric disorders	Confusional state	1	1	0
2022	1	14	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	1	14	Gastrointestinal disorders	Dyspepsia	1	1	0
2022	1	14	General disorders and administration site conditions	Injection site hypoaesthesia	1	1	0
2022	1	14	Investigations	Troponin increased	1	1	0
2022	1	14	Nervous system disorders	Bell's palsy	1	1	0
2022	1	14	Nervous system disorders	Paralysis	1	1	0
2022	1	14	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	1	14	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2022	1	14	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	1	14	Ear and labyrinth disorders	Sudden hearing loss	1	1	0
2022	1	14	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	14	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	1	14	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	1	14	Nervous system disorders	Parosmia	1	1	0
2022	1	14	Cardiac disorders	Myocarditis	1	1	0
2022	1	14	Nervous system disorders	Dysgeusia	1	1	0
2022	1	14	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	1	14	General disorders and administration site conditions	Swelling	1	1	0
2022	1	14	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	14	Nervous system disorders	Migraine	1	1	0
2022	1	14	Reproductive system and breast disorders	Endometriosis	1	1	0
2022	1	14	Social circumstances	Bedridden	1	1	0
2022	1	14	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	1	14	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	1	14	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	1	14	Gastrointestinal disorders	Pancreatitis acute	1	1	0
2022	1	14	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	1	14	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	1	14	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	1	14	General disorders and administration site conditions	Axillary pain	1	1	0
2022	1	14	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2022	1	14	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	1	14	General disorders and administration site conditions	Swelling face	1	1	0
2022	1	14	Vascular disorders	Pallor	1	1	0
2022	1	15	Musculoskeletal and connective tissue disorders	Pain in extremity	5	4	0
2022	1	15	General disorders and administration site conditions	Pyrexia	5	5	0
2022	1	15	General disorders and administration site conditions	Chest pain	4	4	0
2022	1	15	General disorders and administration site conditions	Fatigue	4	4	0
2022	1	15	General disorders and administration site conditions	Influenza like illness	3	3	0
2022	1	15	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	1	15	General disorders and administration site conditions	Injection site pain	3	3	0
2022	1	15	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	1	15	General disorders and administration site conditions	Pain	2	2	0
2022	1	15	Gastrointestinal disorders	Nausea	2	2	0
2022	1	15	Cardiac disorders	Myopericarditis	2	2	0
2022	1	15	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	1	15	Nervous system disorders	Headache	1	1	0
2022	1	15	Nervous system disorders	Lethargy	1	1	0
2022	1	15	Psychiatric disorders	Confusional state	1	1	0
2022	1	15	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	1	15	Investigations	Troponin increased	1	1	0
2022	1	15	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	1	15	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	1	15	General disorders and administration site conditions	Inflammation	1	0	0
2022	1	15	Investigations	Electrocardiogram	1	1	0
2022	1	15	Musculoskeletal and connective tissue disorders	Back pain	1	0	0
2022	1	15	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	15	Eye disorders	Ocular discomfort	1	1	0
2022	1	15	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	1	15	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	1	15	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2022	1	15	Reproductive system and breast disorders	Pelvic pain	1	0	0
2022	1	15	Cardiac disorders	Pericarditis	1	1	0
2022	1	15	Psychiatric disorders	Agitation	1	1	0
2022	1	15	Musculoskeletal and connective tissue disorders	Groin pain	1	0	0
2022	1	15	Nervous system disorders	Paraesthesia	1	1	0
2022	1	15	Renal and urinary disorders	Pollakiuria	1	1	0
2022	1	15	Skin and subcutaneous tissue disorders	Skin burning sensation	1	1	0
2022	1	15	General disorders and administration site conditions	Thirst	1	1	0
2022	1	15	Nervous system disorders	Dizziness	1	1	0
2022	1	15	Eye disorders	Vision blurred	1	1	0
2022	1	15	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	1	16	Reproductive system and breast disorders	Menstrual disorder	9	9	0
2022	1	16	Reproductive system and breast disorders	Menstruation irregular	6	6	0
2022	1	16	Nervous system disorders	Headache	5	5	0
2022	1	16	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2022	1	16	Musculoskeletal and connective tissue disorders	Pain in extremity	5	5	0
2022	1	16	General disorders and administration site conditions	Fatigue	4	4	0
2022	1	16	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	1	16	Nervous system disorders	Paraesthesia	3	3	0
2022	1	16	General disorders and administration site conditions	Pyrexia	3	3	0
2022	1	16	General disorders and administration site conditions	Chest pain	3	3	0
2022	1	16	Blood and lymphatic system disorders	Lymphadenopathy	3	2	0
2022	1	16	Nervous system disorders	Balance disorder	2	2	0
2022	1	16	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2022	1	16	General disorders and administration site conditions	Injection site mass	2	1	0
2022	1	16	General disorders and administration site conditions	Injection site pain	2	2	0
2022	1	16	Nervous system disorders	Tremor	2	2	0
2022	1	16	Psychiatric disorders	Insomnia	2	2	0
2022	1	16	Eye disorders	Vision blurred	2	2	0
2022	1	16	Nervous system disorders	Dizziness	2	2	0
2022	1	16	Nervous system disorders	Ageusia	2	2	0
2022	1	16	Cardiac disorders	Palpitations	2	2	0
2022	1	16	Gastrointestinal disorders	Nausea	2	1	0
2022	1	16	Skin and subcutaneous tissue disorders	Petechiae	1	1	0
2022	1	16	General disorders and administration site conditions	Injection site bruising	1	1	0
2022	1	16	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	16	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	16	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2022	1	16	Infections and infestations	Oral herpes	1	1	0
2022	1	16	Nervous system disorders	Lethargy	1	1	0
2022	1	16	Psychiatric disorders	Confusional state	1	1	0
2022	1	16	Reproductive system and breast disorders	Breast pain	1	1	0
2022	1	16	Nervous system disorders	Anosmia	1	1	0
2022	1	16	Psychiatric disorders	Eating disorder	1	1	0
2022	1	16	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	1	16	Nervous system disorders	Migraine	1	1	0
2022	1	16	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2022	1	16	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	1	16	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	1	16	Infections and infestations	Mastitis	1	1	0
2022	1	16	General disorders and administration site conditions	Pain	1	1	0
2022	1	16	Infections and infestations	Ophthalmic herpes simplex	1	1	0
2022	1	16	Nervous system disorders	Burning sensation	1	1	0
2022	1	16	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	1	16	Investigations	Heart rate increased	1	1	0
2022	1	16	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	1	16	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	1	16	Infections and infestations	Herpes zoster	1	1	0
2022	1	16	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2022	1	16	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	1	16	Gastrointestinal disorders	Flatulence	1	1	0
2022	1	16	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	1	16	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	17	Nervous system disorders	Headache	21	21	0
2022	1	17	General disorders and administration site conditions	Chest pain	15	14	0
2022	1	17	Blood and lymphatic system disorders	Lymphadenopathy	12	11	0
2022	1	17	Musculoskeletal and connective tissue disorders	Myalgia	12	12	0
2022	1	17	General disorders and administration site conditions	Fatigue	11	10	0
2022	1	17	General disorders and administration site conditions	Injection site pain	8	7	0
2022	1	17	General disorders and administration site conditions	Chills	8	7	0
2022	1	17	Musculoskeletal and connective tissue disorders	Arthralgia	8	7	0
2022	1	17	General disorders and administration site conditions	Malaise	7	7	0
2022	1	17	General disorders and administration site conditions	Pyrexia	7	7	0
2022	1	17	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2022	1	17	Nervous system disorders	Lethargy	5	5	0
2022	1	17	Nervous system disorders	Dizziness	5	5	0
2022	1	17	Metabolism and nutrition disorders	Decreased appetite	4	4	0
2022	1	17	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	1	17	Musculoskeletal and connective tissue disorders	Back pain	4	4	0
2022	1	17	Skin and subcutaneous tissue disorders	Rash	4	4	0
2022	1	17	Nervous system disorders	Paraesthesia	4	4	0
2022	1	17	Cardiac disorders	Pericarditis	3	2	0
2022	1	17	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	3	3	0
2022	1	17	Cardiac disorders	Palpitations	3	3	0
2022	1	17	Gastrointestinal disorders	Vomiting	3	3	0
2022	1	17	Psychiatric disorders	Confusional state	3	2	0
2022	1	17	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2022	1	17	Gastrointestinal disorders	Nausea	3	3	0
2022	1	17	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	1	17	Renal and urinary disorders	Polyuria	2	1	0
2022	1	17	Investigations	Fibrin D dimer increased	2	2	0
2022	1	17	Vascular disorders	Flushing	2	2	0
2022	1	17	Cardiac disorders	Myocarditis	2	2	0
2022	1	17	General disorders and administration site conditions	Pain	2	2	0
2022	1	17	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	1	17	Ear and labyrinth disorders	Vertigo	2	2	0
2022	1	17	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	1	17	Nervous system disorders	Hypoaesthesia	2	2	0
2022	1	17	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	2	1	0
2022	1	17	Nervous system disorders	Migraine	2	2	0
2022	1	17	Vascular disorders	Hypertension	2	2	0
2022	1	17	General disorders and administration site conditions	Injection site swelling	2	2	0
2022	1	17	Musculoskeletal and connective tissue disorders	Limb discomfort	2	2	0
2022	1	17	Respiratory, thoracic and mediastinal disorders	Asthma	2	2	0
2022	1	17	Blood and lymphatic system disorders	Immune thrombocytopenia	1	1	0
2022	1	17	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	1	17	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	1	17	Ear and labyrinth disorders	Deafness	1	1	0
2022	1	17	Metabolism and nutrition disorders	Dehydration	1	1	0
2022	1	17	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	1	17	Nervous system disorders	Restless legs syndrome	1	1	0
2022	1	17	Nervous system disorders	Seizure	1	0	0
2022	1	17	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2022	1	17	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	17	Infections and infestations	Infection	1	1	0
2022	1	17	Investigations	Heart rate increased	1	1	0
2022	1	17	General disorders and administration site conditions	Gait disturbance	1	1	0
2022	1	17	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2022	1	17	Immune system disorders	Hypersensitivity	1	1	0
2022	1	17	Psychiatric disorders	Insomnia	1	1	0
2022	1	17	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	1	17	General disorders and administration site conditions	Feeling hot	1	1	0
2022	1	17	General disorders and administration site conditions	Swelling	1	1	0
2022	1	17	Infections and infestations	Respiratory tract infection	1	1	0
2022	1	17	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	1	17	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2022	1	17	Reproductive system and breast disorders	Polymenorrhoea	1	1	0
2022	1	17	Social circumstances	Bedridden	1	1	0
2022	1	17	Eye disorders	Photopsia	1	0	0
2022	1	17	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	1	17	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2022	1	17	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	1	17	Nervous system disorders	Tremor	1	1	0
2022	1	17	Cardiac disorders	Tachycardia	1	1	0
2022	1	17	Infections and infestations	Urinary tract infection	1	1	0
2022	1	17	Nervous system disorders	Burning sensation	1	1	0
2022	1	17	Renal and urinary disorders	Pollakiuria	1	0	0
2022	1	17	Cardiac disorders	Bradycardia	1	1	0
2022	1	17	Gastrointestinal disorders	Mouth ulceration	1	1	0
2022	1	17	General disorders and administration site conditions	Injection site bruising	1	1	0
2022	1	17	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	17	Nervous system disorders	Formication	1	1	0
2022	1	17	Skin and subcutaneous tissue disorders	Angioedema	1	0	0
2022	1	17	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	1	17	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	1	17	General disorders and administration site conditions	Injection site rash	1	1	0
2022	1	17	Vascular disorders	Hot flush	1	1	0
2022	1	17	Investigations	Oxygen saturation decreased	1	1	0
2022	1	17	Metabolism and nutrition disorders	Hyperglycaemia	1	1	0
2022	1	17	Investigations	Body temperature abnormal	1	1	0
2022	1	17	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	17	Musculoskeletal and connective tissue disorders	Tendonitis	1	1	0
2022	1	17	Respiratory, thoracic and mediastinal disorders	Sinus disorder	1	1	0
2022	1	17	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	1	18	Nervous system disorders	Headache	9	9	0
2022	1	18	General disorders and administration site conditions	Fatigue	6	6	0
2022	1	18	General disorders and administration site conditions	Chest pain	6	6	0
2022	1	18	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2022	1	18	General disorders and administration site conditions	Injection site reaction	6	6	0
2022	1	18	General disorders and administration site conditions	Pyrexia	6	6	0
2022	1	18	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2022	1	18	Cardiac disorders	Tachycardia	5	5	0
2022	1	18	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	1	18	General disorders and administration site conditions	Chills	4	4	0
2022	1	18	General disorders and administration site conditions	Chest discomfort	4	4	0
2022	1	18	Cardiac disorders	Palpitations	4	4	0
2022	1	18	Gastrointestinal disorders	Nausea	4	4	0
2022	1	18	Gastrointestinal disorders	Vomiting	3	3	0
2022	1	18	Nervous system disorders	Dizziness	3	3	0
2022	1	18	Nervous system disorders	Lethargy	3	3	0
2022	1	18	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	1	18	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2022	1	18	Nervous system disorders	Burning sensation	2	2	0
2022	1	18	General disorders and administration site conditions	Feeling abnormal	2	2	0
2022	1	18	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	1	18	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	1	18	Cardiac disorders	Atrial flutter	1	1	0
2022	1	18	Psychiatric disorders	Sleep disorder	1	1	0
2022	1	18	Vascular disorders	Hypertension	1	1	0
2022	1	18	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	1	18	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	1	18	General disorders and administration site conditions	Malaise	1	1	0
2022	1	18	Eye disorders	Vision blurred	1	1	0
2022	1	18	Immune system disorders	Anaphylactic reaction	1	1	0
2022	1	18	Renal and urinary disorders	Urinary incontinence	1	1	0
2022	1	18	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	1	18	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	18	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	1	18	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	1	18	Cardiac disorders	Myocarditis	1	1	0
2022	1	18	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	1	18	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2022	1	18	Immune system disorders	Hypersensitivity	1	1	0
2022	1	18	Nervous system disorders	Dysgeusia	1	1	0
2022	1	18	Nervous system disorders	Paraesthesia	1	1	0
2022	1	18	Psychiatric disorders	Insomnia	1	1	0
2022	1	18	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2022	1	18	Cardiac disorders	Pericarditis	1	1	0
2022	1	18	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	18	General disorders and administration site conditions	Feeling hot	1	1	0
2022	1	18	Investigations	Echocardiogram abnormal	1	1	0
2022	1	18	Nervous system disorders	Migraine	1	1	0
2022	1	18	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	1	18	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	1	18	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	1	18	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	18	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	1	18	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	18	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	1	18	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	1	18	Vascular disorders	Flushing	1	1	0
2022	1	18	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	18	Investigations	Blood pressure systolic increased	1	1	0
2022	1	18	Investigations	Heart rate abnormal	1	1	0
2022	1	18	Cardiac disorders	Myopericarditis	1	1	0
2022	1	18	Endocrine disorders	Anovulatory cycle	1	1	0
2022	1	18	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	1	18	Investigations	Electrocardiogram	1	1	0
2022	1	18	Skin and subcutaneous tissue disorders	Petechiae	1	1	0
2022	1	18	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	1	18	General disorders and administration site conditions	Injection site pain	1	1	0
2022	1	18	Investigations	Fibrin D dimer increased	1	1	0
2022	1	18	Investigations	Troponin I	1	1	0
2022	1	18	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	18	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	1	18	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2022	1	18	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	1	18	Skin and subcutaneous tissue disorders	Skin sensitisation	1	1	0
2022	1	19	Nervous system disorders	Headache	10	9	0
2022	1	19	General disorders and administration site conditions	Chest pain	9	9	0
2022	1	19	General disorders and administration site conditions	Pyrexia	9	9	0
2022	1	19	General disorders and administration site conditions	Injection site reaction	8	8	0
2022	1	19	Musculoskeletal and connective tissue disorders	Myalgia	7	6	0
2022	1	19	Gastrointestinal disorders	Diarrhoea	5	5	0
2022	1	19	Gastrointestinal disorders	Vomiting	5	5	0
2022	1	19	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2022	1	19	General disorders and administration site conditions	Fatigue	5	5	0
2022	1	19	Gastrointestinal disorders	Nausea	5	5	0
2022	1	19	Cardiac disorders	Pericarditis	4	4	0
2022	1	19	General disorders and administration site conditions	Chills	4	4	0
2022	1	19	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	1	19	Nervous system disorders	Lethargy	4	4	0
2022	1	19	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	2	0
2022	1	19	Respiratory, thoracic and mediastinal disorders	Cough	3	3	0
2022	1	19	Skin and subcutaneous tissue disorders	Rash	3	3	0
2022	1	19	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	1	19	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	1	19	Nervous system disorders	Dizziness	3	3	0
2022	1	19	Nervous system disorders	Migraine	3	3	0
2022	1	19	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	1	19	Nervous system disorders	Paraesthesia	2	2	0
2022	1	19	Cardiac disorders	Tachycardia	2	2	0
2022	1	19	Cardiac disorders	Palpitations	2	1	0
2022	1	19	General disorders and administration site conditions	Injection site pain	2	1	0
2022	1	19	General disorders and administration site conditions	Malaise	2	2	0
2022	1	19	Cardiac disorders	Myocarditis	2	2	0
2022	1	19	Investigations	Heart rate increased	2	2	0
2022	1	19	General disorders and administration site conditions	Injection site swelling	2	2	0
2022	1	19	Blood and lymphatic system disorders	Immune thrombocytopenia	1	1	0
2022	1	19	Eye disorders	Visual impairment	1	1	0
2022	1	19	General disorders and administration site conditions	Injection site haematoma	1	1	0
2022	1	19	Infections and infestations	Bronchitis	1	1	0
2022	1	19	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	1	19	Nervous system disorders	Amnesia	1	1	0
2022	1	19	Nervous system disorders	Balance disorder	1	1	0
2022	1	19	Ear and labyrinth disorders	Deafness	1	1	0
2022	1	19	Gastrointestinal disorders	Gingival pain	1	1	0
2022	1	19	Psychiatric disorders	Anxiety	1	1	0
2022	1	19	Renal and urinary disorders	Renal impairment	1	1	0
2022	1	19	Cardiac disorders	Bundle branch block right	1	1	0
2022	1	19	General disorders and administration site conditions	Swelling face	1	1	0
2022	1	19	Nervous system disorders	Facial paralysis	1	1	0
2022	1	19	Psychiatric disorders	Sleep disorder	1	1	0
2022	1	19	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	1	19	General disorders and administration site conditions	Oedema peripheral	1	1	0
2022	1	19	Infections and infestations	Injection site infection	1	1	0
2022	1	19	Metabolism and nutrition disorders	Fluid retention	1	1	0
2022	1	19	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	1	19	Gastrointestinal disorders	Mouth ulceration	1	1	0
2022	1	19	General disorders and administration site conditions	Injection site discolouration	1	1	0
2022	1	19	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	19	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	1	19	Musculoskeletal and connective tissue disorders	Polymyositis	1	0	0
2022	1	19	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	19	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	19	Investigations	Troponin increased	1	1	0
2022	1	19	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	19	Nervous system disorders	Loss of consciousness	1	1	0
2022	1	19	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	1	19	Gastrointestinal disorders	Mouth haemorrhage	1	1	0
2022	1	19	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	19	Investigations	Blood pressure increased	1	1	0
2022	1	19	Nervous system disorders	Burning sensation	1	1	0
2022	1	19	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	19	Skin and subcutaneous tissue disorders	Henoch-Schonlein purpura	1	1	0
2022	1	19	Eye disorders	Eye pain	1	1	0
2022	1	19	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	1	19	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	19	Injury, poisoning and procedural complications	Epicondylitis	1	1	0
2022	1	19	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	1	19	Nervous system disorders	Tremor	1	1	0
2022	1	19	Renal and urinary disorders	Renal pain	1	1	0
2022	1	19	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2022	1	19	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	19	Skin and subcutaneous tissue disorders	Blood blister	1	1	0
2022	1	19	Gastrointestinal disorders	Abnormal faeces	1	1	0
2022	1	19	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	1	19	General disorders and administration site conditions	Injection site mass	1	1	0
2022	1	19	Nervous system disorders	Syncope	1	1	0
2022	1	20	General disorders and administration site conditions	Chest pain	13	13	0
2022	1	20	Respiratory, thoracic and mediastinal disorders	Dyspnoea	9	8	0
2022	1	20	Nervous system disorders	Headache	9	8	0
2022	1	20	General disorders and administration site conditions	Chest discomfort	6	6	0
2022	1	20	General disorders and administration site conditions	Fatigue	6	6	0
2022	1	20	Nervous system disorders	Paraesthesia	6	6	0
2022	1	20	General disorders and administration site conditions	Pyrexia	6	6	0
2022	1	20	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2022	1	20	General disorders and administration site conditions	Influenza like illness	5	5	0
2022	1	20	General disorders and administration site conditions	Concomitant disease aggravated	5	5	0
2022	1	20	Gastrointestinal disorders	Nausea	4	4	0
2022	1	20	Cardiac disorders	Palpitations	4	4	0
2022	1	20	General disorders and administration site conditions	Malaise	4	4	0
2022	1	20	Nervous system disorders	Dizziness	4	4	0
2022	1	20	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	1	20	Nervous system disorders	Lethargy	4	4	0
2022	1	20	Investigations	Heart rate increased	3	2	0
2022	1	20	Musculoskeletal and connective tissue disorders	Muscular weakness	3	3	0
2022	1	20	Musculoskeletal and connective tissue disorders	Pain in extremity	3	2	0
2022	1	20	General disorders and administration site conditions	Injection site pain	3	3	0
2022	1	20	Psychiatric disorders	Anxiety	3	3	0
2022	1	20	General disorders and administration site conditions	Pain	3	3	0
2022	1	20	Skin and subcutaneous tissue disorders	Urticaria	3	3	0
2022	1	20	Gastrointestinal disorders	Diarrhoea	3	3	0
2022	1	20	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	1	20	Cardiac disorders	Tachycardia	3	3	0
2022	1	20	Injury, poisoning and procedural complications	Vaccination error	3	3	0
2022	1	20	Gastrointestinal disorders	Vomiting	3	3	0
2022	1	20	Ear and labyrinth disorders	Vertigo	2	2	0
2022	1	20	General disorders and administration site conditions	Chills	2	2	0
2022	1	20	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	1	20	Respiratory, thoracic and mediastinal disorders	Pharyngeal hypoaesthesia	2	2	0
2022	1	20	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	1	20	Musculoskeletal and connective tissue disorders	Muscle spasms	2	1	0
2022	1	20	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2022	1	20	Vascular disorders	Pallor	2	2	0
2022	1	20	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	1	20	Cardiac disorders	Pericarditis	2	2	0
2022	1	20	Injury, poisoning and procedural complications	Incorrect dosage administered	1	1	0
2022	1	20	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	1	20	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	1	20	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	1	20	Metabolism and nutrition disorders	Dehydration	1	1	0
2022	1	20	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2022	1	20	Eye disorders	Blepharospasm	1	1	0
2022	1	20	Gastrointestinal disorders	Gastrointestinal disorder	1	1	0
2022	1	20	General disorders and administration site conditions	Axillary pain	1	1	0
2022	1	20	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	1	20	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	20	General disorders and administration site conditions	Swelling face	1	1	0
2022	1	20	Nervous system disorders	Cerebrovascular accident	1	1	0
2022	1	20	Nervous system disorders	Presyncope	1	1	0
2022	1	20	Vascular disorders	Hypertension	1	1	0
2022	1	20	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	1	20	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2022	1	20	Eye disorders	Eye irritation	1	1	0
2022	1	20	General disorders and administration site conditions	Injection site bruising	1	1	0
2022	1	20	Injury, poisoning and procedural complications	Expired product administered	1	1	0
2022	1	20	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	20	Infections and infestations	Pneumonia	1	0	0
2022	1	20	Infections and infestations	Varicella zoster virus infection	1	1	0
2022	1	20	Investigations	Troponin increased	1	1	0
2022	1	20	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	20	Musculoskeletal and connective tissue disorders	Muscle swelling	1	1	0
2022	1	20	Psychiatric disorders	Emotional distress	1	1	0
2022	1	20	Renal and urinary disorders	Incontinence	1	1	0
2022	1	20	Hepatobiliary disorders	Cholelithiasis	1	1	0
2022	1	20	Infections and infestations	Lower respiratory tract infection	1	1	0
2022	1	20	Investigations	Body temperature increased	1	1	0
2022	1	20	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	20	Eye disorders	Photophobia	1	1	0
2022	1	20	General disorders and administration site conditions	Feeling cold	1	1	0
2022	1	20	General disorders and administration site conditions	Injection site mass	1	1	0
2022	1	20	Nervous system disorders	Dysgeusia	1	1	0
2022	1	20	Skin and subcutaneous tissue disorders	Rash vesicular	1	1	0
2022	1	20	General disorders and administration site conditions	Feeling hot	1	1	0
2022	1	20	General disorders and administration site conditions	Swelling	1	1	0
2022	1	20	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	1	20	Vascular disorders	Peripheral coldness	1	1	0
2022	1	20	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	20	Vascular disorders	Flushing	1	1	0
2022	1	20	Gastrointestinal disorders	Retching	1	1	0
2022	1	20	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	20	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2022	1	20	Nervous system disorders	Hyperaesthesia	1	1	0
2022	1	20	Nervous system disorders	Tremor	1	1	0
2022	1	20	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2022	1	21	Nervous system disorders	Headache	14	14	0
2022	1	21	General disorders and administration site conditions	Chest pain	11	10	0
2022	1	21	Musculoskeletal and connective tissue disorders	Myalgia	11	11	0
2022	1	21	General disorders and administration site conditions	Pyrexia	9	8	0
2022	1	21	Gastrointestinal disorders	Nausea	9	9	0
2022	1	21	Musculoskeletal and connective tissue disorders	Arthralgia	7	7	0
2022	1	21	General disorders and administration site conditions	Fatigue	7	7	0
2022	1	21	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	6	0
2022	1	21	General disorders and administration site conditions	Injection site pain	5	5	0
2022	1	21	Skin and subcutaneous tissue disorders	Rash	5	3	0
2022	1	21	Gastrointestinal disorders	Vomiting	5	4	0
2022	1	21	Nervous system disorders	Syncope	4	4	0
2022	1	21	Injury, poisoning and procedural complications	Vaccination error	4	4	0
2022	1	21	Cardiac disorders	Palpitations	4	4	0
2022	1	21	Nervous system disorders	Dizziness	4	4	0
2022	1	21	Investigations	Heart rate increased	3	3	0
2022	1	21	Reproductive system and breast disorders	Menstruation irregular	3	2	0
2022	1	21	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2022	1	21	General disorders and administration site conditions	Influenza like illness	3	2	0
2022	1	21	Reproductive system and breast disorders	Menstrual disorder	3	2	0
2022	1	21	General disorders and administration site conditions	Chills	3	3	0
2022	1	21	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2022	1	21	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2022	1	21	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	1	21	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2022	1	21	Nervous system disorders	Paraesthesia	2	1	0
2022	1	21	Cardiac disorders	Tachycardia	2	1	0
2022	1	21	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2022	1	21	Nervous system disorders	Hypoaesthesia	2	1	0
2022	1	21	General disorders and administration site conditions	Swelling	2	2	0
2022	1	21	Nervous system disorders	Lethargy	2	2	0
2022	1	21	General disorders and administration site conditions	Pain	2	2	0
2022	1	21	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	1	21	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	1	21	General disorders and administration site conditions	Malaise	2	2	0
2022	1	21	Investigations	Body temperature increased	1	1	0
2022	1	21	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2022	1	21	Psychiatric disorders	Confusional state	1	1	0
2022	1	21	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	1	21	Vascular disorders	Deep vein thrombosis	1	1	0
2022	1	21	Infections and infestations	Meningitis aseptic	1	1	0
2022	1	21	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	21	Renal and urinary disorders	Incontinence	1	1	0
2022	1	21	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	1	21	Investigations	Blood fibrinogen increased	1	1	0
2022	1	21	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	1	21	Nervous system disorders	Depressed level of consciousness	1	1	0
2022	1	21	Psychiatric disorders	Disorientation	1	0	0
2022	1	21	Investigations	Electrocardiogram	1	1	0
2022	1	21	Eye disorders	Eye pain	1	1	0
2022	1	21	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	1	21	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	1	21	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	21	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	1	21	Nervous system disorders	Tremor	1	1	0
2022	1	21	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	21	Investigations	Blood pressure increased	1	1	0
2022	1	21	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	1	21	Eye disorders	Photophobia	1	1	0
2022	1	21	Investigations	Body temperature fluctuation	1	1	0
2022	1	21	Investigations	SARS-CoV-2 antibody test positive	1	1	0
2022	1	21	Nervous system disorders	Autonomic neuropathy	1	1	0
2022	1	21	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	1	21	Cardiac disorders	Pericarditis	1	1	0
2022	1	21	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	21	Gastrointestinal disorders	Dysphagia	1	1	0
2022	1	21	General disorders and administration site conditions	Feeling hot	1	1	0
2022	1	21	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2022	1	21	Nervous system disorders	Migraine	1	1	0
2022	1	21	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2022	1	21	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2022	1	21	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	1	21	Musculoskeletal and connective tissue disorders	Synovial cyst	1	1	0
2022	1	21	Eye disorders	Vision blurred	1	1	0
2022	1	21	Gastrointestinal disorders	Lip swelling	1	1	0
2022	1	21	Metabolism and nutrition disorders	Dehydration	1	0	0
2022	1	21	Nervous system disorders	Seizure	1	1	0
2022	1	21	General disorders and administration site conditions	Swelling face	1	1	0
2022	1	21	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	1	0
2022	1	21	Psychiatric disorders	Depressed mood	1	1	0
2022	1	21	Psychiatric disorders	Sleep disorder	1	1	0
2022	1	21	Cardiac disorders	Extrasystoles	1	1	0
2022	1	21	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	1	22	Cardiac disorders	Palpitations	4	4	0
2022	1	22	General disorders and administration site conditions	Chest pain	4	4	0
2022	1	22	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	1	22	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	1	22	Nervous system disorders	Paraesthesia	3	3	0
2022	1	22	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	1	22	General disorders and administration site conditions	Fatigue	3	2	0
2022	1	22	General disorders and administration site conditions	Injection site pain	3	2	0
2022	1	22	Nervous system disorders	Headache	3	3	0
2022	1	22	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	1	22	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2022	1	22	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	1	22	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	1	22	Nervous system disorders	Lethargy	2	2	0
2022	1	22	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	1	22	Gastrointestinal disorders	Vomiting	2	2	0
2022	1	22	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	1	22	Nervous system disorders	Dizziness	2	2	0
2022	1	22	Nervous system disorders	Hypoaesthesia	2	2	0
2022	1	22	Gastrointestinal disorders	Nausea	2	2	0
2022	1	22	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	1	22	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	1	22	Investigations	Chest X-ray normal	1	1	0
2022	1	22	Investigations	Troponin I	1	1	0
2022	1	22	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	22	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	1	22	Reproductive system and breast disorders	Breast pain	1	0	0
2022	1	22	Skin and subcutaneous tissue disorders	Skin burning sensation	1	0	0
2022	1	22	Cardiac disorders	Arrhythmia	1	1	0
2022	1	22	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	1	22	Infections and infestations	Appendicitis	1	1	0
2022	1	22	Surgical and medical procedures	Interchange of vaccine products	1	1	0
2022	1	22	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	1	22	General disorders and administration site conditions	Mass	1	1	0
2022	1	22	Nervous system disorders	Muscle contractions involuntary	1	1	0
2022	1	22	Cardiac disorders	Pericarditis	1	1	0
2022	1	22	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2022	1	22	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	1	22	Nervous system disorders	Migraine	1	1	0
2022	1	22	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	22	Reproductive system and breast disorders	Vulvovaginal dryness	1	1	0
2022	1	22	Respiratory, thoracic and mediastinal disorders	Stridor	1	1	0
2022	1	22	Musculoskeletal and connective tissue disorders	Hand deformity	1	1	0
2022	1	22	Nervous system disorders	Tremor	1	1	0
2022	1	22	Skin and subcutaneous tissue disorders	Scar pain	1	1	0
2022	1	22	Investigations	Heart rate increased	1	1	0
2022	1	22	Nervous system disorders	Presyncope	1	1	0
2022	1	22	Cardiac disorders	Cardiac flutter	1	1	0
2022	1	22	General disorders and administration site conditions	Axillary pain	1	1	0
2022	1	22	Reproductive system and breast disorders	Menstrual disorder	1	0	0
2022	1	22	Cardiac disorders	Cardiac disorder	1	1	0
2022	1	22	Infections and infestations	Influenza	1	1	0
2022	1	22	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2022	1	22	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	1	22	General disorders and administration site conditions	Pyrexia	1	1	0
2022	1	22	Nervous system disorders	Status migrainosus	1	0	0
2022	1	22	Respiratory, thoracic and mediastinal disorders	Painful respiration	1	1	0
2022	1	22	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	23	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2022	1	23	General disorders and administration site conditions	Pyrexia	2	2	0
2022	1	23	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	2	2	0
2022	1	23	General disorders and administration site conditions	Fatigue	2	2	0
2022	1	23	Gastrointestinal disorders	Vomiting	2	2	0
2022	1	23	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	1	23	General disorders and administration site conditions	Injection site pain	1	1	0
2022	1	23	Nervous system disorders	Headache	1	1	0
2022	1	23	Gastrointestinal disorders	Nausea	1	1	0
2022	1	23	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	1	23	Infections and infestations	Rash pustular	1	1	0
2022	1	23	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	23	Nervous system disorders	Migraine	1	1	0
2022	1	23	Nervous system disorders	Syncope	1	1	0
2022	1	23	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	1	23	Nervous system disorders	Tremor	1	1	0
2022	1	23	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	1	23	Ear and labyrinth disorders	Ear pain	1	1	0
2022	1	23	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	1	23	Vascular disorders	Pallor	1	1	0
2022	1	23	Infections and infestations	Herpes zoster	1	1	0
2022	1	23	Nervous system disorders	Trigeminal neuralgia	1	1	0
2022	1	23	General disorders and administration site conditions	Chills	1	1	0
2022	1	24	Nervous system disorders	Headache	16	16	0
2022	1	24	General disorders and administration site conditions	Fatigue	14	13	0
2022	1	24	Gastrointestinal disorders	Nausea	12	12	0
2022	1	24	Musculoskeletal and connective tissue disorders	Myalgia	11	10	0
2022	1	24	General disorders and administration site conditions	Injection site reaction	10	9	0
2022	1	24	General disorders and administration site conditions	Pyrexia	8	7	0
2022	1	24	General disorders and administration site conditions	Chest pain	7	7	0
2022	1	24	Cardiac disorders	Palpitations	7	7	0
2022	1	24	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2022	1	24	Blood and lymphatic system disorders	Lymphadenopathy	6	6	0
2022	1	24	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2022	1	24	Nervous system disorders	Dizziness	5	5	0
2022	1	24	Nervous system disorders	Migraine	4	4	0
2022	1	24	Nervous system disorders	Lethargy	4	4	0
2022	1	24	General disorders and administration site conditions	Injection site pain	3	3	0
2022	1	24	Gastrointestinal disorders	Vomiting	3	2	0
2022	1	24	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	1	24	General disorders and administration site conditions	Feeling abnormal	2	1	0
2022	1	24	Respiratory, thoracic and mediastinal disorders	Dysphonia	2	2	0
2022	1	24	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	1	24	Nervous system disorders	Paraesthesia	2	2	0
2022	1	24	Eye disorders	Vision blurred	2	2	0
2022	1	24	General disorders and administration site conditions	Malaise	2	2	0
2022	1	24	Nervous system disorders	Syncope	2	2	0
2022	1	24	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	1	24	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	2	2	0
2022	1	24	Eye disorders	Eye pain	2	2	0
2022	1	24	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2022	1	24	Ear and labyrinth disorders	Ear pain	2	2	0
2022	1	24	Gastrointestinal disorders	Abdominal pain upper	2	1	0
2022	1	24	Ear and labyrinth disorders	Hypoacusis	1	1	0
2022	1	24	Eye disorders	Blepharospasm	1	1	0
2022	1	24	Eye disorders	Eyelid oedema	1	1	0
2022	1	24	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	1	24	General disorders and administration site conditions	Cyst	1	1	0
2022	1	24	Investigations	Heart rate increased	1	1	0
2022	1	24	Investigations	Troponin abnormal	1	1	0
2022	1	24	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	1	24	Psychiatric disorders	Sleep disorder	1	1	0
2022	1	24	Vascular disorders	Hypertension	1	1	0
2022	1	24	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	1	24	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	1	24	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2022	1	24	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	24	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	1	24	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	1	24	Gastrointestinal disorders	Gingival pain	1	1	0
2022	1	24	General disorders and administration site conditions	Chills	1	1	0
2022	1	24	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	1	24	Eye disorders	Iritis	1	1	0
2022	1	24	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	24	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	1	24	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	24	Respiratory, thoracic and mediastinal disorders	Sinus congestion	1	1	0
2022	1	24	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2022	1	24	Cardiac disorders	Myopericarditis	1	1	0
2022	1	24	Ear and labyrinth disorders	Ear swelling	1	1	0
2022	1	24	Infections and infestations	Laryngitis	1	1	0
2022	1	24	Investigations	Electrocardiogram abnormal	1	1	0
2022	1	24	Nervous system disorders	Somnolence	1	1	0
2022	1	24	General disorders and administration site conditions	Injection site induration	1	1	0
2022	1	24	Infections and infestations	Lower respiratory tract infection	1	1	0
2022	1	24	Psychiatric disorders	Confusional state	1	1	0
2022	1	24	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	1	24	Vascular disorders	Deep vein thrombosis	1	1	0
2022	1	24	Nervous system disorders	Bell's palsy	1	1	0
2022	1	24	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	1	24	Cardiac disorders	Myocarditis	1	1	0
2022	1	24	Eye disorders	Photophobia	1	1	0
2022	1	24	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	1	24	Infections and infestations	Otitis externa	1	1	0
2022	1	24	Nervous system disorders	Anosmia	1	1	0
2022	1	24	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2022	1	24	Cardiac disorders	Ventricular extrasystoles	1	1	0
2022	1	24	Gastrointestinal disorders	Faeces discoloured	1	1	0
2022	1	24	General disorders and administration site conditions	Swelling	1	1	0
2022	1	24	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2022	1	24	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2022	1	24	Social circumstances	Bedridden	1	1	0
2022	1	24	Cardiac disorders	Tachycardia	1	1	0
2022	1	24	Gastrointestinal disorders	Constipation	1	1	0
2022	1	24	General disorders and administration site conditions	Pain	1	1	0
2022	1	24	Infections and infestations	Nasopharyngitis	1	1	0
2022	1	24	Investigations	Blood pressure increased	1	1	0
2022	1	24	Nervous system disorders	Vocal cord paralysis	1	1	0
2022	1	24	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2022	1	24	Vascular disorders	Flushing	1	1	0
2022	1	24	Eye disorders	Eye swelling	1	1	0
2022	1	25	General disorders and administration site conditions	Chest pain	14	14	0
2022	1	25	General disorders and administration site conditions	Injection site reaction	13	13	0
2022	1	25	Nervous system disorders	Headache	11	11	0
2022	1	25	Respiratory, thoracic and mediastinal disorders	Dyspnoea	10	10	0
2022	1	25	Cardiac disorders	Palpitations	9	9	0
2022	1	25	General disorders and administration site conditions	Fatigue	8	8	0
2022	1	25	General disorders and administration site conditions	Pyrexia	7	7	0
2022	1	25	Nervous system disorders	Lethargy	7	7	0
2022	1	25	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2022	1	25	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2022	1	25	Nervous system disorders	Dizziness	5	5	0
2022	1	25	Gastrointestinal disorders	Nausea	5	5	0
2022	1	25	General disorders and administration site conditions	Injection site pain	5	5	0
2022	1	25	Reproductive system and breast disorders	Menstrual disorder	4	4	0
2022	1	25	Skin and subcutaneous tissue disorders	Rash	4	4	0
2022	1	25	Injury, poisoning and procedural complications	Vaccination error	4	4	0
2022	1	25	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2022	1	25	Vascular disorders	Hypertension	3	3	0
2022	1	25	General disorders and administration site conditions	Peripheral swelling	3	3	0
2022	1	25	Nervous system disorders	Migraine	3	3	0
2022	1	25	Gastrointestinal disorders	Vomiting	3	3	0
2022	1	25	General disorders and administration site conditions	Feeling abnormal	3	3	0
2022	1	25	Cardiac disorders	Myocarditis	2	2	0
2022	1	25	Renal and urinary disorders	Chromaturia	2	2	0
2022	1	25	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2022	1	25	Social circumstances	Bedridden	2	2	0
2022	1	25	Investigations	Troponin increased	2	2	0
2022	1	25	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2022	1	25	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	1	25	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	1	25	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	1	25	General disorders and administration site conditions	Malaise	2	2	0
2022	1	25	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2022	1	25	General disorders and administration site conditions	Chills	2	2	0
2022	1	25	Psychiatric disorders	Anxiety	2	2	0
2022	1	25	Cardiac disorders	Tachycardia	2	2	0
2022	1	25	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	1	25	Gastrointestinal disorders	Dysphagia	2	2	0
2022	1	25	Cardiac disorders	Atrial fibrillation	2	2	0
2022	1	25	Musculoskeletal and connective tissue disorders	Muscle spasms	2	2	0
2022	1	25	Nervous system disorders	Paraesthesia	2	2	0
2022	1	25	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	1	25	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	1	25	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2022	1	25	Cardiac disorders	Pericarditis	2	2	0
2022	1	25	Ear and labyrinth disorders	Tinnitus	2	2	0
2022	1	25	Injury, poisoning and procedural complications	Wrong product administered	2	2	0
2022	1	25	Eye disorders	Vision blurred	1	1	0
2022	1	25	General disorders and administration site conditions	Feeling drunk	1	1	0
2022	1	25	Nervous system disorders	Balance disorder	1	1	0
2022	1	25	Nervous system disorders	Seizure	1	1	0
2022	1	25	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2022	1	25	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2022	1	25	Ear and labyrinth disorders	Deafness	1	1	0
2022	1	25	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	1	25	Gastrointestinal disorders	Tongue discomfort	1	1	0
2022	1	25	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	1	25	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	1	25	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	1	25	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2022	1	25	Vascular disorders	Haemorrhage	1	1	0
2022	1	25	Respiratory, thoracic and mediastinal disorders	Orthopnoea	1	1	0
2022	1	25	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	1	25	General disorders and administration site conditions	Localised oedema	1	1	0
2022	1	25	Infections and infestations	Herpes zoster	1	1	0
2022	1	25	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	25	Endocrine disorders	Thyroid cyst	1	1	0
2022	1	25	Infections and infestations	COVID-19	1	1	0
2022	1	25	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	1	25	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	1	25	Investigations	C-reactive protein increased	1	1	0
2022	1	25	Nervous system disorders	Dysgeusia	1	1	0
2022	1	25	Nervous system disorders	Syncope	1	1	0
2022	1	25	Psychiatric disorders	Insomnia	1	1	0
2022	1	25	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	1	25	Eye disorders	Diplopia	1	1	0
2022	1	25	Gastrointestinal disorders	Rectal haemorrhage	1	1	0
2022	1	25	General disorders and administration site conditions	Pain	1	1	0
2022	1	25	Investigations	Blood creatine phosphokinase increased	1	1	0
2022	1	25	Nervous system disorders	Taste disorder	1	1	0
2022	1	25	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	1	25	Vascular disorders	Aortic aneurysm	1	1	0
2022	1	25	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	1	25	Gastrointestinal disorders	Retching	1	1	0
2022	1	25	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2022	1	25	Nervous system disorders	Tremor	1	1	0
2022	1	25	Vascular disorders	Aortic stenosis	1	1	0
2022	1	25	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2022	1	25	Psychiatric disorders	Hallucination	1	1	0
2022	1	25	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	1	25	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2022	1	25	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	25	Nervous system disorders	Bell's palsy	1	1	0
2022	1	25	Renal and urinary disorders	Haemorrhage urinary tract	1	1	0
2022	1	25	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	1	25	Investigations	Electrocardiogram abnormal	1	1	0
2022	1	25	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	1	25	Blood and lymphatic system disorders	Haemorrhagic diathesis	1	1	0
2022	1	25	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	1	25	Nervous system disorders	Head discomfort	1	1	0
2022	1	25	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	26	General disorders and administration site conditions	Pyrexia	5	5	0
2022	1	26	General disorders and administration site conditions	Fatigue	4	4	0
2022	1	26	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	1	26	Nervous system disorders	Dizziness	3	3	0
2022	1	26	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	1	26	General disorders and administration site conditions	Chills	3	3	0
2022	1	26	Nervous system disorders	Headache	3	3	0
2022	1	26	General disorders and administration site conditions	Chest pain	3	3	0
2022	1	26	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	1	26	Gastrointestinal disorders	Nausea	2	2	0
2022	1	26	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	1	26	Cardiac disorders	Palpitations	1	1	0
2022	1	26	General disorders and administration site conditions	Injection site pain	1	1	0
2022	1	26	Psychiatric disorders	Confusional state	1	1	0
2022	1	26	Gastrointestinal disorders	Dyspepsia	1	1	0
2022	1	26	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	26	Investigations	Troponin	1	1	0
2022	1	26	Cardiac disorders	Arrhythmia	1	1	0
2022	1	26	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	1	26	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	1	26	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	1	26	General disorders and administration site conditions	Pain	1	1	0
2022	1	26	Nervous system disorders	Chronic inflammatory demyelinating polyradiculoneuropathy	1	1	0
2022	1	26	Respiratory, thoracic and mediastinal disorders	Pharyngeal ulceration	1	1	0
2022	1	26	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	26	Investigations	Heart rate decreased	1	1	0
2022	1	26	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	26	Cardiac disorders	Myocarditis	1	1	0
2022	1	26	Infections and infestations	Pharyngitis	1	1	0
2022	1	26	Nervous system disorders	Paraesthesia	1	1	0
2022	1	26	Blood and lymphatic system disorders	Lymphadenitis	1	1	0
2022	1	26	Reproductive system and breast disorders	Breast milk discolouration	1	1	0
2022	1	26	Vascular disorders	Pallor	1	1	0
2022	1	26	Cardiac disorders	Extrasystoles	1	1	0
2022	1	27	General disorders and administration site conditions	Fatigue	6	5	0
2022	1	27	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2022	1	27	Nervous system disorders	Dizziness	5	4	0
2022	1	27	General disorders and administration site conditions	Pyrexia	5	5	0
2022	1	27	Blood and lymphatic system disorders	Lymphadenopathy	5	5	0
2022	1	27	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2022	1	27	Cardiac disorders	Tachycardia	4	4	0
2022	1	27	General disorders and administration site conditions	Chest pain	4	4	0
2022	1	27	Infections and infestations	Herpes zoster	4	4	0
2022	1	27	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	1	27	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	1	27	General disorders and administration site conditions	Chills	3	3	0
2022	1	27	Nervous system disorders	Syncope	3	3	0
2022	1	27	Nervous system disorders	Migraine	2	1	0
2022	1	27	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	1	27	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2022	1	27	Nervous system disorders	Headache	2	2	0
2022	1	27	General disorders and administration site conditions	Pain	2	1	0
2022	1	27	Cardiac disorders	Palpitations	2	2	0
2022	1	27	Gastrointestinal disorders	Nausea	2	2	0
2022	1	27	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	1	27	General disorders and administration site conditions	Injection site pain	1	1	0
2022	1	27	Nervous system disorders	Lethargy	1	1	0
2022	1	27	Psychiatric disorders	Confusional state	1	1	0
2022	1	27	Investigations	Troponin increased	1	1	0
2022	1	27	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2022	1	27	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	1	27	General disorders and administration site conditions	Inflammation	1	1	0
2022	1	27	Nervous system disorders	Hypoaesthesia	1	1	0
2022	1	27	General disorders and administration site conditions	Injection site rash	1	1	0
2022	1	27	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2022	1	27	General disorders and administration site conditions	Feeling cold	1	1	0
2022	1	27	Nervous system disorders	Paraesthesia	1	1	0
2022	1	27	Cardiac disorders	Acute myocardial infarction	1	1	0
2022	1	27	Cardiac disorders	Pericarditis	1	1	0
2022	1	27	Eye disorders	Eye pain	1	1	0
2022	1	27	Eye disorders	Eye swelling	1	1	0
2022	1	27	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	1	27	Nervous system disorders	Disturbance in attention	1	0	0
2022	1	27	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	27	General disorders and administration site conditions	Illness	1	1	0
2022	1	27	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	1	27	Eye disorders	Vision blurred	1	1	0
2022	1	27	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	1	27	Gastrointestinal disorders	Hypoaesthesia oral	1	1	0
2022	1	27	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	1	27	Cardiac disorders	Bundle branch block right	1	1	0
2022	1	27	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	27	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	1	27	Renal and urinary disorders	Polyuria	1	1	0
2022	1	27	Vascular disorders	Hypertension	1	1	0
2022	1	27	Vascular disorders	Pallor	1	1	0
2022	1	27	General disorders and administration site conditions	Malaise	1	1	0
2022	1	28	General disorders and administration site conditions	Pyrexia	12	11	0
2022	1	28	Nervous system disorders	Headache	11	11	0
2022	1	28	General disorders and administration site conditions	Fatigue	11	11	0
2022	1	28	Musculoskeletal and connective tissue disorders	Myalgia	10	10	0
2022	1	28	Blood and lymphatic system disorders	Lymphadenopathy	9	8	0
2022	1	28	General disorders and administration site conditions	Chest discomfort	8	7	0
2022	1	28	General disorders and administration site conditions	Chest pain	8	8	0
2022	1	28	General disorders and administration site conditions	Injection site reaction	7	6	0
2022	1	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	5	0
2022	1	28	Gastrointestinal disorders	Nausea	5	4	0
2022	1	28	General disorders and administration site conditions	Chills	5	3	0
2022	1	28	Musculoskeletal and connective tissue disorders	Arthralgia	5	3	0
2022	1	28	Nervous system disorders	Lethargy	5	4	0
2022	1	28	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2022	1	28	General disorders and administration site conditions	Injection site pain	4	4	0
2022	1	28	Nervous system disorders	Paraesthesia	4	4	0
2022	1	28	Cardiac disorders	Palpitations	3	3	0
2022	1	28	General disorders and administration site conditions	Influenza like illness	3	3	0
2022	1	28	Immune system disorders	Hypersensitivity	3	3	0
2022	1	28	Gastrointestinal disorders	Vomiting	3	3	0
2022	1	28	Nervous system disorders	Migraine	3	2	0
2022	1	28	General disorders and administration site conditions	Malaise	2	2	0
2022	1	28	Reproductive system and breast disorders	Breast mass	2	1	0
2022	1	28	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2022	1	28	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2022	1	28	Ear and labyrinth disorders	Vertigo	2	2	0
2022	1	28	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	1	28	Nervous system disorders	Dizziness	2	2	0
2022	1	28	Reproductive system and breast disorders	Menstrual disorder	2	1	0
2022	1	28	Renal and urinary disorders	Renal pain	2	2	0
2022	1	28	General disorders and administration site conditions	Injection site swelling	2	2	0
2022	1	28	Reproductive system and breast disorders	Breast pain	2	2	0
2022	1	28	Ear and labyrinth disorders	Ear pain	1	1	0
2022	1	28	Ear and labyrinth disorders	Hypoacusis	1	0	0
2022	1	28	Eye disorders	Eye haemorrhage	1	1	0
2022	1	28	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	28	Investigations	Heart rate increased	1	1	0
2022	1	28	Nervous system disorders	Presyncope	1	1	0
2022	1	28	Vascular disorders	Hypertension	1	1	0
2022	1	28	Cardiac disorders	Cardiac flutter	1	1	0
2022	1	28	General disorders and administration site conditions	Axillary pain	1	1	0
2022	1	28	Injury, poisoning and procedural complications	Incorrect dosage administered	1	1	0
2022	1	28	Blood and lymphatic system disorders	Lymphadenitis	1	1	0
2022	1	28	Gastrointestinal disorders	Gastrooesophageal reflux disease	1	1	0
2022	1	28	Gastrointestinal disorders	Salivary gland pain	1	1	0
2022	1	28	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	1	28	General disorders and administration site conditions	Feeling cold	1	1	0
2022	1	28	Investigations	C-reactive protein increased	1	1	0
2022	1	28	Nervous system disorders	Syncope	1	1	0
2022	1	28	Psychiatric disorders	Insomnia	1	1	0
2022	1	28	Cardiac disorders	Pericarditis	1	1	0
2022	1	28	Gastrointestinal disorders	Haematemesis	1	1	0
2022	1	28	Investigations	Heart rate decreased	1	1	0
2022	1	28	Metabolism and nutrition disorders	Iron deficiency	1	1	0
2022	1	28	Nervous system disorders	Carotid artery dissection	1	1	0
2022	1	28	Reproductive system and breast disorders	Polymenorrhoea	1	1	0
2022	1	28	General disorders and administration site conditions	Pain	1	1	0
2022	1	28	Infections and infestations	Urinary tract infection	1	1	0
2022	1	28	Nervous system disorders	Chronic inflammatory demyelinating polyradiculoneuropathy	1	1	0
2022	1	28	Reproductive system and breast disorders	Menstruation irregular	1	0	0
2022	1	28	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	1	28	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	28	Infections and infestations	Mastitis	1	1	0
2022	1	28	Reproductive system and breast disorders	Breast disorder	1	1	0
2022	1	28	Reproductive system and breast disorders	Breast swelling	1	1	0
2022	1	28	Ear and labyrinth disorders	Ear discomfort	1	0	0
2022	1	28	Infections and infestations	Dysentery	1	1	0
2022	1	28	Reproductive system and breast disorders	Heavy menstrual bleeding	1	0	0
2022	1	28	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	1	28	Vascular disorders	Deep vein thrombosis	1	1	0
2022	1	28	General disorders and administration site conditions	Injection site rash	1	1	0
2022	1	28	Gastrointestinal disorders	Mouth ulceration	1	1	0
2022	1	28	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	1	28	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	1	29	Nervous system disorders	Headache	4	4	0
2022	1	29	General disorders and administration site conditions	Pyrexia	3	3	0
2022	1	29	Nervous system disorders	Paraesthesia	3	3	0
2022	1	29	Nervous system disorders	Dizziness	2	2	0
2022	1	29	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	1	29	Gastrointestinal disorders	Nausea	2	2	0
2022	1	29	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	1	29	General disorders and administration site conditions	Chest pain	2	2	0
2022	1	29	General disorders and administration site conditions	Swelling face	1	1	0
2022	1	29	Investigations	Liver function test	1	1	0
2022	1	29	General disorders and administration site conditions	Gait disturbance	1	0	0
2022	1	29	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	1	29	Eye disorders	Vision blurred	1	1	0
2022	1	29	Gastrointestinal disorders	Lip swelling	1	1	0
2022	1	29	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	1	29	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	1	29	Cardiac disorders	Atrial fibrillation	1	1	0
2022	1	29	General disorders and administration site conditions	Chills	1	1	0
2022	1	29	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	29	General disorders and administration site conditions	Malaise	1	0	0
2022	1	29	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	29	Musculoskeletal and connective tissue disorders	Muscular weakness	1	0	0
2022	1	29	Nervous system disorders	Loss of consciousness	1	1	0
2022	1	29	Cardiac disorders	Palpitations	1	1	0
2022	1	29	Gastrointestinal disorders	Pancreatitis	1	1	0
2022	1	29	General disorders and administration site conditions	Injection site pain	1	1	0
2022	1	29	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	1	29	Nervous system disorders	Cerebellar stroke	1	1	0
2022	1	29	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2022	1	29	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	1	29	Cardiac disorders	Tachycardia	1	1	0
2022	1	29	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2022	1	29	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	1	29	Social circumstances	Bedridden	1	0	0
2022	1	29	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	1	29	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	1	29	Investigations	White blood cell count decreased	1	1	0
2022	1	29	General disorders and administration site conditions	Fatigue	1	1	0
2022	1	29	Nervous system disorders	Syncope	1	1	0
2022	1	29	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2022	1	29	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2022	1	29	Ear and labyrinth disorders	Vertigo	1	1	0
2022	1	30	General disorders and administration site conditions	Pyrexia	3	3	0
2022	1	30	Nervous system disorders	Headache	3	2	0
2022	1	30	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2022	1	30	Musculoskeletal and connective tissue disorders	Myalgia	3	2	0
2022	1	30	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	1	30	General disorders and administration site conditions	Fatigue	2	2	0
2022	1	30	Nervous system disorders	Lethargy	2	2	0
2022	1	30	Reproductive system and breast disorders	Breast swelling	1	1	0
2022	1	30	General disorders and administration site conditions	Pain	1	1	0
2022	1	30	Cardiac disorders	Pericarditis	1	1	0
2022	1	30	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	1	30	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	1	30	Gastrointestinal disorders	Nausea	1	1	0
2022	1	30	Gastrointestinal disorders	Vomiting	1	1	0
2022	1	30	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	1	30	Nervous system disorders	Somnolence	1	1	0
2022	1	30	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	1	30	General disorders and administration site conditions	Chest pain	1	1	0
2022	1	30	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	1	30	Respiratory, thoracic and mediastinal disorders	Sinus congestion	1	1	0
2022	1	30	Eye disorders	Pupil fixed	1	1	0
2022	1	30	Nervous system disorders	Dizziness	1	1	0
2022	1	30	General disorders and administration site conditions	Malaise	1	1	0
2022	1	30	Eye disorders	Vision blurred	1	1	0
2022	1	30	General disorders and administration site conditions	Injection site swelling	1	0	0
2022	1	30	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	1	30	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	1	30	General disorders and administration site conditions	Chills	1	1	0
2022	1	30	Musculoskeletal and connective tissue disorders	Arthritis	1	1	0
2022	1	31	Nervous system disorders	Headache	11	11	0
2022	1	31	General disorders and administration site conditions	Fatigue	11	11	0
2022	1	31	General disorders and administration site conditions	Injection site reaction	11	11	0
2022	1	31	Musculoskeletal and connective tissue disorders	Myalgia	10	10	0
2022	1	31	General disorders and administration site conditions	Pyrexia	10	10	0
2022	1	31	Musculoskeletal and connective tissue disorders	Arthralgia	8	8	0
2022	1	31	General disorders and administration site conditions	Chest pain	8	8	0
2022	1	31	Gastrointestinal disorders	Nausea	8	8	0
2022	1	31	General disorders and administration site conditions	Chills	7	7	0
2022	1	31	Gastrointestinal disorders	Vomiting	6	6	0
2022	1	31	Blood and lymphatic system disorders	Lymphadenopathy	6	6	0
2022	1	31	Musculoskeletal and connective tissue disorders	Pain in extremity	6	6	0
2022	1	31	Nervous system disorders	Paraesthesia	5	5	0
2022	1	31	Nervous system disorders	Lethargy	4	4	0
2022	1	31	General disorders and administration site conditions	Injection site pain	3	3	0
2022	1	31	Nervous system disorders	Hypoaesthesia	3	3	0
2022	1	31	Gastrointestinal disorders	Abdominal pain	3	3	0
2022	1	31	Eye disorders	Vision blurred	2	2	0
2022	1	31	Nervous system disorders	Dizziness	2	2	0
2022	1	31	Cardiac disorders	Tachycardia	2	2	0
2022	1	31	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2022	1	31	Cardiac disorders	Palpitations	2	2	0
2022	1	31	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	1	31	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2022	1	31	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	1	31	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2022	1	31	Cardiac disorders	Pericarditis	2	2	0
2022	1	31	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	1	31	Cardiac disorders	Myocardial ischaemia	1	1	1
2022	1	31	Investigations	Red blood cell sedimentation rate increased	1	1	0
2022	1	31	Nervous system disorders	Restless legs syndrome	1	1	0
2022	1	31	Eye disorders	Visual impairment	1	1	0
2022	1	31	Gastrointestinal disorders	Tongue coated	1	1	0
2022	1	31	Psychiatric disorders	Disorientation	1	1	0
2022	1	31	Renal and urinary disorders	Urinary incontinence	1	1	0
2022	1	31	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	1	31	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	1	31	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	1	31	Skin and subcutaneous tissue disorders	Skin discolouration	1	1	0
2022	1	31	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	1	31	General disorders and administration site conditions	Malaise	1	1	0
2022	1	31	Musculoskeletal and connective tissue disorders	Axillary mass	1	1	0
2022	1	31	Renal and urinary disorders	Renal colic	1	1	0
2022	1	31	Gastrointestinal disorders	Abdominal distension	1	1	0
2022	1	31	Musculoskeletal and connective tissue disorders	Arthritis reactive	1	1	0
2022	1	31	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	1	31	Nervous system disorders	Ageusia	1	1	0
2022	1	31	Cardiac disorders	Hypertensive heart disease	1	1	1
2022	1	31	Nervous system disorders	Autonomic nervous system imbalance	1	0	0
2022	1	31	Nervous system disorders	Hemiparesis	1	1	0
2022	1	31	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	1	31	Vascular disorders	Deep vein thrombosis	1	1	0
2022	1	31	Gastrointestinal disorders	Palatal swelling	1	1	0
2022	1	31	Injury, poisoning and procedural complications	Tongue injury	1	1	0
2022	1	31	Investigations	Electrocardiogram	1	1	0
2022	1	31	Vascular disorders	Hot flush	1	1	0
2022	1	31	General disorders and administration site conditions	Asthenia	1	1	0
2022	1	31	General disorders and administration site conditions	Pain	1	1	0
2022	1	31	Infections and infestations	Urinary tract infection	1	1	0
2022	1	31	Investigations	Echocardiogram normal	1	1	0
2022	1	31	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	1	31	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2022	1	31	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	1	31	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	1	31	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	1	31	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	1	31	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	1	31	Psychiatric disorders	Conversion disorder	1	1	0
2022	1	31	Cardiac disorders	Myocarditis	1	1	0
2022	1	31	Gastrointestinal disorders	Gingival bleeding	1	1	0
2022	1	31	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	1	31	General disorders and administration site conditions	Feeling cold	1	1	0
2022	1	31	Investigations	C-reactive protein increased	1	1	0
2022	1	31	Nervous system disorders	Anosmia	1	1	0
2022	1	31	Nervous system disorders	Syncope	1	1	0
2022	1	31	Psychiatric disorders	Insomnia	1	1	0
2022	1	31	Respiratory, thoracic and mediastinal disorders	Nasal discomfort	1	1	0
2022	1	31	Gastrointestinal disorders	Tongue discolouration	1	1	0
2022	1	31	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	1	31	Renal and urinary disorders	Haematuria	1	1	0
2022	2	1	Nervous system disorders	Headache	12	12	0
2022	2	1	General disorders and administration site conditions	Injection site reaction	9	9	0
2022	2	1	General disorders and administration site conditions	Fatigue	8	8	0
2022	2	1	Musculoskeletal and connective tissue disorders	Myalgia	8	8	0
2022	2	1	Nervous system disorders	Dizziness	7	7	0
2022	2	1	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2022	2	1	Gastrointestinal disorders	Nausea	6	6	0
2022	2	1	General disorders and administration site conditions	Chest pain	6	6	0
2022	2	1	General disorders and administration site conditions	Pyrexia	6	6	0
2022	2	1	Gastrointestinal disorders	Vomiting	4	4	0
2022	2	1	General disorders and administration site conditions	Chest discomfort	4	4	0
2022	2	1	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2022	2	1	Gastrointestinal disorders	Diarrhoea	3	3	0
2022	2	1	Nervous system disorders	Lethargy	3	3	0
2022	2	1	Gastrointestinal disorders	Abdominal pain	3	3	0
2022	2	1	General disorders and administration site conditions	Asthenia	3	3	0
2022	2	1	General disorders and administration site conditions	Concomitant disease aggravated	3	3	0
2022	2	1	Metabolism and nutrition disorders	Decreased appetite	3	3	0
2022	2	1	General disorders and administration site conditions	Chills	3	3	0
2022	2	1	Nervous system disorders	Syncope	3	3	0
2022	2	1	Ear and labyrinth disorders	Vertigo	2	2	0
2022	2	1	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	2	1	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	2	1	General disorders and administration site conditions	Feeling abnormal	2	2	0
2022	2	1	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2022	2	1	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	1	Nervous system disorders	Paraesthesia	2	2	0
2022	2	1	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	2	1	Cardiac disorders	Palpitations	1	1	0
2022	2	1	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	1	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	2	1	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	2	1	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	1	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2022	2	1	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	2	1	Nervous system disorders	Speech disorder	1	1	0
2022	2	1	Cardiac disorders	Pericarditis	1	1	0
2022	2	1	Investigations	Heart rate decreased	1	1	0
2022	2	1	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2022	2	1	General disorders and administration site conditions	Gait disturbance	1	1	0
2022	2	1	Immune system disorders	Hypersensitivity	1	1	0
2022	2	1	Nervous system disorders	Dysgeusia	1	1	0
2022	2	1	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2022	2	1	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	2	1	Cardiac disorders	Tachycardia	1	1	0
2022	2	1	General disorders and administration site conditions	Pain	1	1	0
2022	2	1	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	1	Eye disorders	Dark circles under eyes	1	1	0
2022	2	1	Gastrointestinal disorders	Retching	1	1	0
2022	2	1	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	2	1	Vascular disorders	Internal haemorrhage	1	1	0
2022	2	1	Ear and labyrinth disorders	Ear pain	1	1	0
2022	2	1	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	2	1	General disorders and administration site conditions	Swelling face	1	1	0
2022	2	1	General disorders and administration site conditions	Axillary pain	1	1	0
2022	2	1	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	2	1	General disorders and administration site conditions	Malaise	1	1	0
2022	2	1	Injury, poisoning and procedural complications	Underdose	1	1	0
2022	2	1	Skin and subcutaneous tissue disorders	Erythema nodosum	1	1	0
2022	2	1	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	2	1	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	1	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	2	1	Psychiatric disorders	Anxiety	1	1	0
2022	2	1	Vascular disorders	Vascular pain	1	1	0
2022	2	1	Eye disorders	Vision blurred	1	1	0
2022	2	1	Eye disorders	Visual impairment	1	1	0
2022	2	1	Injury, poisoning and procedural complications	Incorrect dosage administered	1	1	0
2022	2	1	Nervous system disorders	Balance disorder	1	1	0
2022	2	1	Respiratory, thoracic and mediastinal disorders	Tonsillar hypertrophy	1	1	0
2022	2	1	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	2	General disorders and administration site conditions	Fatigue	8	8	0
2022	2	2	Nervous system disorders	Dizziness	7	7	0
2022	2	2	General disorders and administration site conditions	Pyrexia	6	5	0
2022	2	2	Nervous system disorders	Headache	6	6	0
2022	2	2	Musculoskeletal and connective tissue disorders	Myalgia	6	5	0
2022	2	2	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	4	0
2022	2	2	Gastrointestinal disorders	Nausea	4	4	0
2022	2	2	General disorders and administration site conditions	Chest pain	4	4	0
2022	2	2	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	2	2	General disorders and administration site conditions	Malaise	3	3	0
2022	2	2	Metabolism and nutrition disorders	Decreased appetite	3	3	0
2022	2	2	Cardiac disorders	Palpitations	3	2	0
2022	2	2	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	2	2	Skin and subcutaneous tissue disorders	Rash	3	2	0
2022	2	2	Gastrointestinal disorders	Vomiting	2	2	0
2022	2	2	Nervous system disorders	Paraesthesia	2	2	0
2022	2	2	Gastrointestinal disorders	Diarrhoea	2	1	0
2022	2	2	Infections and infestations	Cellulitis	2	2	0
2022	2	2	Nervous system disorders	Lethargy	2	2	0
2022	2	2	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	2	2	Injury, poisoning and procedural complications	Contusion	2	2	0
2022	2	2	Cardiac disorders	Pericarditis	2	2	0
2022	2	2	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	2	2	Injury, poisoning and procedural complications	Vaccination error	2	1	0
2022	2	2	Investigations	Electrocardiogram abnormal	2	2	0
2022	2	2	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	2	2	Immune system disorders	Anaphylactic reaction	1	1	0
2022	2	2	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	0	0
2022	2	2	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2022	2	2	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2022	2	2	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	2	Injury, poisoning and procedural complications	Underdose	1	1	0
2022	2	2	Cardiac disorders	Angina pectoris	1	1	0
2022	2	2	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	2	2	Injury, poisoning and procedural complications	Fall	1	1	0
2022	2	2	Metabolism and nutrition disorders	Food aversion	1	1	0
2022	2	2	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	2	2	Vascular disorders	Hypertension	1	1	0
2022	2	2	Ear and labyrinth disorders	Ear congestion	1	1	0
2022	2	2	Investigations	Respiratory rate increased	1	1	0
2022	2	2	Investigations	Troponin	1	1	0
2022	2	2	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	2	2	Gastrointestinal disorders	Abdominal pain upper	1	0	0
2022	2	2	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	2	Infections and infestations	Gingivitis	1	1	0
2022	2	2	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	2	2	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	2	2	Injury, poisoning and procedural complications	Fracture	1	1	0
2022	2	2	General disorders and administration site conditions	Therapeutic response unexpected	1	1	0
2022	2	2	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	2	Gastrointestinal disorders	Dry mouth	1	0	0
2022	2	2	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	2	2	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	2	2	Cardiac disorders	Tachycardia	1	1	0
2022	2	2	General disorders and administration site conditions	Pain	1	1	0
2022	2	2	General disorders and administration site conditions	Vaccination site reaction	1	1	0
2022	2	2	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	2	2	Skin and subcutaneous tissue disorders	Sensitive skin	1	1	0
2022	2	2	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2022	2	2	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	2	2	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	2	2	Nervous system disorders	Migraine	1	1	0
2022	2	2	Investigations	Echocardiogram	1	1	0
2022	2	3	General disorders and administration site conditions	Chest pain	9	9	0
2022	2	3	General disorders and administration site conditions	Pyrexia	9	8	0
2022	2	3	Nervous system disorders	Headache	9	8	0
2022	2	3	Musculoskeletal and connective tissue disorders	Arthralgia	8	8	0
2022	2	3	General disorders and administration site conditions	Fatigue	8	7	0
2022	2	3	Cardiac disorders	Palpitations	6	6	0
2022	2	3	Gastrointestinal disorders	Vomiting	5	4	0
2022	2	3	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2022	2	3	Gastrointestinal disorders	Nausea	5	5	0
2022	2	3	General disorders and administration site conditions	Injection site pain	5	5	0
2022	2	3	Nervous system disorders	Lethargy	5	5	0
2022	2	3	General disorders and administration site conditions	Malaise	5	4	0
2022	2	3	Blood and lymphatic system disorders	Lymphadenopathy	5	4	0
2022	2	3	Musculoskeletal and connective tissue disorders	Pain in extremity	4	3	0
2022	2	3	General disorders and administration site conditions	Injection site erythema	3	3	0
2022	2	3	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	2	3	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	2	3	General disorders and administration site conditions	Chills	2	2	0
2022	2	3	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	2	3	Cardiac disorders	Tachycardia	2	2	0
2022	2	3	General disorders and administration site conditions	Peripheral swelling	2	2	0
2022	2	3	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2022	2	3	Nervous system disorders	Paraesthesia	2	2	0
2022	2	3	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	2	3	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2022	2	3	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2022	2	3	Nervous system disorders	Migraine	2	1	0
2022	2	3	Cardiac disorders	Pericarditis	2	2	0
2022	2	3	General disorders and administration site conditions	Injection site swelling	2	2	0
2022	2	3	Eye disorders	Vision blurred	1	1	0
2022	2	3	Gastrointestinal disorders	Toothache	1	0	0
2022	2	3	Hepatobiliary disorders	Autoimmune hepatitis	1	1	0
2022	2	3	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	2	3	Nervous system disorders	Disturbance in attention	1	1	0
2022	2	3	Infections and infestations	Injection site cellulitis	1	1	0
2022	2	3	Investigations	Electrocardiogram normal	1	1	0
2022	2	3	Nervous system disorders	Neuralgia	1	1	0
2022	2	3	Psychiatric disorders	Anxiety	1	1	0
2022	2	3	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	2	3	General disorders and administration site conditions	Swelling face	1	1	0
2022	2	3	Investigations	Electrocardiogram T wave inversion	1	1	0
2022	2	3	Nervous system disorders	Dizziness	1	1	0
2022	2	3	Nervous system disorders	Facial paralysis	1	1	0
2022	2	3	Vascular disorders	Pallor	1	1	0
2022	2	3	Cardiac disorders	Extrasystoles	1	1	0
2022	2	3	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	2	3	Infections and infestations	Herpes zoster	1	1	0
2022	2	3	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2022	2	3	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	2	3	Investigations	SARS-CoV-2 test positive	1	1	0
2022	2	3	Investigations	Troponin	1	1	0
2022	2	3	Investigations	Troponin increased	1	1	0
2022	2	3	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	2	3	Skin and subcutaneous tissue disorders	Piloerection	1	1	0
2022	2	3	Skin and subcutaneous tissue disorders	Rash morbilliform	1	1	0
2022	2	3	Cardiac disorders	Myopericarditis	1	1	0
2022	2	3	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	2	3	Respiratory, thoracic and mediastinal disorders	Pulmonary congestion	1	1	0
2022	2	3	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	2	3	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2022	2	3	Skin and subcutaneous tissue disorders	Petechiae	1	1	0
2022	2	3	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	2	3	Vascular disorders	Hot flush	1	1	0
2022	2	3	Cardiac disorders	Arrhythmia	1	1	0
2022	2	3	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	2	3	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	2	3	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	3	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2022	2	3	Cardiac disorders	Pericardial effusion	1	1	0
2022	2	3	Infections and infestations	Gastrointestinal infection	1	1	0
2022	2	3	Investigations	Blood glucose decreased	1	1	0
2022	2	3	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2022	2	3	Cardiac disorders	Myocarditis	1	1	0
2022	2	3	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	2	3	Immune system disorders	Hypersensitivity	1	1	0
2022	2	3	Psychiatric disorders	Insomnia	1	1	0
2022	2	3	Psychiatric disorders	Irritability	1	1	0
2022	2	3	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	2	3	Eye disorders	Diplopia	1	1	0
2022	2	3	Gastrointestinal disorders	Constipation	1	1	0
2022	2	3	General disorders and administration site conditions	Asthenia	1	1	0
2022	2	3	Investigations	Weight decreased	1	1	0
2022	2	3	Reproductive system and breast disorders	Amenorrhoea	1	1	0
2022	2	3	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	3	Eye disorders	Eye pain	1	1	0
2022	2	3	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	2	3	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	2	3	Injury, poisoning and procedural complications	Maternal exposure during breast feeding	1	0	0
2022	2	3	Investigations	Breath sounds abnormal	1	1	0
2022	2	3	Nervous system disorders	Tremor	1	1	0
2022	2	4	General disorders and administration site conditions	Fatigue	10	10	0
2022	2	4	Nervous system disorders	Headache	10	10	0
2022	2	4	General disorders and administration site conditions	Pyrexia	6	6	0
2022	2	4	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	5	0
2022	2	4	Blood and lymphatic system disorders	Lymphadenopathy	5	5	0
2022	2	4	Nervous system disorders	Lethargy	4	4	0
2022	2	4	Gastrointestinal disorders	Vomiting	4	4	0
2022	2	4	Injury, poisoning and procedural complications	Vaccination error	4	4	0
2022	2	4	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2022	2	4	General disorders and administration site conditions	Chest pain	4	4	0
2022	2	4	Gastrointestinal disorders	Nausea	3	3	0
2022	2	4	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	2	4	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	2	4	Nervous system disorders	Dizziness	3	3	0
2022	2	4	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2022	2	4	General disorders and administration site conditions	Injection site pain	2	2	0
2022	2	4	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	2	4	General disorders and administration site conditions	Axillary pain	2	2	0
2022	2	4	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	2	4	Infections and infestations	Herpes zoster	2	2	0
2022	2	4	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2022	2	4	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	2	4	General disorders and administration site conditions	Malaise	2	2	0
2022	2	4	General disorders and administration site conditions	Asthenia	2	1	0
2022	2	4	Cardiac disorders	Palpitations	2	2	0
2022	2	4	General disorders and administration site conditions	Pain	2	2	0
2022	2	4	Nervous system disorders	Syncope	2	2	0
2022	2	4	Psychiatric disorders	Anxiety	2	1	0
2022	2	4	Gastrointestinal disorders	Oral mucosal blistering	1	1	0
2022	2	4	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	4	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2022	2	4	Vascular disorders	Cyanosis	1	1	0
2022	2	4	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	2	4	Cardiac disorders	Myopericarditis	1	1	0
2022	2	4	Infections and infestations	Pneumonia	1	1	0
2022	2	4	Cardiac disorders	Cyanosis	1	1	0
2022	2	4	Investigations	Troponin	1	1	0
2022	2	4	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	2	4	Investigations	Chest X-ray	1	1	0
2022	2	4	Investigations	Troponin I	1	1	0
2022	2	4	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	2	4	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	2	4	Cardiac disorders	Pericarditis	1	1	0
2022	2	4	General disorders and administration site conditions	Feeling hot	1	1	0
2022	2	4	General disorders and administration site conditions	Swelling	1	1	0
2022	2	4	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	2	4	General disorders and administration site conditions	Injection site mass	1	1	0
2022	2	4	Nervous system disorders	Paraesthesia	1	1	0
2022	2	4	Respiratory, thoracic and mediastinal disorders	Hyperventilation	1	1	0
2022	2	4	Gastrointestinal disorders	Mouth haemorrhage	1	1	0
2022	2	4	Investigations	Weight decreased	1	1	0
2022	2	4	Musculoskeletal and connective tissue disorders	Joint range of motion decreased	1	1	0
2022	2	4	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	4	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	2	4	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	2	4	Eye disorders	Vision blurred	1	1	0
2022	2	4	General disorders and administration site conditions	Illness	1	0	0
2022	2	4	Injury, poisoning and procedural complications	Product administration error	1	1	0
2022	2	4	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	2	4	Nervous system disorders	Amnesia	1	1	0
2022	2	4	Nervous system disorders	Seizure	1	1	0
2022	2	4	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	4	Cardiac disorders	Pericardial rub	1	1	0
2022	2	4	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	4	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	2	4	General disorders and administration site conditions	Chills	1	1	0
2022	2	4	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	2	4	Nervous system disorders	Neuralgia	1	1	0
2022	2	4	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2022	2	4	Vascular disorders	Pallor	1	1	0
2022	2	5	General disorders and administration site conditions	Pyrexia	4	4	0
2022	2	5	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	2	5	General disorders and administration site conditions	Fatigue	3	3	0
2022	2	5	General disorders and administration site conditions	Chest pain	3	3	0
2022	2	5	Nervous system disorders	Headache	2	2	0
2022	2	5	General disorders and administration site conditions	Asthenia	2	2	0
2022	2	5	General disorders and administration site conditions	Injection site pain	2	2	0
2022	2	5	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	2	5	Gastrointestinal disorders	Nausea	2	2	0
2022	2	5	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2022	2	5	Gastrointestinal disorders	Diarrhoea	2	1	0
2022	2	5	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	2	5	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	5	Cardiac disorders	Myocarditis	1	1	0
2022	2	5	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	2	5	Investigations	Body temperature fluctuation	1	1	0
2022	2	5	Cardiac disorders	Pericarditis	1	1	0
2022	2	5	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	2	5	Nervous system disorders	Migraine	1	1	0
2022	2	5	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	2	5	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	2	5	Nervous system disorders	Burning sensation	1	1	0
2022	2	5	Nervous system disorders	Electric shock sensation	1	1	0
2022	2	5	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	5	Cardiac disorders	Palpitations	1	1	0
2022	2	5	Infections and infestations	Gastroenteritis	1	0	0
2022	2	5	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	2	5	Nervous system disorders	Lethargy	1	1	0
2022	2	5	Reproductive system and breast disorders	Breast pain	1	1	0
2022	2	5	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	2	5	Investigations	Electrocardiogram abnormal	1	1	0
2022	2	5	Nervous system disorders	Allodynia	1	1	0
2022	2	5	Nervous system disorders	Hypoaesthesia	1	0	0
2022	2	5	Nervous system disorders	Somnolence	1	1	0
2022	2	5	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	2	5	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	2	5	Nervous system disorders	Syncope	1	0	0
2022	2	5	Respiratory, thoracic and mediastinal disorders	Hyperventilation	1	0	0
2022	2	5	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	2	5	Cardiac disorders	Cardiac flutter	1	1	0
2022	2	5	Cardiac disorders	Extrasystoles	1	1	0
2022	2	5	Gastrointestinal disorders	Vomiting	1	0	0
2022	2	5	Metabolism and nutrition disorders	Fluid retention	1	1	0
2022	2	5	Eye disorders	Swelling of eyelid	1	1	0
2022	2	5	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	2	5	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	2	5	Nervous system disorders	Dizziness	1	1	0
2022	2	5	Psychiatric disorders	Anxiety	1	0	0
2022	2	5	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	2	5	Eye disorders	Ocular hyperaemia	1	1	0
2022	2	5	General disorders and administration site conditions	Chills	1	1	0
2022	2	5	Vascular disorders	Haemorrhage	1	1	0
2022	2	6	Nervous system disorders	Headache	3	2	0
2022	2	6	General disorders and administration site conditions	Fatigue	2	1	0
2022	2	6	Gastrointestinal disorders	Nausea	1	1	0
2022	2	6	General disorders and administration site conditions	Malaise	1	0	0
2022	2	6	Infections and infestations	Oral herpes	1	1	0
2022	2	6	Reproductive system and breast disorders	Heavy menstrual bleeding	1	0	0
2022	2	6	Respiratory, thoracic and mediastinal disorders	Productive cough	1	0	0
2022	2	6	Nervous system disorders	Cognitive disorder	1	0	0
2022	2	6	Cardiac disorders	Tachycardia	1	1	0
2022	2	6	General disorders and administration site conditions	Pain	1	1	0
2022	2	6	Nervous system disorders	Tremor	1	0	0
2022	2	6	Reproductive system and breast disorders	Menstruation irregular	1	0	0
2022	2	6	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	2	6	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	2	6	Eye disorders	Photophobia	1	1	0
2022	2	6	Psychiatric disorders	Insomnia	1	1	0
2022	2	6	General disorders and administration site conditions	Axillary pain	1	1	0
2022	2	6	Nervous system disorders	Dizziness	1	0	0
2022	2	6	Reproductive system and breast disorders	Menstrual disorder	1	0	0
2022	2	6	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	0	0
2022	2	6	General disorders and administration site conditions	Pyrexia	1	1	0
2022	2	6	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	7	Nervous system disorders	Headache	17	17	0
2022	2	7	General disorders and administration site conditions	Chest pain	13	13	0
2022	2	7	General disorders and administration site conditions	Pyrexia	13	13	0
2022	2	7	Blood and lymphatic system disorders	Lymphadenopathy	10	10	0
2022	2	7	Musculoskeletal and connective tissue disorders	Myalgia	9	9	0
2022	2	7	General disorders and administration site conditions	Injection site reaction	8	8	0
2022	2	7	Nervous system disorders	Paraesthesia	8	8	0
2022	2	7	Cardiac disorders	Palpitations	8	8	0
2022	2	7	General disorders and administration site conditions	Fatigue	7	7	0
2022	2	7	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2022	2	7	Gastrointestinal disorders	Nausea	7	7	0
2022	2	7	Nervous system disorders	Dizziness	6	6	0
2022	2	7	Musculoskeletal and connective tissue disorders	Arthralgia	6	6	0
2022	2	7	General disorders and administration site conditions	Chest discomfort	6	6	0
2022	2	7	Injury, poisoning and procedural complications	Vaccination error	6	6	0
2022	2	7	Nervous system disorders	Lethargy	6	6	0
2022	2	7	General disorders and administration site conditions	Chills	5	5	0
2022	2	7	Skin and subcutaneous tissue disorders	Hyperhidrosis	4	4	0
2022	2	7	Skin and subcutaneous tissue disorders	Rash	4	4	0
2022	2	7	Injury, poisoning and procedural complications	Wrong product administered	4	4	0
2022	2	7	General disorders and administration site conditions	Injection site pain	3	3	0
2022	2	7	Cardiac disorders	Pericarditis	3	3	0
2022	2	7	Gastrointestinal disorders	Vomiting	3	3	0
2022	2	7	Cardiac disorders	Tachycardia	2	2	0
2022	2	7	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	2	7	Eye disorders	Vision blurred	2	2	0
2022	2	7	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	7	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2022	2	7	Cardiac disorders	Myocarditis	2	2	0
2022	2	7	General disorders and administration site conditions	Inflammation	2	2	0
2022	2	7	General disorders and administration site conditions	Pain	2	2	0
2022	2	7	Nervous system disorders	Syncope	2	2	0
2022	2	7	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	2	7	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	2	7	General disorders and administration site conditions	Axillary pain	2	2	0
2022	2	7	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	2	7	Psychiatric disorders	Confusional state	2	2	0
2022	2	7	Cardiac disorders	Extrasystoles	1	1	0
2022	2	7	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	2	7	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	2	7	General disorders and administration site conditions	Injection site oedema	1	1	0
2022	2	7	General disorders and administration site conditions	Malaise	1	1	0
2022	2	7	General disorders and administration site conditions	Oedema peripheral	1	1	0
2022	2	7	Infections and infestations	Herpes zoster	1	1	0
2022	2	7	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	2	7	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	2	7	General disorders and administration site conditions	Swelling face	1	1	0
2022	2	7	Injury, poisoning and procedural complications	Fall	1	1	0
2022	2	7	Investigations	Heart rate increased	1	1	0
2022	2	7	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	2	7	Nervous system disorders	Cerebral infarction	1	1	0
2022	2	7	Nervous system disorders	Presyncope	1	1	0
2022	2	7	Nervous system disorders	Transient global amnesia	1	1	0
2022	2	7	Psychiatric disorders	Sleep disorder	1	1	0
2022	2	7	Skin and subcutaneous tissue disorders	Photosensitivity reaction	1	1	0
2022	2	7	Immune system disorders	Anaphylactic reaction	1	1	0
2022	2	7	Musculoskeletal and connective tissue disorders	Myositis	1	1	0
2022	2	7	Nervous system disorders	Disturbance in attention	1	1	0
2022	2	7	Psychiatric disorders	Disorientation	1	1	0
2022	2	7	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	2	7	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2022	2	7	Cardiac disorders	Pericardial rub	1	1	0
2022	2	7	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	2	7	Investigations	Electrocardiogram normal	1	1	0
2022	2	7	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2022	2	7	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	2	7	Nervous system disorders	Neuralgia	1	1	0
2022	2	7	Nervous system disorders	Seizure	1	0	0
2022	2	7	Infections and infestations	Oral herpes	1	1	0
2022	2	7	Investigations	Blood test normal	1	1	0
2022	2	7	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	2	7	Nervous system disorders	Guillain-Barre syndrome	1	1	0
2022	2	7	Psychiatric disorders	Restlessness	1	1	0
2022	2	7	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	2	7	Investigations	Troponin	1	1	0
2022	2	7	Investigations	Troponin increased	1	1	0
2022	2	7	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	2	7	Nervous system disorders	Bell's palsy	1	1	0
2022	2	7	Gastrointestinal disorders	Mouth ulceration	1	1	0
2022	2	7	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	7	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2022	2	7	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	2	7	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	2	7	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	2	7	Infections and infestations	COVID-19	1	1	0
2022	2	7	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	2	7	Skin and subcutaneous tissue disorders	Blister	1	1	0
2022	2	7	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	2	7	General disorders and administration site conditions	Feeling cold	1	1	0
2022	2	7	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	2	7	General disorders and administration site conditions	Asthenia	1	1	0
2022	2	7	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2022	2	7	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	2	7	General disorders and administration site conditions	Generalised oedema	1	1	0
2022	2	7	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	2	7	Nervous system disorders	Neuropathy peripheral	1	1	0
2022	2	7	Nervous system disorders	Tremor	1	1	0
2022	2	7	Vascular disorders	Superficial vein thrombosis	1	1	0
2022	2	8	General disorders and administration site conditions	Chest pain	13	13	0
2022	2	8	General disorders and administration site conditions	Fatigue	9	9	0
2022	2	8	Cardiac disorders	Palpitations	8	8	0
2022	2	8	Nervous system disorders	Headache	8	8	0
2022	2	8	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2022	2	8	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2022	2	8	Cardiac disorders	Pericarditis	6	6	0
2022	2	8	General disorders and administration site conditions	Pyrexia	6	6	0
2022	2	8	Gastrointestinal disorders	Vomiting	4	4	0
2022	2	8	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2022	2	8	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	2	8	General disorders and administration site conditions	Chest discomfort	4	4	0
2022	2	8	Nervous system disorders	Dizziness	4	4	0
2022	2	8	General disorders and administration site conditions	Malaise	4	4	0
2022	2	8	Nervous system disorders	Lethargy	3	3	0
2022	2	8	Gastrointestinal disorders	Abdominal pain	3	3	0
2022	2	8	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2022	2	8	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2022	2	8	Investigations	C-reactive protein increased	2	2	0
2022	2	8	General disorders and administration site conditions	Extensive swelling of vaccinated limb	2	2	0
2022	2	8	Nervous system disorders	Burning sensation	2	2	0
2022	2	8	Nervous system disorders	Syncope	2	2	0
2022	2	8	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	2	8	Investigations	Echocardiogram	2	2	0
2022	2	8	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2022	2	8	Skin and subcutaneous tissue disorders	Urticaria	2	1	0
2022	2	8	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	8	Nervous system disorders	Neuralgia	2	2	0
2022	2	8	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	2	8	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	2	8	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	2	8	Immune system disorders	Anaphylactic shock	1	1	0
2022	2	8	Infections and infestations	Mastitis	1	1	0
2022	2	8	Psychiatric disorders	Poor quality sleep	1	1	0
2022	2	8	Skin and subcutaneous tissue disorders	Alopecia	1	1	0
2022	2	8	General disorders and administration site conditions	Asthenia	1	1	0
2022	2	8	General disorders and administration site conditions	Pain	1	1	0
2022	2	8	Investigations	Urine output increased	1	1	0
2022	2	8	Renal and urinary disorders	Bladder discomfort	1	1	0
2022	2	8	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	2	8	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	2	8	Vascular disorders	Flushing	1	1	0
2022	2	8	Cardiac disorders	Myocarditis	1	1	0
2022	2	8	Nervous system disorders	Anosmia	1	1	0
2022	2	8	Nervous system disorders	Paraesthesia	1	1	0
2022	2	8	Psychiatric disorders	Irritability	1	1	0
2022	2	8	Respiratory, thoracic and mediastinal disorders	Atelectasis	1	1	0
2022	2	8	Social circumstances	Refusal of vaccination	1	1	0
2022	2	8	Ear and labyrinth disorders	Vertigo	1	1	0
2022	2	8	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	2	8	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2022	2	8	Gastrointestinal disorders	Intussusception	1	1	0
2022	2	8	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	8	Investigations	Fibrin D dimer increased	1	1	0
2022	2	8	Investigations	Troponin I	1	1	0
2022	2	8	Investigations	Troponin T	1	1	0
2022	2	8	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	2	8	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2022	2	8	Gastrointestinal disorders	Nausea	1	1	0
2022	2	8	Nervous system disorders	Ageusia	1	1	0
2022	2	8	Nervous system disorders	Loss of consciousness	1	1	0
2022	2	8	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	2	8	Cardiac disorders	Arrhythmia	1	1	0
2022	2	8	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	2	8	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	8	Investigations	Electrocardiogram abnormal	1	1	0
2022	2	8	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	2	8	Skin and subcutaneous tissue disorders	Dry skin	1	1	0
2022	2	8	Vascular disorders	Hypotension	1	1	0
2022	2	8	General disorders and administration site conditions	Chills	1	1	0
2022	2	8	Infections and infestations	Cellulitis	1	1	0
2022	2	8	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	2	8	Investigations	Troponin I increased	1	1	0
2022	2	8	Eye disorders	Vision blurred	1	1	0
2022	2	8	Injury, poisoning and procedural complications	Incorrect route of product administration	1	1	0
2022	2	8	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	2	8	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2022	2	8	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	2	8	Infections and infestations	Herpes zoster	1	1	0
2022	2	8	Nervous system disorders	Poor quality sleep	1	1	0
2022	2	8	Cardiac disorders	Bundle branch block right	1	1	0
2022	2	8	Investigations	Heart rate increased	1	1	0
2022	2	8	Vascular disorders	Hypertension	1	1	0
2022	2	9	General disorders and administration site conditions	Chest pain	12	12	0
2022	2	9	Respiratory, thoracic and mediastinal disorders	Dyspnoea	10	10	0
2022	2	9	Nervous system disorders	Headache	9	8	0
2022	2	9	General disorders and administration site conditions	Fatigue	7	6	0
2022	2	9	Nervous system disorders	Dizziness	6	6	0
2022	2	9	General disorders and administration site conditions	Pyrexia	6	6	0
2022	2	9	General disorders and administration site conditions	Injection site reaction	5	4	0
2022	2	9	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2022	2	9	General disorders and administration site conditions	Chest discomfort	4	4	0
2022	2	9	Skin and subcutaneous tissue disorders	Hyperhidrosis	4	3	0
2022	2	9	General disorders and administration site conditions	Chills	4	3	0
2022	2	9	Musculoskeletal and connective tissue disorders	Pain in extremity	4	3	0
2022	2	9	Gastrointestinal disorders	Nausea	3	3	0
2022	2	9	Cardiac disorders	Myocarditis	3	3	0
2022	2	9	Cardiac disorders	Palpitations	3	3	0
2022	2	9	Gastrointestinal disorders	Vomiting	3	2	0
2022	2	9	General disorders and administration site conditions	Influenza like illness	3	2	0
2022	2	9	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	2	9	Nervous system disorders	Paraesthesia	3	3	0
2022	2	9	General disorders and administration site conditions	Pain	2	1	0
2022	2	9	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2022	2	9	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	2	9	General disorders and administration site conditions	Peripheral swelling	2	1	0
2022	2	9	Nervous system disorders	Lethargy	2	2	0
2022	2	9	Cardiac disorders	Pericarditis	2	2	0
2022	2	9	General disorders and administration site conditions	Injection site swelling	2	2	0
2022	2	9	Nervous system disorders	Migraine	2	1	0
2022	2	9	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2022	2	9	General disorders and administration site conditions	Asthenia	2	2	0
2022	2	9	Eye disorders	Blepharospasm	1	1	0
2022	2	9	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	2	9	General disorders and administration site conditions	Axillary pain	1	1	0
2022	2	9	General disorders and administration site conditions	Malaise	1	1	0
2022	2	9	General disorders and administration site conditions	Oedema peripheral	1	1	0
2022	2	9	Infections and infestations	Herpes zoster	1	1	0
2022	2	9	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	2	9	Endocrine disorders	Thyroiditis	1	0	0
2022	2	9	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	2	9	General disorders and administration site conditions	Swelling face	1	1	0
2022	2	9	Nervous system disorders	Facial paralysis	1	1	0
2022	2	9	Eye disorders	Vision blurred	1	1	0
2022	2	9	Eye disorders	Visual impairment	1	1	0
2022	2	9	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	2	9	Investigations	Lipase increased	1	1	0
2022	2	9	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2022	2	9	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2022	2	9	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	2	9	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2022	2	9	Eye disorders	Eye swelling	1	1	0
2022	2	9	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	2	9	Vascular disorders	Superficial vein thrombosis	1	1	0
2022	2	9	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	2	9	Infections and infestations	Nasopharyngitis	1	1	0
2022	2	9	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2022	2	9	Psychiatric disorders	Nervousness	1	1	0
2022	2	9	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	9	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	2	9	Skin and subcutaneous tissue disorders	Skin odour abnormal	1	1	0
2022	2	9	Vascular disorders	Vasodilatation	1	1	0
2022	2	9	General disorders and administration site conditions	Injection site mass	1	1	0
2022	2	9	Investigations	C-reactive protein increased	1	1	0
2022	2	9	Nervous system disorders	Anosmia	1	1	0
2022	2	9	Respiratory, thoracic and mediastinal disorders	Nasal discomfort	1	1	0
2022	2	9	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	2	9	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	2	9	General disorders and administration site conditions	Swelling	1	1	0
2022	2	9	Investigations	Heart rate decreased	1	1	0
2022	2	9	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	9	Psychiatric disorders	Confusional state	1	1	0
2022	2	9	Skin and subcutaneous tissue disorders	Erythema	1	0	0
2022	2	9	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	2	9	Cardiac disorders	Cyanosis	1	1	0
2022	2	9	Eye disorders	Asthenopia	1	1	0
2022	2	9	Gastrointestinal disorders	Abdominal distension	1	1	0
2022	2	9	Investigations	Troponin increased	1	1	0
2022	2	9	Nervous system disorders	Ageusia	1	1	0
2022	2	9	Nervous system disorders	Clonic convulsion	1	1	0
2022	2	9	Renal and urinary disorders	Micturition disorder	1	1	0
2022	2	9	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	2	9	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	2	9	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	9	Vascular disorders	Cyanosis	1	1	0
2022	2	9	Cardiac disorders	Myopericarditis	1	1	0
2022	2	9	Nervous system disorders	Somnolence	1	1	0
2022	2	9	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	2	10	Nervous system disorders	Headache	10	9	0
2022	2	10	Musculoskeletal and connective tissue disorders	Myalgia	10	10	0
2022	2	10	General disorders and administration site conditions	Chest pain	8	7	0
2022	2	10	Gastrointestinal disorders	Nausea	8	8	0
2022	2	10	General disorders and administration site conditions	Pyrexia	7	6	0
2022	2	10	General disorders and administration site conditions	Fatigue	7	7	0
2022	2	10	Nervous system disorders	Dizziness	6	6	0
2022	2	10	Cardiac disorders	Palpitations	6	6	0
2022	2	10	Cardiac disorders	Tachycardia	5	5	0
2022	2	10	Musculoskeletal and connective tissue disorders	Arthralgia	5	5	0
2022	2	10	Cardiac disorders	Pericarditis	4	4	0
2022	2	10	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	2	10	Gastrointestinal disorders	Diarrhoea	4	4	0
2022	2	10	Investigations	Electrocardiogram abnormal	4	3	0
2022	2	10	Nervous system disorders	Lethargy	4	4	0
2022	2	10	General disorders and administration site conditions	Chest discomfort	4	3	0
2022	2	10	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2022	2	10	Nervous system disorders	Migraine	3	3	0
2022	2	10	Gastrointestinal disorders	Vomiting	3	3	0
2022	2	10	General disorders and administration site conditions	Concomitant disease aggravated	3	3	0
2022	2	10	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2022	2	10	Cardiac disorders	Myocarditis	3	2	0
2022	2	10	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2022	2	10	Investigations	Heart rate increased	3	3	0
2022	2	10	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	2	10	General disorders and administration site conditions	Malaise	2	2	0
2022	2	10	Investigations	Troponin increased	2	2	0
2022	2	10	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2022	2	10	General disorders and administration site conditions	Chills	2	2	0
2022	2	10	General disorders and administration site conditions	Swelling	2	2	0
2022	2	10	Infections and infestations	Herpes zoster	2	2	0
2022	2	10	Respiratory, thoracic and mediastinal disorders	Throat tightness	2	2	0
2022	2	10	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	2	10	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	2	10	Investigations	Magnetic resonance imaging heart	1	1	0
2022	2	10	Investigations	Troponin I increased	1	1	0
2022	2	10	Metabolism and nutrition disorders	Dehydration	1	1	0
2022	2	10	Psychiatric disorders	Anxiety	1	1	0
2022	2	10	Nervous system disorders	Disturbance in attention	1	1	0
2022	2	10	Nervous system disorders	Seizure	1	1	0
2022	2	10	Cardiac disorders	Atrial flutter	1	1	0
2022	2	10	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	2	10	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	2	10	Nervous system disorders	Facial paralysis	1	1	0
2022	2	10	General disorders and administration site conditions	Axillary pain	1	1	0
2022	2	10	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	2	10	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	2	10	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	2	10	Nervous system disorders	Paraesthesia	1	1	0
2022	2	10	Investigations	Blood potassium decreased	1	1	0
2022	2	10	Investigations	Echocardiogram	1	0	0
2022	2	10	Investigations	Troponin T	1	0	0
2022	2	10	Eye disorders	Vision blurred	1	0	0
2022	2	10	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	2	10	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	2	10	Skin and subcutaneous tissue disorders	Alopecia	1	1	0
2022	2	10	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	2	10	General disorders and administration site conditions	Asthenia	1	1	0
2022	2	10	General disorders and administration site conditions	Pain	1	1	0
2022	2	10	Investigations	Blood creatine phosphokinase increased	1	1	0
2022	2	10	Investigations	Echocardiogram normal	1	1	0
2022	2	10	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	2	10	Cardiac disorders	Myopericarditis	1	1	0
2022	2	10	Cardiac disorders	Tachyarrhythmia	1	1	0
2022	2	10	Eye disorders	Eye irritation	1	1	0
2022	2	10	Nervous system disorders	Hemiplegia	1	1	0
2022	2	10	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	10	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	2	10	Investigations	Troponin	1	1	0
2022	2	10	Psychiatric disorders	Delirium	1	1	0
2022	2	10	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	10	Infections and infestations	Oral herpes	1	1	0
2022	2	10	Investigations	N-terminal prohormone brain natriuretic peptide increased	1	1	0
2022	2	10	Nervous system disorders	Memory impairment	1	1	0
2022	2	11	General disorders and administration site conditions	Fatigue	8	8	0
2022	2	11	Nervous system disorders	Headache	8	8	0
2022	2	11	Gastrointestinal disorders	Nausea	4	4	0
2022	2	11	Nervous system disorders	Dizziness	4	4	0
2022	2	11	General disorders and administration site conditions	Chills	4	4	0
2022	2	11	Gastrointestinal disorders	Vomiting	4	4	0
2022	2	11	General disorders and administration site conditions	Chest pain	3	3	0
2022	2	11	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	2	11	Musculoskeletal and connective tissue disorders	Back pain	3	3	0
2022	2	11	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	2	11	Skin and subcutaneous tissue disorders	Urticaria	3	3	0
2022	2	11	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	2	11	General disorders and administration site conditions	Pyrexia	3	3	0
2022	2	11	Gastrointestinal disorders	Diarrhoea	3	3	0
2022	2	11	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	2	11	Nervous system disorders	Paraesthesia	2	2	0
2022	2	11	Nervous system disorders	Seizure	2	2	0
2022	2	11	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	11	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	2	11	Cardiac disorders	Palpitations	2	2	0
2022	2	11	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	2	11	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2022	2	11	Cardiac disorders	Pericarditis	2	2	0
2022	2	11	Injury, poisoning and procedural complications	Wrong product administered	2	2	0
2022	2	11	Gastrointestinal disorders	Abdominal pain upper	2	2	0
2022	2	11	Nervous system disorders	Tremor	2	2	0
2022	2	11	General disorders and administration site conditions	Injection site pain	2	2	0
2022	2	11	General disorders and administration site conditions	Concomitant disease progression	1	1	0
2022	2	11	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	2	11	Infections and infestations	Myelitis	1	1	0
2022	2	11	Nervous system disorders	Presyncope	1	1	0
2022	2	11	Psychiatric disorders	Sleep disorder	1	1	0
2022	2	11	Vascular disorders	Hypertension	1	1	0
2022	2	11	Gastrointestinal disorders	Lip swelling	1	1	0
2022	2	11	Immune system disorders	Anaphylactic reaction	1	1	0
2022	2	11	Injury, poisoning and procedural complications	Incorrect dosage administered	1	1	0
2022	2	11	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	11	Cardiac disorders	Cardiac disorder	1	1	0
2022	2	11	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	11	Infections and infestations	Injection site cellulitis	1	1	0
2022	2	11	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	2	11	Investigations	White blood cell count increased	1	1	0
2022	2	11	Nervous system disorders	Neuralgia	1	1	0
2022	2	11	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	2	11	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2022	2	11	Nervous system disorders	Lethargy	1	1	0
2022	2	11	Psychiatric disorders	Confusional state	1	1	0
2022	2	11	Reproductive system and breast disorders	Priapism	1	1	0
2022	2	11	Skin and subcutaneous tissue disorders	Skin irritation	1	1	0
2022	2	11	Gastrointestinal disorders	Abdominal distension	1	1	0
2022	2	11	Musculoskeletal and connective tissue disorders	Groin pain	1	1	0
2022	2	11	Infections and infestations	Herpes simplex reactivation	1	1	0
2022	2	11	Vascular disorders	Hot flush	1	1	0
2022	2	11	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	2	11	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	2	11	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	2	11	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2022	2	11	Cardiac disorders	Cardiac failure	1	1	0
2022	2	11	Cardiac disorders	Tachycardia	1	1	0
2022	2	11	General disorders and administration site conditions	Asthenia	1	1	0
2022	2	11	General disorders and administration site conditions	Pain	1	1	0
2022	2	11	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	2	11	Endocrine disorders	Basedow's disease	1	1	0
2022	2	11	Immune system disorders	Hypersensitivity	1	1	0
2022	2	11	Psychiatric disorders	Insomnia	1	1	0
2022	2	11	Skin and subcutaneous tissue disorders	Eczema	1	1	0
2022	2	11	General disorders and administration site conditions	Swelling	1	1	0
2022	2	11	Nervous system disorders	Migraine	1	1	0
2022	2	11	Renal and urinary disorders	Bladder disorder	1	1	0
2022	2	12	Reproductive system and breast disorders	Menstrual disorder	5	5	0
2022	2	12	General disorders and administration site conditions	Pyrexia	5	5	0
2022	2	12	Nervous system disorders	Headache	3	3	0
2022	2	12	Reproductive system and breast disorders	Heavy menstrual bleeding	3	3	0
2022	2	12	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	2	12	Gastrointestinal disorders	Vomiting	2	2	0
2022	2	12	Nervous system disorders	Paraesthesia	2	2	0
2022	2	12	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	12	Nervous system disorders	Dizziness	2	2	0
2022	2	12	General disorders and administration site conditions	Fatigue	2	2	0
2022	2	12	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	2	12	Gastrointestinal disorders	Nausea	2	2	0
2022	2	12	Cardiac disorders	Palpitations	2	2	0
2022	2	12	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	2	12	General disorders and administration site conditions	Chest pain	2	2	0
2022	2	12	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	2	12	General disorders and administration site conditions	Injection site pain	2	2	0
2022	2	12	Nervous system disorders	Migraine	2	2	0
2022	2	12	Reproductive system and breast disorders	Dysmenorrhoea	2	2	0
2022	2	12	Eye disorders	Blepharospasm	1	1	0
2022	2	12	Investigations	Heart rate increased	1	1	0
2022	2	12	Nervous system disorders	Optic neuritis	1	1	0
2022	2	12	Vascular disorders	Hypertension	1	1	0
2022	2	12	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2022	2	12	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	2	12	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2022	2	12	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	12	General disorders and administration site conditions	Inflammation	1	1	0
2022	2	12	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	12	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2022	2	12	Investigations	SARS-CoV-2 test positive	1	1	0
2022	2	12	Investigations	Troponin increased	1	1	0
2022	2	12	Nervous system disorders	Lethargy	1	1	0
2022	2	12	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	2	12	Cardiac disorders	Coronary artery disease	1	1	0
2022	2	12	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	2	12	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	2	12	Nervous system disorders	Hyperaesthesia	1	1	0
2022	2	12	Cardiac disorders	Tachycardia	1	1	0
2022	2	12	General disorders and administration site conditions	Pain	1	1	0
2022	2	12	Immune system disorders	Allergy to arthropod bite	1	1	0
2022	2	12	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	2	12	Immune system disorders	Hypersensitivity	1	1	0
2022	2	12	Nervous system disorders	Dysgeusia	1	1	0
2022	2	12	Nervous system disorders	Syncope	1	1	0
2022	2	12	Psychiatric disorders	Insomnia	1	1	0
2022	2	12	Reproductive system and breast disorders	Menometrorrhagia	1	1	0
2022	2	12	Ear and labyrinth disorders	Vertigo	1	1	0
2022	2	12	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	2	12	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2022	2	12	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2022	2	13	General disorders and administration site conditions	Pyrexia	3	3	0
2022	2	13	Nervous system disorders	Headache	2	2	0
2022	2	13	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	2	13	General disorders and administration site conditions	Chills	1	1	0
2022	2	13	Investigations	Magnetic resonance imaging heart	1	1	0
2022	2	13	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	2	13	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	2	13	General disorders and administration site conditions	Pain	1	1	0
2022	2	13	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	13	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	2	13	General disorders and administration site conditions	Feeling hot	1	1	0
2022	2	13	General disorders and administration site conditions	Fatigue	1	1	0
2022	2	13	General disorders and administration site conditions	Chest pain	1	1	0
2022	2	13	Cardiac disorders	Myopericarditis	1	1	0
2022	2	13	Gastrointestinal disorders	Nausea	1	1	0
2022	2	13	Investigations	Troponin increased	1	1	0
2022	2	13	Nervous system disorders	Loss of consciousness	1	1	0
2022	2	13	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	2	14	General disorders and administration site conditions	Chest pain	8	8	0
2022	2	14	Nervous system disorders	Headache	4	4	0
2022	2	14	General disorders and administration site conditions	Pyrexia	4	4	0
2022	2	14	Cardiac disorders	Palpitations	4	4	0
2022	2	14	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2022	2	14	Nervous system disorders	Paraesthesia	3	3	1
2022	2	14	Nervous system disorders	Dizziness	3	3	0
2022	2	14	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2022	2	14	Gastrointestinal disorders	Nausea	3	3	0
2022	2	14	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	2	14	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	2	14	Nervous system disorders	Syncope	2	2	0
2022	2	14	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	2	14	General disorders and administration site conditions	Fatigue	2	2	0
2022	2	14	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	2	14	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	14	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2022	2	14	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	2	14	Reproductive system and breast disorders	Dysmenorrhoea	2	2	0
2022	2	14	Cardiac disorders	Pericarditis	2	2	0
2022	2	14	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	2	14	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	2	14	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	2	14	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	14	Gastrointestinal disorders	Tongue discomfort	1	1	0
2022	2	14	General disorders and administration site conditions	Chills	1	1	0
2022	2	14	Infections and infestations	Vestibular neuronitis	1	1	0
2022	2	14	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2022	2	14	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	2	14	General disorders and administration site conditions	Injection site pruritus	1	1	0
2022	2	14	General disorders and administration site conditions	Malaise	1	1	0
2022	2	14	Infections and infestations	Herpes zoster	1	1	0
2022	2	14	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	2	14	Investigations	Heart rate increased	1	1	0
2022	2	14	Social circumstances	Sight disability	1	1	0
2022	2	14	Ear and labyrinth disorders	Vertigo	1	1	0
2022	2	14	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	2	14	General disorders and administration site conditions	Swelling	1	1	0
2022	2	14	Vascular disorders	Peripheral coldness	1	1	0
2022	2	14	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	2	14	Investigations	Echocardiogram	1	1	0
2022	2	14	Nervous system disorders	Dysgeusia	1	1	0
2022	2	14	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	2	14	Eye disorders	Eye pain	1	1	0
2022	2	14	Eye disorders	Eye swelling	1	1	0
2022	2	14	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	2	14	Nervous system disorders	Tremor	1	1	0
2022	2	14	Renal and urinary disorders	Renal pain	1	1	0
2022	2	14	Cardiac disorders	Tachycardia	1	1	0
2022	2	14	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	2	14	Investigations	Blood pressure increased	1	1	0
2022	2	14	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2022	2	14	General disorders and administration site conditions	Peripheral swelling	1	1	1
2022	2	14	Investigations	Blood fibrinogen increased	1	1	0
2022	2	14	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	2	14	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	14	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	2	14	Investigations	Electrocardiogram	1	1	0
2022	2	14	Skin and subcutaneous tissue disorders	Rash	1	0	0
2022	2	14	Eye disorders	Eye discharge	1	1	0
2022	2	14	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	14	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2022	2	14	Nervous system disorders	Lethargy	1	1	0
2022	2	14	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	2	14	Gastrointestinal disorders	Vomiting	1	1	0
2022	2	14	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	2	14	Reproductive system and breast disorders	Penile swelling	1	1	1
2022	2	15	Nervous system disorders	Headache	10	9	0
2022	2	15	General disorders and administration site conditions	Chest pain	10	9	0
2022	2	15	General disorders and administration site conditions	Fatigue	9	8	0
2022	2	15	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	7	0
2022	2	15	General disorders and administration site conditions	Pyrexia	7	6	0
2022	2	15	Gastrointestinal disorders	Nausea	7	6	0
2022	2	15	General disorders and administration site conditions	Concomitant disease aggravated	6	5	0
2022	2	15	Musculoskeletal and connective tissue disorders	Arthralgia	6	4	0
2022	2	15	Cardiac disorders	Palpitations	6	6	0
2022	2	15	Nervous system disorders	Lethargy	6	6	0
2022	2	15	Nervous system disorders	Dizziness	5	4	0
2022	2	15	General disorders and administration site conditions	Malaise	5	5	0
2022	2	15	General disorders and administration site conditions	Injection site reaction	4	3	0
2022	2	15	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	2	15	Gastrointestinal disorders	Diarrhoea	3	2	0
2022	2	15	General disorders and administration site conditions	Injection site pain	3	3	0
2022	2	15	Gastrointestinal disorders	Vomiting	3	3	0
2022	2	15	Musculoskeletal and connective tissue disorders	Myalgia	3	2	0
2022	2	15	Cardiac disorders	Myocarditis	2	2	0
2022	2	15	General disorders and administration site conditions	Pain	2	2	0
2022	2	15	Skin and subcutaneous tissue disorders	Rash pruritic	2	2	0
2022	2	15	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2022	2	15	Cardiac disorders	Cardiac flutter	2	1	0
2022	2	15	Cardiac disorders	Tachycardia	2	2	0
2022	2	15	Respiratory, thoracic and mediastinal disorders	Cough	2	1	0
2022	2	15	Vascular disorders	Hot flush	2	2	0
2022	2	15	Ear and labyrinth disorders	Tinnitus	2	1	0
2022	2	15	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	2	15	Nervous system disorders	Tremor	2	2	0
2022	2	15	Musculoskeletal and connective tissue disorders	Pain in extremity	2	1	0
2022	2	15	Nervous system disorders	Paraesthesia	2	1	0
2022	2	15	General disorders and administration site conditions	Axillary pain	2	2	0
2022	2	15	Eye disorders	Vision blurred	1	1	0
2022	2	15	Gastrointestinal disorders	Mouth ulceration	1	0	0
2022	2	15	Immune system disorders	Anaphylactic reaction	1	1	0
2022	2	15	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2022	2	15	Infections and infestations	Injection site cellulitis	1	1	0
2022	2	15	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	2	15	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2022	2	15	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	2	15	Nervous system disorders	Dysarthria	1	1	0
2022	2	15	Ear and labyrinth disorders	Deafness unilateral	1	0	0
2022	2	15	Investigations	Body temperature decreased	1	1	0
2022	2	15	Musculoskeletal and connective tissue disorders	Muscle fatigue	1	0	0
2022	2	15	Nervous system disorders	Balance disorder	1	0	0
2022	2	15	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2022	2	15	Ear and labyrinth disorders	Ear pain	1	1	0
2022	2	15	Nervous system disorders	Coordination abnormal	1	0	0
2022	2	15	Nervous system disorders	Poor quality sleep	1	0	0
2022	2	15	Vascular disorders	Hypertension	1	1	0
2022	2	15	Vascular disorders	Pallor	1	1	0
2022	2	15	Psychiatric disorders	Emotional distress	1	0	0
2022	2	15	Cardiac disorders	Pericarditis	1	1	0
2022	2	15	Eye disorders	Ocular discomfort	1	0	0
2022	2	15	Musculoskeletal and connective tissue disorders	Pain in jaw	1	0	0
2022	2	15	Nervous system disorders	Migraine	1	1	0
2022	2	15	Psychiatric disorders	Agitation	1	1	0
2022	2	15	Investigations	Blood pressure measurement	1	1	0
2022	2	15	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2022	2	15	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	2	15	Vascular disorders	Flushing	1	1	0
2022	2	15	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	2	15	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	2	15	Renal and urinary disorders	Nocturia	1	0	0
2022	2	15	Vascular disorders	Superficial vein thrombosis	1	1	0
2022	2	15	Gastrointestinal disorders	Abdominal distension	1	1	0
2022	2	15	Nervous system disorders	Taste disorder	1	0	0
2022	2	15	Gastrointestinal disorders	Abdominal pain	1	0	0
2022	2	15	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	2	15	Cardiac disorders	Arrhythmia	1	1	0
2022	2	15	General disorders and administration site conditions	Swelling	1	0	0
2022	2	15	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	15	Psychiatric disorders	Poor quality sleep	1	0	0
2022	2	15	Infections and infestations	Oral herpes	1	0	0
2022	2	16	General disorders and administration site conditions	Chest pain	8	8	0
2022	2	16	Musculoskeletal and connective tissue disorders	Pain in extremity	7	6	0
2022	2	16	Gastrointestinal disorders	Nausea	7	6	0
2022	2	16	Nervous system disorders	Lethargy	7	7	0
2022	2	16	General disorders and administration site conditions	Pyrexia	6	6	0
2022	2	16	Cardiac disorders	Palpitations	6	6	0
2022	2	16	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2022	2	16	Nervous system disorders	Headache	6	6	0
2022	2	16	Musculoskeletal and connective tissue disorders	Myalgia	5	5	0
2022	2	16	General disorders and administration site conditions	Malaise	4	3	0
2022	2	16	General disorders and administration site conditions	Fatigue	4	4	0
2022	2	16	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2022	2	16	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	2	16	Musculoskeletal and connective tissue disorders	Back pain	3	3	0
2022	2	16	Cardiac disorders	Tachycardia	3	3	0
2022	2	16	Nervous system disorders	Dizziness	3	3	0
2022	2	16	General disorders and administration site conditions	Chills	2	2	0
2022	2	16	General disorders and administration site conditions	Concomitant disease aggravated	2	1	0
2022	2	16	Nervous system disorders	Syncope	2	2	0
2022	2	16	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	2	16	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	2	16	Skin and subcutaneous tissue disorders	Petechiae	2	2	0
2022	2	16	Nervous system disorders	Tremor	2	2	0
2022	2	16	Immune system disorders	Hypersensitivity	2	2	0
2022	2	16	Psychiatric disorders	Confusional state	2	2	0
2022	2	16	Endocrine disorders	Hyperthyroidism	2	2	0
2022	2	16	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	2	16	Vascular disorders	Hypertension	2	2	0
2022	2	16	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	16	General disorders and administration site conditions	Injection site hypersensitivity	1	1	0
2022	2	16	Infections and infestations	Cellulitis	1	1	0
2022	2	16	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	2	16	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	2	16	Psychiatric disorders	Anxiety	1	1	0
2022	2	16	Skin and subcutaneous tissue disorders	Acne	1	1	0
2022	2	16	Nervous system disorders	Paraesthesia	1	0	0
2022	2	16	Nervous system disorders	Seizure	1	1	0
2022	2	16	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	2	16	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	2	16	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	16	General disorders and administration site conditions	Axillary pain	1	1	0
2022	2	16	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	2	16	General disorders and administration site conditions	Discomfort	1	0	0
2022	2	16	General disorders and administration site conditions	Swelling face	1	1	0
2022	2	16	Nervous system disorders	Presyncope	1	1	0
2022	2	16	Psychiatric disorders	Sleep disorder	1	1	0
2022	2	16	Gastrointestinal disorders	Vomiting	1	1	0
2022	2	16	Infections and infestations	Varicella zoster virus infection	1	1	0
2022	2	16	Investigations	Troponin increased	1	1	0
2022	2	16	Respiratory, thoracic and mediastinal disorders	Allergic cough	1	1	0
2022	2	16	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	2	16	Nervous system disorders	Hemiparesis	1	1	0
2022	2	16	Reproductive system and breast disorders	Breast pain	1	1	0
2022	2	16	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	2	16	General disorders and administration site conditions	Inflammation	1	1	0
2022	2	16	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	2	16	Nervous system disorders	Cerebral thrombosis	1	1	0
2022	2	16	General disorders and administration site conditions	Injection site rash	1	1	0
2022	2	16	Nervous system disorders	Speech disorder	1	1	0
2022	2	16	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	2	16	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	2	16	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	2	16	Psychiatric disorders	Conversion disorder	1	1	0
2022	2	16	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2022	2	16	Vascular disorders	Superficial vein thrombosis	1	1	0
2022	2	16	Cardiac disorders	Myocardial infarction	1	1	0
2022	2	16	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	2	16	General disorders and administration site conditions	Illness	1	1	0
2022	2	16	Investigations	Coagulation factor increased	1	1	0
2022	2	16	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	2	16	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	16	Vascular disorders	Flushing	1	1	0
2022	2	16	General disorders and administration site conditions	Injection site urticaria	1	1	0
2022	2	16	Investigations	Platelet count increased	1	1	0
2022	2	16	Nervous system disorders	Sensory disturbance	1	0	0
2022	2	16	Psychiatric disorders	Depression	1	1	0
2022	2	16	Blood and lymphatic system disorders	Anaemia	1	1	0
2022	2	16	Cardiac disorders	Pericarditis	1	1	0
2022	2	16	Nervous system disorders	Migraine	1	1	0
2022	2	16	Skin and subcutaneous tissue disorders	Rash macular	1	1	0
2022	2	17	General disorders and administration site conditions	Chest pain	8	8	0
2022	2	17	Respiratory, thoracic and mediastinal disorders	Dyspnoea	7	7	0
2022	2	17	Cardiac disorders	Palpitations	7	7	0
2022	2	17	General disorders and administration site conditions	Injection site pain	5	5	0
2022	2	17	Nervous system disorders	Headache	4	4	0
2022	2	17	Blood and lymphatic system disorders	Lymphadenopathy	3	3	0
2022	2	17	General disorders and administration site conditions	Pyrexia	3	3	0
2022	2	17	General disorders and administration site conditions	Fatigue	3	3	0
2022	2	17	General disorders and administration site conditions	Malaise	3	3	0
2022	2	17	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	2	17	Nervous system disorders	Migraine	2	2	0
2022	2	17	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	2	17	Nervous system disorders	Lethargy	2	2	0
2022	2	17	Cardiac disorders	Tachycardia	2	2	0
2022	2	17	Gastrointestinal disorders	Vomiting	2	2	0
2022	2	17	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2022	2	17	Nervous system disorders	Syncope	2	2	0
2022	2	17	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	2	17	Gastrointestinal disorders	Nausea	2	2	0
2022	2	17	Gastrointestinal disorders	Abdominal distension	1	1	0
2022	2	17	Investigations	Troponin	1	1	0
2022	2	17	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	2	17	Nervous system disorders	Bell's palsy	1	1	0
2022	2	17	Investigations	Fibrin D dimer increased	1	1	0
2022	2	17	Psychiatric disorders	Confusional state	1	1	0
2022	2	17	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	2	17	General disorders and administration site conditions	Inflammation	1	1	0
2022	2	17	Vascular disorders	Orthostatic hypotension	1	1	0
2022	2	17	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	2	17	Infections and infestations	Pneumonia	1	1	0
2022	2	17	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	2	17	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	2	17	Cardiac disorders	Atrial tachycardia	1	1	0
2022	2	17	Investigations	SARS-CoV-2 antibody test positive	1	1	0
2022	2	17	General disorders and administration site conditions	Pain	1	1	0
2022	2	17	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	2	17	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	2	17	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	2	17	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	2	17	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	2	17	Vascular disorders	Thrombosis	1	1	0
2022	2	17	General disorders and administration site conditions	Axillary pain	1	1	0
2022	2	17	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	2	17	Nervous system disorders	Dizziness	1	1	0
2022	2	17	Cardiac disorders	Postural orthostatic tachycardia syndrome	1	1	0
2022	2	17	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	17	Cardiac disorders	Atrial fibrillation	1	1	0
2022	2	17	Metabolism and nutrition disorders	Dehydration	1	1	0
2022	2	17	Nervous system disorders	Neuralgia	1	1	0
2022	2	17	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2022	2	18	Respiratory, thoracic and mediastinal disorders	Dyspnoea	10	9	0
2022	2	18	General disorders and administration site conditions	Chest pain	7	7	0
2022	2	18	General disorders and administration site conditions	Pyrexia	5	5	0
2022	2	18	Cardiac disorders	Palpitations	4	3	0
2022	2	18	Blood and lymphatic system disorders	Lymphadenopathy	4	3	0
2022	2	18	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	4	4	0
2022	2	18	Nervous system disorders	Headache	4	3	0
2022	2	18	Injury, poisoning and procedural complications	Vaccination error	4	4	0
2022	2	18	Nervous system disorders	Dizziness	3	3	0
2022	2	18	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2022	2	18	Cardiac disorders	Tachycardia	3	2	0
2022	2	18	General disorders and administration site conditions	Fatigue	3	3	0
2022	2	18	Cardiac disorders	Pericarditis	3	3	0
2022	2	18	Respiratory, thoracic and mediastinal disorders	Cough	3	3	0
2022	2	18	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	2	18	Musculoskeletal and connective tissue disorders	Pain in extremity	2	1	0
2022	2	18	Vascular disorders	Hypertension	2	2	0
2022	2	18	Skin and subcutaneous tissue disorders	Urticaria	2	1	0
2022	2	18	General disorders and administration site conditions	Pain	2	2	0
2022	2	18	Nervous system disorders	Syncope	2	2	0
2022	2	18	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	2	18	Musculoskeletal and connective tissue disorders	Myalgia	2	1	0
2022	2	18	Cardiac disorders	Myocarditis	1	1	0
2022	2	18	General disorders and administration site conditions	Gait disturbance	1	1	0
2022	2	18	Injury, poisoning and procedural complications	Product preparation issue	1	1	0
2022	2	18	Psychiatric disorders	Insomnia	1	1	0
2022	2	18	Skin and subcutaneous tissue disorders	Skin burning sensation	1	1	0
2022	2	18	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2022	2	18	Cardiac disorders	Pericardial effusion	1	1	0
2022	2	18	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	2	18	General disorders and administration site conditions	Swelling	1	1	0
2022	2	18	Immune system disorders	Autoimmune disorder	1	1	0
2022	2	18	Investigations	Echocardiogram abnormal	1	1	0
2022	2	18	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	2	18	Reproductive system and breast disorders	Polymenorrhoea	1	1	0
2022	2	18	Investigations	Blood pressure abnormal	1	1	0
2022	2	18	Nervous system disorders	Burning sensation	1	1	0
2022	2	18	Nervous system disorders	Movement disorder	1	1	0
2022	2	18	Reproductive system and breast disorders	Intermenstrual bleeding	1	1	0
2022	2	18	Skin and subcutaneous tissue disorders	Swelling face	1	0	0
2022	2	18	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	2	18	Nervous system disorders	Tremor	1	1	0
2022	2	18	Investigations	Heart rate irregular	1	1	0
2022	2	18	Nervous system disorders	Formication	1	1	0
2022	2	18	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	18	Social circumstances	Loss of personal independence in daily activities	1	1	0
2022	2	18	Vascular disorders	Vein disorder	1	1	0
2022	2	18	Infections and infestations	Pneumonia	1	1	0
2022	2	18	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	2	18	Investigations	Blood glucose fluctuation	1	1	0
2022	2	18	Investigations	Electrocardiogram abnormal	1	1	0
2022	2	18	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Lipoma	1	1	0
2022	2	18	Vascular disorders	Hypotension	1	1	0
2022	2	18	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	18	Nervous system disorders	Guillain-Barre syndrome	1	1	0
2022	2	18	Nervous system disorders	Lethargy	1	1	0
2022	2	18	Vascular disorders	Hot flush	1	0	0
2022	2	18	Gastrointestinal disorders	Dyspepsia	1	1	0
2022	2	18	Gastrointestinal disorders	Nausea	1	1	0
2022	2	18	Musculoskeletal and connective tissue disorders	Muscular weakness	1	0	0
2022	2	18	Respiratory, thoracic and mediastinal disorders	Dyspnoea at rest	1	1	0
2022	2	18	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	18	Eye disorders	Vitreous floaters	1	1	0
2022	2	18	General disorders and administration site conditions	Chills	1	1	0
2022	2	18	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	2	18	Nervous system disorders	Neuralgia	1	1	0
2022	2	18	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2022	2	18	Vascular disorders	Vascular pain	1	1	0
2022	2	18	Eye disorders	Vision blurred	1	1	0
2022	2	18	General disorders and administration site conditions	Chest discomfort	1	0	0
2022	2	18	General disorders and administration site conditions	Swelling face	1	0	0
2022	2	18	Nervous system disorders	Paraesthesia	1	0	0
2022	2	18	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	2	18	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	18	Social circumstances	Impaired work ability	1	1	0
2022	2	18	Eye disorders	Lacrimation increased	1	1	0
2022	2	18	General disorders and administration site conditions	Malaise	1	1	0
2022	2	18	Respiratory, thoracic and mediastinal disorders	Pneumothorax	1	1	0
2022	2	18	General disorders and administration site conditions	Temperature regulation disorder	1	1	0
2022	2	18	Infections and infestations	Oral candidiasis	1	0	0
2022	2	18	Investigations	Heart rate increased	1	1	0
2022	2	19	General disorders and administration site conditions	Fatigue	4	4	0
2022	2	19	Vascular disorders	Hot flush	2	2	0
2022	2	19	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	2	19	Immune system disorders	Hypersensitivity	2	2	0
2022	2	19	Psychiatric disorders	Confusional state	2	2	0
2022	2	19	General disorders and administration site conditions	Axillary pain	1	1	0
2022	2	19	General disorders and administration site conditions	Oedema	1	1	0
2022	2	19	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	2	19	Nervous system disorders	Dizziness	1	1	0
2022	2	19	Reproductive system and breast disorders	Breast inflammation	1	1	0
2022	2	19	Eye disorders	Vision blurred	1	1	0
2022	2	19	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	2	19	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	19	General disorders and administration site conditions	Chills	1	1	0
2022	2	19	General disorders and administration site conditions	Injection site inflammation	1	1	0
2022	2	19	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	19	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	2	19	Nervous system disorders	Headache	1	1	0
2022	2	19	General disorders and administration site conditions	Inhibitory drug interaction	1	1	0
2022	2	19	General disorders and administration site conditions	Hunger	1	1	0
2022	2	19	General disorders and administration site conditions	Inflammation	1	1	0
2022	2	19	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	2	19	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	19	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	2	19	General disorders and administration site conditions	Injection site rash	1	1	0
2022	2	19	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	2	19	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	2	19	Gastrointestinal disorders	Constipation	1	1	0
2022	2	19	Renal and urinary disorders	Chromaturia	1	1	0
2022	2	19	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	19	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	2	19	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	2	19	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	2	19	General disorders and administration site conditions	Swelling	1	1	0
2022	2	19	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	2	19	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	2	20	Nervous system disorders	Headache	3	3	0
2022	2	20	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	2	20	General disorders and administration site conditions	Fatigue	2	2	0
2022	2	20	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	20	Cardiac disorders	Myocarditis	1	1	0
2022	2	20	Ear and labyrinth disorders	Vertigo	1	1	0
2022	2	20	Gastrointestinal disorders	Dysphagia	1	1	0
2022	2	20	Gastrointestinal disorders	Eructation	1	1	0
2022	2	20	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	2	20	Vascular disorders	Thrombosis	1	1	0
2022	2	20	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	2	20	Nervous system disorders	Phrenic nerve paralysis	1	1	0
2022	2	20	Cardiac disorders	Arrhythmia	1	1	0
2022	2	20	General disorders and administration site conditions	Chest pain	1	1	0
2022	2	20	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	20	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2022	2	20	General disorders and administration site conditions	Injection site rash	1	1	0
2022	2	20	Nervous system disorders	Somnolence	1	1	0
2022	2	20	Vascular disorders	Hot flush	1	1	0
2022	2	20	Ear and labyrinth disorders	Tinnitus	1	0	0
2022	2	20	Gastrointestinal disorders	Vomiting	1	1	0
2022	2	20	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	2	20	Cardiac disorders	Palpitations	1	1	0
2022	2	20	Investigations	Fibrin D dimer increased	1	1	0
2022	2	20	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	2	20	Cardiac disorders	Extrasystoles	1	1	0
2022	2	20	General disorders and administration site conditions	Malaise	1	1	0
2022	2	20	Nervous system disorders	Presyncope	1	1	0
2022	2	20	General disorders and administration site conditions	Pyrexia	1	1	0
2022	2	20	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	2	20	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	20	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	2	21	General disorders and administration site conditions	Chest pain	17	17	0
2022	2	21	Musculoskeletal and connective tissue disorders	Myalgia	8	8	0
2022	2	21	Nervous system disorders	Headache	8	8	0
2022	2	21	General disorders and administration site conditions	Pyrexia	7	7	0
2022	2	21	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2022	2	21	Cardiac disorders	Palpitations	5	5	0
2022	2	21	Nervous system disorders	Lethargy	5	4	0
2022	2	21	General disorders and administration site conditions	Influenza like illness	4	4	0
2022	2	21	General disorders and administration site conditions	Fatigue	4	4	0
2022	2	21	Cardiac disorders	Pericarditis	4	4	0
2022	2	21	General disorders and administration site conditions	Chest discomfort	4	4	0
2022	2	21	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	2	21	Nervous system disorders	Dysgeusia	3	3	0
2022	2	21	Gastrointestinal disorders	Nausea	3	3	0
2022	2	21	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	2	21	Skin and subcutaneous tissue disorders	Hyperhidrosis	3	3	0
2022	2	21	Nervous system disorders	Tremor	3	3	0
2022	2	21	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	2	21	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2022	2	21	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	2	21	Nervous system disorders	Dizziness	2	2	0
2022	2	21	Reproductive system and breast disorders	Menstrual disorder	2	1	0
2022	2	21	Reproductive system and breast disorders	Heavy menstrual bleeding	2	1	0
2022	2	21	Nervous system disorders	Bell's palsy	2	2	0
2022	2	21	Cardiac disorders	Myocarditis	2	2	0
2022	2	21	Gastrointestinal disorders	Vomiting	2	1	0
2022	2	21	Nervous system disorders	Burning sensation	2	2	0
2022	2	21	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	2	21	Reproductive system and breast disorders	Menstruation irregular	2	1	0
2022	2	21	General disorders and administration site conditions	Injection site pain	2	2	0
2022	2	21	General disorders and administration site conditions	Axillary pain	1	1	0
2022	2	21	Ear and labyrinth disorders	Ear pain	1	1	0
2022	2	21	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	2	21	Investigations	Heart rate increased	1	1	0
2022	2	21	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	2	21	Nervous system disorders	Migraine	1	0	0
2022	2	21	Nervous system disorders	Presyncope	1	1	0
2022	2	21	Vascular disorders	Hypertension	1	1	0
2022	2	21	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	2	21	General disorders and administration site conditions	Chills	1	1	0
2022	2	21	Metabolism and nutrition disorders	Dehydration	1	1	0
2022	2	21	Eye disorders	Vision blurred	1	1	0
2022	2	21	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	2	21	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2022	2	21	Vascular disorders	Lymphoedema	1	1	0
2022	2	21	Cardiac disorders	Bradycardia	1	1	0
2022	2	21	General disorders and administration site conditions	Swelling	1	0	0
2022	2	21	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	2	21	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	21	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	2	21	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	2	21	Cardiac disorders	Myopericarditis	1	1	0
2022	2	21	Infections and infestations	Vaccine breakthrough infection	1	1	0
2022	2	21	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2022	2	21	Gastrointestinal disorders	Frequent bowel movements	1	1	0
2022	2	21	Investigations	Respiratory rate increased	1	1	0
2022	2	21	Investigations	SARS-CoV-2 test positive	1	1	0
2022	2	21	Investigations	Troponin increased	1	1	0
2022	2	21	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	2	21	Cardiac disorders	Tachycardia	1	1	0
2022	2	21	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	2	21	General disorders and administration site conditions	Asthenia	1	1	0
2022	2	21	Infections and infestations	Nasopharyngitis	1	1	0
2022	2	21	Nervous system disorders	Dyskinesia	1	1	0
2022	2	21	Nervous system disorders	Hypersomnia	1	1	0
2022	2	21	Skin and subcutaneous tissue disorders	Urticaria chronic	1	1	0
2022	2	21	Cardiac disorders	Ventricular dysfunction	1	1	0
2022	2	21	General disorders and administration site conditions	Feeling cold	1	1	0
2022	2	21	General disorders and administration site conditions	Injection site mass	1	1	0
2022	2	21	Investigations	C-reactive protein increased	1	1	0
2022	2	21	Musculoskeletal and connective tissue disorders	Spinal pain	1	1	0
2022	2	21	Nervous system disorders	Paraesthesia	1	1	0
2022	2	21	Nervous system disorders	Syncope	1	1	0
2022	2	21	Psychiatric disorders	Eating disorder	1	1	0
2022	2	21	Skin and subcutaneous tissue disorders	Rash vesicular	1	1	0
2022	2	21	General disorders and administration site conditions	Feeling hot	1	1	0
2022	2	21	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	2	22	Musculoskeletal and connective tissue disorders	Myalgia	6	5	0
2022	2	22	Nervous system disorders	Headache	6	5	0
2022	2	22	General disorders and administration site conditions	Pyrexia	4	3	0
2022	2	22	General disorders and administration site conditions	Chest pain	4	4	0
2022	2	22	Nervous system disorders	Dizziness	3	3	0
2022	2	22	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	2	22	General disorders and administration site conditions	Malaise	3	2	0
2022	2	22	General disorders and administration site conditions	Fatigue	3	3	0
2022	2	22	Cardiac disorders	Pericarditis	3	3	0
2022	2	22	Vascular disorders	Hypertension	2	2	0
2022	2	22	General disorders and administration site conditions	Injection site pain	2	2	0
2022	2	22	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	2	2	0
2022	2	22	General disorders and administration site conditions	Peripheral swelling	2	2	0
2022	2	22	Gastrointestinal disorders	Vomiting	2	1	0
2022	2	22	Nervous system disorders	Syncope	2	2	0
2022	2	22	Gastrointestinal disorders	Nausea	2	2	0
2022	2	22	Investigations	Troponin increased	1	1	0
2022	2	22	Musculoskeletal and connective tissue disorders	Arthritis reactive	1	1	0
2022	2	22	Nervous system disorders	Bell's palsy	1	1	0
2022	2	22	Nervous system disorders	Lethargy	1	0	0
2022	2	22	Product issues	Needle issue	1	1	0
2022	2	22	General disorders and administration site conditions	Concomitant disease aggravated	1	1	1
2022	2	22	Infections and infestations	Tonsillitis	1	0	0
2022	2	22	Vascular disorders	Deep vein thrombosis	1	1	0
2022	2	22	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	2	22	Investigations	Heart rate irregular	1	1	0
2022	2	22	Reproductive system and breast disorders	Suppressed lactation	1	1	0
2022	2	22	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	2	22	Vascular disorders	Orthostatic hypotension	1	1	0
2022	2	22	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	2	22	Vascular disorders	Hypotension	1	1	0
2022	2	22	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	2	22	Nervous system disorders	Migraine	1	1	0
2022	2	22	Cardiac disorders	Myocarditis	1	1	0
2022	2	22	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	2	22	Nervous system disorders	Paraesthesia	1	1	0
2022	2	22	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	2	22	Nervous system disorders	Tremor	1	1	0
2022	2	22	Reproductive system and breast disorders	Breast swelling	1	1	0
2022	2	22	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	2	22	General disorders and administration site conditions	Pain	1	1	0
2022	2	22	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	22	General disorders and administration site conditions	Swelling face	1	1	0
2022	2	22	Nervous system disorders	Presyncope	1	1	0
2022	2	22	Cardiac disorders	Cardiac failure	1	1	1
2022	2	22	Infections and infestations	Herpes zoster	1	1	0
2022	2	22	Injury, poisoning and procedural complications	Underdose	1	1	0
2022	2	22	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	2	22	Gastrointestinal disorders	Crohn's disease	1	1	0
2022	2	22	Musculoskeletal and connective tissue disorders	Arthritis	1	1	0
2022	2	22	Nervous system disorders	Seizure	1	1	0
2022	2	22	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	2	22	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	2	23	General disorders and administration site conditions	Chest pain	10	10	0
2022	2	23	Respiratory, thoracic and mediastinal disorders	Dyspnoea	8	6	0
2022	2	23	General disorders and administration site conditions	Fatigue	8	7	0
2022	2	23	Nervous system disorders	Headache	7	6	0
2022	2	23	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2022	2	23	General disorders and administration site conditions	Pyrexia	6	5	0
2022	2	23	Cardiac disorders	Palpitations	5	4	0
2022	2	23	General disorders and administration site conditions	Chest discomfort	4	4	0
2022	2	23	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2022	2	23	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	2	23	Musculoskeletal and connective tissue disorders	Pain in extremity	4	4	0
2022	2	23	Gastrointestinal disorders	Nausea	3	2	0
2022	2	23	Musculoskeletal and connective tissue disorders	Back pain	3	3	0
2022	2	23	Skin and subcutaneous tissue disorders	Pruritus	3	2	0
2022	2	23	Cardiac disorders	Tachycardia	3	2	0
2022	2	23	General disorders and administration site conditions	Asthenia	3	3	0
2022	2	23	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	2	23	Nervous system disorders	Memory impairment	3	3	0
2022	2	23	Nervous system disorders	Dizziness	3	3	0
2022	2	23	Nervous system disorders	Hypoaesthesia	3	3	0
2022	2	23	Gastrointestinal disorders	Vomiting	2	2	0
2022	2	23	Vascular disorders	Hypertension	2	1	0
2022	2	23	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	2	23	Nervous system disorders	Tremor	2	2	0
2022	2	23	Cardiac disorders	Pericarditis	2	2	0
2022	2	23	General disorders and administration site conditions	Injection site swelling	2	2	0
2022	2	23	Skin and subcutaneous tissue disorders	Rash	2	1	0
2022	2	23	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	2	23	General disorders and administration site conditions	Concomitant disease aggravated	2	2	0
2022	2	23	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	23	General disorders and administration site conditions	Chills	1	1	0
2022	2	23	General disorders and administration site conditions	Peripheral swelling	1	0	0
2022	2	23	Investigations	Fibrin D dimer	1	1	0
2022	2	23	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2022	2	23	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	2	23	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2022	2	23	Cardiac disorders	Cardiogenic shock	1	1	0
2022	2	23	Cardiac disorders	Postural orthostatic tachycardia syndrome	1	1	0
2022	2	23	Eye disorders	Vision blurred	1	1	0
2022	2	23	Eye disorders	Visual impairment	1	1	0
2022	2	23	Nervous system disorders	Seizure	1	1	0
2022	2	23	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	2	23	Ear and labyrinth disorders	Ear pain	1	1	0
2022	2	23	General disorders and administration site conditions	Temperature regulation disorder	1	1	0
2022	2	23	Cardiac disorders	Cardiomyopathy	1	1	0
2022	2	23	Infections and infestations	Herpes zoster	1	1	0
2022	2	23	Skin and subcutaneous tissue disorders	Urticaria	1	0	0
2022	2	23	Nervous system disorders	Lethargy	1	1	0
2022	2	23	Skin and subcutaneous tissue disorders	Dermatitis	1	1	0
2022	2	23	Cardiac disorders	Cyanosis	1	1	0
2022	2	23	Investigations	Troponin	1	1	0
2022	2	23	Investigations	Troponin increased	1	1	0
2022	2	23	Nervous system disorders	Bell's palsy	1	1	0
2022	2	23	Infections and infestations	Pneumonia	1	1	0
2022	2	23	Investigations	Electrocardiogram abnormal	1	1	0
2022	2	23	Nervous system disorders	Autonomic nervous system imbalance	1	1	0
2022	2	23	General disorders and administration site conditions	Inflammation	1	1	0
2022	2	23	Nervous system disorders	Depressed level of consciousness	1	1	0
2022	2	23	Respiratory, thoracic and mediastinal disorders	Acute pulmonary oedema	1	1	0
2022	2	23	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2022	2	23	Skin and subcutaneous tissue disorders	Angioedema	1	0	0
2022	2	23	Social circumstances	Loss of personal independence in daily activities	1	1	0
2022	2	23	Vascular disorders	Cyanosis	1	1	0
2022	2	23	Ear and labyrinth disorders	Vertigo	1	1	0
2022	2	23	Gastrointestinal disorders	Dysphagia	1	1	0
2022	2	23	General disorders and administration site conditions	Swelling	1	1	0
2022	2	23	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	2	23	Nervous system disorders	Migraine	1	1	0
2022	2	23	Renal and urinary disorders	Haematuria	1	1	0
2022	2	23	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2022	2	23	Vascular disorders	Peripheral coldness	1	1	0
2022	2	23	Cardiac disorders	Left ventricular dysfunction	1	1	0
2022	2	23	General disorders and administration site conditions	Feeling cold	1	1	0
2022	2	23	Investigations	Body temperature fluctuation	1	1	0
2022	2	23	Investigations	Echocardiogram	1	1	0
2022	2	23	Nervous system disorders	Paraesthesia	1	1	0
2022	2	23	Nervous system disorders	Syncope	1	1	0
2022	2	23	Psychiatric disorders	Insomnia	1	1	0
2022	2	23	Endocrine disorders	Hypothyroidism	1	1	0
2022	2	23	Infections and infestations	Oral candidiasis	1	1	0
2022	2	23	Cardiac disorders	Bundle branch block left	1	1	0
2022	2	23	Infections and infestations	Tonsillitis	1	1	0
2022	2	23	Nervous system disorders	Burning sensation	1	1	0
2022	2	23	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	2	23	Vascular disorders	Flushing	1	1	0
2022	2	24	Nervous system disorders	Headache	9	8	0
2022	2	24	Gastrointestinal disorders	Nausea	5	5	0
2022	2	24	Nervous system disorders	Lethargy	5	4	0
2022	2	24	General disorders and administration site conditions	Concomitant disease aggravated	4	3	0
2022	2	24	General disorders and administration site conditions	Chest pain	4	4	0
2022	2	24	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2022	2	24	Cardiac disorders	Pericarditis	3	3	0
2022	2	24	General disorders and administration site conditions	Chills	3	2	0
2022	2	24	Skin and subcutaneous tissue disorders	Rash	3	3	0
2022	2	24	General disorders and administration site conditions	Chest discomfort	3	3	0
2022	2	24	Nervous system disorders	Dizziness	3	3	0
2022	2	24	General disorders and administration site conditions	Malaise	3	2	0
2022	2	24	Gastrointestinal disorders	Vomiting	2	2	0
2022	2	24	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	2	24	Cardiac disorders	Tachycardia	2	2	0
2022	2	24	Cardiac disorders	Palpitations	2	2	0
2022	2	24	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	2	24	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	2	24	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	1	0
2022	2	24	General disorders and administration site conditions	Pyrexia	2	2	0
2022	2	24	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	2	24	Respiratory, thoracic and mediastinal disorders	Haemoptysis	1	1	0
2022	2	24	Respiratory, thoracic and mediastinal disorders	Productive cough	1	1	0
2022	2	24	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	24	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	2	24	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	2	24	Investigations	Sinus rhythm	1	1	0
2022	2	24	Musculoskeletal and connective tissue disorders	Arthralgia	1	0	0
2022	2	24	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Gastrointestinal carcinoma	1	1	0
2022	2	24	Blood and lymphatic system disorders	Platelet disorder	1	1	0
2022	2	24	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	2	24	Respiratory, thoracic and mediastinal disorders	Sputum discoloured	1	1	0
2022	2	24	Skin and subcutaneous tissue disorders	Erythema multiforme	1	1	0
2022	2	24	Investigations	Heart rate increased	1	1	0
2022	2	24	Psychiatric disorders	Sleep disorder	1	1	0
2022	2	24	Cardiac disorders	Right atrial enlargement	1	1	0
2022	2	24	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	24	Cardiac disorders	Supraventricular extrasystoles	1	1	0
2022	2	24	Investigations	Troponin increased	1	1	0
2022	2	24	Psychiatric disorders	Emotional distress	1	1	0
2022	2	24	Cardiac disorders	Bradycardia	1	1	0
2022	2	24	Nervous system disorders	Hypoaesthesia	1	1	0
2022	2	24	General disorders and administration site conditions	Discomfort	1	1	0
2022	2	24	Infections and infestations	Pneumonia viral	1	1	0
2022	2	24	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	2	24	Investigations	Electrocardiogram	1	1	0
2022	2	24	Nervous system disorders	Coordination abnormal	1	1	0
2022	2	24	General disorders and administration site conditions	Asthenia	1	1	0
2022	2	24	Nervous system disorders	Electric shock sensation	1	1	0
2022	2	24	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	2	24	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	2	24	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	2	24	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	2	24	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	2	24	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	2	24	General disorders and administration site conditions	Feeling hot	1	1	0
2022	2	24	Psychiatric disorders	Tic	1	1	0
2022	2	24	Skin and subcutaneous tissue disorders	Blister	1	1	0
2022	2	25	Cardiac disorders	Palpitations	3	3	0
2022	2	25	General disorders and administration site conditions	Pyrexia	3	2	0
2022	2	25	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	2	25	General disorders and administration site conditions	Fatigue	3	3	0
2022	2	25	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2022	2	25	General disorders and administration site conditions	Chest pain	2	2	0
2022	2	25	Infections and infestations	Lower respiratory tract infection	2	2	0
2022	2	25	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	2	25	General disorders and administration site conditions	Asthenia	2	1	0
2022	2	25	Gastrointestinal disorders	Vomiting	2	2	0
2022	2	25	Eye disorders	Visual impairment	2	2	0
2022	2	25	Nervous system disorders	Dizziness	2	2	0
2022	2	25	General disorders and administration site conditions	Feeling cold	1	1	0
2022	2	25	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2022	2	25	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2022	2	25	Cardiac disorders	Pericarditis	1	1	0
2022	2	25	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	2	25	General disorders and administration site conditions	Swelling	1	1	0
2022	2	25	Infections and infestations	COVID-19	1	1	0
2022	2	25	Social circumstances	Bedridden	1	1	0
2022	2	25	Cardiac disorders	Tachycardia	1	1	0
2022	2	25	Investigations	Blood pressure increased	1	1	0
2022	2	25	Renal and urinary disorders	Renal disorder	1	1	0
2022	2	25	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	2	25	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	2	25	Vascular disorders	Thrombosis	1	1	0
2022	2	25	Gastrointestinal disorders	Nausea	1	1	0
2022	2	25	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	2	25	Nervous system disorders	Headache	1	1	0
2022	2	25	Nervous system disorders	Loss of consciousness	1	0	0
2022	2	25	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	2	25	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	2	25	Investigations	Heart rate irregular	1	1	0
2022	2	25	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	2	25	Vascular disorders	Hypotension	1	1	0
2022	2	25	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	2	25	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	2	25	General disorders and administration site conditions	Chills	1	0	0
2022	2	25	General disorders and administration site conditions	Swelling face	1	1	0
2022	2	25	Immune system disorders	Anaphylactic reaction	1	1	0
2022	2	25	Musculoskeletal and connective tissue disorders	Bone pain	1	0	0
2022	2	25	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Cutaneous T-cell lymphoma	1	1	0
2022	2	25	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	2	26	Cardiac disorders	Tachycardia	1	1	0
2022	2	26	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	2	26	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	2	26	General disorders and administration site conditions	Swelling	1	1	0
2022	2	26	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	2	26	Nervous system disorders	Migraine	1	1	0
2022	2	26	General disorders and administration site conditions	Chest pain	1	1	0
2022	2	26	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	2	26	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	2	26	Nervous system disorders	Amnesia	1	1	0
2022	2	26	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	2	26	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	2	27	Gastrointestinal disorders	Nausea	2	2	0
2022	2	27	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	2	27	Nervous system disorders	Headache	1	1	0
2022	2	27	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	2	27	Gastrointestinal disorders	Mouth swelling	1	1	0
2022	2	27	Infections and infestations	Pneumonia	1	1	0
2022	2	27	Cardiac disorders	Tachycardia	1	1	0
2022	2	27	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	2	27	General disorders and administration site conditions	Pain	1	1	0
2022	2	27	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	2	27	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	2	27	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	2	27	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	2	27	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	2	27	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	2	27	General disorders and administration site conditions	Fatigue	1	1	0
2022	2	27	Cardiac disorders	Atrial flutter	1	1	0
2022	2	27	Nervous system disorders	Dizziness	1	1	0
2022	2	27	General disorders and administration site conditions	Malaise	1	1	0
2022	2	27	General disorders and administration site conditions	Pyrexia	1	1	0
2022	2	27	Cardiac disorders	Atrial fibrillation	1	1	0
2022	2	27	General disorders and administration site conditions	Chills	1	1	0
2022	2	27	Infections and infestations	Cellulitis	1	1	0
2022	2	27	Psychiatric disorders	Anxiety	1	1	0
2022	2	28	Nervous system disorders	Headache	5	4	0
2022	2	28	Injury, poisoning and procedural complications	Vaccination error	5	5	0
2022	2	28	Nervous system disorders	Lethargy	4	4	0
2022	2	28	Nervous system disorders	Paraesthesia	4	4	0
2022	2	28	Nervous system disorders	Dizziness	4	3	0
2022	2	28	General disorders and administration site conditions	Pyrexia	4	3	0
2022	2	28	General disorders and administration site conditions	Chest pain	4	4	0
2022	2	28	General disorders and administration site conditions	Fatigue	4	3	0
2022	2	28	Injury, poisoning and procedural complications	Expired product administered	3	3	0
2022	2	28	Nervous system disorders	Cerebrovascular accident	3	3	0
2022	2	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	2	28	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	2	28	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	2	28	Gastrointestinal disorders	Nausea	3	2	0
2022	2	28	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	2	28	Musculoskeletal and connective tissue disorders	Neck pain	2	2	0
2022	2	28	General disorders and administration site conditions	Axillary pain	2	2	0
2022	2	28	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2022	2	28	General disorders and administration site conditions	Chills	2	2	0
2022	2	28	General disorders and administration site conditions	Concomitant disease aggravated	2	1	0
2022	2	28	General disorders and administration site conditions	Pain	2	2	0
2022	2	28	Nervous system disorders	Presyncope	2	2	0
2022	2	28	Psychiatric disorders	Confusional state	2	1	0
2022	2	28	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	2	28	General disorders and administration site conditions	Malaise	2	2	0
2022	2	28	Cardiac disorders	Palpitations	1	1	0
2022	2	28	General disorders and administration site conditions	Injection site pain	1	1	0
2022	2	28	Investigations	Red blood cell count decreased	1	1	0
2022	2	28	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2022	2	28	Psychiatric disorders	Depressed mood	1	0	0
2022	2	28	Gastrointestinal disorders	Vomiting	1	1	0
2022	2	28	Hepatobiliary disorders	Cholecystitis	1	1	0
2022	2	28	Infections and infestations	Viral infection	1	1	0
2022	2	28	Nervous system disorders	Nervous system disorder	1	1	0
2022	2	28	Nervous system disorders	Taste disorder	1	0	0
2022	2	28	General disorders and administration site conditions	Feeling abnormal	1	0	0
2022	2	28	Nervous system disorders	Parosmia	1	0	0
2022	2	28	Infections and infestations	Pneumonia	1	1	0
2022	2	28	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	2	28	Vascular disorders	Hypotension	1	1	0
2022	2	28	Infections and infestations	Mastitis	1	1	0
2022	2	28	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	2	28	Nervous system disorders	Disturbance in attention	1	0	0
2022	2	28	Skin and subcutaneous tissue disorders	Night sweats	1	0	0
2022	2	28	Cardiac disorders	Myocardial infarction	1	1	0
2022	2	28	Skin and subcutaneous tissue disorders	Sensitive skin	1	1	0
2022	2	28	Cardiac disorders	Pericardial effusion	1	1	0
2022	2	28	Cardiac disorders	Pericarditis	1	1	0
2022	2	28	General disorders and administration site conditions	Swelling	1	1	0
2022	2	28	Infections and infestations	COVID-19	1	1	0
2022	2	28	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	2	28	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Neoplasm malignant	1	1	0
2022	2	28	Nervous system disorders	Migraine	1	1	0
2022	2	28	Nervous system disorders	Somnolence	1	0	0
2022	2	28	Psychiatric disorders	Tearfulness	1	0	0
2022	2	28	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2022	2	28	Gastrointestinal disorders	Diarrhoea	1	0	0
2022	2	28	Nervous system disorders	Seizure	1	1	0
2022	2	28	Psychiatric disorders	Insomnia	1	0	0
2022	2	28	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	2	28	Skin and subcutaneous tissue disorders	Rash pruritic	1	0	0
2022	2	28	Cardiac disorders	Long QT syndrome	1	1	0
2022	2	28	General disorders and administration site conditions	Asthenia	1	0	0
2022	2	28	Eye disorders	Asthenopia	1	0	0
2022	2	28	Infections and infestations	Herpes zoster	1	1	0
2022	2	28	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Skin papilloma	1	1	0
2022	2	28	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	1	0
2022	2	28	Nervous system disorders	Coordination abnormal	1	0	0
2022	2	28	Psychiatric disorders	Anxiety	1	0	0
2022	2	28	Respiratory, thoracic and mediastinal disorders	Hypoxia	1	1	0
2022	3	1	General disorders and administration site conditions	Chest pain	4	4	0
2022	3	1	General disorders and administration site conditions	Injection site pain	3	3	0
2022	3	1	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	3	1	Nervous system disorders	Headache	2	2	0
2022	3	1	Injury, poisoning and procedural complications	Adverse event following immunisation	2	2	0
2022	3	1	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	1	Cardiac disorders	Myocarditis	2	2	0
2022	3	1	Cardiac disorders	Palpitations	2	2	0
2022	3	1	Gastrointestinal disorders	Nausea	2	2	0
2022	3	1	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	3	1	Hepatobiliary disorders	Cholelithiasis	2	2	0
2022	3	1	Nervous system disorders	Dizziness	2	2	0
2022	3	1	General disorders and administration site conditions	Fatigue	1	1	0
2022	3	1	Nervous system disorders	Dysgeusia	1	1	0
2022	3	1	Nervous system disorders	Syncope	1	1	0
2022	3	1	Renal and urinary disorders	Nephrolithiasis	1	1	0
2022	3	1	Cardiac disorders	Pericarditis	1	1	0
2022	3	1	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	3	1	Infections and infestations	COVID-19	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	3	1	Reproductive system and breast disorders	Pelvic pain	1	1	0
2022	3	1	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	1	Infections and infestations	Urinary tract infection	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Joint range of motion decreased	1	1	0
2022	3	1	Nervous system disorders	Burning sensation	1	1	0
2022	3	1	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	3	1	Immune system disorders	Allergic oedema	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	1	Skin and subcutaneous tissue disorders	Alopecia	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	3	1	Infections and infestations	Diverticulitis	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	3	1	General disorders and administration site conditions	Therapeutic response unexpected	1	1	0
2022	3	1	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	3	1	Nervous system disorders	Hypoaesthesia	1	1	0
2022	3	1	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2022	3	1	Cardiac disorders	Arteriospasm coronary	1	1	0
2022	3	1	Infections and infestations	Pneumonia	1	1	0
2022	3	1	Reproductive system and breast disorders	Infertility	1	1	0
2022	3	1	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2022	3	1	Vascular disorders	Hypotension	1	1	0
2022	3	1	Cardiac disorders	Atrial fibrillation	1	1	0
2022	3	1	Cardiac disorders	Cardiac disorder	1	1	0
2022	3	1	Cardiac disorders	Supraventricular tachyarrhythmia	1	1	0
2022	3	1	Injury, poisoning and procedural complications	Wrist fracture	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Scoliosis	1	1	0
2022	3	1	Investigations	Blood urine present	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Bursitis	1	1	0
2022	3	1	Cardiac disorders	Atrial flutter	1	1	0
2022	3	1	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	3	1	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	3	1	Skin and subcutaneous tissue disorders	Skin discolouration	1	1	0
2022	3	1	Infections and infestations	Herpes zoster	1	1	0
2022	3	1	Infections and infestations	Post-acute COVID-19 syndrome	1	1	0
2022	3	2	Ear and labyrinth disorders	Vertigo	4	4	0
2022	3	2	General disorders and administration site conditions	Chest pain	4	4	0
2022	3	2	Infections and infestations	COVID-19	4	4	0
2022	3	2	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	3	2	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	3	2	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Neoplasm malignant	2	2	0
2022	3	2	General disorders and administration site conditions	Injection site erythema	2	2	0
2022	3	2	Infections and infestations	Pneumonia	2	2	0
2022	3	2	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	3	2	Nervous system disorders	Lethargy	2	2	0
2022	3	2	Cardiac disorders	Palpitations	2	2	0
2022	3	2	General disorders and administration site conditions	Shoulder injury related to vaccine administration	2	2	0
2022	3	2	Injury, poisoning and procedural complications	Adverse event following immunisation	2	2	0
2022	3	2	Investigations	Electrocardiogram abnormal	2	2	0
2022	3	2	Cardiac disorders	Pericarditis	2	2	0
2022	3	2	General disorders and administration site conditions	Injection site rash	2	2	0
2022	3	2	Nervous system disorders	Headache	2	2	0
2022	3	2	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2022	3	2	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	2	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	3	2	Eye disorders	Eye haemorrhage	1	1	0
2022	3	2	General disorders and administration site conditions	Swelling face	1	1	0
2022	3	2	Nervous system disorders	Dizziness	1	1	0
2022	3	2	Cardiac disorders	Postural orthostatic tachycardia syndrome	1	1	0
2022	3	2	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	2	Immune system disorders	Anaphylactic reaction	1	1	0
2022	3	2	Nervous system disorders	Seizure	1	1	0
2022	3	2	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2022	3	2	Skin and subcutaneous tissue disorders	Cutaneous vasculitis	1	1	0
2022	3	2	Surgical and medical procedures	Surgery	1	1	0
2022	3	2	Cardiac disorders	Atrial fibrillation	1	1	0
2022	3	2	General disorders and administration site conditions	Chills	1	1	0
2022	3	2	Metabolism and nutrition disorders	Dehydration	1	1	0
2022	3	2	Nervous system disorders	Thalamic infarction	1	1	0
2022	3	2	Injury, poisoning and procedural complications	Skin laceration	1	1	0
2022	3	2	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	3	2	Metabolism and nutrition disorders	Gout	1	1	0
2022	3	2	Social circumstances	Loss of personal independence in daily activities	1	1	0
2022	3	2	Vascular disorders	Orthostatic hypotension	1	1	0
2022	3	2	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Lipoma	1	1	0
2022	3	2	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	3	2	Vascular disorders	Hypotension	1	1	0
2022	3	2	Gastrointestinal disorders	Nausea	1	1	0
2022	3	2	General disorders and administration site conditions	Ulcer	1	1	0
2022	3	2	Investigations	Troponin	1	1	0
2022	3	2	Investigations	Troponin increased	1	1	0
2022	3	2	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	3	2	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Malignant melanoma	1	1	0
2022	3	2	Nervous system disorders	Bell's palsy	1	1	0
2022	3	2	General disorders and administration site conditions	Concomitant disease aggravated	1	1	1
2022	3	2	Nervous system disorders	Memory impairment	1	1	0
2022	3	2	Psychiatric disorders	Confusional state	1	1	0
2022	3	2	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	3	2	Skin and subcutaneous tissue disorders	Skin swelling	1	1	0
2022	3	2	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	3	2	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	3	2	Metabolism and nutrition disorders	Hypomagnesaemia	1	1	0
2022	3	2	General disorders and administration site conditions	Pain	1	1	0
2022	3	2	Nervous system disorders	Occipital neuralgia	1	1	0
2022	3	2	Respiratory, thoracic and mediastinal disorders	Pleural effusion	1	1	0
2022	3	2	Cardiac disorders	Myocarditis	1	1	0
2022	3	2	Eye disorders	Conjunctival haemorrhage	1	1	0
2022	3	2	General disorders and administration site conditions	Fatigue	1	1	0
2022	3	2	General disorders and administration site conditions	Feeling cold	1	1	0
2022	3	2	Nervous system disorders	Paraesthesia	1	1	0
2022	3	2	Nervous system disorders	Syncope	1	1	0
2022	3	2	Cardiac disorders	Acute myocardial infarction	1	1	0
2022	3	2	Eye disorders	Photopsia	1	1	0
2022	3	2	Investigations	Echocardiogram abnormal	1	1	0
2022	3	2	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2022	3	2	Nervous system disorders	Migraine	1	1	0
2022	3	3	General disorders and administration site conditions	Chest pain	6	6	0
2022	3	3	Respiratory, thoracic and mediastinal disorders	Dyspnoea	5	5	0
2022	3	3	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2022	3	3	Gastrointestinal disorders	Vomiting	3	3	0
2022	3	3	General disorders and administration site conditions	Pyrexia	3	3	0
2022	3	3	Nervous system disorders	Dizziness	3	3	0
2022	3	3	Psychiatric disorders	Confusional state	3	3	0
2022	3	3	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2022	3	3	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	3	3	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	3	3	Nervous system disorders	Headache	2	2	0
2022	3	3	Blood and lymphatic system disorders	Neutropenia	2	2	0
2022	3	3	Nervous system disorders	Transient global amnesia	1	1	0
2022	3	3	Vascular disorders	Hypertension	1	1	0
2022	3	3	Immune system disorders	Anaphylactic reaction	1	1	0
2022	3	3	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2022	3	3	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	3	3	Ear and labyrinth disorders	Deafness neurosensory	1	1	0
2022	3	3	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	3	3	Infections and infestations	Cytomegalovirus infection	1	1	0
2022	3	3	Infections and infestations	Endometritis	1	1	0
2022	3	3	Cardiac disorders	Pericarditis	1	1	0
2022	3	3	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	3	3	General disorders and administration site conditions	Feeling hot	1	1	0
2022	3	3	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	3	3	Nervous system disorders	Migraine	1	1	0
2022	3	3	Gastrointestinal disorders	Colitis	1	1	0
2022	3	3	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	3	Cardiac disorders	Myocardial infarction	1	1	0
2022	3	3	Cardiac disorders	Tachycardia	1	1	0
2022	3	3	Infections and infestations	Tonsillitis	1	1	0
2022	3	3	Gastrointestinal disorders	Nausea	1	1	0
2022	3	3	Infections and infestations	Diverticulitis	1	1	0
2022	3	3	Investigations	Troponin	1	1	0
2022	3	3	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	3	3	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Colon cancer	1	1	0
2022	3	3	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Malignant melanoma	1	1	0
2022	3	3	Cardiac disorders	Palpitations	1	1	0
2022	3	3	Nervous system disorders	Lethargy	1	1	0
2022	3	3	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	3	Nervous system disorders	Transient ischaemic attack	1	1	0
2022	3	3	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	3	3	Infections and infestations	Pneumonia	1	1	0
2022	3	3	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	3	3	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	3	4	General disorders and administration site conditions	Chest pain	4	3	0
2022	3	4	General disorders and administration site conditions	Pyrexia	3	3	0
2022	3	4	General disorders and administration site conditions	Fatigue	3	3	0
2022	3	4	Nervous system disorders	Headache	3	3	0
2022	3	4	Cardiac disorders	Pericarditis	2	2	0
2022	3	4	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	3	4	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	4	Immune system disorders	Hypersensitivity	2	2	0
2022	3	4	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	4	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	3	4	Nervous system disorders	Paresis	1	1	0
2022	3	4	Cardiac disorders	Cardiac discomfort	1	1	0
2022	3	4	Cardiac disorders	Myocarditis	1	1	0
2022	3	4	Injury, poisoning and procedural complications	Hip fracture	1	1	0
2022	3	4	Investigations	Echocardiogram	1	1	0
2022	3	4	Nervous system disorders	Dysgeusia	1	1	0
2022	3	4	Nervous system disorders	Paraesthesia	1	1	0
2022	3	4	Psychiatric disorders	Depression	1	1	0
2022	3	4	Renal and urinary disorders	Nephrolithiasis	1	1	0
2022	3	4	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	3	4	Nervous system disorders	Tremor	1	1	0
2022	3	4	Psychiatric disorders	Conversion disorder	1	1	0
2022	3	4	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	4	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	4	Hepatobiliary disorders	Liver disorder	1	1	0
2022	3	4	Infections and infestations	Appendicitis perforated	1	1	0
2022	3	4	Investigations	Computerised tomogram thorax	1	1	0
2022	3	4	Investigations	Electrocardiogram	1	1	0
2022	3	4	Nervous system disorders	Speech disorder	1	1	0
2022	3	4	Gastrointestinal disorders	Nausea	1	1	0
2022	3	4	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	4	Investigations	Troponin	1	1	0
2022	3	4	Metabolism and nutrition disorders	Electrolyte imbalance	1	1	0
2022	3	4	Nervous system disorders	Lethargy	1	0	0
2022	3	4	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2022	3	4	Psychiatric disorders	Suicidal ideation	1	1	0
2022	3	4	Cardiac disorders	Palpitations	1	1	0
2022	3	4	Psychiatric disorders	Confusional state	1	1	0
2022	3	4	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	3	4	Investigations	Blood creatine phosphokinase	1	0	0
2022	3	4	Nervous system disorders	Facial paralysis	1	1	0
2022	3	4	General disorders and administration site conditions	Chills	1	1	0
2022	3	4	Psychiatric disorders	Anxiety	1	1	0
2022	3	4	Skin and subcutaneous tissue disorders	Rash pruritic	1	0	0
2022	3	5	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2022	3	5	General disorders and administration site conditions	Fatigue	3	3	0
2022	3	5	General disorders and administration site conditions	Pyrexia	2	2	0
2022	3	5	Nervous system disorders	Headache	2	2	0
2022	3	5	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	5	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	1	0
2022	3	5	General disorders and administration site conditions	Chills	2	2	0
2022	3	5	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	3	5	Gastrointestinal disorders	Nausea	2	1	0
2022	3	5	Skin and subcutaneous tissue disorders	Pruritus	2	2	0
2022	3	5	Gastrointestinal disorders	Tongue disorder	1	1	0
2022	3	5	General disorders and administration site conditions	Discomfort	1	1	0
2022	3	5	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	3	5	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	5	Immune system disorders	Hypersensitivity	1	0	0
2022	3	5	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	3	5	Skin and subcutaneous tissue disorders	Pain of skin	1	1	0
2022	3	5	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	3	5	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	3	5	General disorders and administration site conditions	Pain	1	1	0
2022	3	5	Nervous system disorders	Taste disorder	1	1	0
2022	3	5	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	3	5	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	3	5	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	3	5	General disorders and administration site conditions	Swelling	1	1	0
2022	3	5	Nervous system disorders	Paraesthesia	1	1	0
2022	3	5	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	0	0
2022	3	5	General disorders and administration site conditions	Malaise	1	1	0
2022	3	5	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	1	0
2022	3	5	Nervous system disorders	Dizziness	1	1	0
2022	3	5	Respiratory, thoracic and mediastinal disorders	Wheezing	1	0	0
2022	3	6	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	3	6	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	6	Nervous system disorders	Migraine	1	1	0
2022	3	6	General disorders and administration site conditions	Chest pain	1	1	0
2022	3	6	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	3	6	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	6	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	3	6	Nervous system disorders	Headache	1	1	0
2022	3	6	Nervous system disorders	Lethargy	1	1	0
2022	3	6	General disorders and administration site conditions	Malaise	1	1	0
2022	3	6	Skin and subcutaneous tissue disorders	Erythema multiforme	1	1	0
2022	3	6	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	6	Eye disorders	Blindness	1	1	0
2022	3	6	Skin and subcutaneous tissue disorders	Alopecia areata	1	1	0
2022	3	7	General disorders and administration site conditions	Chest pain	4	4	0
2022	3	7	Nervous system disorders	Dizziness	3	3	0
2022	3	7	Nervous system disorders	Headache	3	3	0
2022	3	7	General disorders and administration site conditions	Pyrexia	2	2	0
2022	3	7	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	7	General disorders and administration site conditions	Injection site pain	2	2	0
2022	3	7	General disorders and administration site conditions	Fatigue	2	2	0
2022	3	7	Gastrointestinal disorders	Vomiting	2	2	0
2022	3	7	Musculoskeletal and connective tissue disorders	Back pain	2	2	0
2022	3	7	Cardiac disorders	Palpitations	2	2	0
2022	3	7	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	7	Nervous system disorders	Hypoaesthesia	1	1	0
2022	3	7	Investigations	Chest X-ray abnormal	1	1	0
2022	3	7	Respiratory, thoracic and mediastinal disorders	Pleurisy	1	1	0
2022	3	7	Gastrointestinal disorders	Nausea	1	1	0
2022	3	7	Hepatobiliary disorders	Cholecystitis	1	1	0
2022	3	7	Investigations	Troponin	1	1	0
2022	3	7	Psychiatric disorders	Delirium	1	1	0
2022	3	7	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	3	7	Gastrointestinal disorders	Pancreatitis	1	1	0
2022	3	7	Hepatobiliary disorders	Cholelithiasis	1	1	0
2022	3	7	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	3	7	Cardiac disorders	Myocarditis	1	1	0
2022	3	7	Nervous system disorders	Syncope	1	1	0
2022	3	7	Renal and urinary disorders	Nephrolithiasis	1	1	0
2022	3	7	Skin and subcutaneous tissue disorders	Eczema	1	1	0
2022	3	7	Blood and lymphatic system disorders	Anaemia	1	1	0
2022	3	7	Cardiac disorders	Pericarditis	1	1	0
2022	3	7	Investigations	Echocardiogram abnormal	1	1	0
2022	3	7	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Breast cancer	1	1	0
2022	3	7	Nervous system disorders	Migraine	1	1	0
2022	3	7	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2022	3	7	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	3	7	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	7	Pregnancy, puerperium and perinatal conditions	Stillbirth	1	1	0
2022	3	7	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	7	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	3	7	General disorders and administration site conditions	Asthenia	1	1	0
2022	3	7	Infections and infestations	Urinary tract infection	1	1	0
2022	3	7	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	3	7	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	3	7	Infections and infestations	Herpes zoster	1	1	0
2022	3	7	Ear and labyrinth disorders	Ear pain	1	1	0
2022	3	7	General disorders and administration site conditions	Oedema	1	1	0
2022	3	7	Nervous system disorders	Cerebrovascular accident	1	1	0
2022	3	7	Vascular disorders	Pallor	1	1	0
2022	3	7	Cardiac disorders	Atrial fibrillation	1	1	0
2022	3	7	Investigations	Fibrin D dimer	1	1	0
2022	3	7	Investigations	Magnetic resonance imaging heart	1	1	0
2022	3	7	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	3	7	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	3	7	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	3	8	General disorders and administration site conditions	Chest pain	4	4	0
2022	3	8	Infections and infestations	Herpes zoster	4	4	0
2022	3	8	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2022	3	8	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	3	8	Nervous system disorders	Dizziness	3	3	0
2022	3	8	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	3	8	Nervous system disorders	Migraine	3	3	0
2022	3	8	General disorders and administration site conditions	Fatigue	3	3	0
2022	3	8	Nervous system disorders	Headache	3	3	0
2022	3	8	Cardiac disorders	Pericarditis	3	3	0
2022	3	8	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2022	3	8	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	8	General disorders and administration site conditions	Chills	2	2	0
2022	3	8	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	2	2	0
2022	3	8	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	2	2	0
2022	3	8	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	3	8	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	8	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	8	Investigations	SARS-CoV-2 test positive	1	1	0
2022	3	8	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	3	8	Nervous system disorders	Bell's palsy	1	1	0
2022	3	8	Cardiac disorders	Palpitations	1	1	0
2022	3	8	General disorders and administration site conditions	Injection site inflammation	1	1	0
2022	3	8	General disorders and administration site conditions	Injection site pain	1	1	0
2022	3	8	Nervous system disorders	Lethargy	1	1	0
2022	3	8	Psychiatric disorders	Confusional state	1	1	0
2022	3	8	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	3	8	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	3	8	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	3	8	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	8	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	8	Cardiac disorders	Myocardial infarction	1	1	0
2022	3	8	Cardiac disorders	Tachycardia	1	1	0
2022	3	8	Reproductive system and breast disorders	Amenorrhoea	1	1	0
2022	3	8	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	3	8	Cardiac disorders	Myocarditis	1	1	0
2022	3	8	Gastrointestinal disorders	Oesophageal varices haemorrhage	1	1	0
2022	3	8	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2022	3	8	Immune system disorders	Hypersensitivity	1	1	0
2022	3	8	Nervous system disorders	Syncope	1	1	0
2022	3	8	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2022	3	8	Ear and labyrinth disorders	Vertigo	1	1	0
2022	3	8	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Breast cancer	1	1	0
2022	3	8	Reproductive system and breast disorders	Adnexa uteri pain	1	1	0
2022	3	8	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2022	3	8	Social circumstances	Bedridden	1	1	0
2022	3	8	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	3	8	General disorders and administration site conditions	Malaise	1	1	0
2022	3	8	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	3	8	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	3	8	General disorders and administration site conditions	Swelling face	1	1	0
2022	3	8	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	8	Reproductive system and breast disorders	Uterine haemorrhage	1	1	0
2022	3	8	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	3	8	Skin and subcutaneous tissue disorders	Skin mass	1	1	0
2022	3	9	Blood and lymphatic system disorders	Lymphadenopathy	5	5	0
2022	3	9	General disorders and administration site conditions	Chest pain	3	3	0
2022	3	9	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	9	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	3	9	Nervous system disorders	Headache	2	2	0
2022	3	9	Nervous system disorders	Paraesthesia	2	2	0
2022	3	9	Cardiac disorders	Myocarditis	2	2	0
2022	3	9	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	9	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	3	9	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	3	9	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	3	9	Investigations	Troponin increased	1	1	0
2022	3	9	Vascular disorders	Peripheral artery thrombosis	1	1	0
2022	3	9	Cardiac disorders	Pericarditis	1	1	0
2022	3	9	Ear and labyrinth disorders	Vertigo	1	1	0
2022	3	9	General disorders and administration site conditions	Swelling	1	1	0
2022	3	9	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	3	9	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	3	9	General disorders and administration site conditions	Fatigue	1	1	0
2022	3	9	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	3	9	Cardiac disorders	Tachycardia	1	1	0
2022	3	9	General disorders and administration site conditions	Asthenia	1	1	0
2022	3	9	General disorders and administration site conditions	Pain	1	1	0
2022	3	9	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	3	9	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	3	9	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	9	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	3	9	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	3	9	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	3	10	General disorders and administration site conditions	Chest pain	4	4	0
2022	3	10	Musculoskeletal and connective tissue disorders	Myalgia	3	2	0
2022	3	10	General disorders and administration site conditions	Pyrexia	3	3	0
2022	3	10	Nervous system disorders	Paraesthesia	3	3	0
2022	3	10	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	3	10	General disorders and administration site conditions	Malaise	2	2	0
2022	3	10	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2022	3	10	Infections and infestations	Herpes zoster	2	2	0
2022	3	10	Immune system disorders	Anaphylactic reaction	1	1	0
2022	3	10	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	3	10	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	3	10	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	3	10	General disorders and administration site conditions	Chills	1	1	0
2022	3	10	Investigations	Hepatitis C virus test positive	1	1	0
2022	3	10	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2022	3	10	Eye disorders	Swelling of eyelid	1	1	0
2022	3	10	General disorders and administration site conditions	Injection site pain	1	0	0
2022	3	10	Nervous system disorders	Dizziness	1	1	0
2022	3	10	Nervous system disorders	Presyncope	1	1	0
2022	3	10	Nervous system disorders	Headache	1	1	0
2022	3	10	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	3	10	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	3	10	Gastrointestinal disorders	Nausea	1	1	0
2022	3	10	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	10	Psychiatric disorders	Dysphemia	1	0	0
2022	3	10	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	3	10	General disorders and administration site conditions	Injection site rash	1	1	0
2022	3	10	Investigations	Electrocardiogram	1	1	0
2022	3	10	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	3	10	Skin and subcutaneous tissue disorders	Rash	1	0	0
2022	3	10	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	3	10	General disorders and administration site conditions	Inflammation	1	1	0
2022	3	10	Investigations	Liver function test abnormal	1	1	0
2022	3	10	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	3	10	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	3	10	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	3	10	Cardiac disorders	Myocarditis	1	1	0
2022	3	10	General disorders and administration site conditions	Fatigue	1	1	0
2022	3	10	Infections and infestations	Cytomegalovirus infection	1	1	0
2022	3	10	Psychiatric disorders	Insomnia	1	1	0
2022	3	10	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	3	10	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	3	10	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	10	Infections and infestations	Epstein-Barr virus infection	1	1	0
2022	3	10	Infections and infestations	Nasopharyngitis	1	1	0
2022	3	10	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	3	10	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	3	11	General disorders and administration site conditions	Chest pain	3	3	0
2022	3	11	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	3	11	Musculoskeletal and connective tissue disorders	Neck pain	2	2	0
2022	3	11	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	3	11	General disorders and administration site conditions	Pyrexia	2	2	0
2022	3	11	General disorders and administration site conditions	Fatigue	2	2	0
2022	3	11	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	11	Nervous system disorders	Tremor	1	1	0
2022	3	11	Psychiatric disorders	Conversion disorder	1	1	0
2022	3	11	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	3	11	General disorders and administration site conditions	Asthenia	1	1	0
2022	3	11	General disorders and administration site conditions	Pain	1	1	0
2022	3	11	General disorders and administration site conditions	Vaccination site movement impairment	1	1	0
2022	3	11	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	3	11	Nervous system disorders	Migraine	1	1	0
2022	3	11	Eye disorders	Photophobia	1	1	0
2022	3	11	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	3	11	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	3	11	Gastrointestinal disorders	Nausea	1	1	0
2022	3	11	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	11	Nervous system disorders	Headache	1	1	0
2022	3	11	Nervous system disorders	Lethargy	1	1	0
2022	3	11	Vascular disorders	Varicose vein	1	1	0
2022	3	11	Eye disorders	Vision blurred	1	1	0
2022	3	11	Gastrointestinal disorders	Colitis ulcerative	1	1	0
2022	3	11	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	3	11	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	3	11	General disorders and administration site conditions	Swelling face	1	1	0
2022	3	11	Investigations	Heart rate increased	1	1	0
2022	3	11	Vascular disorders	Pallor	1	1	0
2022	3	11	General disorders and administration site conditions	Malaise	1	1	0
2022	3	11	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	3	12	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	3	12	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	3	12	Psychiatric disorders	Depressed mood	1	1	0
2022	3	12	Nervous system disorders	Trigeminal neuralgia	1	1	0
2022	3	13	Renal and urinary disorders	Renal pain	1	1	0
2022	3	14	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2022	3	14	General disorders and administration site conditions	Chest pain	3	3	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	14	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	3	14	General disorders and administration site conditions	Pyrexia	2	2	0
2022	3	14	General disorders and administration site conditions	Fatigue	2	2	0
2022	3	14	General disorders and administration site conditions	Peripheral swelling	2	2	0
2022	3	14	Nervous system disorders	Dizziness	2	2	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	2	2	0
2022	3	14	General disorders and administration site conditions	Injection site pain	2	1	0
2022	3	14	Cardiac disorders	Palpitations	1	1	0
2022	3	14	Infections and infestations	Appendicitis	1	0	0
2022	3	14	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	3	14	Nervous system disorders	Memory impairment	1	1	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Haemoptysis	1	0	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Nasal dryness	1	0	0
2022	3	14	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	14	General disorders and administration site conditions	Injection site bruising	1	1	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	0	0
2022	3	14	General disorders and administration site conditions	Mass	1	1	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Interstitial lung disease	1	0	0
2022	3	14	General disorders and administration site conditions	Systemic inflammatory response syndrome	1	0	0
2022	3	14	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2022	3	14	Nervous system disorders	Headache	1	0	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Upper respiratory tract inflammation	1	0	0
2022	3	14	Gastrointestinal disorders	Abdominal pain lower	1	0	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Nasal crusting	1	0	0
2022	3	14	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	14	General disorders and administration site conditions	Pain	1	1	0
2022	3	14	Musculoskeletal and connective tissue disorders	Muscle fatigue	1	1	0
2022	3	14	Nervous system disorders	Balance disorder	1	1	0
2022	3	14	Gastrointestinal disorders	Inflammatory bowel disease	1	0	0
2022	3	14	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	3	14	Metabolism and nutrition disorders	Decreased appetite	1	0	0
2022	3	14	Respiratory, thoracic and mediastinal disorders	Cough	1	0	0
2022	3	15	Injury, poisoning and procedural complications	Vaccination error	6	6	0
2022	3	15	General disorders and administration site conditions	Chest discomfort	5	4	0
2022	3	15	Nervous system disorders	Paraesthesia	4	3	0
2022	3	15	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	3	0
2022	3	15	Nervous system disorders	Headache	4	4	0
2022	3	15	General disorders and administration site conditions	Injection site reaction	4	3	0
2022	3	15	General disorders and administration site conditions	Chest pain	4	3	0
2022	3	15	Nervous system disorders	Dizziness	3	3	0
2022	3	15	Nervous system disorders	Lethargy	3	2	0
2022	3	15	Gastrointestinal disorders	Nausea	3	3	0
2022	3	15	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	3	3	0
2022	3	15	General disorders and administration site conditions	Fatigue	3	3	0
2022	3	15	Injury, poisoning and procedural complications	Wrong product administered	2	2	0
2022	3	15	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	3	15	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	15	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	3	15	Cardiac disorders	Palpitations	2	2	0
2022	3	15	Nervous system disorders	Seizure	2	1	0
2022	3	15	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	3	15	Investigations	C-reactive protein increased	1	1	0
2022	3	15	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	3	15	Cardiac disorders	Pericarditis	1	1	0
2022	3	15	Nervous system disorders	Migraine	1	1	0
2022	3	15	Infections and infestations	Metapneumovirus infection	1	0	0
2022	3	15	Skin and subcutaneous tissue disorders	Alopecia	1	1	0
2022	3	15	Vascular disorders	Pallor	1	0	0
2022	3	15	Cardiac disorders	Tachycardia	1	1	0
2022	3	15	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	3	15	Investigations	Blood pressure increased	1	1	0
2022	3	15	Gastrointestinal disorders	Dry mouth	1	1	0
2022	3	15	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	3	15	Infections and infestations	Appendicitis	1	1	0
2022	3	15	Nervous system disorders	Hypoaesthesia	1	1	0
2022	3	15	Skin and subcutaneous tissue disorders	Cutaneous vasculitis	1	0	0
2022	3	15	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	3	15	Musculoskeletal and connective tissue disorders	Costochondritis	1	0	0
2022	3	15	Nervous system disorders	Somnolence	1	1	0
2022	3	15	Reproductive system and breast disorders	Ovarian cyst ruptured	1	1	0
2022	3	15	Skin and subcutaneous tissue disorders	Rash	1	0	0
2022	3	15	Blood and lymphatic system disorders	Anaemia	1	0	0
2022	3	15	General disorders and administration site conditions	Injection site pain	1	1	0
2022	3	15	Metabolism and nutrition disorders	Diabetes mellitus	1	1	0
2022	3	15	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	3	15	Nervous system disorders	Loss of consciousness	1	0	0
2022	3	15	Psychiatric disorders	Confusional state	1	1	0
2022	3	15	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	15	Injury, poisoning and procedural complications	Product storage error	1	1	0
2022	3	15	Nervous system disorders	Bell's palsy	1	1	0
2022	3	15	Cardiac disorders	Atrial fibrillation	1	0	0
2022	3	15	Cardiac disorders	Cardiac flutter	1	1	0
2022	3	15	General disorders and administration site conditions	Oedema	1	0	0
2022	3	15	Cardiac disorders	Atrial flutter	1	1	0
2022	3	15	General disorders and administration site conditions	Influenza like illness	1	0	0
2022	3	15	Investigations	Heart rate increased	1	1	0
2022	3	15	Vascular disorders	Hypertension	1	1	0
2022	3	15	Eye disorders	Eye pruritus	1	1	0
2022	3	15	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	3	15	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2022	3	15	Renal and urinary disorders	Renal impairment	1	1	0
2022	3	15	Eye disorders	Visual impairment	1	1	0
2022	3	15	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	15	Psychiatric disorders	Disorientation	1	1	0
2022	3	15	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	3	16	Injury, poisoning and procedural complications	Vaccination error	4	4	0
2022	3	16	General disorders and administration site conditions	Pyrexia	3	3	0
2022	3	16	Cardiac disorders	Pericarditis	3	2	0
2022	3	16	General disorders and administration site conditions	Chest pain	2	2	0
2022	3	16	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	16	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	3	16	General disorders and administration site conditions	Fatigue	2	2	0
2022	3	16	Psychiatric disorders	Insomnia	2	2	0
2022	3	16	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	1	0
2022	3	16	Gastrointestinal disorders	Vomiting	2	2	0
2022	3	16	General disorders and administration site conditions	Peripheral swelling	2	2	0
2022	3	16	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2022	3	16	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	3	16	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	3	16	Gastrointestinal disorders	Nausea	2	2	0
2022	3	16	General disorders and administration site conditions	Malaise	2	2	0
2022	3	16	General disorders and administration site conditions	Injection site pain	1	1	0
2022	3	16	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	3	16	Nervous system disorders	Headache	1	1	0
2022	3	16	Social circumstances	Loss of personal independence in daily activities	1	1	0
2022	3	16	Nervous system disorders	Hypokinesia	1	1	0
2022	3	16	Immune system disorders	Hypersensitivity	1	1	0
2022	3	16	Nervous system disorders	Paraesthesia	1	1	0
2022	3	16	Nervous system disorders	Syncope	1	1	0
2022	3	16	Gastrointestinal disorders	Gastritis	1	1	0
2022	3	16	General disorders and administration site conditions	Swelling	1	1	0
2022	3	16	Investigations	Grip strength decreased	1	1	0
2022	3	16	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	16	Cardiac disorders	Postural orthostatic tachycardia syndrome	1	0	0
2022	3	16	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	3	16	General disorders and administration site conditions	Asthenia	1	1	0
2022	3	16	General disorders and administration site conditions	Pain	1	1	0
2022	3	16	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	3	16	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	3	16	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	3	16	Skin and subcutaneous tissue disorders	Dermatitis bullous	1	1	0
2022	3	16	Cardiac disorders	Atrial fibrillation	1	1	0
2022	3	16	Infections and infestations	Cellulitis	1	1	0
2022	3	16	Musculoskeletal and connective tissue disorders	Arthritis	1	1	0
2022	3	16	General disorders and administration site conditions	Thirst	1	1	0
2022	3	16	Infections and infestations	Diabetic foot infection	1	1	0
2022	3	16	General disorders and administration site conditions	Oedema	1	1	0
2022	3	16	Nervous system disorders	Dizziness	1	1	0
2022	3	17	General disorders and administration site conditions	Chest pain	5	5	0
2022	3	17	General disorders and administration site conditions	Fatigue	3	3	0
2022	3	17	Nervous system disorders	Headache	3	3	0
2022	3	17	Nervous system disorders	Syncope	3	3	0
2022	3	17	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	3	17	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	3	17	Cardiac disorders	Palpitations	2	2	0
2022	3	17	Injury, poisoning and procedural complications	Adverse event following immunisation	2	2	1
2022	3	17	Cardiac disorders	Pericarditis	2	2	0
2022	3	17	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	17	General disorders and administration site conditions	Chills	1	1	0
2022	3	17	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	3	17	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	3	17	Investigations	Heart rate increased	1	1	0
2022	3	17	Vascular disorders	Hypertension	1	1	0
2022	3	17	General disorders and administration site conditions	Malaise	1	1	0
2022	3	17	Nervous system disorders	Incoherent	1	1	0
2022	3	17	General disorders and administration site conditions	Pain	1	1	0
2022	3	17	Investigations	Blood creatine phosphokinase increased	1	1	0
2022	3	17	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	3	17	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	17	Nervous system disorders	Neuropathy peripheral	1	1	0
2022	3	17	Cardiac disorders	Arrhythmia	1	1	0
2022	3	17	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	17	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	3	17	Nervous system disorders	Cerebral thrombosis	1	1	0
2022	3	17	Nervous system disorders	Lacunar stroke	1	1	0
2022	3	17	Skin and subcutaneous tissue disorders	Skin reaction	1	1	0
2022	3	17	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	3	17	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	3	17	General disorders and administration site conditions	Injection site pain	1	1	0
2022	3	17	Hepatobiliary disorders	Hypertransaminasaemia	1	1	0
2022	3	17	Psychiatric disorders	Confusional state	1	1	0
2022	3	17	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	3	17	Vascular disorders	Deep vein thrombosis	1	1	0
2022	3	17	Gastrointestinal disorders	Nausea	1	1	0
2022	3	17	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	18	Nervous system disorders	Headache	4	4	0
2022	3	18	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	3	18	Skin and subcutaneous tissue disorders	Rash	3	3	0
2022	3	18	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	18	Nervous system disorders	Tremor	2	2	0
2022	3	18	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	3	18	General disorders and administration site conditions	Pyrexia	2	2	0
2022	3	18	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	3	18	General disorders and administration site conditions	Chest discomfort	2	2	0
2022	3	18	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2022	3	18	Gastrointestinal disorders	Vomiting	2	2	0
2022	3	18	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	3	18	Ear and labyrinth disorders	Vertigo	1	1	0
2022	3	18	General disorders and administration site conditions	Swelling	1	1	0
2022	3	18	Nervous system disorders	Migraine	1	1	0
2022	3	18	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	3	18	Gastrointestinal disorders	Reflux gastritis	1	1	0
2022	3	18	General disorders and administration site conditions	Fatigue	1	1	0
2022	3	18	Infections and infestations	Pharyngitis	1	1	0
2022	3	18	Eye disorders	Pupillary reflex impaired	1	1	0
2022	3	18	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	3	18	General disorders and administration site conditions	Pain	1	1	0
2022	3	18	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	3	18	Cardiac disorders	Palpitations	1	1	0
2022	3	18	Eye disorders	Vitreous haemorrhage	1	1	0
2022	3	18	Investigations	Body temperature increased	1	1	0
2022	3	18	Nervous system disorders	Lethargy	1	1	0
2022	3	18	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	3	18	Gastrointestinal disorders	Nausea	1	1	0
2022	3	18	Musculoskeletal and connective tissue disorders	Foot deformity	1	1	0
2022	3	18	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	3	18	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	3	18	General disorders and administration site conditions	Chest pain	1	1	0
2022	3	18	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	3	18	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	3	18	Gastrointestinal disorders	Crohn's disease	1	1	0
2022	3	18	General disorders and administration site conditions	Chills	1	1	0
2022	3	18	Infections and infestations	Sepsis	1	1	0
2022	3	18	Respiratory, thoracic and mediastinal disorders	Tachypnoea	1	1	0
2022	3	18	Eye disorders	Vision blurred	1	1	0
2022	3	18	Immune system disorders	Anaphylactic reaction	1	1	0
2022	3	18	General disorders and administration site conditions	Swelling face	1	1	0
2022	3	18	Investigations	Heart rate increased	1	1	0
2022	3	18	Nervous system disorders	Optic neuritis	1	1	0
2022	3	18	General disorders and administration site conditions	Malaise	1	1	0
2022	3	18	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	3	19	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	3	19	Reproductive system and breast disorders	Heavy menstrual bleeding	2	2	0
2022	3	19	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	3	19	Nervous system disorders	Sedation complication	1	1	0
2022	3	19	Endocrine disorders	Autoimmune thyroid disorder	1	1	0
2022	3	19	Injury, poisoning and procedural complications	Sedation complication	1	1	0
2022	3	19	General disorders and administration site conditions	Chest pain	1	1	0
2022	3	19	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	3	19	Investigations	Troponin increased	1	1	0
2022	3	19	Infections and infestations	Nasopharyngitis	1	1	0
2022	3	19	Renal and urinary disorders	Chromaturia	1	1	0
2022	3	19	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	3	19	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	3	19	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	3	19	Vascular disorders	Thrombosis	1	1	0
2022	3	19	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	3	19	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	3	19	General disorders and administration site conditions	Fatigue	1	1	0
2022	3	19	General disorders and administration site conditions	Feeling cold	1	1	0
2022	3	19	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	3	20	General disorders and administration site conditions	Pyrexia	3	3	0
2022	3	20	General disorders and administration site conditions	Fatigue	3	3	0
2022	3	20	Nervous system disorders	Headache	3	3	0
2022	3	20	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	20	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	3	20	Social circumstances	Impaired work ability	2	2	0
2022	3	20	General disorders and administration site conditions	Injection site pain	1	1	0
2022	3	20	Psychiatric disorders	Confusional state	1	1	0
2022	3	20	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	20	General disorders and administration site conditions	Chest pain	1	1	0
2022	3	20	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	3	20	General disorders and administration site conditions	Swelling	1	1	0
2022	3	20	Nervous system disorders	Migraine	1	1	0
2022	3	20	Nervous system disorders	Paraesthesia	1	1	0
2022	3	20	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	20	General disorders and administration site conditions	Pain	1	1	0
2022	3	20	Nervous system disorders	Dizziness	1	1	0
2022	3	20	Musculoskeletal and connective tissue disorders	Muscle discomfort	1	1	0
2022	3	20	General disorders and administration site conditions	Chills	1	1	0
2022	3	21	General disorders and administration site conditions	Chest pain	4	4	0
2022	3	21	Cardiac disorders	Myocarditis	3	3	0
2022	3	21	Investigations	Troponin increased	3	3	0
2022	3	21	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	3	21	Gastrointestinal disorders	Vomiting	2	2	0
2022	3	21	Injury, poisoning and procedural complications	Adverse event following immunisation	2	2	1
2022	3	21	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	21	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	3	21	Gastrointestinal disorders	Lip swelling	1	1	0
2022	3	21	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	21	Musculoskeletal and connective tissue disorders	Bursitis	1	1	0
2022	3	21	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	3	21	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	3	21	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	3	21	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	1	0
2022	3	21	Nervous system disorders	Cerebrovascular accident	1	1	0
2022	3	21	Investigations	Echocardiogram abnormal	1	1	0
2022	3	21	Nervous system disorders	Migraine	1	1	0
2022	3	21	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2022	3	21	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	3	21	Investigations	Echocardiogram	1	1	0
2022	3	21	Nervous system disorders	Syncope	1	1	0
2022	3	21	Renal and urinary disorders	Nephrolithiasis	1	1	0
2022	3	21	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	3	21	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	3	21	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	3	21	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	3	21	Gastrointestinal disorders	Constipation	1	1	0
2022	3	21	General disorders and administration site conditions	Asthenia	1	1	0
2022	3	21	Injury, poisoning and procedural complications	Fracture	1	1	0
2022	3	21	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	3	21	Investigations	Electrocardiogram	1	1	0
2022	3	21	Nervous system disorders	Generalised tonic-clonic seizure	1	1	0
2022	3	21	Nervous system disorders	Hypoaesthesia	1	1	0
2022	3	21	Gastrointestinal disorders	Nausea	1	1	0
2022	3	21	Cardiac disorders	Palpitations	1	1	0
2022	3	21	Hepatobiliary disorders	Cholelithiasis	1	1	0
2022	3	21	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	3	22	General disorders and administration site conditions	Fatigue	4	4	0
2022	3	22	General disorders and administration site conditions	Chest pain	4	4	0
2022	3	22	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	3	22	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	3	22	Nervous system disorders	Headache	3	3	0
2022	3	22	Cardiac disorders	Pericarditis	3	3	0
2022	3	22	Musculoskeletal and connective tissue disorders	Arthralgia	3	2	0
2022	3	22	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	3	22	Nervous system disorders	Paraesthesia	2	2	0
2022	3	22	Gastrointestinal disorders	Nausea	2	2	0
2022	3	22	General disorders and administration site conditions	Influenza like illness	2	2	0
2022	3	22	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	3	22	General disorders and administration site conditions	Chills	1	1	0
2022	3	22	Nervous system disorders	Neuropathy peripheral	1	0	0
2022	3	22	Respiratory, thoracic and mediastinal disorders	Dyspnoea exertional	1	1	0
2022	3	22	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	22	Immune system disorders	Anaphylactic reaction	1	1	0
2022	3	22	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	3	22	Ear and labyrinth disorders	Ear pain	1	1	0
2022	3	22	Nervous system disorders	Cerebrovascular accident	1	1	0
2022	3	22	Vascular disorders	Hypertension	1	1	0
2022	3	22	General disorders and administration site conditions	Facial pain	1	1	0
2022	3	22	Musculoskeletal and connective tissue disorders	Musculoskeletal stiffness	1	1	0
2022	3	22	Nervous system disorders	Lethargy	1	1	0
2022	3	22	Ear and labyrinth disorders	Hyperacusis	1	1	0
2022	3	22	Investigations	Fibrin D dimer increased	1	0	0
2022	3	22	Nervous system disorders	Bell's palsy	1	1	0
2022	3	22	Reproductive system and breast disorders	Ovarian cyst ruptured	1	1	0
2022	3	22	Cardiac disorders	Arrhythmia	1	1	0
2022	3	22	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	3	22	Endocrine disorders	Goitre	1	1	0
2022	3	22	Gastrointestinal disorders	Gastritis	1	1	0
2022	3	22	Nervous system disorders	Migraine	1	1	0
2022	3	22	Cardiac disorders	Myocarditis	1	1	0
2022	3	22	Immune system disorders	Hypersensitivity	1	1	0
2022	3	22	Nervous system disorders	Burning sensation	1	0	0
2022	3	22	Cardiac disorders	Tachycardia	1	1	0
2022	3	22	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	3	22	Nervous system disorders	Taste disorder	1	1	0
2022	3	22	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	3	22	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	3	22	Eye disorders	Vision blurred	1	0	0
2022	3	22	Investigations	Inflammatory marker increased	1	1	0
2022	3	22	Nervous system disorders	Tremor	1	1	0
2022	3	23	Respiratory, thoracic and mediastinal disorders	Dyspnoea	6	6	0
2022	3	23	Nervous system disorders	Headache	5	5	0
2022	3	23	Blood and lymphatic system disorders	Lymphadenopathy	4	4	0
2022	3	23	Gastrointestinal disorders	Vomiting	4	4	0
2022	3	23	General disorders and administration site conditions	Fatigue	4	4	0
2022	3	23	Cardiac disorders	Palpitations	4	4	0
2022	3	23	General disorders and administration site conditions	Pyrexia	4	4	0
2022	3	23	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	3	23	Injury, poisoning and procedural complications	Vaccination error	3	3	0
2022	3	23	General disorders and administration site conditions	Chest pain	3	3	0
2022	3	23	General disorders and administration site conditions	Malaise	3	3	0
2022	3	23	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	3	23	Eye disorders	Eye pain	2	2	0
2022	3	23	Nervous system disorders	Hypoaesthesia	2	2	0
2022	3	23	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	3	23	General disorders and administration site conditions	Chills	2	2	0
2022	3	23	Nervous system disorders	Lethargy	2	2	0
2022	3	23	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	3	23	Respiratory, thoracic and mediastinal disorders	Dysphonia	2	2	0
2022	3	23	Gastrointestinal disorders	Nausea	2	2	0
2022	3	23	General disorders and administration site conditions	Exercise tolerance decreased	2	2	0
2022	3	23	Skin and subcutaneous tissue disorders	Hyperhidrosis	2	2	0
2022	3	23	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	3	23	Musculoskeletal and connective tissue disorders	Rhabdomyolysis	1	1	0
2022	3	23	Product issues	Needle issue	1	1	0
2022	3	23	General disorders and administration site conditions	Injection site pain	1	1	0
2022	3	23	Investigations	Fibrin D dimer increased	1	1	0
2022	3	23	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	23	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2022	3	23	Gastrointestinal disorders	Mouth swelling	1	1	0
2022	3	23	Infections and infestations	Pneumonia	1	1	0
2022	3	23	Nervous system disorders	Generalised tonic-clonic seizure	1	1	0
2022	3	23	Vascular disorders	Hot flush	1	1	0
2022	3	23	Infections and infestations	Tonsillitis	1	1	0
2022	3	23	Investigations	Blood pressure increased	1	1	0
2022	3	23	Investigations	Weight decreased	1	1	0
2022	3	23	Nervous system disorders	Phrenic nerve paralysis	1	1	0
2022	3	23	Reproductive system and breast disorders	Amenorrhoea	1	1	0
2022	3	23	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	3	23	Skin and subcutaneous tissue disorders	Mechanical urticaria	1	0	0
2022	3	23	Gastrointestinal disorders	Eructation	1	1	0
2022	3	23	Gastrointestinal disorders	Toothache	1	1	0
2022	3	23	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	3	23	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	23	Vascular disorders	Thrombosis	1	1	0
2022	3	23	Cardiac disorders	Pericarditis	1	1	0
2022	3	23	Gastrointestinal disorders	Dysphagia	1	1	0
2022	3	23	Injury, poisoning and procedural complications	Incorrect dose administered	1	1	0
2022	3	23	Investigations	Coagulation time prolonged	1	1	0
2022	3	23	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2022	3	23	Cardiac disorders	Myocarditis	1	1	0
2022	3	23	Eye disorders	Pterygium	1	1	0
2022	3	23	General disorders and administration site conditions	Feeling cold	1	1	0
2022	3	23	Infections and infestations	Pharyngitis	1	1	0
2022	3	23	Nervous system disorders	Paraesthesia	1	1	0
2022	3	23	Nervous system disorders	Syncope	1	1	0
2022	3	23	Psychiatric disorders	Depression	1	1	0
2022	3	23	Psychiatric disorders	Insomnia	1	1	0
2022	3	23	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	3	23	Cardiac disorders	Atrial flutter	1	1	0
2022	3	23	Ear and labyrinth disorders	Ear pain	1	1	0
2022	3	23	General disorders and administration site conditions	Swelling face	1	1	0
2022	3	23	Investigations	Blood iron increased	1	1	0
2022	3	23	Investigations	Heart rate increased	1	1	0
2022	3	23	Nervous system disorders	Dizziness	1	1	0
2022	3	23	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	3	23	Skin and subcutaneous tissue disorders	Urticaria	1	0	0
2022	3	23	Eye disorders	Ocular hyperaemia	1	1	0
2022	3	23	Musculoskeletal and connective tissue disorders	Costochondritis	1	1	0
2022	3	23	Psychiatric disorders	Anxiety	1	1	0
2022	3	23	Eye disorders	Visual impairment	1	1	0
2022	3	23	Injury, poisoning and procedural complications	Product administration error	1	1	0
2022	3	23	Renal and urinary disorders	Myoglobinuria	1	1	0
2022	3	23	Renal and urinary disorders	Urinary incontinence	1	1	0
2022	3	23	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	3	24	Injury, poisoning and procedural complications	Vaccination error	3	2	0
2022	3	24	Gastrointestinal disorders	Vomiting	2	2	0
2022	3	24	Nervous system disorders	Dizziness	2	2	0
2022	3	24	General disorders and administration site conditions	Chills	2	2	0
2022	3	24	Nervous system disorders	Lethargy	2	2	0
2022	3	24	General disorders and administration site conditions	Pyrexia	2	2	0
2022	3	24	Eye disorders	Visual impairment	1	1	0
2022	3	24	Nervous system disorders	Seizure	1	1	0
2022	3	24	Psychiatric disorders	Disorientation	1	1	0
2022	3	24	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	3	24	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	3	24	Psychiatric disorders	Anxiety	1	1	0
2022	3	24	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	3	24	Gastrointestinal disorders	Gastrointestinal disorder	1	1	0
2022	3	24	Infections and infestations	Herpes zoster	1	1	0
2022	3	24	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	3	24	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	24	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	24	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	3	24	General disorders and administration site conditions	Asthenia	1	1	0
2022	3	24	Infections and infestations	Epstein-Barr virus infection	1	1	0
2022	3	24	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	3	24	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	3	24	General disorders and administration site conditions	Fatigue	1	1	0
2022	3	24	Nervous system disorders	Syncope	1	1	0
2022	3	24	Nervous system disorders	Migraine	1	1	0
2022	3	24	Injury, poisoning and procedural complications	Expired product administered	1	1	0
2022	3	24	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	3	24	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	3	24	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	3	24	Hepatobiliary disorders	Hepatitis	1	1	0
2022	3	24	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	3	24	Nervous system disorders	Headache	1	1	0
2022	3	25	General disorders and administration site conditions	Pyrexia	4	4	0
2022	3	25	General disorders and administration site conditions	Chest pain	4	4	0
2022	3	25	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	3	25	Musculoskeletal and connective tissue disorders	Arthralgia	3	3	0
2022	3	25	Gastrointestinal disorders	Vomiting	3	3	0
2022	3	25	General disorders and administration site conditions	Fatigue	3	3	0
2022	3	25	Nervous system disorders	Headache	3	3	0
2022	3	25	Cardiac disorders	Pericarditis	2	2	0
2022	3	25	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	25	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	3	25	General disorders and administration site conditions	Peripheral swelling	2	2	0
2022	3	25	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	3	25	Nervous system disorders	Dizziness	2	2	0
2022	3	25	Gastrointestinal disorders	Nausea	2	2	0
2022	3	25	Investigations	Troponin	1	1	0
2022	3	25	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	3	25	Cardiac disorders	Palpitations	1	1	0
2022	3	25	General disorders and administration site conditions	Injection site pain	1	1	0
2022	3	25	Psychiatric disorders	Confusional state	1	1	0
2022	3	25	Reproductive system and breast disorders	Breast pain	1	1	0
2022	3	25	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	3	25	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	3	25	Investigations	Electrocardiogram abnormal	1	1	0
2022	3	25	Reproductive system and breast disorders	Polycystic ovaries	1	1	0
2022	3	25	Respiratory, thoracic and mediastinal disorders	Pleurisy	1	1	0
2022	3	25	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	25	Infections and infestations	Appendicitis	1	1	0
2022	3	25	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	3	25	Nervous system disorders	Paraesthesia	1	1	0
2022	3	25	Renal and urinary disorders	Nephrolithiasis	1	1	0
2022	3	25	Gastrointestinal disorders	Gastric disorder	1	1	0
2022	3	25	Nervous system disorders	Migraine	1	1	0
2022	3	25	Reproductive system and breast disorders	Endometriosis	1	1	0
2022	3	25	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	3	25	Renal and urinary disorders	Renal disorder	1	1	0
2022	3	25	Injury, poisoning and procedural complications	Rib fracture	1	1	0
2022	3	25	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	25	Skin and subcutaneous tissue disorders	Rash papular	1	1	0
2022	3	25	General disorders and administration site conditions	Chills	1	1	0
2022	3	25	Infections and infestations	Cellulitis	1	1	0
2022	3	25	Infections and infestations	Orchitis	1	1	0
2022	3	25	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	3	25	Nervous system disorders	Neuralgia	1	1	0
2022	3	25	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	3	25	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	3	25	Cardiac disorders	Cardiac flutter	1	1	0
2022	3	25	General disorders and administration site conditions	Axillary pain	1	1	0
2022	3	25	General disorders and administration site conditions	Malaise	1	1	0
2022	3	25	Infections and infestations	Herpes zoster	1	1	0
2022	3	26	Nervous system disorders	Dizziness	3	3	0
2022	3	26	Gastrointestinal disorders	Nausea	2	2	0
2022	3	26	General disorders and administration site conditions	Chest pain	2	2	0
2022	3	26	Nervous system disorders	Headache	2	2	0
2022	3	26	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	26	Nervous system disorders	Neuralgia	1	1	0
2022	3	26	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	26	Cardiac disorders	Carditis	1	1	0
2022	3	26	General disorders and administration site conditions	Injection site nodule	1	1	0
2022	3	26	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	26	Injury, poisoning and procedural complications	Expired product administered	1	1	0
2022	3	26	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	3	26	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	3	26	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	3	26	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	3	26	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	26	Nervous system disorders	Occipital neuralgia	1	1	0
2022	3	26	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	3	26	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	3	26	Skin and subcutaneous tissue disorders	Blister	1	1	0
2022	3	26	Nervous system disorders	Paraesthesia	1	1	0
2022	3	27	Nervous system disorders	Headache	2	2	0
2022	3	27	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	27	Nervous system disorders	Dizziness	1	1	0
2022	3	27	Nervous system disorders	Presyncope	1	1	0
2022	3	27	General disorders and administration site conditions	Axillary pain	1	1	0
2022	3	27	General disorders and administration site conditions	Malaise	1	1	0
2022	3	27	Nervous system disorders	Juvenile absence epilepsy	1	1	0
2022	3	27	Reproductive system and breast disorders	Amenorrhoea	1	1	0
2022	3	27	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	3	27	Psychiatric disorders	Conversion disorder	1	1	0
2022	3	27	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2022	3	27	General disorders and administration site conditions	Swelling	1	1	0
2022	3	27	Reproductive system and breast disorders	Premenstrual syndrome	1	1	0
2022	3	27	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	27	Vascular disorders	Hot flush	1	1	0
2022	3	27	Gastrointestinal disorders	Vomiting	1	1	0
2022	3	27	Cardiac disorders	Palpitations	1	1	0
2022	3	27	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	3	27	Reproductive system and breast disorders	Breast pain	1	1	0
2022	3	27	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	3	28	General disorders and administration site conditions	Malaise	2	2	1
2022	3	28	General disorders and administration site conditions	Fatigue	2	2	0
2022	3	28	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	3	28	General disorders and administration site conditions	Chest pain	2	2	0
2022	3	28	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	3	28	General disorders and administration site conditions	Pyrexia	2	2	0
2022	3	28	Eye disorders	Visual impairment	1	1	0
2022	3	28	Immune system disorders	Anaphylactic reaction	1	1	0
2022	3	28	Nervous system disorders	Dysarthria	1	0	0
2022	3	28	Nervous system disorders	Seizure	1	1	0
2022	3	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	3	28	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	3	28	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2022	3	28	Nervous system disorders	Dizziness	1	1	0
2022	3	28	Vascular disorders	Hypertension	1	1	0
2022	3	28	Vascular disorders	Pallor	1	1	0
2022	3	28	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	3	28	Cardiac disorders	Myocarditis	1	1	1
2022	3	28	Cardiac disorders	Pericarditis	1	1	0
2022	3	28	General disorders and administration site conditions	Swelling	1	1	0
2022	3	28	Infections and infestations	Rhinovirus infection	1	1	1
2022	3	28	Investigations	Neurotransmitter level altered	1	1	0
2022	3	28	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	3	28	Nervous system disorders	Tunnel vision	1	1	0
2022	3	28	Immune system disorders	Hypersensitivity	1	1	0
2022	3	28	Nervous system disorders	Paraesthesia	1	1	0
2022	3	28	Cardiac disorders	Cardiac arrest	1	1	1
2022	3	28	Cardiac disorders	Sinus tachycardia	1	1	0
2022	3	28	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	3	28	Musculoskeletal and connective tissue disorders	Mastication disorder	1	0	0
2022	3	28	Respiratory, thoracic and mediastinal disorders	Hyperventilation	1	1	0
2022	3	28	Respiratory, thoracic and mediastinal disorders	Productive cough	1	1	1
2022	3	28	General disorders and administration site conditions	Pain	1	1	0
2022	3	28	Infections and infestations	Pneumonia	1	1	1
2022	3	28	Gastrointestinal disorders	Dysphagia	1	0	0
2022	3	28	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	3	28	Investigations	Troponin increased	1	1	1
2022	3	28	Psychiatric disorders	Mental disorder	1	1	0
2022	3	28	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	3	28	Vascular disorders	Cyanosis	1	1	0
2022	3	28	Cardiac disorders	Myopericarditis	1	1	0
2022	3	28	Eye disorders	Eyelid ptosis	1	0	0
2022	3	28	Nervous system disorders	Sensory loss	1	1	0
2022	3	28	Respiratory, thoracic and mediastinal disorders	Haemoptysis	1	1	1
2022	3	28	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	3	28	Cardiac disorders	Cyanosis	1	1	0
2022	3	28	Nervous system disorders	Paralysis	1	1	0
2022	3	28	Cardiac disorders	Palpitations	1	1	0
2022	3	28	General disorders and administration site conditions	Injection site pain	1	1	0
2022	3	28	Nervous system disorders	Headache	1	1	0
2022	3	28	Nervous system disorders	Lethargy	1	1	0
2022	3	28	Skin and subcutaneous tissue disorders	Angioedema	1	1	0
2022	3	28	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	3	29	Gastrointestinal disorders	Nausea	4	4	0
2022	3	29	Cardiac disorders	Pericarditis	4	4	0
2022	3	29	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	3	29	General disorders and administration site conditions	Pyrexia	3	3	0
2022	3	29	Gastrointestinal disorders	Diarrhoea	3	3	0
2022	3	29	Musculoskeletal and connective tissue disorders	Pain in extremity	3	3	0
2022	3	29	Nervous system disorders	Headache	3	3	0
2022	3	29	Gastrointestinal disorders	Proctalgia	2	2	0
2022	3	29	General disorders and administration site conditions	Chest pain	2	2	0
2022	3	29	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	3	29	Psychiatric disorders	Confusional state	2	2	0
2022	3	29	Renal and urinary disorders	Acute kidney injury	2	2	0
2022	3	29	General disorders and administration site conditions	Fatigue	2	2	0
2022	3	29	Musculoskeletal and connective tissue disorders	Back pain	2	1	0
2022	3	29	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	3	29	Cardiac disorders	Palpitations	1	1	0
2022	3	29	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	3	29	Gastrointestinal disorders	Food poisoning	1	1	0
2022	3	29	Investigations	Troponin increased	1	1	0
2022	3	29	Psychiatric disorders	Delirium	1	1	0
2022	3	29	Skin and subcutaneous tissue disorders	Rash maculo-papular	1	1	0
2022	3	29	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	3	29	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	3	29	Reproductive system and breast disorders	Vaginal haemorrhage	1	1	0
2022	3	29	Gastrointestinal disorders	Dry mouth	1	1	0
2022	3	29	Infections and infestations	Herpes virus infection	1	1	0
2022	3	29	Infections and infestations	Norovirus infection	1	1	0
2022	3	29	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	3	29	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	3	29	Cardiac disorders	Tachycardia	1	1	0
2022	3	29	Gastrointestinal disorders	Constipation	1	1	0
2022	3	29	General disorders and administration site conditions	Pain	1	1	0
2022	3	29	Infections and infestations	Urinary tract infection	1	1	0
2022	3	29	Nervous system disorders	Taste disorder	1	1	0
2022	3	29	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	3	29	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	3	29	Nervous system disorders	Myelitis transverse	1	0	0
2022	3	29	Skin and subcutaneous tissue disorders	Lichen planus	1	1	0
2022	3	29	Ear and labyrinth disorders	Vertigo	1	1	0
2022	3	29	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	3	29	Reproductive system and breast disorders	Vulvovaginal pain	1	1	0
2022	3	29	General disorders and administration site conditions	Axillary pain	1	1	0
2022	3	29	General disorders and administration site conditions	Malaise	1	1	0
2022	3	29	Nervous system disorders	Dizziness	1	1	0
2022	3	29	Renal and urinary disorders	Renal failure	1	1	0
2022	3	29	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	3	29	Infections and infestations	Viral tonsillitis	1	1	0
2022	3	29	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	1	0
2022	3	29	Vascular disorders	Haemorrhage	1	1	0
2022	3	30	General disorders and administration site conditions	Chest pain	5	5	0
2022	3	30	General disorders and administration site conditions	Pyrexia	2	2	0
2022	3	30	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	3	30	Immune system disorders	Anaphylactic reaction	2	2	0
2022	3	30	Investigations	Troponin increased	1	1	0
2022	3	30	Cardiac disorders	Palpitations	1	1	0
2022	3	30	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	3	30	Nervous system disorders	Headache	1	1	0
2022	3	30	Nervous system disorders	Lethargy	1	1	0
2022	3	30	Cardiac disorders	Arrhythmia	1	1	0
2022	3	30	Nervous system disorders	Hypoaesthesia	1	1	0
2022	3	30	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	3	30	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	3	30	Cardiac disorders	Tachycardia	1	1	0
2022	3	30	Eye disorders	Eye pain	1	1	0
2022	3	30	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	3	30	Psychiatric disorders	Panic attack	1	1	0
2022	3	30	Vascular disorders	Superficial vein thrombosis	1	1	0
2022	3	30	Cardiac disorders	Pericarditis	1	1	0
2022	3	30	Investigations	Echocardiogram abnormal	1	1	0
2022	3	30	Cardiac disorders	Myocarditis	1	1	0
2022	3	30	Eye disorders	Pterygium	1	1	0
2022	3	30	Investigations	C-reactive protein increased	1	1	0
2022	3	30	Psychiatric disorders	Insomnia	1	1	0
2022	3	30	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	3	30	Eye disorders	Ocular hyperaemia	1	1	0
2022	3	30	Investigations	Heart rate increased	1	1	0
2022	3	30	Nervous system disorders	Dizziness	1	1	0
2022	3	30	Nervous system disorders	Multiple sclerosis	1	1	0
2022	3	31	Musculoskeletal and connective tissue disorders	Arthralgia	4	4	0
2022	3	31	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2022	3	31	Nervous system disorders	Headache	3	3	0
2022	3	31	Gastrointestinal disorders	Nausea	2	2	0
2022	3	31	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	3	31	General disorders and administration site conditions	Fatigue	2	2	0
2022	3	31	Nervous system disorders	Lethargy	2	2	0
2022	3	31	Gastrointestinal disorders	Vomiting	2	2	0
2022	3	31	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	3	31	Nervous system disorders	Dizziness	2	2	0
2022	3	31	Nervous system disorders	Paraesthesia	1	1	0
2022	3	31	Nervous system disorders	Syncope	1	1	0
2022	3	31	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	3	31	Infections and infestations	COVID-19	1	1	0
2022	3	31	Musculoskeletal and connective tissue disorders	Joint swelling	1	1	0
2022	3	31	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	3	31	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	3	31	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	3	31	Vascular disorders	Thrombosis	1	1	0
2022	3	31	General disorders and administration site conditions	Pain	1	1	0
2022	3	31	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	3	31	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	3	31	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	3	31	Nervous system disorders	Hypoaesthesia	1	1	0
2022	3	31	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	3	31	Eye disorders	Vision blurred	1	1	0
2022	3	31	Eye disorders	Visual impairment	1	1	0
2022	3	31	General disorders and administration site conditions	Pyrexia	1	1	0
2022	3	31	Nervous system disorders	Seizure	1	1	0
2022	3	31	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	3	31	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	3	31	General disorders and administration site conditions	Chills	1	1	0
2022	3	31	Musculoskeletal and connective tissue disorders	Arthritis	1	1	0
2022	3	31	Nervous system disorders	Neuralgia	1	1	0
2022	3	31	Nervous system disorders	Thunderclap headache	1	1	0
2022	3	31	Vascular disorders	Haemorrhage	1	1	0
2022	3	31	General disorders and administration site conditions	Foaming at mouth	1	1	0
2022	3	31	General disorders and administration site conditions	Malaise	1	1	0
2022	4	1	Nervous system disorders	Lethargy	3	3	0
2022	4	1	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Neoplasm malignant	3	3	0
2022	4	1	Nervous system disorders	Headache	3	3	0
2022	4	1	General disorders and administration site conditions	Pyrexia	2	2	0
2022	4	1	General disorders and administration site conditions	Chest pain	2	2	0
2022	4	1	General disorders and administration site conditions	Injection site pain	2	2	0
2022	4	1	Cardiac disorders	Palpitations	2	2	0
2022	4	1	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	4	1	Injury, poisoning and procedural complications	Fracture	2	2	0
2022	4	1	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	1	Cardiac disorders	Myocardial infarction	1	1	0
2022	4	1	Cardiac disorders	Tachycardia	1	1	0
2022	4	1	Injury, poisoning and procedural complications	Radius fracture	1	1	0
2022	4	1	Investigations	Blood pressure increased	1	1	0
2022	4	1	Nervous system disorders	Burning sensation	1	1	0
2022	4	1	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	4	1	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	4	1	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	4	1	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	4	1	Musculoskeletal and connective tissue disorders	Musculoskeletal disorder	1	1	0
2022	4	1	Cardiac disorders	Pericarditis	1	1	0
2022	4	1	Infections and infestations	Tooth infection	1	1	0
2022	4	1	Nervous system disorders	Migraine	1	1	0
2022	4	1	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	1	Hepatobiliary disorders	Gallbladder disorder	1	1	0
2022	4	1	Renal and urinary disorders	Nephrolithiasis	1	1	0
2022	4	1	General disorders and administration site conditions	Hernia	1	1	0
2022	4	1	Injury, poisoning and procedural complications	Accidental overdose	1	1	0
2022	4	1	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	4	1	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	4	1	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	4	1	Infections and infestations	Pneumonia	1	1	0
2022	4	1	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	4	1	Injury, poisoning and procedural complications	Joint dislocation	1	1	0
2022	4	1	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	4	1	Musculoskeletal and connective tissue disorders	Neck mass	1	1	0
2022	4	1	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	4	1	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	4	1	Gastrointestinal disorders	Nausea	1	1	0
2022	4	1	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	4	1	General disorders and administration site conditions	Malaise	1	1	0
2022	4	1	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	1	0
2022	4	1	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	1	Cardiac disorders	Atrial fibrillation	1	1	0
2022	4	1	Cardiac disorders	Cardiac disorder	1	1	0
2022	4	1	Ear and labyrinth disorders	Deafness	1	1	0
2022	4	1	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	4	1	Musculoskeletal and connective tissue disorders	Periarthritis	1	1	0
2022	4	2	Nervous system disorders	Dizziness	2	2	0
2022	4	2	Cardiac disorders	Palpitations	2	2	0
2022	4	2	General disorders and administration site conditions	Pyrexia	2	2	0
2022	4	2	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	2	General disorders and administration site conditions	Chills	1	1	0
2022	4	2	General disorders and administration site conditions	Axillary pain	1	1	0
2022	4	2	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	4	2	Metabolism and nutrition disorders	Fluid retention	1	1	0
2022	4	2	Cardiac disorders	Arrhythmia	1	1	0
2022	4	2	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	4	2	General disorders and administration site conditions	Chest pain	1	1	0
2022	4	2	Gastrointestinal disorders	Nausea	1	1	0
2022	4	2	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	4	2	Nervous system disorders	Headache	1	1	0
2022	4	2	Cardiac disorders	Myocarditis	1	1	0
2022	4	2	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	2	General disorders and administration site conditions	Systemic inflammatory response syndrome	1	1	0
2022	4	2	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	4	2	General disorders and administration site conditions	Asthenia	1	1	0
2022	4	2	General disorders and administration site conditions	Pain	1	1	0
2022	4	2	Cardiac disorders	Sinus tachycardia	1	1	0
2022	4	3	Nervous system disorders	Dizziness	3	3	0
2022	4	3	Gastrointestinal disorders	Nausea	2	2	0
2022	4	3	Nervous system disorders	Migraine	2	2	0
2022	4	3	Investigations	Heart rate increased	1	1	0
2022	4	3	General disorders and administration site conditions	Pyrexia	1	1	0
2022	4	3	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	3	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	4	3	General disorders and administration site conditions	Chills	1	1	0
2022	4	3	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	3	Pregnancy, puerperium and perinatal conditions	Abortion spontaneous	1	1	0
2022	4	3	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	4	3	Nervous system disorders	Headache	1	1	0
2022	4	3	Nervous system disorders	Lethargy	1	1	0
2022	4	3	Nervous system disorders	Memory impairment	1	1	0
2022	4	3	Vascular disorders	Deep vein thrombosis	1	1	0
2022	4	3	Infections and infestations	Kidney infection	1	1	0
2022	4	3	Nervous system disorders	Sensory loss	1	1	0
2022	4	3	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	4	3	Vascular disorders	Hot flush	1	1	0
2022	4	3	Eye disorders	Eye swelling	1	1	0
2022	4	3	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	4	3	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	4	3	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	4	3	Ear and labyrinth disorders	Vertigo	1	1	0
2022	4	3	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	4	3	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	4	3	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	3	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2022	4	3	Respiratory, thoracic and mediastinal disorders	Nasal discomfort	1	1	0
2022	4	4	General disorders and administration site conditions	Fatigue	2	2	0
2022	4	4	Nervous system disorders	Headache	2	2	0
2022	4	4	Injury, poisoning and procedural complications	Adverse event following immunisation	2	2	0
2022	4	4	Vascular disorders	Hypertension	1	1	0
2022	4	4	Vascular disorders	Vasodilatation	1	1	0
2022	4	4	Ear and labyrinth disorders	Vertigo	1	1	0
2022	4	4	Infections and infestations	Respiratory tract infection	1	1	0
2022	4	4	Renal and urinary disorders	Haematuria	1	1	0
2022	4	4	Infections and infestations	Ear infection	1	1	0
2022	4	4	Respiratory, thoracic and mediastinal disorders	Reflux laryngitis	1	1	0
2022	4	4	Cardiac disorders	Arrhythmia	1	1	0
2022	4	4	General disorders and administration site conditions	Chest pain	1	1	0
2022	4	4	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	4	4	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	4	4	Vascular disorders	Vascular occlusion	1	1	0
2022	4	4	Gastrointestinal disorders	Nausea	1	1	0
2022	4	4	Infections and infestations	Pyelonephritis	1	1	0
2022	4	4	Nervous system disorders	Bell's palsy	1	1	0
2022	4	4	General disorders and administration site conditions	Facial pain	1	1	0
2022	4	4	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	4	4	Renal and urinary disorders	Dysuria	1	1	0
2022	4	5	Cardiac disorders	Palpitations	4	4	0
2022	4	5	Psychiatric disorders	Confusional state	3	3	0
2022	4	5	Gastrointestinal disorders	Nausea	3	3	0
2022	4	5	Nervous system disorders	Headache	3	3	0
2022	4	5	Musculoskeletal and connective tissue disorders	Pain in extremity	3	2	0
2022	4	5	General disorders and administration site conditions	Chest pain	2	2	0
2022	4	5	Metabolism and nutrition disorders	Decreased appetite	2	2	0
2022	4	5	Nervous system disorders	Dizziness	2	2	0
2022	4	5	General disorders and administration site conditions	Fatigue	2	2	0
2022	4	5	General disorders and administration site conditions	Injected limb mobility decreased	2	2	0
2022	4	5	Eye disorders	Vision blurred	1	0	0
2022	4	5	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	4	5	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2022	4	5	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	4	5	Nervous system disorders	Taste disorder	1	1	0
2022	4	5	Eye disorders	Dry eye	1	0	0
2022	4	5	Immune system disorders	Anaphylactic reaction	1	0	0
2022	4	5	Nervous system disorders	Burning sensation	1	0	0
2022	4	5	Nervous system disorders	Paraesthesia	1	1	0
2022	4	5	Cardiac disorders	Pericarditis	1	1	0
2022	4	5	Eye disorders	Eye haemorrhage	1	0	0
2022	4	5	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	5	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	4	5	Investigations	Heart rate irregular	1	1	0
2022	4	5	Nervous system disorders	Hypoaesthesia	1	1	0
2022	4	5	Nervous system disorders	Syncope	1	0	0
2022	4	5	Nervous system disorders	Migraine	1	0	0
2022	4	5	Psychiatric disorders	Sleep disorder	1	1	0
2022	4	5	Eye disorders	Vitreous floaters	1	0	0
2022	4	5	Metabolism and nutrition disorders	Dehydration	1	1	0
2022	4	5	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	4	5	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	6	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	2	0
2022	4	6	Nervous system disorders	Lethargy	3	1	0
2022	4	6	General disorders and administration site conditions	Influenza like illness	2	1	0
2022	4	6	Cardiac disorders	Palpitations	2	0	0
2022	4	6	General disorders and administration site conditions	Chest pain	2	1	0
2022	4	6	Injury, poisoning and procedural complications	Adverse event following immunisation	2	2	0
2022	4	6	Nervous system disorders	Paraesthesia	2	1	0
2022	4	6	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	4	6	Musculoskeletal and connective tissue disorders	Myalgia	2	1	0
2022	4	6	Nervous system disorders	Dizziness	2	2	0
2022	4	6	Nervous system disorders	Headache	2	1	0
2022	4	6	Cardiac disorders	Pericarditis	1	0	0
2022	4	6	Cardiac disorders	Tachycardia	1	0	0
2022	4	6	Musculoskeletal and connective tissue disorders	Musculoskeletal discomfort	1	1	0
2022	4	6	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	4	6	Gastrointestinal disorders	Nausea	1	1	0
2022	4	6	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	6	Musculoskeletal and connective tissue disorders	Rhabdomyolysis	1	1	0
2022	4	6	Nervous system disorders	Bell's palsy	1	1	0
2022	4	6	General disorders and administration site conditions	Feeling abnormal	1	0	0
2022	4	6	Nervous system disorders	Hypoaesthesia	1	1	0
2022	4	6	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	0	0
2022	4	6	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	6	General disorders and administration site conditions	Feeling hot	1	1	0
2022	4	6	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	4	6	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	6	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	4	6	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	0	0
2022	4	6	Skin and subcutaneous tissue disorders	Acne cystic	1	1	0
2022	4	6	Infections and infestations	Cellulitis	1	1	0
2022	4	6	Musculoskeletal and connective tissue disorders	Arthritis	1	1	0
2022	4	6	General disorders and administration site conditions	Chest discomfort	1	0	0
2022	4	6	Musculoskeletal and connective tissue disorders	Neck pain	1	0	0
2022	4	6	Pregnancy, puerperium and perinatal conditions	Ectopic pregnancy	1	1	0
2022	4	6	Psychiatric disorders	Depression	1	0	0
2022	4	6	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	4	6	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	4	6	General disorders and administration site conditions	Injection site pain	1	0	0
2022	4	6	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	0	0
2022	4	7	Nervous system disorders	Dizziness	4	4	0
2022	4	7	General disorders and administration site conditions	Peripheral swelling	3	2	0
2022	4	7	Cardiac disorders	Tachycardia	3	3	0
2022	4	7	Nervous system disorders	Headache	3	3	0
2022	4	7	General disorders and administration site conditions	Chest pain	3	3	0
2022	4	7	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	4	7	General disorders and administration site conditions	Pyrexia	2	2	0
2022	4	7	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	4	7	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	4	7	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	4	7	Gastrointestinal disorders	Nausea	2	2	0
2022	4	7	General disorders and administration site conditions	Fatigue	2	1	0
2022	4	7	Cardiac disorders	Myopericarditis	2	2	0
2022	4	7	General disorders and administration site conditions	Injection site pain	1	1	0
2022	4	7	Nervous system disorders	Memory impairment	1	1	0
2022	4	7	Vascular disorders	Deep vein thrombosis	1	1	0
2022	4	7	Cardiac disorders	Cardiac disorder	1	0	0
2022	4	7	Gastrointestinal disorders	Dyspepsia	1	1	0
2022	4	7	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	4	7	Cardiac disorders	Palpitations	1	0	0
2022	4	7	Gastrointestinal disorders	Mouth ulceration	1	1	0
2022	4	7	Infections and infestations	Pilonidal disease	1	1	0
2022	4	7	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	4	7	Nervous system disorders	Hypoaesthesia	1	1	0
2022	4	7	Skin and subcutaneous tissue disorders	Night sweats	1	1	0
2022	4	7	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	4	7	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	4	7	Nervous system disorders	Somnolence	1	1	0
2022	4	7	Vascular disorders	Hypotension	1	1	0
2022	4	7	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	7	General disorders and administration site conditions	Pain	1	1	0
2022	4	7	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	4	7	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	4	7	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	4	7	Musculoskeletal and connective tissue disorders	Muscular weakness	1	1	0
2022	4	7	Cardiac disorders	Pericarditis	1	1	0
2022	4	7	Cardiac disorders	Ventricular extrasystoles	1	1	0
2022	4	7	Gastrointestinal disorders	Haematemesis	1	1	0
2022	4	7	Gastrointestinal disorders	Lip blister	1	1	0
2022	4	7	Gastrointestinal disorders	Lip erythema	1	1	0
2022	4	7	Nervous system disorders	Migraine	1	1	0
2022	4	7	Gastrointestinal disorders	Paraesthesia oral	1	1	0
2022	4	7	Nervous system disorders	Paraesthesia	1	1	0
2022	4	7	Gastrointestinal disorders	Lip swelling	1	1	0
2022	4	7	Immune system disorders	Anaphylactic reaction	1	1	0
2022	4	7	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	4	7	Eye disorders	Eye pruritus	1	1	0
2022	4	7	General disorders and administration site conditions	Chills	1	1	0
2022	4	7	Psychiatric disorders	Anxiety	1	1	0
2022	4	7	Endocrine disorders	Autoimmune thyroid disorder	1	1	0
2022	4	7	Psychiatric disorders	Personality change	1	1	0
2022	4	7	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	0	0
2022	4	8	General disorders and administration site conditions	Chest pain	4	3	0
2022	4	8	Injury, poisoning and procedural complications	Adverse event following immunisation	3	3	0
2022	4	8	Gastrointestinal disorders	Nausea	2	2	0
2022	4	8	Cardiac disorders	Palpitations	2	1	0
2022	4	8	Musculoskeletal and connective tissue disorders	Myalgia	2	1	0
2022	4	8	General disorders and administration site conditions	Influenza like illness	2	1	0
2022	4	8	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	4	8	General disorders and administration site conditions	Chest discomfort	2	1	0
2022	4	8	Nervous system disorders	Headache	2	2	0
2022	4	8	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	4	8	Blood and lymphatic system disorders	Lymphadenitis	1	1	0
2022	4	8	General disorders and administration site conditions	Peripheral swelling	1	0	0
2022	4	8	Nervous system disorders	Neuralgia	1	1	0
2022	4	8	Psychiatric disorders	Anxiety	1	1	0
2022	4	8	Eye disorders	Vision blurred	1	1	0
2022	4	8	General disorders and administration site conditions	Pyrexia	1	1	0
2022	4	8	Musculoskeletal and connective tissue disorders	Neck pain	1	0	0
2022	4	8	Nervous system disorders	Formication	1	0	0
2022	4	8	Nervous system disorders	Paraesthesia	1	0	0
2022	4	8	Psychiatric disorders	Insomnia	1	0	0
2022	4	8	General disorders and administration site conditions	Malaise	1	1	0
2022	4	8	Nervous system disorders	Dizziness	1	0	0
2022	4	8	Psychiatric disorders	Irritability	1	0	0
2022	4	8	Respiratory, thoracic and mediastinal disorders	Cough	1	0	0
2022	4	8	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	4	8	Cardiac disorders	Angina pectoris	1	0	0
2022	4	8	Cardiac disorders	Myocarditis	1	1	0
2022	4	8	General disorders and administration site conditions	Gait disturbance	1	1	0
2022	4	8	Renal and urinary disorders	Nephrolithiasis	1	1	0
2022	4	8	Nervous system disorders	Migraine	1	1	0
2022	4	8	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	8	Cardiac disorders	Tachycardia	1	1	0
2022	4	8	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	4	8	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	4	8	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	4	8	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	4	8	General disorders and administration site conditions	Pain	1	0	0
2022	4	8	Cardiac disorders	Pericarditis	1	0	0
2022	4	8	Gastrointestinal disorders	Pancreatitis	1	1	0
2022	4	8	Psychiatric disorders	Confusional state	1	1	0
2022	4	8	Investigations	Troponin increased	1	1	0
2022	4	8	Nervous system disorders	Lethargy	1	0	0
2022	4	8	Nervous system disorders	Memory impairment	1	0	0
2022	4	8	Cardiac disorders	Arrhythmia	1	1	0
2022	4	8	Nervous system disorders	Parosmia	1	0	0
2022	4	8	Nervous system disorders	Transient ischaemic attack	1	1	0
2022	4	8	Nervous system disorders	Hypoaesthesia	1	0	0
2022	4	9	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	4	9	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	4	9	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	4	9	General disorders and administration site conditions	Malaise	1	1	0
2022	4	9	General disorders and administration site conditions	Fatigue	1	0	0
2022	4	11	General disorders and administration site conditions	Pyrexia	5	4	0
2022	4	11	General disorders and administration site conditions	Chest pain	4	2	0
2022	4	11	Nervous system disorders	Headache	4	3	0
2022	4	11	Nervous system disorders	Dizziness	3	1	0
2022	4	11	General disorders and administration site conditions	Injection site reaction	3	3	0
2022	4	11	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	4	11	Musculoskeletal and connective tissue disorders	Muscular weakness	3	2	0
2022	4	11	Musculoskeletal and connective tissue disorders	Pain in extremity	2	2	0
2022	4	11	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	1	0
2022	4	11	General disorders and administration site conditions	Malaise	2	2	0
2022	4	11	Musculoskeletal and connective tissue disorders	Arthralgia	2	1	0
2022	4	11	Investigations	Heart rate increased	1	1	0
2022	4	11	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	4	11	Gastrointestinal disorders	Vomiting	1	0	0
2022	4	11	Respiratory, thoracic and mediastinal disorders	Cough	1	0	0
2022	4	11	Gastrointestinal disorders	Abdominal discomfort	1	1	0
2022	4	11	Musculoskeletal and connective tissue disorders	Limb discomfort	1	1	0
2022	4	11	Nervous system disorders	Paraesthesia	1	0	0
2022	4	11	Cardiac disorders	Palpitations	1	1	0
2022	4	11	Gastrointestinal disorders	Retching	1	0	0
2022	4	11	General disorders and administration site conditions	Injection site nodule	1	1	0
2022	4	11	General disorders and administration site conditions	Injection site pain	1	1	0
2022	4	11	Nervous system disorders	Lethargy	1	1	0
2022	4	11	Gastrointestinal disorders	Nausea	1	1	0
2022	4	11	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	4	11	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	4	11	General disorders and administration site conditions	Discomfort	1	1	0
2022	4	11	Infections and infestations	Pneumonia	1	1	0
2022	4	11	Infections and infestations	Sinusitis	1	1	0
2022	4	11	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	4	11	Cardiac disorders	Tachycardia	1	1	0
2022	4	11	General disorders and administration site conditions	Asthenia	1	1	0
2022	4	11	General disorders and administration site conditions	Pain	1	1	0
2022	4	11	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	4	11	Skin and subcutaneous tissue disorders	Sensitive skin	1	1	0
2022	4	11	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	4	11	Infections and infestations	Ear infection	1	1	0
2022	4	11	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	4	11	Infections and infestations	COVID-19	1	1	0
2022	4	12	General disorders and administration site conditions	Chest pain	4	4	0
2022	4	12	Respiratory, thoracic and mediastinal disorders	Dyspnoea	4	4	0
2022	4	12	Nervous system disorders	Headache	3	3	0
2022	4	12	General disorders and administration site conditions	Fatigue	3	3	1
2022	4	12	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	4	12	Cardiac disorders	Myocarditis	2	2	1
2022	4	12	Nervous system disorders	Lethargy	2	2	0
2022	4	12	Psychiatric disorders	Insomnia	2	2	0
2022	4	12	General disorders and administration site conditions	Pyrexia	2	2	1
2022	4	12	Cardiac disorders	Palpitations	2	2	0
2022	4	12	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	4	12	Skin and subcutaneous tissue disorders	Pruritus	2	1	0
2022	4	12	Gastrointestinal disorders	Abdominal pain	2	2	1
2022	4	12	Nervous system disorders	Paraesthesia	2	2	1
2022	4	12	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	4	12	Cardiac disorders	Angina pectoris	1	1	0
2022	4	12	Infections and infestations	Infection	1	1	0
2022	4	12	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	4	12	Nervous system disorders	Multiple sclerosis	1	1	0
2022	4	12	Nervous system disorders	Spinal cord infarction	1	1	1
2022	4	12	Renal and urinary disorders	Renal impairment	1	1	1
2022	4	12	Vascular disorders	Femoral artery embolism	1	1	1
2022	4	12	Vascular disorders	Hypertension	1	1	0
2022	4	12	Gastrointestinal disorders	Gingival pain	1	1	0
2022	4	12	General disorders and administration site conditions	Chills	1	1	0
2022	4	12	Infections and infestations	Cellulitis	1	1	0
2022	4	12	Injury, poisoning and procedural complications	Contusion	1	1	0
2022	4	12	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Neuroendocrine tumour	1	1	0
2022	4	12	Respiratory, thoracic and mediastinal disorders	Tachypnoea	1	1	0
2022	4	12	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	4	12	Gastrointestinal disorders	Nausea	1	1	1
2022	4	12	General disorders and administration site conditions	Malaise	1	1	1
2022	4	12	Immune system disorders	Hypersensitivity	1	0	0
2022	4	12	Infections and infestations	Appendicitis	1	1	0
2022	4	12	Investigations	Echocardiogram abnormal	1	1	1
2022	4	12	Investigations	Heart rate irregular	1	1	0
2022	4	12	Investigations	Troponin increased	1	1	1
2022	4	12	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	4	12	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	4	12	Vascular disorders	Peripheral ischaemia	1	1	1
2022	4	12	General disorders and administration site conditions	Injection site rash	1	1	0
2022	4	12	Infections and infestations	Sinusitis	1	1	0
2022	4	12	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	4	12	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2022	4	12	Investigations	Oxygen saturation decreased	1	1	0
2022	4	12	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	4	12	General disorders and administration site conditions	Hyperthermia	1	1	0
2022	4	12	Skin and subcutaneous tissue disorders	Erythema	1	0	0
2022	4	12	Cardiac disorders	Cardiac arrest	1	1	1
2022	4	12	Cardiac disorders	Cardiogenic shock	1	1	1
2022	4	12	Eye disorders	Eye pain	1	1	0
2022	4	12	Gastrointestinal disorders	Toothache	1	1	0
2022	4	12	Psychiatric disorders	Panic attack	1	1	0
2022	4	12	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	12	Cardiac disorders	Tachycardia	1	1	0
2022	4	12	General disorders and administration site conditions	Asthenia	1	1	0
2022	4	12	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2022	4	12	Infections and infestations	Urinary tract infection	1	1	0
2022	4	12	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	4	12	Cardiac disorders	Pericarditis	1	1	0
2022	4	12	Cardiac disorders	Ventricular dysfunction	1	1	1
2022	4	12	Ear and labyrinth disorders	Vertigo	1	1	0
2022	4	12	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	4	12	Musculoskeletal and connective tissue disorders	Muscle twitching	1	1	0
2022	4	12	Respiratory, thoracic and mediastinal disorders	Oropharyngeal discomfort	1	0	0
2022	4	12	General disorders and administration site conditions	Mass	1	1	0
2022	4	12	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	0	0
2022	4	12	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	4	12	Respiratory, thoracic and mediastinal disorders	Sneezing	1	1	0
2022	4	13	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	4	13	Nervous system disorders	Headache	4	4	0
2022	4	13	General disorders and administration site conditions	Chest pain	3	2	0
2022	4	13	General disorders and administration site conditions	Pyrexia	3	3	0
2022	4	13	Skin and subcutaneous tissue disorders	Rash	3	3	0
2022	4	13	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	4	13	Gastrointestinal disorders	Nausea	2	2	0
2022	4	13	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	4	13	Cardiac disorders	Pericarditis	1	0	0
2022	4	13	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	4	13	Nervous system disorders	Lethargy	1	1	0
2022	4	13	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	13	Cardiac disorders	Palpitations	1	0	0
2022	4	13	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	4	13	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	4	13	Investigations	Troponin increased	1	0	0
2022	4	13	Cardiac disorders	Myocardial infarction	1	1	0
2022	4	13	Cardiac disorders	Myocarditis	1	0	0
2022	4	13	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	13	Immune system disorders	Hypersensitivity	1	1	0
2022	4	13	Nervous system disorders	Dysgeusia	1	1	0
2022	4	13	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	4	13	Metabolism and nutrition disorders	Food aversion	1	1	0
2022	4	13	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	4	13	Musculoskeletal and connective tissue disorders	Muscle spasms	1	1	0
2022	4	13	Nervous system disorders	Neuralgia	1	1	0
2022	4	14	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	4	14	Gastrointestinal disorders	Nausea	3	2	0
2022	4	14	General disorders and administration site conditions	Chest pain	2	2	0
2022	4	14	General disorders and administration site conditions	Pyrexia	2	1	0
2022	4	14	Nervous system disorders	Paraesthesia	2	2	0
2022	4	14	Blood and lymphatic system disorders	Thrombocytopenia	1	1	0
2022	4	14	Cardiac disorders	Pericarditis	1	1	0
2022	4	14	Nervous system disorders	Migraine	1	1	0
2022	4	14	Nervous system disorders	Tunnel vision	1	1	0
2022	4	14	Skin and subcutaneous tissue disorders	Eczema	1	1	0
2022	4	14	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	14	Cardiac disorders	Myocardial infarction	1	1	0
2022	4	14	Cardiac disorders	Tachycardia	1	1	0
2022	4	14	General disorders and administration site conditions	Mass	1	0	0
2022	4	14	Respiratory, thoracic and mediastinal disorders	Epistaxis	1	1	0
2022	4	14	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	4	14	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	4	14	Nervous system disorders	Hypoaesthesia	1	1	0
2022	4	14	General disorders and administration site conditions	Vaccination site rash	1	0	0
2022	4	14	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	4	14	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	0
2022	4	14	Musculoskeletal and connective tissue disorders	Myalgia	1	0	0
2022	4	14	Cardiac disorders	Palpitations	1	1	0
2022	4	14	Gastrointestinal disorders	Abdominal pain	1	0	0
2022	4	14	Nervous system disorders	Headache	1	1	0
2022	4	14	Vascular disorders	Deep vein thrombosis	1	1	0
2022	4	14	Musculoskeletal and connective tissue disorders	Pain in extremity	1	0	0
2022	4	14	Nervous system disorders	Dizziness	1	1	0
2022	4	14	General disorders and administration site conditions	Injection site nerve damage	1	1	0
2022	4	14	Skin and subcutaneous tissue disorders	Urticaria	1	0	0
2022	4	14	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	4	14	Investigations	Electrocardiogram ST segment elevation	1	1	0
2022	4	14	Investigations	Heart rate increased	1	0	0
2022	4	14	Musculoskeletal and connective tissue disorders	Arthralgia	1	0	0
2022	4	14	Nervous system disorders	Neuralgia	1	1	0
2022	4	15	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	15	Nervous system disorders	Headache	1	1	0
2022	4	15	Nervous system disorders	Neurological symptom	1	1	0
2022	4	15	General disorders and administration site conditions	Pyrexia	1	1	0
2022	4	15	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	15	Renal and urinary disorders	Renal impairment	1	1	0
2022	4	16	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	4	18	General disorders and administration site conditions	Chest pain	2	2	0
2022	4	18	Nervous system disorders	Dizziness	1	1	0
2022	4	18	Psychiatric disorders	Sleep disorder	1	1	0
2022	4	18	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	4	18	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	18	Infections and infestations	Nasopharyngitis	1	1	0
2022	4	18	Infections and infestations	Tonsillitis	1	1	0
2022	4	18	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	4	18	Musculoskeletal and connective tissue disorders	Mobility decreased	1	1	0
2022	4	18	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	4	18	Cardiac disorders	Pericarditis	1	1	0
2022	4	18	Psychiatric disorders	Stress	1	1	0
2022	4	19	General disorders and administration site conditions	Chest pain	4	3	0
2022	4	19	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	4	19	Cardiac disorders	Palpitations	2	2	0
2022	4	19	Nervous system disorders	Dizziness	2	1	0
2022	4	19	Musculoskeletal and connective tissue disorders	Pain in extremity	2	1	0
2022	4	19	Investigations	Body temperature increased	1	0	0
2022	4	19	Immune system disorders	Anaphylactic reaction	1	1	0
2022	4	19	Nervous system disorders	Balance disorder	1	1	0
2022	4	19	Nervous system disorders	Paraesthesia	1	0	0
2022	4	19	Respiratory, thoracic and mediastinal disorders	Pharyngeal swelling	1	1	0
2022	4	19	Skin and subcutaneous tissue disorders	Rash pruritic	1	0	0
2022	4	19	Musculoskeletal and connective tissue disorders	Arthralgia	1	0	0
2022	4	19	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	4	19	General disorders and administration site conditions	Feeling cold	1	0	0
2022	4	19	Investigations	Blood pressure increased	1	0	0
2022	4	19	Musculoskeletal and connective tissue disorders	Muscle spasms	1	0	0
2022	4	19	Respiratory, thoracic and mediastinal disorders	Sleep apnoea syndrome	1	1	0
2022	4	19	Gastrointestinal disorders	Nausea	1	0	0
2022	4	19	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	19	Cardiac disorders	Tachycardia	1	1	0
2022	4	19	Ear and labyrinth disorders	Vertigo	1	0	0
2022	4	19	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	4	19	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	4	19	Nervous system disorders	Tremor	1	1	0
2022	4	19	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	4	19	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	4	19	Musculoskeletal and connective tissue disorders	Back pain	1	0	0
2022	4	19	Nervous system disorders	Hypoaesthesia	1	0	0
2022	4	19	Psychiatric disorders	Sleep disorder	1	0	0
2022	4	19	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	0	0
2022	4	19	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	19	Nervous system disorders	Lethargy	1	0	0
2022	4	19	Nervous system disorders	Headache	1	1	0
2022	4	19	Nervous system disorders	Loss of consciousness	1	0	0
2022	4	19	Vascular disorders	Hot flush	1	0	0
2022	4	20	General disorders and administration site conditions	Chest pain	4	4	0
2022	4	20	Nervous system disorders	Headache	3	3	0
2022	4	20	Cardiac disorders	Pericarditis	2	2	0
2022	4	20	General disorders and administration site conditions	Pyrexia	2	2	0
2022	4	20	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	4	20	General disorders and administration site conditions	Fatigue	2	2	0
2022	4	20	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	4	20	Cardiac disorders	Tachycardia	1	1	0
2022	4	20	General disorders and administration site conditions	Asthenia	1	1	0
2022	4	20	General disorders and administration site conditions	Pain	1	1	0
2022	4	20	Gastrointestinal disorders	Lip blister	1	1	0
2022	4	20	Cardiac disorders	Myocarditis	1	1	0
2022	4	20	Nervous system disorders	Syncope	1	1	0
2022	4	20	Psychiatric disorders	Insomnia	1	1	0
2022	4	20	Infections and infestations	Pneumonia	1	1	0
2022	4	20	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	4	20	Cardiac disorders	Arrhythmia	1	1	0
2022	4	20	Investigations	Heart rate irregular	1	1	0
2022	4	20	Gastrointestinal disorders	Dyspepsia	1	1	0
2022	4	20	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	20	Investigations	Oxygen saturation decreased	1	1	0
2022	4	20	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	4	20	Cardiac disorders	Palpitations	1	1	0
2022	4	20	Investigations	Fibrin D dimer increased	1	1	0
2022	4	20	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	4	20	Nervous system disorders	Lethargy	1	1	0
2022	4	20	Cardiac disorders	Cardiac flutter	1	1	0
2022	4	20	General disorders and administration site conditions	Malaise	1	1	0
2022	4	20	General disorders and administration site conditions	Injection site erythema	1	1	0
2022	4	20	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	4	20	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	20	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	4	20	Cardiac disorders	Atrial fibrillation	1	1	0
2022	4	20	Cardiac disorders	Cardiac disorder	1	1	0
2022	4	20	Psychiatric disorders	Anxiety	1	1	0
2022	4	21	Nervous system disorders	Lethargy	2	2	0
2022	4	21	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	4	21	Gastrointestinal disorders	Eructation	1	1	0
2022	4	21	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	4	21	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	4	21	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	4	21	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	4	21	Cardiac disorders	Ventricular extrasystoles	1	1	0
2022	4	21	Gastrointestinal disorders	Gastrointestinal pain	1	1	0
2022	4	21	Social circumstances	Bedridden	1	1	0
2022	4	21	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	21	Nervous system disorders	Paraesthesia	1	1	0
2022	4	21	General disorders and administration site conditions	Chest pain	1	1	0
2022	4	21	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	4	21	Vascular disorders	Hot flush	1	1	0
2022	4	21	Gastrointestinal disorders	Dyspepsia	1	1	0
2022	4	21	Gastrointestinal disorders	Nausea	1	1	0
2022	4	21	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	21	General disorders and administration site conditions	Injection site pain	1	1	0
2022	4	21	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	4	21	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	4	21	Nervous system disorders	Dizziness	1	1	0
2022	4	21	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	4	22	General disorders and administration site conditions	Chest pain	4	3	0
2022	4	22	Nervous system disorders	Headache	4	4	0
2022	4	22	Nervous system disorders	Lethargy	3	2	0
2022	4	22	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	4	22	Nervous system disorders	Hypoaesthesia	2	0	0
2022	4	22	Gastrointestinal disorders	Nausea	2	2	0
2022	4	22	Cardiac disorders	Pericarditis	2	1	0
2022	4	22	Nervous system disorders	Migraine	2	2	0
2022	4	22	Metabolism and nutrition disorders	Decreased appetite	1	0	0
2022	4	22	Nervous system disorders	Dizziness	1	0	0
2022	4	22	Cardiac disorders	Ventricular hypertrophy	1	1	0
2022	4	22	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	4	22	Eye disorders	Visual impairment	1	1	0
2022	4	22	General disorders and administration site conditions	Chest discomfort	1	0	0
2022	4	22	General disorders and administration site conditions	Pyrexia	1	1	0
2022	4	22	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	1
2022	4	22	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	22	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	4	22	Investigations	Magnetic resonance imaging heart	1	1	0
2022	4	22	General disorders and administration site conditions	Inflammation	1	0	0
2022	4	22	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	4	22	Investigations	Electrocardiogram abnormal	1	1	0
2022	4	22	Injury, poisoning and procedural complications	Overdose	1	1	0
2022	4	22	Investigations	Troponin T	1	1	0
2022	4	22	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	4	22	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	4	22	General disorders and administration site conditions	Pain	1	0	0
2022	4	22	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	4	22	Nervous system disorders	Tremor	1	1	0
2022	4	22	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	22	Cardiac disorders	Myocardial infarction	1	1	0
2022	4	22	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	4	22	General disorders and administration site conditions	Asthenia	1	1	0
2022	4	22	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	22	Immune system disorders	Hypersensitivity	1	1	0
2022	4	22	Investigations	C-reactive protein increased	1	1	0
2022	4	22	Musculoskeletal and connective tissue disorders	Muscle atrophy	1	0	0
2022	4	22	Cardiac disorders	Pericardial effusion	1	1	0
2022	4	22	Investigations	Echocardiogram abnormal	1	1	0
2022	4	23	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	23	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	4	23	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	4	23	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	23	Nervous system disorders	Paraesthesia	1	1	0
2022	4	23	Psychiatric disorders	Insomnia	1	1	0
2022	4	23	Blood and lymphatic system disorders	Lymph node pain	1	1	0
2022	4	23	Nervous system disorders	Dizziness	1	1	0
2022	4	23	General disorders and administration site conditions	Axillary pain	1	1	0
2022	4	23	General disorders and administration site conditions	Pyrexia	1	1	0
2022	4	23	Infections and infestations	Bronchitis	1	1	0
2022	4	24	Reproductive system and breast disorders	Menstrual disorder	3	3	0
2022	4	24	Nervous system disorders	Headache	3	3	0
2022	4	24	Gastrointestinal disorders	Diarrhoea	2	2	0
2022	4	24	General disorders and administration site conditions	Injection site pain	2	2	0
2022	4	24	General disorders and administration site conditions	Malaise	1	1	0
2022	4	24	Investigations	Heart rate increased	1	1	0
2022	4	24	General disorders and administration site conditions	Pyrexia	1	1	0
2022	4	24	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	4	24	Psychiatric disorders	Libido decreased	1	1	0
2022	4	24	Gastrointestinal disorders	Dry mouth	1	1	0
2022	4	24	Gastrointestinal disorders	Nausea	1	1	0
2022	4	24	Gastrointestinal disorders	Vomiting	1	1	0
2022	4	24	Infections and infestations	Candida infection	1	1	0
2022	4	24	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	4	24	Nervous system disorders	Lethargy	1	1	0
2022	4	24	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	24	Investigations	Weight decreased	1	1	0
2022	4	24	Reproductive system and breast disorders	Dysmenorrhoea	1	1	0
2022	4	24	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	4	24	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	4	24	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	24	Renal and urinary disorders	Pollakiuria	1	1	0
2022	4	24	Reproductive system and breast disorders	Oligomenorrhoea	1	1	0
2022	4	24	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	1	0
2022	4	25	Gastrointestinal disorders	Abdominal pain lower	1	1	0
2022	4	25	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	4	25	General disorders and administration site conditions	Chest pain	1	1	0
2022	4	25	Gastrointestinal disorders	Nausea	1	1	0
2022	4	25	Investigations	SARS-CoV-2 test positive	1	1	0
2022	4	25	Cardiac disorders	Palpitations	1	1	0
2022	4	25	Nervous system disorders	Headache	1	1	0
2022	4	25	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	4	25	Cardiac disorders	Atrial flutter	1	1	0
2022	4	25	Nervous system disorders	Dizziness	1	1	0
2022	4	25	Cardiac disorders	Extrasystoles	1	1	0
2022	4	25	General disorders and administration site conditions	Malaise	1	1	0
2022	4	25	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	26	Gastrointestinal disorders	Vomiting	3	2	0
2022	4	26	Nervous system disorders	Headache	3	3	0
2022	4	26	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	4	26	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	4	26	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	4	26	General disorders and administration site conditions	Chills	2	2	0
2022	4	26	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	4	26	General disorders and administration site conditions	Extensive swelling of vaccinated limb	2	2	0
2022	4	26	Nervous system disorders	Syncope	1	0	0
2022	4	26	General disorders and administration site conditions	Pyrexia	1	0	0
2022	4	26	Gastrointestinal disorders	Nausea	1	1	0
2022	4	26	General disorders and administration site conditions	Malaise	1	0	0
2022	4	26	General disorders and administration site conditions	Injection site pain	1	1	0
2022	4	26	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	26	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	4	26	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	4	26	General disorders and administration site conditions	Pain	1	1	0
2022	4	27	Nervous system disorders	Headache	3	3	0
2022	4	27	General disorders and administration site conditions	Chest pain	3	3	0
2022	4	27	Injury, poisoning and procedural complications	Vaccination error	2	2	0
2022	4	27	Nervous system disorders	Lethargy	2	2	0
2022	4	27	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	2	2	0
2022	4	27	Cardiac disorders	Palpitations	2	2	0
2022	4	27	Gastrointestinal disorders	Nausea	2	2	0
2022	4	27	General disorders and administration site conditions	Fatigue	2	1	0
2022	4	27	General disorders and administration site conditions	Malaise	2	2	0
2022	4	27	Ear and labyrinth disorders	Ear discomfort	1	0	0
2022	4	27	Reproductive system and breast disorders	Ovarian cyst	1	1	0
2022	4	27	Ear and labyrinth disorders	Tinnitus	1	0	0
2022	4	27	Gastrointestinal disorders	Dyspepsia	1	1	0
2022	4	27	Investigations	Troponin	1	1	0
2022	4	27	Nervous system disorders	Loss of consciousness	1	1	0
2022	4	27	Investigations	Heart rate irregular	1	1	0
2022	4	27	Nervous system disorders	Hypoaesthesia	1	1	0
2022	4	27	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	4	27	Reproductive system and breast disorders	Adnexal torsion	1	1	0
2022	4	27	Nervous system disorders	Migraine	1	1	0
2022	4	27	Cardiac disorders	Myocarditis	1	1	0
2022	4	27	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	4	27	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	4	27	Cardiac disorders	Myocardial infarction	1	1	0
2022	4	27	Nervous system disorders	Brain injury	1	1	1
2022	4	27	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	0	0
2022	4	27	Cardiac disorders	Sinus arrhythmia	1	1	0
2022	4	27	General disorders and administration site conditions	Pyrexia	1	1	0
2022	4	27	Immune system disorders	Anaphylactic reaction	1	1	0
2022	4	27	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	27	Infections and infestations	Encephalitis enteroviral	1	1	1
2022	4	27	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	4	27	Nervous system disorders	Dizziness	1	0	0
2022	4	28	Nervous system disorders	Headache	2	2	0
2022	4	28	Eye disorders	Visual impairment	1	1	0
2022	4	28	Gastrointestinal disorders	Diarrhoea	1	0	0
2022	4	28	Immune system disorders	Anaphylactic reaction	1	1	0
2022	4	28	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	4	28	Skin and subcutaneous tissue disorders	Rash pruritic	1	0	0
2022	4	28	Cardiac disorders	Atrial fibrillation	1	1	0
2022	4	28	Infections and infestations	Influenza	1	1	0
2022	4	28	Ear and labyrinth disorders	Ear pain	1	1	0
2022	4	28	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	1	0
2022	4	28	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	4	28	Nervous system disorders	Dizziness	1	1	0
2022	4	28	General disorders and administration site conditions	Concomitant disease progression	1	1	0
2022	4	28	Cardiac disorders	Tachycardia	1	1	0
2022	4	28	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	4	28	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	4	28	General disorders and administration site conditions	Feeling hot	1	1	0
2022	4	28	General disorders and administration site conditions	Fatigue	1	1	0
2022	4	28	Cardiac disorders	Palpitations	1	0	0
2022	4	28	Immune system disorders	Hypersensitivity	1	0	0
2022	4	28	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	4	28	Respiratory, thoracic and mediastinal disorders	Sinus congestion	1	1	0
2022	4	28	Respiratory, thoracic and mediastinal disorders	Upper-airway cough syndrome	1	1	0
2022	4	28	Infections and infestations	Laryngitis	1	1	0
2022	4	28	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	4	28	Gastrointestinal disorders	Gastrointestinal disorder	1	0	0
2022	4	28	Gastrointestinal disorders	Nausea	1	1	0
2022	4	28	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	4	28	Nervous system disorders	Bell's palsy	1	1	0
2022	4	29	General disorders and administration site conditions	Chest pain	4	3	0
2022	4	29	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	2	0
2022	4	29	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	4	29	Nervous system disorders	Headache	2	2	0
2022	4	29	Vascular disorders	Hypertension	2	2	0
2022	4	29	Nervous system disorders	Lethargy	2	1	0
2022	4	29	Nervous system disorders	Syncope	2	2	0
2022	4	29	General disorders and administration site conditions	Exercise tolerance decreased	2	2	0
2022	4	29	Gastrointestinal disorders	Nausea	1	1	0
2022	4	29	General disorders and administration site conditions	Malaise	1	0	0
2022	4	29	Cardiac disorders	Pericarditis	1	0	0
2022	4	29	Cardiac disorders	Palpitations	1	0	0
2022	4	29	Nervous system disorders	Hypoaesthesia	1	1	0
2022	4	29	General disorders and administration site conditions	Pyrexia	1	0	0
2022	4	29	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	4	29	Immune system disorders	Hypersensitivity	1	1	0
2022	4	29	Nervous system disorders	Paraesthesia	1	1	0
2022	4	29	Psychiatric disorders	Insomnia	1	1	0
2022	4	29	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	4	29	Cardiac disorders	Tachycardia	1	1	0
2022	4	29	General disorders and administration site conditions	Pain	1	1	0
2022	4	29	Infections and infestations	Nasopharyngitis	1	1	0
2022	4	29	Blood and lymphatic system disorders	Neutrophilia	1	1	0
2022	4	29	Investigations	White blood cell count decreased	1	1	0
2022	4	29	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	4	29	General disorders and administration site conditions	Chills	1	1	0
2022	4	29	Musculoskeletal and connective tissue disorders	Arthritis	1	1	0
2022	4	29	Psychiatric disorders	Anxiety	1	1	0
2022	4	29	Gastrointestinal disorders	Diarrhoea	1	0	0
2022	4	29	General disorders and administration site conditions	Injected limb mobility decreased	1	1	0
2022	4	29	Nervous system disorders	Dizziness	1	0	0
2022	4	30	Cardiac disorders	Cardiac failure congestive	1	0	0
2022	4	30	General disorders and administration site conditions	Chest discomfort	1	0	0
2022	4	30	General disorders and administration site conditions	Chest pain	1	0	0
2022	4	30	General disorders and administration site conditions	Chills	1	1	0
2022	4	30	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	4	30	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	4	30	General disorders and administration site conditions	Pyrexia	1	1	0
2022	4	30	Musculoskeletal and connective tissue disorders	Musculoskeletal chest pain	1	0	0
2022	4	30	Musculoskeletal and connective tissue disorders	Myalgia	1	0	0
2022	4	30	Nervous system disorders	Syncope	1	0	0
2022	4	30	Respiratory, thoracic and mediastinal disorders	Cough	1	0	0
2022	4	30	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	0	0
2022	4	30	Skin and subcutaneous tissue disorders	Rash macular	1	1	0
2022	4	30	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	4	30	Skin and subcutaneous tissue disorders	Skin haemorrhage	1	1	0
2022	4	30	Vascular disorders	Thrombosis	1	1	0
2022	5	1	Cardiac disorders	Tachycardia	1	1	0
2022	5	1	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	1	Nervous system disorders	Headache	1	1	0
2022	5	1	Nervous system disorders	Memory impairment	1	1	0
2022	5	1	Vascular disorders	Hypertension	1	1	0
2022	5	2	General disorders and administration site conditions	Pyrexia	2	2	0
2022	5	2	Skin and subcutaneous tissue disorders	Urticaria	2	1	0
2022	5	2	Cardiac disorders	Tachycardia	1	1	0
2022	5	2	Ear and labyrinth disorders	Vertigo	1	0	0
2022	5	2	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	2	General disorders and administration site conditions	Injection site pain	1	1	0
2022	5	2	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	2	General disorders and administration site conditions	Malaise	1	1	0
2022	5	2	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	5	2	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	5	2	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	5	2	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	5	2	Nervous system disorders	Burning sensation	1	1	0
2022	5	2	Nervous system disorders	Dizziness	1	0	0
2022	5	2	Nervous system disorders	Headache	1	1	0
2022	5	2	Nervous system disorders	Lethargy	1	1	0
2022	5	2	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	5	3	Nervous system disorders	Lethargy	3	3	0
2022	5	3	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	5	3	Nervous system disorders	Headache	3	3	0
2022	5	3	General disorders and administration site conditions	Chest pain	3	3	0
2022	5	3	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	5	3	Musculoskeletal and connective tissue disorders	Muscular weakness	2	2	0
2022	5	3	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	5	3	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	5	3	Cardiac disorders	Pericarditis	1	1	0
2022	5	3	Nervous system disorders	Paraesthesia	1	1	0
2022	5	3	Infections and infestations	Nasopharyngitis	1	1	0
2022	5	3	Infections and infestations	Tonsillitis	1	1	0
2022	5	3	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	5	3	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	5	3	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	5	3	Reproductive system and breast disorders	Breast swelling	1	1	0
2022	5	3	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	5	3	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	5	3	Psychiatric disorders	Stress	1	1	0
2022	5	3	Gastrointestinal disorders	Nausea	1	1	0
2022	5	3	Cardiac disorders	Palpitations	1	1	0
2022	5	3	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	0	0
2022	5	3	Reproductive system and breast disorders	Breast pain	1	1	0
2022	5	3	Infections and infestations	Herpes zoster	1	1	0
2022	5	3	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	5	3	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2022	5	3	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2022	5	4	Injury, poisoning and procedural complications	Adverse event following immunisation	3	3	1
2022	5	4	General disorders and administration site conditions	Chest pain	2	2	0
2022	5	4	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	5	4	Cardiac disorders	Myocarditis	1	1	0
2022	5	4	Cardiac disorders	Tachycardia	1	1	0
2022	5	4	Ear and labyrinth disorders	Deafness unilateral	1	1	0
2022	5	4	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	5	4	Eye disorders	Eye pain	1	1	0
2022	5	4	Eye disorders	Visual impairment	1	1	0
2022	5	4	General disorders and administration site conditions	Concomitant disease progression	1	1	0
2022	5	4	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	4	Infections and infestations	Herpes zoster	1	0	0
2022	5	4	Infections and infestations	Meningitis	1	1	0
2022	5	4	Infections and infestations	Urinary tract infection bacterial	1	1	0
2022	5	4	Infections and infestations	Varicella zoster virus infection	1	1	0
2022	5	4	Injury, poisoning and procedural complications	Expired product administered	1	1	0
2022	5	4	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	5	4	Investigations	Electrocardiogram abnormal	1	1	0
2022	5	4	Investigations	Troponin increased	1	1	0
2022	5	4	Musculoskeletal and connective tissue disorders	Bone pain	1	1	0
2022	5	4	Musculoskeletal and connective tissue disorders	Muscle tightness	1	1	0
2022	5	4	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Neoplasm malignant	1	1	0
2022	5	4	Nervous system disorders	Dizziness	1	1	0
2022	5	4	Nervous system disorders	Optic neuritis	1	1	0
2022	5	4	Nervous system disorders	Paraesthesia	1	1	0
2022	5	4	Nervous system disorders	Syncope	1	1	0
2022	5	4	Renal and urinary disorders	Nephrolithiasis	1	1	0
2022	5	4	Reproductive system and breast disorders	Breast swelling	1	1	0
2022	5	4	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	5	4	Respiratory, thoracic and mediastinal disorders	Pleuritic pain	1	1	0
2022	5	4	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	5	5	Nervous system disorders	Taste disorder	1	1	0
2022	5	5	Renal and urinary disorders	Pollakiuria	1	0	0
2022	5	5	Blood and lymphatic system disorders	Neutrophilia	1	1	0
2022	5	5	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	5	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	5	5	Nervous system disorders	Lethargy	1	0	0
2022	5	5	Gastrointestinal disorders	Vomiting	1	0	0
2022	5	5	Immune system disorders	Anaphylactic reaction	1	1	0
2022	5	6	Nervous system disorders	Headache	2	2	0
2022	5	6	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	2	0
2022	5	6	Cardiac disorders	Carditis	1	1	0
2022	5	6	Cardiac disorders	Palpitations	1	1	0
2022	5	6	Cardiac disorders	Pericarditis	1	1	0
2022	5	6	Gastrointestinal disorders	Gastritis	1	1	0
2022	5	6	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	6	General disorders and administration site conditions	Injection site pain	1	1	0
2022	5	6	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	5	6	General disorders and administration site conditions	Pyrexia	1	1	0
2022	5	6	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	5	6	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	5	6	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	5	6	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	5	6	Nervous system disorders	Dizziness	1	1	0
2022	5	6	Nervous system disorders	Lethargy	1	1	0
2022	5	6	Nervous system disorders	Migraine	1	1	0
2022	5	6	Nervous system disorders	Multiple sclerosis	1	1	0
2022	5	6	Nervous system disorders	Syncope	1	1	0
2022	5	6	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	5	6	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	5	8	Cardiac disorders	Myocardial infarction	1	1	0
2022	5	8	Skin and subcutaneous tissue disorders	Erythema	1	1	0
2022	5	8	Vascular disorders	Thrombosis	1	1	0
2022	5	8	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	5	8	Nervous system disorders	Radiculitis brachial	1	1	0
2022	5	8	General disorders and administration site conditions	Injection site pain	1	1	0
2022	5	8	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	5	8	General disorders and administration site conditions	Pyrexia	1	1	0
2022	5	8	Injury, poisoning and procedural complications	Wrong technique in product usage process	1	1	0
2022	5	9	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	2	0
2022	5	9	General disorders and administration site conditions	Chest pain	2	2	0
2022	5	9	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	2	2	0
2022	5	9	General disorders and administration site conditions	Fatigue	2	1	0
2022	5	9	Musculoskeletal and connective tissue disorders	Myalgia	1	0	0
2022	5	9	Cardiac disorders	Palpitations	1	1	0
2022	5	9	Infections and infestations	Lower respiratory tract infection	1	1	0
2022	5	9	Investigations	Fibrin D dimer increased	1	1	0
2022	5	9	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	5	9	Investigations	SARS-CoV-2 test positive	1	0	0
2022	5	9	General disorders and administration site conditions	Pyrexia	1	0	0
2022	5	9	Investigations	Electrocardiogram abnormal	1	1	0
2022	5	9	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	0	0
2022	5	9	Cardiac disorders	Sinus tachycardia	1	1	0
2022	5	9	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	5	9	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	5	9	Infections and infestations	Vaccine breakthrough infection	1	0	0
2022	5	9	Nervous system disorders	Headache	1	0	0
2022	5	9	Gastrointestinal disorders	Nausea	1	0	0
2022	5	9	Vascular disorders	Pallor	1	1	0
2022	5	9	General disorders and administration site conditions	Exercise tolerance decreased	1	1	0
2022	5	9	Metabolism and nutrition disorders	Decreased appetite	1	0	0
2022	5	9	Respiratory, thoracic and mediastinal disorders	Cough	1	0	0
2022	5	9	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	1	0	0
2022	5	9	Skin and subcutaneous tissue disorders	Rash erythematous	1	1	0
2022	5	9	Respiratory, thoracic and mediastinal disorders	Haemoptysis	1	1	0
2022	5	10	General disorders and administration site conditions	Chest pain	3	1	0
2022	5	10	Musculoskeletal and connective tissue disorders	Myalgia	3	2	0
2022	5	10	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	2	0
2022	5	10	Cardiac disorders	Palpitations	2	1	0
2022	5	10	Cardiac disorders	Pericarditis	2	2	0
2022	5	10	Gastrointestinal disorders	Abdominal pain	2	2	0
2022	5	10	General disorders and administration site conditions	Malaise	2	0	0
2022	5	10	General disorders and administration site conditions	Pyrexia	2	1	0
2022	5	10	Infections and infestations	COVID-19	2	2	0
2022	5	10	Nervous system disorders	Headache	2	2	0
2022	5	10	Nervous system disorders	Lethargy	2	2	0
2022	5	10	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	5	10	Cardiac disorders	Bradycardia	1	0	0
2022	5	10	Cardiac disorders	Cardiac disorder	1	1	0
2022	5	10	Cardiac disorders	Cardiac failure congestive	1	0	0
2022	5	10	Cardiac disorders	Cardiomyopathy	1	1	0
2022	5	10	Cardiac disorders	Supraventricular extrasystoles	1	0	0
2022	5	10	Cardiac disorders	Tachycardia	1	0	0
2022	5	10	Cardiac disorders	Ventricular extrasystoles	1	0	0
2022	5	10	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	5	10	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	5	10	Gastrointestinal disorders	Lip swelling	1	1	0
2022	5	10	Gastrointestinal disorders	Nausea	1	1	0
2022	5	10	Gastrointestinal disorders	Vomiting	1	1	0
2022	5	10	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	5	10	General disorders and administration site conditions	Extensive swelling of vaccinated limb	1	1	0
2022	5	10	General disorders and administration site conditions	Injection site pain	1	0	0
2022	5	10	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	10	Infections and infestations	Upper respiratory tract infection	1	1	0
2022	5	10	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	0
2022	5	10	Metabolism and nutrition disorders	Diabetes mellitus	1	1	0
2022	5	10	Metabolism and nutrition disorders	Hypercholesterolaemia	1	1	0
2022	5	10	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	5	10	Musculoskeletal and connective tissue disorders	Pain in extremity	1	0	0
2022	5	10	Nervous system disorders	Carotid artery thrombosis	1	1	0
2022	5	10	Nervous system disorders	Cerebrovascular accident	1	1	0
2022	5	10	Nervous system disorders	Syncope	1	1	0
2022	5	10	Reproductive system and breast disorders	Heavy menstrual bleeding	1	1	0
2022	5	10	Reproductive system and breast disorders	Menstrual disorder	1	1	0
2022	5	10	Reproductive system and breast disorders	Menstruation irregular	1	1	0
2022	5	10	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	5	10	Respiratory, thoracic and mediastinal disorders	Nasal congestion	1	1	0
2022	5	10	Vascular disorders	Deep vein thrombosis	1	0	0
2022	5	11	Cardiac disorders	Palpitations	2	2	0
2022	5	11	General disorders and administration site conditions	Chest pain	2	2	0
2022	5	11	Nervous system disorders	Headache	2	2	0
2022	5	11	General disorders and administration site conditions	Pyrexia	1	1	0
2022	5	11	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	5	11	Nervous system disorders	Dizziness	1	1	0
2022	5	11	Skin and subcutaneous tissue disorders	Dermatitis allergic	1	1	0
2022	5	11	Infections and infestations	Pneumonia	1	1	0
2022	5	11	Cardiac disorders	Tachycardia	1	1	0
2022	5	11	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	5	11	Infections and infestations	COVID-19	1	1	0
2022	5	11	Respiratory, thoracic and mediastinal disorders	Asthma	1	1	0
2022	5	11	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	11	Immune system disorders	Hypersensitivity	1	1	0
2022	5	11	Nervous system disorders	Paraesthesia	1	1	0
2022	5	12	Infections and infestations	Vaccine breakthrough infection	1	0	0
2022	5	12	Immune system disorders	Hypersensitivity	1	1	0
2022	5	12	Skin and subcutaneous tissue disorders	Rash vesicular	1	1	0
2022	5	12	Gastrointestinal disorders	Oral mucosal blistering	1	1	0
2022	5	12	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	12	Investigations	SARS-CoV-2 test positive	1	0	0
2022	5	12	Psychiatric disorders	Stress	1	1	0
2022	5	12	Skin and subcutaneous tissue disorders	Rash pruritic	1	1	0
2022	5	12	Nervous system disorders	Trigeminal neuralgia	1	1	0
2022	5	13	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	5	13	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	5	13	Respiratory, thoracic and mediastinal disorders	Wheezing	1	1	0
2022	5	13	Infections and infestations	Vaccine breakthrough infection	1	0	0
2022	5	13	Investigations	Epstein-Barr virus antibody positive	1	0	0
2022	5	13	Investigations	SARS-CoV-2 antibody test positive	1	0	0
2022	5	13	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	13	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	13	Investigations	Alanine aminotransferase increased	1	0	0
2022	5	13	Gastrointestinal disorders	Vomiting	1	1	0
2022	5	13	Skin and subcutaneous tissue disorders	Rash maculo-papular	1	1	0
2022	5	13	Injury, poisoning and procedural complications	Inappropriate schedule of product administration	1	0	0
2022	5	13	General disorders and administration site conditions	Swelling face	1	1	0
2022	5	13	Investigations	Gamma-glutamyltransferase increased	1	0	0
2022	5	13	Skin and subcutaneous tissue disorders	Erythema multiforme	1	0	0
2022	5	13	General disorders and administration site conditions	Malaise	1	1	0
2022	5	13	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	5	13	General disorders and administration site conditions	Pyrexia	1	1	0
2022	5	13	Injury, poisoning and procedural complications	Vaccination error	1	0	0
2022	5	15	General disorders and administration site conditions	Pain	1	1	0
2022	5	15	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	5	15	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	15	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	15	Gastrointestinal disorders	Nausea	1	1	0
2022	5	15	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Liposarcoma	1	1	0
2022	5	15	Nervous system disorders	Headache	1	1	0
2022	5	15	Nervous system disorders	Dizziness	1	1	0
2022	5	15	General disorders and administration site conditions	Injection site pruritus	1	1	0
2022	5	16	Nervous system disorders	Headache	6	6	0
2022	5	16	Nervous system disorders	Lethargy	6	5	0
2022	5	16	Musculoskeletal and connective tissue disorders	Myalgia	6	6	0
2022	5	16	Musculoskeletal and connective tissue disorders	Arthralgia	6	6	0
2022	5	16	Gastrointestinal disorders	Diarrhoea	4	3	0
2022	5	16	General disorders and administration site conditions	Pyrexia	4	4	0
2022	5	16	General disorders and administration site conditions	Injection site reaction	4	4	0
2022	5	16	Gastrointestinal disorders	Nausea	2	1	0
2022	5	16	Respiratory, thoracic and mediastinal disorders	Cough	2	2	0
2022	5	16	Gastrointestinal disorders	Vomiting	2	2	0
2022	5	16	Nervous system disorders	Migraine	1	1	0
2022	5	16	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	16	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	5	16	Investigations	Blood creatine phosphokinase increased	1	1	0
2022	5	16	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	5	16	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	5	16	Cardiac disorders	Palpitations	1	1	0
2022	5	16	General disorders and administration site conditions	Malaise	1	0	0
2022	5	16	Musculoskeletal and connective tissue disorders	Rhabdomyolysis	1	1	0
2022	5	16	Skin and subcutaneous tissue disorders	Urticaria	1	0	0
2022	5	16	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	5	16	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2022	5	17	Nervous system disorders	Headache	3	3	0
2022	5	17	Nervous system disorders	Lethargy	3	3	0
2022	5	17	Respiratory, thoracic and mediastinal disorders	Dyspnoea	3	3	0
2022	5	17	Gastrointestinal disorders	Nausea	2	2	0
2022	5	17	General disorders and administration site conditions	Chest pain	2	2	0
2022	5	17	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	5	17	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	5	17	Nervous system disorders	Paraesthesia	2	2	0
2022	5	17	Cardiac disorders	Pericarditis	1	1	0
2022	5	17	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	5	17	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	5	17	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	5	17	Gastrointestinal disorders	Dysphagia	1	1	0
2022	5	17	Gastrointestinal disorders	Intestinal obstruction	1	1	0
2022	5	17	Gastrointestinal disorders	Lip swelling	1	1	0
2022	5	17	Gastrointestinal disorders	Swollen tongue	1	1	0
2022	5	17	Gastrointestinal disorders	Vomiting	1	1	0
2022	5	17	General disorders and administration site conditions	Chills	1	1	0
2022	5	17	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	5	17	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	5	17	General disorders and administration site conditions	Pyrexia	1	1	0
2022	5	17	Immune system disorders	Anaphylactic reaction	1	1	0
2022	5	17	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	5	17	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	5	17	Injury, poisoning and procedural complications	Wrong product administered	1	1	0
2022	5	17	Musculoskeletal and connective tissue disorders	Back pain	1	1	0
2022	5	17	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	5	17	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Skin cancer	1	1	0
2022	5	17	Nervous system disorders	Dizziness	1	1	0
2022	5	17	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	5	17	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	0	0
2022	5	17	Respiratory, thoracic and mediastinal disorders	Rhinorrhoea	1	1	0
2022	5	17	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2022	5	17	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	5	17	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	5	17	Vascular disorders	Flushing	1	1	0
2022	5	18	Cardiac disorders	Acute myocardial infarction	1	1	0
2022	5	18	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	5	18	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	5	18	Infections and infestations	Varicella	1	1	0
2022	5	18	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	1
2022	5	18	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	5	18	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	5	18	Nervous system disorders	Neuralgia	1	1	0
2022	5	18	Nervous system disorders	Paraesthesia	1	1	0
2022	5	19	General disorders and administration site conditions	Pyrexia	2	2	0
2022	5	19	Nervous system disorders	Headache	2	2	0
2022	5	19	Cardiac disorders	Pericarditis	1	1	0
2022	5	19	Gastrointestinal disorders	Lip swelling	1	1	0
2022	5	19	Gastrointestinal disorders	Nausea	1	1	0
2022	5	19	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	19	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	19	General disorders and administration site conditions	Malaise	1	1	0
2022	5	19	General disorders and administration site conditions	Pain	1	1	0
2022	5	19	Immune system disorders	Hypersensitivity	1	1	0
2022	5	19	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	1
2022	5	19	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	5	19	Nervous system disorders	Depressed level of consciousness	1	1	1
2022	5	19	Nervous system disorders	Lethargy	1	1	0
2022	5	19	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	5	19	Respiratory, thoracic and mediastinal disorders	Tachypnoea	1	1	1
2022	5	19	Skin and subcutaneous tissue disorders	Dermatitis allergic	1	1	0
2022	5	20	Skin and subcutaneous tissue disorders	Rash	2	2	0
2022	5	20	Skin and subcutaneous tissue disorders	Urticaria	2	2	0
2022	5	20	Musculoskeletal and connective tissue disorders	Myalgia	1	1	1
2022	5	20	Nervous system disorders	Cerebrovascular accident	1	1	0
2022	5	20	Gastrointestinal disorders	Lip swelling	1	1	0
2022	5	20	General disorders and administration site conditions	Pyrexia	1	1	0
2022	5	20	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	1
2022	5	20	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	1
2022	5	20	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2022	5	20	Ear and labyrinth disorders	Tinnitus	1	1	0
2022	5	20	Gastrointestinal disorders	Gastrooesophageal reflux disease	1	1	0
2022	5	20	Metabolism and nutrition disorders	Decreased appetite	1	1	1
2022	5	20	Respiratory, thoracic and mediastinal disorders	Pulmonary oedema	1	1	1
2022	5	20	General disorders and administration site conditions	Concomitant disease progression	1	1	1
2022	5	20	Vascular disorders	Flushing	1	1	0
2022	5	20	General disorders and administration site conditions	Fatigue	1	1	1
2022	5	20	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	20	Skin and subcutaneous tissue disorders	Mechanical urticaria	1	1	0
2022	5	20	Cardiac disorders	Ventricular tachycardia	1	1	1
2022	5	20	General disorders and administration site conditions	Concomitant disease aggravated	1	1	0
2022	5	20	Investigations	Blood magnesium decreased	1	1	1
2022	5	20	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	1
2022	5	20	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	20	General disorders and administration site conditions	Asthenia	1	1	1
2022	5	20	Gastrointestinal disorders	Vomiting	1	1	0
2022	5	20	Nervous system disorders	Hemiparesis	1	1	0
2022	5	20	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	5	21	Nervous system disorders	Headache	2	1	0
2022	5	21	General disorders and administration site conditions	Malaise	1	0	0
2022	5	21	General disorders and administration site conditions	Pain	1	1	0
2022	5	21	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	1
2022	5	21	Nervous system disorders	Dizziness	1	0	0
2022	5	21	Nervous system disorders	Syncope	1	0	0
2022	5	21	Vascular disorders	Superficial vein thrombosis	1	1	0
2022	5	22	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	5	23	General disorders and administration site conditions	Pyrexia	2	2	0
2022	5	23	Nervous system disorders	Bell's palsy	2	2	0
2022	5	23	Nervous system disorders	Headache	2	2	0
2022	5	23	Nervous system disorders	Paraesthesia	2	2	0
2022	5	23	Respiratory, thoracic and mediastinal disorders	Oropharyngeal pain	2	1	0
2022	5	23	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	5	23	Cardiac disorders	Myopericarditis	1	1	0
2022	5	23	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	5	23	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	5	23	Gastrointestinal disorders	Glossodynia	1	0	0
2022	5	23	Gastrointestinal disorders	Mouth ulceration	1	0	0
2022	5	23	Gastrointestinal disorders	Nausea	1	1	0
2022	5	23	Gastrointestinal disorders	Oral disorder	1	0	0
2022	5	23	Gastrointestinal disorders	Oral pain	1	0	0
2022	5	23	Gastrointestinal disorders	Tongue erythema	1	0	0
2022	5	23	General disorders and administration site conditions	Chest discomfort	1	1	0
2022	5	23	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	23	General disorders and administration site conditions	Concomitant disease aggravated	1	0	0
2022	5	23	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	23	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	23	General disorders and administration site conditions	Injection site swelling	1	1	0
2022	5	23	General disorders and administration site conditions	Shoulder injury related to vaccine administration	1	1	0
2022	5	23	Infections and infestations	Herpes zoster	1	1	0
2022	5	23	Investigations	Echocardiogram abnormal	1	1	0
2022	5	23	Investigations	Liver function test increased	1	1	0
2022	5	23	Investigations	Magnetic resonance imaging abnormal	1	1	0
2022	5	23	Investigations	Troponin increased	1	1	0
2022	5	23	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	5	23	Musculoskeletal and connective tissue disorders	Bursitis	1	1	0
2022	5	23	Musculoskeletal and connective tissue disorders	Periarthritis	1	1	0
2022	5	23	Nervous system disorders	Lethargy	1	1	0
2022	5	23	Nervous system disorders	Post herpetic neuralgia	1	1	0
2022	5	23	Nervous system disorders	Restless legs syndrome	1	1	0
2022	5	23	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	5	23	Respiratory, thoracic and mediastinal disorders	Dysphonia	1	1	0
2022	5	23	Respiratory, thoracic and mediastinal disorders	Pharyngeal erythema	1	0	0
2022	5	23	Respiratory, thoracic and mediastinal disorders	Throat irritation	1	1	0
2022	5	23	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	5	24	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	24	Infections and infestations	Pneumonia	1	1	0
2022	5	24	Gastrointestinal disorders	Nausea	1	1	0
2022	5	24	Nervous system disorders	Dizziness	1	1	0
2022	5	25	Eye disorders	Eye pain	1	1	0
2022	5	25	General disorders and administration site conditions	Influenza like illness	1	1	0
2022	5	25	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	25	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	5	25	General disorders and administration site conditions	Fatigue	1	1	0
2022	5	25	Musculoskeletal and connective tissue disorders	Chondrocalcinosis pyrophosphate	1	1	0
2022	5	25	General disorders and administration site conditions	Pyrexia	1	0	0
2022	5	25	Musculoskeletal and connective tissue disorders	Myalgia	1	0	0
2022	5	25	General disorders and administration site conditions	Chest pain	1	0	0
2022	5	25	Nervous system disorders	Headache	1	1	0
2022	5	25	Investigations	Allergy test positive	1	0	0
2022	5	25	Eye disorders	Retinal vein thrombosis	1	1	0
2022	5	25	Infections and infestations	Herpes zoster	1	1	0
2022	5	25	Skin and subcutaneous tissue disorders	Urticaria	1	0	0
2022	5	25	Respiratory, thoracic and mediastinal disorders	Cough	1	1	0
2022	5	25	Eye disorders	Ocular hyperaemia	1	1	0
2022	5	25	General disorders and administration site conditions	Peripheral swelling	1	0	0
2022	5	26	Cardiac disorders	Myocarditis	1	1	0
2022	5	26	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	26	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	5	26	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	5	26	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	5	26	Vascular disorders	Deep vein thrombosis	1	1	0
2022	5	26	Vascular disorders	Peripheral artery thrombosis	1	1	0
2022	5	27	Respiratory, thoracic and mediastinal disorders	Dyspnoea	2	1	0
2022	5	27	Cardiac disorders	Myocardial infarction	1	1	0
2022	5	27	General disorders and administration site conditions	Fatigue	1	0	0
2022	5	27	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	5	27	Immune system disorders	Seasonal allergy	1	1	0
2022	5	27	Infections and infestations	COVID-19	1	1	0
2022	5	27	Injury, poisoning and procedural complications	Muscle injury	1	1	0
2022	5	27	Injury, poisoning and procedural complications	Tissue injury	1	1	0
2022	5	27	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	5	27	Musculoskeletal and connective tissue disorders	Groin pain	1	1	0
2022	5	27	Musculoskeletal and connective tissue disorders	Neck pain	1	1	0
2022	5	27	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2022	5	27	Nervous system disorders	Headache	1	1	0
2022	5	27	Nervous system disorders	Neuropathy peripheral	1	1	0
2022	5	27	Skin and subcutaneous tissue disorders	Alopecia	1	1	0
2022	5	27	Vascular disorders	Giant cell arteritis	1	1	0
2022	5	28	General disorders and administration site conditions	Asthenia	1	1	0
2022	5	28	Nervous system disorders	Transient ischaemic attack	1	1	0
2022	5	28	Respiratory, thoracic and mediastinal disorders	Pulmonary congestion	1	1	0
2022	5	29	Investigations	Weight decreased	1	1	0
2022	5	29	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	5	29	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	29	Gastrointestinal disorders	Vomiting	1	1	0
2022	5	30	General disorders and administration site conditions	Fatigue	4	3	0
2022	5	30	Musculoskeletal and connective tissue disorders	Myalgia	4	4	0
2022	5	30	General disorders and administration site conditions	Chest pain	3	2	0
2022	5	30	Musculoskeletal and connective tissue disorders	Pain in extremity	3	1	0
2022	5	30	Cardiac disorders	Pericarditis	2	2	0
2022	5	30	Gastrointestinal disorders	Nausea	2	2	0
2022	5	30	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	5	30	Musculoskeletal and connective tissue disorders	Arthralgia	2	2	0
2022	5	30	Musculoskeletal and connective tissue disorders	Musculoskeletal pain	2	2	0
2022	5	30	Nervous system disorders	Headache	2	1	0
2022	5	30	Nervous system disorders	Lethargy	2	2	0
2022	5	30	Nervous system disorders	Migraine	2	2	0
2022	5	30	Eye disorders	Photophobia	1	1	0
2022	5	30	General disorders and administration site conditions	Asthenia	1	1	0
2022	5	30	General disorders and administration site conditions	Chest discomfort	1	0	0
2022	5	30	General disorders and administration site conditions	Feeling abnormal	1	1	0
2022	5	30	General disorders and administration site conditions	Feeling of body temperature change	1	1	0
2022	5	30	General disorders and administration site conditions	Injection site bruising	1	0	0
2022	5	30	General disorders and administration site conditions	Injection site pain	1	0	0
2022	5	30	General disorders and administration site conditions	Injection site pruritus	1	0	0
2022	5	30	General disorders and administration site conditions	Peripheral swelling	1	1	0
2022	5	30	General disorders and administration site conditions	Pyrexia	1	1	0
2022	5	30	Infections and infestations	Herpes simplex reactivation	1	1	0
2022	5	30	Injury, poisoning and procedural complications	Fall	1	1	0
2022	5	30	Investigations	Echocardiogram normal	1	1	0
2022	5	30	Investigations	Electrocardiogram abnormal	1	1	0
2022	5	30	Investigations	Heart rate increased	1	0	0
2022	5	30	Metabolism and nutrition disorders	Decreased appetite	1	1	0
2022	5	30	Musculoskeletal and connective tissue disorders	Muscle spasms	1	0	0
2022	5	30	Musculoskeletal and connective tissue disorders	Sjogren's syndrome	1	0	0
2022	5	30	Nervous system disorders	Cluster headache	1	1	0
2022	5	30	Nervous system disorders	Hypoaesthesia	1	0	0
2022	5	30	Nervous system disorders	Ischaemic stroke	1	1	0
2022	5	30	Nervous system disorders	Loss of consciousness	1	1	0
2022	5	30	Nervous system disorders	Paraesthesia	1	0	0
2022	5	30	Nervous system disorders	Peripheral sensory neuropathy	1	0	0
2022	5	30	Nervous system disorders	Tremor	1	0	0
2022	5	30	Psychiatric disorders	Insomnia	1	1	0
2022	5	30	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	0	0
2022	5	30	Respiratory, thoracic and mediastinal disorders	Pulmonary embolism	1	1	1
2022	5	30	Skin and subcutaneous tissue disorders	Night sweats	1	0	0
2022	5	30	Vascular disorders	Deep vein thrombosis	1	1	1
2022	5	30	Vascular disorders	Superficial vein thrombosis	1	1	0
2022	5	31	Musculoskeletal and connective tissue disorders	Myalgia	3	3	0
2022	5	31	Reproductive system and breast disorders	Heavy menstrual bleeding	3	3	0
2022	5	31	Nervous system disorders	Headache	3	3	0
2022	5	31	General disorders and administration site conditions	Pyrexia	2	2	0
2022	5	31	Reproductive system and breast disorders	Menstruation irregular	2	2	0
2022	5	31	Reproductive system and breast disorders	Menstrual disorder	2	2	0
2022	5	31	General disorders and administration site conditions	Fatigue	2	2	0
2022	5	31	Gastrointestinal disorders	Abdominal pain upper	1	1	0
2022	5	31	General disorders and administration site conditions	Injection site reaction	1	1	0
2022	5	31	Vascular disorders	Thrombosis	1	1	0
2022	5	31	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	5	31	General disorders and administration site conditions	Pain	1	1	0
2022	5	31	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	5	31	Musculoskeletal and connective tissue disorders	Arthralgia	1	1	0
2022	5	31	Nervous system disorders	Migraine	1	1	0
2022	5	31	Reproductive system and breast disorders	Menstruation delayed	1	1	0
2022	5	31	General disorders and administration site conditions	Injection site urticaria	1	1	0
2022	5	31	General disorders and administration site conditions	Chest pain	1	1	0
2022	5	31	Injury, poisoning and procedural complications	Vaccination error	1	1	0
2022	5	31	Skin and subcutaneous tissue disorders	Urticaria	1	1	0
2022	5	31	Injury, poisoning and procedural complications	Product administered to patient of inappropriate age	1	1	0
2022	5	31	Musculoskeletal and connective tissue disorders	Pain in jaw	1	1	0
2022	5	31	Nervous system disorders	Lethargy	1	1	0
2022	5	31	Gastrointestinal disorders	Nausea	1	1	0
2022	5	31	Cardiac disorders	Cardiomyopathy	1	1	0
2022	5	31	General disorders and administration site conditions	Malaise	1	1	0
2022	5	31	Infections and infestations	Infection	1	1	0
2022	5	31	Nervous system disorders	Dizziness	1	1	0
2022	5	31	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	6	1	Musculoskeletal and connective tissue disorders	Myalgia	2	2	0
2022	6	1	Blood and lymphatic system disorders	Lymphadenopathy	2	2	0
2022	6	1	General disorders and administration site conditions	Injection site reaction	2	2	0
2022	6	1	General disorders and administration site conditions	Pyrexia	2	2	0
2022	6	1	Gastrointestinal disorders	Lip swelling	1	1	0
2022	6	1	Immune system disorders	Anaphylactic reaction	1	1	0
2022	6	1	Nervous system disorders	Disturbance in attention	1	1	0
2022	6	1	Nervous system disorders	Seizure	1	1	0
2022	6	1	Renal and urinary disorders	Urinary incontinence	1	1	0
2022	6	1	Respiratory, thoracic and mediastinal disorders	Throat tightness	1	1	0
2022	6	1	General disorders and administration site conditions	Swelling face	1	1	0
2022	6	1	Nervous system disorders	Dizziness	1	1	0
2022	6	1	Skin and subcutaneous tissue disorders	Swelling face	1	1	0
2022	6	1	Skin and subcutaneous tissue disorders	Urticaria	1	0	0
2022	6	1	Nervous system disorders	Headache	1	1	0
2022	6	1	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	6	1	Gastrointestinal disorders	Nausea	1	1	0
2022	6	1	Gastrointestinal disorders	Vomiting	1	1	0
2022	6	1	General disorders and administration site conditions	Chest pain	1	1	0
2022	6	1	Vascular disorders	Hypotension	1	1	0
2022	6	1	General disorders and administration site conditions	Fatigue	1	1	0
2022	6	1	Nervous system disorders	Syncope	1	1	0
2022	6	1	Psychiatric disorders	Insomnia	1	1	0
2022	6	1	Gastrointestinal disorders	Abdominal pain	1	1	0
2022	6	1	Musculoskeletal and connective tissue disorders	Pain in extremity	1	1	0
2022	6	2	General disorders and administration site conditions	Chest pain	2	2	0
2022	6	2	General disorders and administration site conditions	Fatigue	2	2	0
2022	6	2	Cardiac disorders	Pericarditis	1	1	0
2022	6	2	Gastrointestinal disorders	Diarrhoea	1	1	0
2022	6	2	Gastrointestinal disorders	Vomiting	1	1	0
2022	6	2	General disorders and administration site conditions	Feeling hot	1	1	0
2022	6	2	General disorders and administration site conditions	Malaise	1	1	0
2022	6	2	General disorders and administration site conditions	Pain	1	1	0
2022	6	2	General disorders and administration site conditions	Pyrexia	1	1	0
2022	6	2	Infections and infestations	Nasopharyngitis	1	1	0
2022	6	2	Infections and infestations	Respiratory tract infection	1	1	0
2022	6	2	Injury, poisoning and procedural complications	Adverse event following immunisation	1	1	1
2022	6	2	Investigations	Troponin increased	1	1	0
2022	6	2	Nervous system disorders	Syncope	1	1	0
2022	6	2	Psychiatric disorders	Disorientation	1	1	0
2022	6	2	Psychiatric disorders	Hallucination	1	1	0
2022	6	2	Respiratory, thoracic and mediastinal disorders	Dyspnoea	1	1	0
2022	6	2	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	6	2	Skin and subcutaneous tissue disorders	Hyperhidrosis	1	1	0
2022	6	2	Skin and subcutaneous tissue disorders	Pruritus	1	1	0
2022	6	2	Skin and subcutaneous tissue disorders	Rash	1	1	0
2022	6	2	Surgical and medical procedures	Interchange of vaccine products	1	1	0
2022	6	2	Vascular disorders	Hypotension	1	1	0
2022	6	3	General disorders and administration site conditions	Chest pain	2	2	0
2022	6	3	Nervous system disorders	Paraesthesia	2	1	0
2022	6	3	General disorders and administration site conditions	Chills	1	1	0
2022	6	3	General disorders and administration site conditions	Pyrexia	1	1	0
2022	6	3	Nervous system disorders	Dizziness	1	1	0
2022	6	3	Blood and lymphatic system disorders	Lymphadenopathy	1	1	0
2022	6	3	Cardiac disorders	Pericardial effusion	1	1	0
2022	6	3	Cardiac disorders	Pericarditis	1	1	0
2022	6	3	Cardiac disorders	Myocarditis	1	1	0
2022	6	3	Nervous system disorders	Syncope	1	1	0
2022	6	3	Infections and infestations	Appendicitis	1	1	0
2022	6	3	Gastrointestinal disorders	Nausea	1	1	0
2022	6	3	Investigations	Troponin	1	1	0
2022	6	3	Skin and subcutaneous tissue disorders	Cold sweat	1	1	0
2022	6	3	Cardiac disorders	Palpitations	1	1	0
2022	6	3	Musculoskeletal and connective tissue disorders	Myalgia	1	1	0
2022	6	3	Nervous system disorders	Headache	1	1	0
